{
  "33743211": {
    "title": "Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions.",
    "sentences": [
      {
        "text": "SARS-CoV-2 is the cause of a pandemic with growing global mortality."
      },
      {
        "text": "Using comprehensive identification of RNA-binding proteins by mass spectrometry (ChIRP-MS), we identified 309 host proteins that bind the SARS-CoV-2 RNA during active infection."
      },
      {
        "text": "Integration of this data with ChIRP-MS data from three other RNA viruses defined viral specificity of RNA-host protein interactions."
      },
      {
        "text": "Targeted CRISPR screens revealed that the majority of functional RNA-binding proteins protect the host from virus-induced cell death, and comparative CRISPR screens across seven RNA viruses revealed shared and SARS-specific antiviral factors."
      },
      {
        "text": "Finally, by combining the RNA-centric approach and functional CRISPR screens, we demonstrated a physical and functional connection between SARS-CoV-2 and mitochondria, highlighting this organelle as a general platform for antiviral activity."
      },
      {
        "text": "Altogether, these data provide a comprehensive catalog of functional SARS-CoV-2 RNA-host protein interactions, which may inform studies to understand the host-virus interface and nominate host pathways that could be targeted for therapeutic benefit."
      }
    ]
  },
  "33739987": {
    "title": "Understanding the clinical and demographic characteristics of second coronavirus spike in 192 patients in Tehran, Iran: A retrospective study.",
    "sentences": [
      {
        "text": "During the last months of the coronavirus pandemic, with all those public restrictions and health interventions, the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) appears now to have been raised in some countries around the world."
      },
      {
        "text": "Iran was one of those first countries facing the second wave of coronavirus, due to the lack of appropriate public restrictions because of economic problems the country is facing."
      },
      {
        "text": "The clinical and demographic characteristics of severe cases and non-severe cases of Coronavirus Disease (COVID-19) in 192 patients in Tehran, Iran, between June 16 and July 11, 2020, were investigated."
      },
      {
        "text": "The patients were divided into severe cases (n = 82) and non-severe cases (n = 110)."
      },
      {
        "text": "Demographic and clinical characteristics were compared between the two study clusters."
      },
      {
        "text": "The mean age was 54.6 Â± 17.2 years, and the most common presenting symptom was persistent cough (81.8%) and fever (79.7%)."
      },
      {
        "text": "The logistic regression model revealed that age, BMI, and affected family members were statistically associated with severity."
      },
      {
        "text": "Patients with complicated conditions of disorders faced more hospitalization days and medical care than the average statistical data."
      },
      {
        "text": "As the coronavirus spike in the case and death reports from June 2020, we observed the rise in the incidence of severe cases, where 42.7% (82/192) of cases have resulted in severe conditions."
      },
      {
        "text": "Our findings also suggested that the effect of IFB (Betamethasone) was more valid than the other alternative drugs such as LPV/r and IVIg."
      }
    ]
  },
  "33738432": {
    "title": "SARS-CoV-2 infection aggravates chronic comorbidities of cardiovascular diseases and diabetes in mice.",
    "sentences": [
      {
        "text": "Background Cardiovascular diseases (CVDs) and diabetes mellitus (DM) are top two chronic comorbidities that increase the severity and mortality of COVID-19."
      },
      {
        "text": "However, how SARS-CoV-2 alters the progression of chronic diseases remain unclear."
      },
      {
        "text": "Methods We used adenovirus to deliver h-ACE2 to lung to enable SARS-CoV-2 infection in mice."
      },
      {
        "text": "SARS-CoV-2's impacts on pathogenesis of chronic diseases were studied through histopathological, virologic and molecular biology analysis."
      },
      {
        "text": "Results Pre-existing CVDs resulted in viral invasion, ROS elevation and activation of apoptosis pathways contribute myocardial injury during SARS-CoV-2 infection."
      },
      {
        "text": "Viral infection increased fasting blood glucose and reduced insulin response in DM model."
      },
      {
        "text": "Bone mineral density decreased shortly after infection, which associated with impaired PI3K/AKT/mTOR signaling."
      },
      {
        "text": "Conclusion We established mouse models mimicked the complex pathological symptoms of COVID-19 patients with chronic diseases."
      },
      {
        "text": "Pre-existing diseases could impair the inflammatory responses to SARS-CoV-2 infection, which further aggravated the pre-existing diseases."
      },
      {
        "text": "This work provided valuable information to better understand the interplay between the primary diseases and SARS-CoV-2 infection."
      }
    ]
  },
  "33738043": {
    "title": "Angiotensin-converting enzyme 2 connects COVID-19 with cancer and cancer immunotherapy.",
    "sentences": [
      {
        "text": "The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in more than two million deaths."
      },
      {
        "text": "Underlying diseases, including cancer, are high-risk factors for severe COVID-19 outcomes."
      },
      {
        "text": "Angiotensin-converting enzyme 2 (ACE2), as a SARS-CoV-2 host cell receptor, plays a crucial role in SARS-CoV-2 invading human cells."
      },
      {
        "text": "ACE2 also has significant associations with cancer."
      },
      {
        "text": "Recent studies showed that ACE2 was inversely correlated with the activities of multiple oncogenic pathways and tumor progression phenotypes, and was positively correlated with antitumor immune response and survival prognosis in diverse cancers, suggesting a potential protective role of ACE2 in cancer progression."
      },
      {
        "text": "Positive expression of ACE2 is also correlated with programmed death-ligand 1 (PD-L1) in cancer."
      },
      {
        "text": "The positive associations of ACE2 expression with antitumor immune signatures and PD-L1 expression indicate that ACE2 expression is a positive predictor for the response to immune checkpoint inhibitors (ICIs)."
      },
      {
        "text": "This was evidenced in multiple cancer cohorts treated with ICIs."
      },
      {
        "text": "Thus, ACE2 may build potential connections between COVID-19 and cancer and cancer immunotherapy."
      },
      {
        "text": "The potential connections suggest that ACE2 inhibitors may not be a good option for treating COVID-19 patients with cancer, particularly in cancer patients who are receiving immunotherapy."
      },
      {
        "text": "Furthermore, the relationships between ACE2, COVID-19, and cancer are worth confirming by more experimental and clinical data, considering that many cancer patients are at high risk for COVID-19."
      }
    ]
  },
  "33732419": {
    "title": "Complicated sinusitis with sphenopalatine artery thrombosis in a COVID-19 patient: a case report.",
    "sentences": [
      {
        "text": "COVID-19 has been a mystery against healthcare professionals."
      },
      {
        "text": "We herein report a rare presentation of complicated sinusitis with pre-septal cellulitis and hard palatal necrosis in a COVID-19 patient."
      },
      {
        "text": "A 52-year-old male was admitted to the hospital with typical COVID manifestations where he had two successive COVID-19 positive swabs."
      },
      {
        "text": "During his admission, he developed symptoms of right orbital complications of sinusitis along with both clinical and radiological evidence of ipsilateral hard palatal necrosis."
      },
      {
        "text": "Imaging confirmed a diagnosis of right pan-sinusitis complicated with right pre-septal infection and hard palatal bony defect on the same side."
      },
      {
        "text": "Our case focuses on the possible association between these manifestations and the known thromboembolic complications of COVID-19."
      },
      {
        "text": "Ongoing management of such complicated rare cases should be through multidisciplinary team."
      }
    ]
  },
  "33732261": {
    "title": "Association of HLA Class I Genotypes With Severity of Coronavirus Disease-19.",
    "sentences": [
      {
        "text": "Human leukocyte antigen (HLA) class I molecules play a crucial role in the development of a specific immune response to viral infections by presenting viral peptides at the cell surface where they will be further recognized by T cells."
      },
      {
        "text": "In the present manuscript, we explored whether HLA class I genotypes can be associated with the critical course of Coronavirus Disease-19 by searching possible connections between genotypes of deceased patients and their age at death."
      },
      {
        "text": "HLA-A, HLA-B, and HLA-C genotypes of n = 111 deceased patients with COVID-19 (Moscow, Russia) and n = 428 volunteers were identified with next-generation sequencing."
      },
      {
        "text": "Deceased patients were split into two groups according to age at the time of death: n = 26 adult patients aged below 60 and n = 85 elderly patients over 60."
      },
      {
        "text": "With the use of HLA class I genotypes, we developed a risk score (RS) which was associated with the ability to present severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) peptides by the HLA class I molecule set of an individual."
      },
      {
        "text": "The resulting RS was significantly higher in the group of deceased adults compared to elderly adults [p = 0.00348, area under the receiver operating characteristic curve (AUC ROC = 0.68)]."
      },
      {
        "text": "In particular, presence of HLA-A*01:01 allele was associated with high risk, while HLA-A*02:01 and HLA-A*03:01 mainly contributed to low risk."
      },
      {
        "text": "The analysis of patients with homozygosity strongly highlighted these results: homozygosity by HLA-A*01:01 accompanied early deaths, while only one HLA-A*02:01 homozygote died before 60 years of age."
      },
      {
        "text": "Application of the constructed RS model to an independent Spanish patients cohort (n = 45) revealed that the score was also associated with the severity of the disease."
      },
      {
        "text": "The obtained results suggest the important role of HLA class I peptide presentation in the development of a specific immune response to COVID-19."
      }
    ]
  },
  "33734627": {
    "title": "Poor Survival in COVID-19 Associated with Lymphopenia and Higher Neutrophile-Lymphocyte Ratio.",
    "sentences": [
      {
        "text": "BACKGROUND Immune cell counts in blood in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection may be useful prognostic biomarkers of disease severity, mortality, and response to treatment."
      },
      {
        "text": "OBJECTIVES To analyze sub-populations of lymphocytes at hospital admission in survivors and deceased from severe pneumonia due to coronavirus disease-2019 (COVID-19)."
      },
      {
        "text": "METHODS We conducted a cross-sectional study of healthcare workers confirmed with SARS-CoV-2 in convalescents (control group) and healthy controls (HC) diagnosed with severe COVID-19."
      },
      {
        "text": "Serum samples were taken at hospital admission and after recovery."
      },
      {
        "text": "Serum samples â¥ 25 days after onset of symptoms were analyzed for lymphocyte subpopulations through flow cytometry."
      },
      {
        "text": "Descriptive statistics, Kruskall-Wallis test, receiver operating characteristic curve, calculation of sensitivity, specificity, predictive values, and Kaplan-Meier analysis were performed."
      },
      {
        "text": "RESULTS We included 337 patients: 120 HC, 127 convalescents, and 90 severe COVID-19 disease patients (50 survivors, 40 deceased)."
      },
      {
        "text": "For T cells, total lymphocytes â¥ 800/Î¼L, CD3+ â¥ 400/Î¼L, CD4+ â¥ 180/Î¼L, CD8+ â¥ 150/Î¼L, B cells CD19+ â¥ 80/Î¼L, and NK â¥ 34/Î¼L subsets were associated with survival in severe COVID-19 disease patients."
      },
      {
        "text": "All subtypes of lymphocytes had higher concentrations in survivors than deceased, but similar between HC and convalescents."
      },
      {
        "text": "Leukocytes â¥ 10.150/Î¼L or neutrophils â¥ 10,000/Î¼L were associated with increased mortality."
      },
      {
        "text": "The neutrophil-to-lymphocyte ratio (NLR) â¥ 8.5 increased the probability of death in severe COVID-19 (odds ratio 11.68)."
      },
      {
        "text": "CONCLUSIONS Total lymphocytes; NLR; and levels of CD3+, CD4+, CD8+, and NK cells are useful as biomarkers of survival or mortality in severe COVID-19 disease and commonly reach normal levels in convalescents."
      }
    ]
  },
  "33733611": {
    "title": "Med1 controls CD8 T cell maintenance through IL-7R-mediated cell survival signalling.",
    "sentences": [
      {
        "text": "Under steady-state conditions, the pool size of peripheral CD8+ T cells is maintained through turnover and survival."
      },
      {
        "text": "Beyond TCR and IL-7R signals, the underlying mechanisms are less well understood."
      },
      {
        "text": "In the present study, we found a significant reduction of CD8+ T cell proportion in spleens but not in thymi of mice with T cell-specific deletion of Mediator Subunit 1 (Med1)."
      },
      {
        "text": "A competitive transfer of wild-type (WT) and Med1-deficient CD8+ T cells reproduced the phenotype in the same recipients and confirmed intrinsic role of Med1."
      },
      {
        "text": "Furthermore, we observed a comparable degree of migration and proliferation but a significant increase of cell death in Med1-deficient CD8+ T cells compared with WT counterparts."
      },
      {
        "text": "Finally, Med1-deficient CD8+ T cells exhibited a decreased expression of interleukin-7 receptor Î± (IL-7RÎ±), down-regulation of phosphorylated-STAT5 (pSTAT5) and Bim up-regulation."
      },
      {
        "text": "Collectively, our study reveals a novel role of Med1 in the maintenance of CD8+ T cells through IL-7RÎ±/STAT5 pathway-mediated cell survival."
      }
    ]
  },
  "33728324": {
    "title": "Immunoinformatics and Molecular Docking Studies Predicted Potential Multiepitope-Based Peptide Vaccine and Novel Compounds against Novel SARS-CoV-2 through Virtual Screening.",
    "sentences": [
      {
        "text": "Background Coronaviruses (CoVs) are enveloped positive-strand RNA viruses which have club-like spikes at the surface with a unique replication process."
      },
      {
        "text": "Coronaviruses are categorized as major pathogenic viruses causing a variety of diseases in birds and mammals including humans (lethal respiratory dysfunctions)."
      },
      {
        "text": "Nowadays, a new strain of coronaviruses is identified and named as SARS-CoV-2."
      },
      {
        "text": "Multiple cases of SARS-CoV-2 attacks are being reported all over the world."
      },
      {
        "text": "SARS-CoV-2 showed high death rate; however, no specific treatment is available against SARS-CoV-2."
      },
      {
        "text": "Methods In the current study, immunoinformatics approaches were employed to predict the antigenic epitopes against SARS-CoV-2 for the development of the coronavirus vaccine."
      },
      {
        "text": "Cytotoxic T-lymphocyte and B-cell epitopes were predicted for SARS-CoV-2 coronavirus protein."
      },
      {
        "text": "Multiple sequence alignment of three genomes (SARS-CoV, MERS-CoV, and SARS-CoV-2) was used to conserved binding domain analysis."
      },
      {
        "text": "Results The docking complexes of 4 CTL epitopes with antigenic sites were analyzed followed by binding affinity and binding interaction analyses of top-ranked predicted peptides with MHC-I HLA molecule."
      },
      {
        "text": "The molecular docking (Food and Drug Regulatory Authority library) was performed, and four compounds exhibiting least binding energy were identified."
      },
      {
        "text": "The designed epitopes lead to the molecular docking against MHC-I, and interactional analyses of the selected docked complexes were investigated."
      },
      {
        "text": "In conclusion, four CTL epitopes (GTDLEGNFY, TVNVLAWLY, GSVGFNIDY, and QTFSVLACY) and four FDA-scrutinized compounds exhibited potential targets as peptide vaccines and potential biomolecules against deadly SARS-CoV-2, respectively."
      },
      {
        "text": "A multiepitope vaccine was also designed from different epitopes of coronavirus proteins joined by linkers and led by an adjuvant."
      },
      {
        "text": "Conclusion Our investigations predicted epitopes and the reported molecules that may have the potential to inhibit the SARS-CoV-2 virus."
      },
      {
        "text": "These findings can be a step towards the development of a peptide-based vaccine or natural compound drug target against SARS-CoV-2."
      }
    ]
  },
  "33552315": {
    "title": "The preventive effect of Xuebijing injection against cytokine storm for severe patients with COVID-19: A prospective randomized controlled trial.",
    "sentences": [
      {
        "text": "Introduction COVID-19 is severely affecting countries globally and mortality is high."
      },
      {
        "text": "Xuebijing (XBJ) injection is widely used in the treatment of severe pneumonia and sepsis in China due to its anti-inflammatory effect and immunoregulation."
      },
      {
        "text": "This study investigated whether Xuebijing injection can prevent the cytokine storm and reduce the mortality from severe COVID-19."
      },
      {
        "text": "Methods This was a randomized, double-blinded trial in which 60 eligible patients were recruited from the First people's Hospital of Jingzhou from February 16 to March 25 in 2020."
      },
      {
        "text": "A total of 57 completed the trial, 3 dropped out."
      },
      {
        "text": "The treatment group received routine medication plus Xuebijing injection while the control group received routine medication plus saline."
      },
      {
        "text": "Results The secretion of interleukin-6(IL-6), interleukin-8(IL-8) and tumor necrosis factor-Î±(TNF-Î±) was suppressed significantly (PÂ <Â 0.05) by Xuebijing."
      },
      {
        "text": "After 14 days treatment, lymphocyte levels in Xuebijing group was substantially higher than control, C-reactive protein (CRP) level in Xuebijing group was remarkably lower."
      },
      {
        "text": "The 28-day mortality was not significantly different between the two group."
      },
      {
        "text": "After 14 days of treatment, there were significant differences in the rate of mechanical ventilation, rate of septic shock, the proportion of patients severely affected who became critically ill, the duration of improvement of main clinical symptoms (PÂ <Â 0.05) and the length of ICU hospitalization stay (PÂ <Â 0.01) for the Xuebijing group compared with controls."
      },
      {
        "text": "No serious adverse reactions were identified in either group."
      },
      {
        "text": "Conclusions This study demonstrates that Xuebijing injection may suppress the cytokine storm in severe COVID-19 patients by regulating the secretion of pro- inflammatory cytokine IL-6, IL-8 and TNF -Î±."
      },
      {
        "text": "However, Xuebijing did not significantly reduce the 28-day mortality."
      }
    ]
  },
  "33723251": {
    "title": "Plasma IL-6 levels following corticosteroid therapy as an indicator of ICU length of stay in critically ill COVID-19 patients.",
    "sentences": [
      {
        "text": "Intensive care unit (ICU) admissions and mortality in severe COVID-19 patients are driven by \"cytokine storms\" and acute respiratory distress syndrome (ARDS)."
      },
      {
        "text": "Interim clinical trial results suggest that the corticosteroid dexamethasone displays better 28-day survival in severe COVID-19 patients requiring ventilation or oxygen."
      },
      {
        "text": "In this study, 10 out of 16 patients (62.5%) that had an average plasma IL-6 value over 10âpg/mL post administration of corticosteroids also had worse outcomes (i.e., ICU stay >15 days or death), compared to 8 out of 41 patients (19.5%) who did not receive corticosteroids (p-valueâ=â0.0024)."
      },
      {
        "text": "Given this potential association between post-corticosteroid IL-6 levels and COVID-19 severity, we hypothesized that the glucocorticoid receptor (GR or NR3C1) may be coupled to IL-6 expression in specific cell types that govern cytokine release syndrome (CRS)."
      },
      {
        "text": "Examining single-cell RNA-seq data from BALF of severe COVID-19 patients and nearly 2 million cells from a pan-tissue scan shows that alveolar macrophages, smooth muscle cells, and endothelial cells co-express NR3C1 and IL-6, motivating future studies on the links between the regulation of NR3C1 function and IL-6 levels."
      }
    ]
  },
  "33718934": {
    "title": "Membrane remodeling by SARS-CoV-2 - double-enveloped viral replication.",
    "sentences": [
      {
        "text": "The ongoing pandemic of the new severe acute respiratory syndrome coronavirus (SARS-CoV-2) has caused more than one million deaths, overwhelmed many public health systems, and led to a worldwide economic recession."
      },
      {
        "text": "This has raised an unprecedented need to develop antiviral drugs and vaccines, which requires profound knowledge of the fundamental pathology of the virus, including its entry, replication, and release from host cells."
      },
      {
        "text": "The genome of coronaviruses comprises around 30 kb of positive single-stranded RNA, representing one of the largest RNA genomes of viruses."
      },
      {
        "text": "The 5' part of the genome encodes a large polyprotein, PP1ab, which gives rise to 16 non-structural proteins (nsp1- nsp16)."
      },
      {
        "text": "Two proteases encoded in nsp3 and nsp5 cleave the polyprotein into individual proteins."
      },
      {
        "text": "Most nsps belong to the viral replicase complex that promotes replication of the viral genome and translation of structural proteins by producing subgenomic mRNAs."
      },
      {
        "text": "The replicase complexes are found on double-membrane vesicles (DMVs) that contain viral double-stranded RNA."
      },
      {
        "text": "Expression of a small subset of viral proteins, including nsp3 and nsp4, is sufficient to induce formation of these DMVs in human cells, suggesting that both proteins deform host membranes into such structures."
      },
      {
        "text": "We will discuss the formation of DMVs and provide an overview of other membrane remodeling processes that are induced by coronaviruses."
      }
    ]
  },
  "33717195": {
    "title": "COVID-19 Impairs Immune Response to Candida albicans.",
    "sentences": [
      {
        "text": "Infection with SARS-CoV-2 can lead to Coronavirus disease-2019 (COVID-19) and result in severe acute respiratory distress syndrome (ARDS)."
      },
      {
        "text": "Recent reports indicate an increased rate of fungal coinfections during COVID-19."
      },
      {
        "text": "With incomplete understanding of the pathogenesis and without any causative therapy available, secondary infections may be detrimental to the prognosis."
      },
      {
        "text": "We monitored 11 COVID-19 patients with ARDS for their immune phenotype, plasma cytokines, and clinical parameters on the day of ICU admission and on day 4 and day 7 of their ICU stay."
      },
      {
        "text": "Whole blood stimulation assays with lipopolysaccharide (LPS), heat-killed Listeria monocytogenes (HKLM), Aspergillus fumigatus, and Candida albicans were used to mimic secondary infections, and changes in immune phenotype and cytokine release were assessed."
      },
      {
        "text": "COVID-19 patients displayed an immune phenotype characterized by increased HLA-DR+CD38+ and PD-1+ CD4+ and CD8+ T cells, and elevated CD8+CD244+ lymphocytes, compared to healthy controls."
      },
      {
        "text": "Monocyte activation markers and cytokines IL-6, IL-8, TNF, IL-10, and sIL2RÎ± were elevated, corresponding to monocyte activation syndrome, while IL-1Î² levels were low."
      },
      {
        "text": "LPS, HKLM and Aspergillus fumigatus antigen stimulation provoked an immune response that did not differ between COVID-19 patients and healthy controls, while COVID-19 patients showed an attenuated monocyte CD80 upregulation and abrogated release of IL-6, TNF, IL-1Î±, and IL-1Î² toward Candida albicans."
      },
      {
        "text": "This study adds further detail to the characterization of the immune response in critically ill COVID-19 patients and hints at an increased susceptibility for Candida albicans infection."
      }
    ]
  },
  "33717140": {
    "title": "Epigenetic Landscapes of Single-Cell Chromatin Accessibility and Transcriptomic Immune Profiles of T Cells in COVID-19 Patients.",
    "sentences": [
      {
        "text": "T cells play a critical role in coronavirus diseases."
      },
      {
        "text": "How they do so in COVID-19 may be revealed by analyzing the epigenetic chromatin accessibility of cis- and trans-regulatory elements and creating transcriptomic immune profiles."
      },
      {
        "text": "We performed single-cell assay for transposase-accessible chromatin (scATAC) and single-cell RNA (scRNA) sequencing (seq) on the peripheral blood mononuclear cells (PBMCs) of severely ill/critical patients (SCPs) infected with COVID-19, moderate patients (MPs), and healthy volunteer controls (HCs)."
      },
      {
        "text": "About 76,570 and 107,862 single cells were used, respectively, for analyzing the characteristics of chromatin accessibility and transcriptomic immune profiles by the application of scATAC-seq (nine cases) and scRNA-seq (15 cases)."
      },
      {
        "text": "The scATAC-seq detected 28,535 different peaks in the three groups; among these peaks, 41.6 and 10.7% were located in the promoter and enhancer regions, respectively."
      },
      {
        "text": "Compared to HCs, among the peak-located genes in the total T cells and its subsets, CD4+ T and CD8+ T cells, from SCPs and MPs were enriched with inflammatory pathways, such as mitogen-activated protein kinase (MAPK) signaling pathway and tumor necrosis factor (TNF) signaling pathway."
      },
      {
        "text": "The motifs of TBX21 were less accessible in the CD4+ T cells of SCPs compared with those in MPs."
      },
      {
        "text": "Furthermore, the scRNA-seq showed that the proportion of T cells, especially the CD4+ T cells, was decreased in SCPs and MPs compared with those in HCs."
      },
      {
        "text": "Transcriptomic results revealed that histone-related genes, and inflammatory genes, such as NFKBIA, S100A9, and PIK3R1, were highly expressed in the total T cells, CD4+ T and CD8+ T cells, both in the cases of SCPs and MPs."
      },
      {
        "text": "In the CD4+ T cells, decreased T helper-1 (Th1) cells were observed in SCPs and MPs."
      },
      {
        "text": "In the CD8+T cells, activation markers, such as CD69 and HLA class II genes (HLA-DRA, HLA-DRB1, and HLA-DRB5), were significantly upregulated in SCPs."
      },
      {
        "text": "An integrated analysis of the data from scATAC-seq and scRNA-seq showed some consistency between the approaches."
      },
      {
        "text": "Cumulatively, we have generated a landscape of chromatin epigenetic status and transcriptomic immune profiles of T cells in patients with COVID-19."
      },
      {
        "text": "This has provided a deeper dissection of the characteristics of the T cells involved at a higher resolution than from previously obtained data merely by the scRNA-seq analysis."
      },
      {
        "text": "Our data led us to suggest that the T-cell inflammatory states accompanied with defective functions in the CD4+ T cells of SCPs may be the key factors for determining the pathogenesis of and recovery from COVID-19."
      }
    ]
  },
  "33553708": {
    "title": "Recent updates in the clinical trials of therapeutic monoclonal antibodies targeting cytokine storm for the management of COVID-19.",
    "sentences": [
      {
        "text": "Clinical studies have identified a cytokine storm in the third stage of disease progression in critical ill patients with coronavirus disease 2019 (COVID-19)."
      },
      {
        "text": "Hence, effectively suppressing the uncontrolled immune response of the host towards the invaded viruses in a cytokine storm is a critical step to prevent the deterioration of patient conditions and decrease the rate of mortality."
      },
      {
        "text": "Therapeutic monoclonal antibodies (mAbs) are found to be effective for the management of acute respiratory distress syndrome in patients with COVID-19."
      },
      {
        "text": "In this review, we compiled all therapeutic mAbs targeting cytokine storm, which are in clinical trials for its repurposing in the management of COVID-19."
      },
      {
        "text": "Compilation of clinical trial data indicated that therapeutic monoclonal antibodies targeting interleukins (IL-6, IL-1ra, IL-8, IL-1Î², IL-17A, IL-33), interferon-gamma, tumor necrosis factor-alpha, P-selectin, connective tissue growth factor, plasma kallikrein, tumor necrosis factor superfamily 14, granulocyte macrophage colony stimulating factor, colony stimulating factor 1 receptor, C-C chemokine receptor type 5, cluster of differentiation 14 and 147, vascular endothelial growth factor, programmed cell death protein-1, Angiopoietin - 2, human factor XIIa, complementary protein 5, natural killer cell receptor G2A, human epidermal growth factor receptor 2, immunoglobulin-like transcript 7 receptor, complement component fragment 5a receptor and viral attachment to the human cell were under investigation for management of severely ill patients with COVID-19."
      },
      {
        "text": "Among these, about 65 clinical trials are targeting IL-6 inhibition as the most promising one and Tocilizumab, an IL-6 inhibitor is considered to be the potential candidate to treat cytokine storm associated with the COVID-19."
      }
    ]
  },
  "33721144": {
    "title": "Longitudinal multi-omics transition associated with fatality in critically ill COVID-19 patients.",
    "sentences": [
      {
        "text": "PURPOSE Critically ill COVID-19 patients have significantly increased risk of death."
      },
      {
        "text": "Although several circulating biomarkers are thought to be related to COVID-19 severity, few studies have focused on the characteristics of critically ill patients with different outcomes."
      },
      {
        "text": "The objective of this study was to perform a longitudinal investigation of the potential mechanisms affecting the prognosis of critically ill COVID-19 patients."
      },
      {
        "text": "METHODS In addition to clinical data, 113 whole blood samples and 85 serum samples were collected from 33 severe and critical COVID-19 patients without selected comorbidities."
      },
      {
        "text": "Multi-omics analysis was then performed using longitudinal samples."
      },
      {
        "text": "RESULTS Obvious transcriptional transitions were more frequent in critical survivors than in critical non-survivors, indicating that phase transition may be related to survival."
      },
      {
        "text": "Based on analysis of differentially expressed genes during transition, the erythrocyte differentiation pathway was significantly enriched."
      },
      {
        "text": "Furthermore, clinical data indicated that red blood cell counts showed greater fluctuation in survivors than in non-survivors."
      },
      {
        "text": "Moreover, declining red blood cell counts and hemoglobin levels were validated as prognostic markers of poor outcome in an independent cohort of 114 critical COVID-19 patients."
      },
      {
        "text": "Protein-metabolite-lipid network analysis indicated that tryptophan metabolism and melatonin may contribute to molecular transitions in critical COVID-19 patients with different outcomes."
      },
      {
        "text": "CONCLUSIONS This study systematically and comprehensively depicted the longitudinal hallmarks of critical COVID-19 patients and indicated that multi-omics transition may impact the prognosis."
      },
      {
        "text": "TAKE HOME MESSAGE Frequent transcriptional phase transitions may contribute to outcome in critically ill COVID-19 patients."
      },
      {
        "text": "Furthermore, fluctuation in red blood cell and hemoglobin levels may relate to poor prognosis."
      },
      {
        "text": "The biological function of melatonin was suppressed in COVID-19 non-survivors, which may provide a potential theoretical basis for clinical administration."
      }
    ]
  },
  "33721136": {
    "title": "HCl-induced acute lung injury: a study of the curative role of mesenchymal stem/stromal cells and cobalt protoporphyrin.",
    "sentences": [
      {
        "text": "BACKGROUND This study was designed to investigate bone marrow mesenchymal stem/stromal cells (BM-MSCs) and cobalt protoporphyrin (CoPP) curable effects on HCl-induced acute lung injury (ALI) and its underlying mechanisms hoping this might aid to offer a therapeutic opportunity for ALI."
      },
      {
        "text": "RESULTS Forty male Sprague Dawley rats were randomly allocated into four groups; normal (normal rats), ALI (rats injected with 2 ml hydrochloric acid (HCl)/kg via trachea), ALI + BM-MSCs (ALI rats intravenously injected twice with 1 Ã 106 BM-MSCs/rat/week), and ALI + CoPP (ALI rats intraperitoneally injected twice with CoPP (0.5 mg/100 g/week))."
      },
      {
        "text": "White blood cells (WBCs), red blood cells (RBCs), hemoglobin (Hb), serum tumor necrosis factor-alpha (TNF-Î±), lung histopathology, apoptosis markers (caspase-3 and Bcl2), and oxidative stress markers (malondialdehyde (MDA), superoxide dismutase (SOD), and catalase (CAT)) were measured."
      },
      {
        "text": "ALI caused increases in WBCs, TNF-Î±, caspase-3, and MDA, and morphological damage score of lungs with decreases in RBCs, Hb, Bcl2, SOD, and CAT (p < 0.05)."
      },
      {
        "text": "BM-MSCs or CoPP treatment reversed these ALI-induced changes (p < 0.05) towards normal."
      },
      {
        "text": "CONCLUSIONS BM-MSCs and CoPP could attenuate ALI by modulation of inflammation, oxidative stress, and apoptosis."
      },
      {
        "text": "Curative roles of BM-MSCs were more effective than those of CoPP."
      },
      {
        "text": "This highlights BM-MSCs as a potent therapy for HCl-associated ALI."
      }
    ]
  },
  "33720944": {
    "title": "Laboratory biomarkers of COVID-19 disease severity and outcome: Findings from a developing country.",
    "sentences": [
      {
        "text": "AIM To identify laboratory biomarkers that predict disease severity and outcome among COVID-19 patients admitted to the Millennium COVID-19 Care Center in Ethiopia."
      },
      {
        "text": "METHODS A retrospective cohort study was conducted among 429 COVID-19 patients who were on follow up from July to October 2020."
      },
      {
        "text": "Data was described using frequency tables."
      },
      {
        "text": "Robust Poisson regression model was used to identify predictors of COVID-19 severity where adjusted relative risk (ARR), P-value and 95 CI for ARR were used to test significance."
      },
      {
        "text": "Binary Logistic regression model was used to assess the presence of statistically significant association between the explanatory variables and COVID-19 outcome where adjusted odds ratio (AOR), P-value and 95%CI for AOR were used for testing significance."
      },
      {
        "text": "RESULTS Among the 429 patients studied, 182 (42.4%) had Severe disease at admission and the rest 247 (57.6%) had Non-severe disease."
      },
      {
        "text": "Regarding disease outcome, 45 (10.5%) died and 384 (89.5%) were discharged alive."
      },
      {
        "text": "Age group (ARR = 1.779, 95%CI = 1.405-2.252, p-value <0.0001), Neutrophil to Lymphocyte ratio (NLR) (ARR = 4.769, 95%CI = 2.419-9.402 p-value <0.0001), Serum glutamic oxaloacetic transaminase (SGOT) (ARR = 1.358, 95%CI = 1.109-1.662 p-value = 0.003), Sodium (ARR = 1.321, 95%CI = 1.091-1.600 p-value = 0.004) and Potassium (ARR = 1.269, 95%CI = 1.059-1.521 p-value = 0.010) were found to be significant predictors of COVID-19 severity."
      },
      {
        "text": "The following factors were significantly associated with COVID-19 outcome; age group (AOR = 2.767, 95%CI = 1.099-6.067, p-value = 0.031), white blood cell count (WBC) (AOR = 4.253, 95%CI = 1.918-9.429, p-value = 0.0001) and sodium level (AOR = 3.435, 95%CI = 1.439-8.198, p-value = 0.005)."
      },
      {
        "text": "CONCLUSIONS Assessing and monitoring the laboratory markers of WBC, NLR, SGOT, sodium and potassium levels at the earliest stage of the disease could have a considerable role in halting disease progression and death."
      }
    ]
  },
  "33718825": {
    "title": "SARS-CoV-2, SARS-CoV-1, and HIV-1 derived ssRNA sequences activate the NLRP3 inflammasome in human macrophages through a non-classical pathway.",
    "sentences": [
      {
        "text": "Macrophages promote an early host response to infection by releasing pro-inflammatory cytokines such as interleukin-1Î² (IL-1Î²), TNF, and IL-6."
      },
      {
        "text": "The bioactivity of IL-1Î² is classically dependent on NLRP3 inflammasome activation, which culminates in caspase-1 activation and pyroptosis."
      },
      {
        "text": "Recent studies suggest a role for NLRP3 inflammasome activation in lung inflammation and fibrosis in both COVID-19 and SARS, and there is evidence of NLRP3 involvement in HIV-1 disease."
      },
      {
        "text": "Here, we show that GU-rich single-stranded RNA (GU-rich RNA) derived from SARS-CoV-2, SARS-CoV-1, and HIV-1 trigger a TLR8-dependent pro-inflammatory cytokine response from human macrophages in the absence of pyroptosis, with GU-rich RNA from the SARS-CoV-2 spike protein triggering the greatest inflammatory response."
      },
      {
        "text": "Using genetic and pharmacological inhibition, we show that the induction of mature IL-1Î² is through a non-classical pathway dependent on caspase-1, caspase-8, the NLRP3 inflammasome, potassium efflux, and autophagy while being independent of TRIF (TICAM1), vitamin D3, and pyroptosis."
      }
    ]
  },
  "33718270": {
    "title": "T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression.",
    "sentences": [
      {
        "text": "The immune response type organized against viral infection is determinant in the prognosis of some infections."
      },
      {
        "text": "This work has aimed to study Th polarization in acute COVID-19 and its possible association with the outcome through an observational prospective study."
      },
      {
        "text": "Fifty-eight COVID-19 patients were recruited in the Medicine Department of the hospital \"12 de Octubre,\" 55 patients remaining after losses to follow-up."
      },
      {
        "text": "Four groups were established according to maximum degree of disease progression."
      },
      {
        "text": "T-helper cell percentages and phenotypes, analyzed by flow cytometer, and serum cytokines levels, analyzed by Luminex, were evaluated when the microbiological diagnosis (acute phase) of the disease was obtained."
      },
      {
        "text": "Our study found a significant reduction of %Th1 and %Th17 cells with higher activated %Th2 cells in the COVID-19 patients compared with reference population."
      },
      {
        "text": "A higher percent of senescent Th2 cells was found in the patients who died than in those who survived."
      },
      {
        "text": "Senescent Th2 cell percentage was an independent risk factor for death (OR: 13.88) accompanied by the numbers of total lymphocytes (OR: 0.15) with an AUC of 0.879."
      },
      {
        "text": "COVID-19 patients showed a profile of pro-inflammatory serum cytokines compared to controls, with higher levels of IL-2, IL-6, IL-15, and IP-10."
      },
      {
        "text": "IL-10 and IL-13 were also elevated in patients compared to controls."
      },
      {
        "text": "Patients who did not survive presented significantly higher levels of IL-15 than those who recovered."
      },
      {
        "text": "No significant differences were observed according to disease progression groups."
      },
      {
        "text": "The study has shown that increased levels of IL-15 and a high Th2 response are associated with a fatal outcome of the disease."
      }
    ]
  },
  "33714258": {
    "title": "Insight into the emerging role of SARS-CoV-2 nonstructural and accessory proteins in modulation of multiple mechanisms of host innate defense.",
    "sentences": [
      {
        "text": "Coronavirus disease-19 (COVID-19) is an extremely infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that has become a major global health concern."
      },
      {
        "text": "The induction of a coordinated immune response is crucial to the elimination of any pathogenic infection."
      },
      {
        "text": "However, SARS-CoV-2 can modulate the host immune system to favor viral adaptation and persistence within the host."
      },
      {
        "text": "The virus can counteract type I interferon (IFN-I) production, attenuating IFN-I signaling pathway activation and disrupting antigen presentation."
      },
      {
        "text": "Simultaneously, SARS-CoV-2 infection can enhance apoptosis and the production of inflammatory mediators, which ultimately results in increased disease severity."
      },
      {
        "text": "SARS-CoV-2 produces an array of effector molecules, including nonstructural proteins (NSPs) and open-reading frames (ORFs) accessory proteins."
      },
      {
        "text": "We describe the complex molecular interplay of SARS-CoV-2 NSPs and accessory proteins with the host's signaling mediating immune evasion in the current review."
      },
      {
        "text": "In addition, the crucial role played by immunomodulation therapy to address immune evasion is discussed."
      },
      {
        "text": "Thus, the current review can provide new directions for the development of vaccines and specific therapies."
      }
    ]
  },
  "33713619": {
    "title": "Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19.",
    "sentences": [
      {
        "text": "COVID-19 exhibits extensive patient-to-patient heterogeneity."
      },
      {
        "text": "To link immune response variation to disease severity and outcome over time, we longitudinally assessed circulating proteins as well as 188 surface protein markers, transcriptome, and TÂ cell receptor sequence simultaneously in single peripheral immune cells from COVID-19 patients."
      },
      {
        "text": "Conditional-independence network analysis revealed primary correlates of disease severity, including gene expression signatures of apoptosis in plasmacytoid dendritic cells and attenuated inflammation but increased fatty acid metabolism in CD56dimCD16hi NK cells linked positively to circulating interleukin (IL)-15."
      },
      {
        "text": "CD8+ TÂ cell activation was apparent without signs of exhaustion."
      },
      {
        "text": "Although cellular inflammation was depressed in severe patients early after hospitalization, it became elevated by days 17-23 post symptom onset, suggestive of a late wave of inflammatory responses."
      },
      {
        "text": "Furthermore, circulating protein trajectories at this time were divergent between and predictive of recovery versus fatal outcomes."
      },
      {
        "text": "Our findings stress the importance of timing in the analysis, clinical monitoring, and therapeutic intervention of COVID-19."
      }
    ]
  },
  "33520081": {
    "title": "Psychological impact of the COVID-19 pandemic on patients with allergic diseases.",
    "sentences": [
      {
        "text": "Background On March 2020, World Health Organization (WHO) declared COVID-19 to be a pandemic disease."
      },
      {
        "text": "Interactions between allergy-related inflammatory and psychiatric disorders including depression, anxiety, and post-traumatic stress disorder (PTSD) have been documented."
      },
      {
        "text": "Therefore, those who have pre-existing allergic conditions may have an increased psychiatric reaction to the stresses of the COVID-19 pandemic."
      },
      {
        "text": "Objective Identify the psychological impact of COVID-19 in patients with allergic diseases and determine if these individuals have a greater risk of presenting with post-traumatic stress disorder (PTSD)."
      },
      {
        "text": "Methods It is a cross-sectional, survey-based study designed to assess the degree of symptoms of depression and the risk of PTSD using the Patient Health Questionnaire (PHQ-9) and the Impact of Event Scale-Revised (IES-R), respectively, in allergic patients."
      },
      {
        "text": "Results A total of 4106 surveys were evaluated; 1656 (40.3%) were patients with allergic disease, and 2450 (59.7%) were non-allergic (control) individuals."
      },
      {
        "text": "Of those with allergies, 76.6% had respiratory allergic disease including asthma and allergic rhinitis."
      },
      {
        "text": "Individuals with allergic disease reported higher scores regarding symptoms of PTSD on the IES-R scale (pÂ =Â 0.052, OR 1.24 CI 0.99-1.55) as well as a higher depression risk score in the PHQ-9 questionnaire (mean 6.82 vs."
      },
      {
        "text": "5.28) pÂ =Â 0.000 zÂ =Â -8.76."
      },
      {
        "text": "The allergy group presented a higher score in the IES-R questionnaire (mean 25.42 vs."
      },
      {
        "text": "20.59), being more susceptible to presenting PTSD (pÂ =Â 0.000, zÂ =Â -7.774)."
      },
      {
        "text": "The individuals with allergic conditions were further divided into subgroups of those with respiratory allergies such as allergic rhinitis and asthma vs those with non-respiratory allergies such as drug and food allergy, urticaria and atopic dermatitis."
      },
      {
        "text": "This subgroup analysis compares respiratory versus non-respiratory allergic patients, with similar results on the IES-R (mean 25.87 vs 23.9) pÂ =Â 0.0124, zÂ =Â -1.539."
      },
      {
        "text": "There was no significant difference on intrusion (pÂ =Â 0.061, zÂ =Â -1.873) and avoidance (pÂ =Â 0.767, zÂ =Â -0.297), but in the hyperarousal subscale, patients with respiratory allergy had higher scores (mean 1.15 vs."
      },
      {
        "text": "0.99) pÂ =Â 0.013 zÂ =Â -2.486."
      },
      {
        "text": "Conclusions Psychological consequences such as depression and reported PTSD are present during the COVID-19 pandemic causing an impact particularly in individuals with allergic diseases."
      },
      {
        "text": "If we acknowledge the impact and how it is affecting our patients, we are able to implement interventions, follow up, and contribute to their overall well-being."
      }
    ]
  },
  "33712574": {
    "title": "Evidences for lipid involvement in SARS-CoV-2 cytopathogenesis.",
    "sentences": [
      {
        "text": "The pathogenesis of SARS-CoV-2 remains to be completely understood, and detailed SARS-CoV-2 cellular cytopathic effects requires definition."
      },
      {
        "text": "We performed a comparative ultrastructural study of SARS-CoV-1 and SARS-CoV-2 infection in Vero E6 cells and in lungs from deceased COVID-19 patients."
      },
      {
        "text": "SARS-CoV-2 induces rapid death associated with profound ultrastructural changes in Vero cells."
      },
      {
        "text": "Type II pneumocytes in lung tissue showed prominent altered features with numerous vacuoles and swollen mitochondria with presence of abundant lipid droplets."
      },
      {
        "text": "The accumulation of lipids was the most striking finding we observed in SARS-CoV-2 infected cells, both in vitro and in the lungs of patients, suggesting that lipids can be involved in SARS-CoV-2 pathogenesis."
      },
      {
        "text": "Considering that in most cases, COVID-19 patients show alteration of blood cholesterol and lipoprotein homeostasis, our findings highlight a peculiar important topic that can suggest new approaches for pharmacological treatment to contrast the pathogenicity of SARS-CoV-2."
      }
    ]
  },
  "33711813": {
    "title": "Clinical characteristics and peripheral immunocyte subsets alteration of 85 COVID-19 deaths.",
    "sentences": [
      {
        "text": "OBJECTIVES To retrospectively evaluate the clinical and immunological characteristics of patients who died of COVID-19 and to identify patients at high risk of death at an early stage and reduce their mortality."
      },
      {
        "text": "RESULTS Total white blood cell count, neutrophil count and C-reactive protein were significantly higher in patients who died of COVID-19 than those who recovered from it (p < 0.05), but the total lymphocyte count, CD4 + T cells, CD8 + T cells, B cells and natural killer cells were significantly lower when compared in the same groups."
      },
      {
        "text": "Multiple logistic regression analysis showed that increased D-dimer, decreased CD4 + T cells and increased neutrophils were risk factors for mortality."
      },
      {
        "text": "Further multiple COX regression demonstrated that neutrophil â¥ 5.27 Ã 109/L increased the risk of death in COVID-19 patients after adjustment for age and gender."
      },
      {
        "text": "However, CD4 + T cells â¥ 260/Î¼L appeared to reduce the risk of death."
      },
      {
        "text": "CONCLUSION SARS-CoV-2 infection led to a significant decrease of lymphocytes, and decreased CD4 + T cell count was a risk factor for COVID-19 patients to develop severe disease and death."
      },
      {
        "text": "METHODS This study included 190 hospitalized COVID-19 patients from January 30, 2020 to March 4, 2020 in Wuhan, China, of whom 85 died and 105 recovered."
      },
      {
        "text": "Two researchers independently collected the clinical and laboratory data from electronic medical records."
      }
    ]
  },
  "33708857": {
    "title": "A biomarker-based age, biomarkers, clinical history, sex (ABCS)-mortality risk score for patients with coronavirus disease 2019.",
    "sentences": [
      {
        "text": "Background Early identification and timely therapeutic strategies for potential critical patients with coronavirus disease 2019 (COVID-19) are of crucial importance to reduce mortality."
      },
      {
        "text": "We aimed to develop and validate a prediction tool for 30-day mortality for these patients on admission."
      },
      {
        "text": "Methods Consecutive hospitalized patients admitted to Tongji Hospital and Hubei Xinhua Hospital from January 1 to March 10, 2020, were retrospective analyzed."
      },
      {
        "text": "They were grouped as derivation and external validation set."
      },
      {
        "text": "Multivariate Cox regression was applied to identify the risk factors associated with death, and a nomogram was developed and externally validated by calibration plots, C-index, Kaplan-Meier curves and decision curve."
      },
      {
        "text": "Results Data from 1,717 patients at the Tongji Hospital and 188 cases at the Hubei Xinhua Hospital were included in our study."
      },
      {
        "text": "Using multivariate Cox regression with backward stepwise selection of variables in the derivation cohort, age, sex, chronic obstructive pulmonary disease (COPD), as well as seven biomarkers (aspartate aminotransferase, high-sensitivity C-reactive protein, high-sensitivity troponin I, white blood cell count, lymphocyte count, D-dimer, and procalcitonin) were incorporated in the model."
      },
      {
        "text": "An age, biomarkers, clinical history, sex (ABCS)-mortality score was developed, which yielded a higher C-index than the conventional CURB-65 score for predicting 30-day mortality in both the derivation cohort {0.888 [95% confidence interval (CI), 0.869-0.907] vs."
      },
      {
        "text": "0.696 (95% CI, 0.660-0.731)} and validation cohort [0.838 (95% CI, 0.777-0.899) vs."
      },
      {
        "text": "0.619 (95% CI, 0.519-0.720)], respectively."
      },
      {
        "text": "Furthermore, risk stratified Kaplan-Meier curves showed good discriminatory capacity of the model for classifying patients into distinct mortality risk groups for both derivation and validation cohorts."
      },
      {
        "text": "Conclusions The ABCS-mortality score might be offered to clinicians to strengthen the prognosis-based clinical decision-making, which would be helpful for reducing mortality of COVID-19 patients."
      }
    ]
  },
  "33708343": {
    "title": "Targeting mesenchymal stem cell therapy for severe pneumonia patients.",
    "sentences": [
      {
        "text": "Pneumonia is the inflammation of the lungs and it is the world's leading cause of death for children under 5 years of age."
      },
      {
        "text": "The latest coronavirus disease 2019 (COVID-19) virus is a prominent culprit to severe pneumonia."
      },
      {
        "text": "With the pandemic running rampant for the past year, more than 1590000 deaths has occurred worldwide up to December 2020 and are substantially attributable to severe pneumonia and induced cytokine storm."
      },
      {
        "text": "Effective therapeutic approaches in addition to the vaccines and drugs under development are hence greatly sought after."
      },
      {
        "text": "Therapies harnessing stem cells and their derivatives have been established by basic research for their versatile capacity to specifically inhibit inflammation due to pneumonia and prevent alveolar/pulmonary fibrosis while enhancing antibacterial/antiviral immunity, thus significantly alleviating the severe clinical conditions of pneumonia."
      },
      {
        "text": "In recent clinical trials, mesenchymal stem cells have shown effectiveness in reducing COVID-19-associated pneumonia morbidity and mortality; positioning these cells as worthy candidates for combating one of the greatest challenges of our time and shedding light on their prospects as a next-generation therapy to counter future challenges."
      }
    ]
  },
  "33707411": {
    "title": "Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers.",
    "sentences": [
      {
        "text": "The circulating metabolome provides a snapshot of the physiological state of the organism responding to pathogenic challenges."
      },
      {
        "text": "Here we report alterations in the plasma metabolome reflecting the clinical presentation of COVID-19 patients with mild (ambulatory) diseases, moderate disease (radiologically confirmed pneumonitis, hospitalization and oxygen therapy), and critical disease (in intensive care)."
      },
      {
        "text": "This analysis revealed major disease- and stage-associated shifts in the metabolome, meaning that at least 77 metabolites including amino acids, lipids, polyamines and sugars, as well as their derivatives, were altered in critical COVID-19 patient's plasma as compared to mild COVID-19 patients."
      },
      {
        "text": "Among a uniformly moderate cohort of patients who received tocilizumab, only 10 metabolites were different among individuals with a favorable evolution as compared to those who required transfer into the intensive care unit."
      },
      {
        "text": "The elevation of one single metabolite, anthranilic acid, had a poor prognostic value, correlating with the maintenance of high interleukin-10 and -18 levels."
      },
      {
        "text": "Given that products of the kynurenine pathway including anthranilic acid have immunosuppressive properties, we speculate on the therapeutic utility to inhibit the rate-limiting enzymes of this pathway including indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase."
      }
    ]
  },
  "33707314": {
    "title": "Interrogation of the cellular immunome of cancer patients with regard to the COVID-19 pandemic.",
    "sentences": [
      {
        "text": "While vaccines directed against the SARS-CoV-2 spike protein will have varying degrees of effectiveness in preventing SARS-CoV-2 infections, the severity of infection will be determined by multiple host factors including the ability of immune cells to lyse virus-infected cells."
      },
      {
        "text": "This review will discuss the complexity of both adaptive and innate immunomes and how a flow-based assay can detect up to 158 distinct cell subsets in the periphery."
      },
      {
        "text": "This assay has been employed to show the effect of age on differences in specific immune cell subsets, and the differences in the immunome between healthy donors and age-matched cancer patients."
      },
      {
        "text": "Also reviewed are the numerous soluble factors, in addition to cytokines, that may vary in the pathogenesis of SARS-CoV-2 infections and may also be employed to help define the effectiveness of a given vaccine or other antiviral agents."
      },
      {
        "text": "Various steroids have been employed in the management of autoimmune adverse events in cancer patients receiving immunotherapeutics and may be employed in the management of SARS-CoV-2 infections."
      },
      {
        "text": "The influence of steroids on multiple immune cells subsets will also be discussed."
      }
    ]
  },
  "33706082": {
    "title": "Coronavirus disease-19: The multi-level, multi-faceted vasculopathy.",
    "sentences": [
      {
        "text": "BACKGROUND AND AIMS The new coronavirus disease (COVID-19) is a systemic disease."
      },
      {
        "text": "Mounting evidence depict signs and symptoms involving multiple organs, most of which supported by pathological data."
      },
      {
        "text": "A plausible link to these manifestations is vascular and endothelial dysfunction/damage."
      },
      {
        "text": "However, much of the current knowledge relies on opinion and incipient evidence."
      },
      {
        "text": "We aim to objectively appraise current evidence on the association between COVID-19 and vascular disease, specifically endotheliitis and vasculitis."
      },
      {
        "text": "METHODS Two researchers independently entered the search terms COVID-19 OR SARS-CoV-2 AND vasculitis, endotheliitis OR endothelium in the following online platforms: MedRxiv and LitCovid (PubMed)."
      },
      {
        "text": "The search period was set from November 1, 2019 to August 28, 2020."
      },
      {
        "text": "Manuscripts with unavailable full texts, not in English, mainly on pre-clinical data, presenting only study designs or not directly related to the topics of this review were excluded."
      },
      {
        "text": "Retrospective and prospective studies, especially longitudinal ones, were given priority to the purpose of this review."
      },
      {
        "text": "Since there was paucity of prospective controlled evidence, case reports/series were also considered."
      },
      {
        "text": "RESULTS A total of 318 manuscripts were initially found."
      },
      {
        "text": "Sixty-seven (21%) were excluded: 59 (18.5%) met exclusion criteria and 8 (2.5%) were duplicates."
      },
      {
        "text": "One hundred and forty-two manuscripts (44,6%) did not provide original data and were also excluded: 35 (11%) were comments, 108 (33.9%) reviews; 1 (0.3%) position paper."
      },
      {
        "text": "One hundred and seven (33.6%) studies were considered for the present scoping review: 81 (25,5%) case reports/series; 18 (5.7%) prospective; 8 (2.5%) retrospective."
      },
      {
        "text": "Viral inclusions in endothelial cells, mononuclear cell infiltrates in the intima of small vessels and markers of endothelial cell apoptosis were demonstrated."
      },
      {
        "text": "Specificities of COVID-19 may lead to diverse vascular manifestations in different levels of the vascular bed."
      },
      {
        "text": "CONCLUSIONS Evidence indicates that COVID-19 targets vasculature and endothelium."
      },
      {
        "text": "However, high quality data is still lacking and studies with prospective designs and appropriately matched controls are needed."
      }
    ]
  },
  "33692615": {
    "title": "Beware of Steroid-Induced Avascular Necrosis of the Femoral Head in the Treatment of COVID-19-Experience and Lessons from the SARS Epidemic.",
    "sentences": [
      {
        "text": "Summary The recent outbreak of coronavirus disease 2019 (COVID-19) has become a global epidemic."
      },
      {
        "text": "Corticosteroids have been widely used in the treatment of severe acute respiratory syndrome (SARS), and the pathological findings seen in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are very similar to those observed in severe acute respiratory syndrome-related coronavirus (SARS-CoV) infection."
      },
      {
        "text": "However, the long-term use of corticosteroids (especially at high doses) is associated with potentially serious adverse events, particularly steroid-induced avascular necrosis of the femoral head (SANFH)."
      },
      {
        "text": "In today's global outbreak, whether corticosteroid therapy should be used, the dosage and duration of treatment, and ways for the prevention, early detection, and timely intervention of SANFH are some important issues that need to be addressed."
      },
      {
        "text": "This review aims to provide a reference for health care providers in COVID-19 endemic countries and regions."
      },
      {
        "text": "Article Focus Hormones are a double-edged sword."
      },
      {
        "text": "This review aims to provide a reference for health care providers in coronavirus disease 2019 (COVID-19) endemic countries and regions, especially with respect to the pros and cons of corticosteroid use in the treatment of patients with COVID-19."
      },
      {
        "text": "Key Messages In today's global outbreak, whether corticosteroid therapy should be used, the dosage and duration of treatment, and ways for the prevention, early detection, and timely intervention of SANFH are some important issues that need to be addressed."
      },
      {
        "text": "Strengths and Limitations Since SARS was mainly prevalent in China at that time, many evidences in this paper came from the reports of Chinese scholars."
      },
      {
        "text": "There is a bias in the selection of data, which may ignore the differences in environment, race, living habits, medical level and so on."
      },
      {
        "text": "SANFH may be the result of multiple factors."
      },
      {
        "text": "Whether the virus itself is an independent risk factor for SANFH has not been confirmed."
      },
      {
        "text": "In this paper, through literature retrieval, some reference opinions on glucocorticoid usage, diagnosis and treatment of SANFH are given."
      },
      {
        "text": "However, due to the lack of large-scale research data support, it can not be used as the gold standard for the above problems."
      }
    ]
  },
  "33688646": {
    "title": "Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.",
    "sentences": [
      {
        "text": "Established in vitro models for SARS-CoV-2 infection are limited and include cell lines of non-human origin and those engineered to overexpress ACE2, the cognate host cell receptor."
      },
      {
        "text": "We identified human H522 lung adenocarcinoma cells as naturally permissive to SARS-CoV-2 infection despite complete absence of ACE2."
      },
      {
        "text": "Infection of H522 cells required the SARS-CoV-2 spike protein, though in contrast to ACE2-dependent models, spike alone was not sufficient for H522 infection."
      },
      {
        "text": "Temporally resolved transcriptomic and proteomic profiling revealed alterations in cell cycle and the antiviral host cell response, including MDA5-dependent activation of type-I interferon signaling."
      },
      {
        "text": "Focused chemical screens point to important roles for clathrin-mediated endocytosis and endosomal cathepsins in SARS-CoV-2 infection of H522 cells."
      },
      {
        "text": "These findings imply the utilization of an alternative SARS-CoV-2 host cell receptor which may impact tropism of SARS-CoV-2 and consequently human disease pathogenesis."
      }
    ]
  },
  "33688601": {
    "title": "Pedal Gangrene in a Patient with COVID-19 Treated with Prone Positioning and Extracorporeal Membrane Oxygenation.",
    "sentences": [
      {
        "text": "Many patients hospitalized with coronavirus disease 2019 (COVID-19) are treated with veno-venous ECMO (VV-ECMO) and prone positioning to optimize oxygenation."
      },
      {
        "text": "However, this combination can result in lower extremity tissue necrosis, especially without adequate offloading."
      },
      {
        "text": "We report a case of a 31-year-old male who required mechanical ventilation and VV-ECMO secondary to complications from COVID-19, and subsequently developed pedal dry gangrene."
      },
      {
        "text": "The patient was discharged and healed without requiring an amputation."
      },
      {
        "text": "Our institution has since revised the prone positioning protocol to address offloading the lower extremities and feet."
      }
    ]
  },
  "33535156": {
    "title": "Eyes on coronavirus.",
    "sentences": [
      {
        "text": "Recently, coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 has spread around the world and is receiving worldwide attention."
      },
      {
        "text": "Approximately 20% of infected patients are suffering from severe disease of multiple systems and in danger of death, while the ocular complications of SARS-CoV-2-infected patients have not been reported generally."
      },
      {
        "text": "Herein, we focus on two major receptors of SARS-CoV-2, ACE2 and CD147 (BSG), in human ocular cells, and interpret the potential roles of coronaviruses in human ocular tissues and diseases."
      }
    ]
  },
  "33692801": {
    "title": "The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein/Kinin System.",
    "sentences": [
      {
        "text": "An important manifestation of severe COVID-19 is the ARDS-like lung injury that is associated with vascular endothelialitis, thrombosis, and angiogenesis."
      },
      {
        "text": "The intravascular innate immune system (IIIS), including the complement, contact, coagulation, and fibrinolysis systems, which is crucial for recognizing and eliminating microorganisms and debris in the body, is likely to be involved in the pathogenesis of COVID-19 ARDS."
      },
      {
        "text": "Biomarkers for IIIS activation were studied in the first 66 patients with COVID-19 admitted to the ICU in Uppsala University Hospital, both cross-sectionally on day 1 and in 19 patients longitudinally for up to a month, in a prospective study."
      },
      {
        "text": "IIIS analyses were compared with biochemical parameters and clinical outcome and survival."
      },
      {
        "text": "Blood cascade systems activation leading to an overreactive conjunct thromboinflammation was demonstrated, reflected in consumption of individual cascade system components, e.g., FXII, prekallikrein, and high molecular weight kininogen and in increased levels of activation products, e.g., C4d, C3a, C3d,g, sC5b-9, TAT, and D-dimer."
      },
      {
        "text": "Strong associations were found between the blood cascade systems and organ damage, illness severity scores, and survival."
      },
      {
        "text": "We show that critically ill COVID-19 patients display a conjunct activation of the IIIS that is linked to organ damage of the lung, heart, kidneys, and death."
      },
      {
        "text": "We present evidence that the complement and in particular the kallikrein/kinin system is strongly activated and that both systems are prognostic markers of the outcome of the patients suggesting their role in driving the inflammation."
      },
      {
        "text": "Already licensed kallikrein/kinin inhibitors are potential drugs for treatment of critically ill patients with COVID-19."
      }
    ]
  },
  "33692788": {
    "title": "Reduced Expression of Autophagy Markers and Expansion of Myeloid-Derived Suppressor Cells Correlate With Poor T Cell Response in Severe COVID-19 Patients.",
    "sentences": [
      {
        "text": "Widespread coronavirus disease (COVID)-19 is causing pneumonia, respiratory and multiorgan failure in susceptible individuals."
      },
      {
        "text": "Dysregulated immune response marks severe COVID-19, but the immunological mechanisms driving COVID-19 pathogenesis are still largely unknown, which is hampering the development of efficient treatments."
      },
      {
        "text": "Here we analyzed ~140 parameters of cellular and humoral immune response in peripheral blood of 41 COVID-19 patients and 16 age/gender-matched healthy donors by flow-cytometry, quantitative PCR, western blot and ELISA, followed by integrated correlation analyses with ~30 common clinical and laboratory parameters."
      },
      {
        "text": "We found that lymphocytopenia in severe COVID-19 patients (n=20) strongly affects T, NK and NKT cells, but not B cells and antibody production."
      },
      {
        "text": "Unlike increased activation of ICOS-1+ CD4+ T cells in mild COVID-19 patients (n=21), T cells in severe patients showed impaired activation, low IFN-Î³ production and high functional exhaustion, which correlated with significantly down-regulated HLA-DR expression in monocytes, dendritic cells and B cells."
      },
      {
        "text": "The latter phenomenon was followed by lower interferon responsive factor (IRF)-8 and autophagy-related genes expressions, and the expansion of myeloid derived suppressor cells (MDSC)."
      },
      {
        "text": "Intriguingly, PD-L1-, ILT-3-, and IDO-1-expressing monocytic MDSC were the dominant producers of IL-6 and IL-10, which correlated with the increased inflammation and accumulation of regulatory B and T cell subsets in severe COVID-19 patients."
      },
      {
        "text": "Overall, down-regulated IRF-8 and autophagy-related genes expression, and the expansion of MDSC subsets could play critical roles in dysregulating T cell response in COVID-19, which could have large implications in diagnostics and design of novel therapeutics for this disease."
      }
    ]
  },
  "33692570": {
    "title": "COVID-19 and liver disease: mechanistic and clinical perspectives.",
    "sentences": [
      {
        "text": "Our understanding of the hepatic consequences of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and its resultant coronavirus disease 2019 (COVID-19) has evolved rapidly since the onset of the pandemic."
      },
      {
        "text": "In this Review, we discuss the hepatotropism of SARS-CoV-2, including the differential expression of viral receptors on liver cell types, and we describe the liver histology features present in patients with COVID-19."
      },
      {
        "text": "We also provide an overview of the pattern and relevance of abnormal liver biochemistry during COVID-19 and present the possible underlying direct and indirect mechanisms for liver injury."
      },
      {
        "text": "Furthermore, large international cohorts have been able to characterize the disease course of COVID-19 in patients with pre-existing chronic liver disease."
      },
      {
        "text": "Patients with cirrhosis have particularly high rates of hepatic decompensation and death following SARS-CoV-2 infection and we outline hypotheses to explain these findings, including the possible role of cirrhosis-associated immune dysfunction."
      },
      {
        "text": "This finding contrasts with outcome data in pharmacologically immunosuppressed patients after liver transplantation who seem to have comparatively better outcomes from COVID-19 than those with advanced liver disease."
      },
      {
        "text": "Finally, we discuss the approach to SARS-CoV-2 vaccination in patients with cirrhosis and after liver transplantation and predict how changes in social behaviours and clinical care pathways during the pandemic might lead to increased liver disease incidence and severity."
      }
    ]
  },
  "33691765": {
    "title": "Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.",
    "sentences": [
      {
        "text": "OBJECTIVES To determine the effect of therapeutic anticoagulation, with low molecular weight heparin (LMWH) or unfractionated heparin (UFH, high dose nomogram), compared to standard care in hospitalized patients admitted for COVID-19 with an elevated D-dimer on the composite outcome of intensive care unit (ICU) admission, non-invasive positive pressure ventilation, invasive mechanical ventilation or death up to 28 days."
      },
      {
        "text": "TRIAL DESIGN Open-label, parallel, 1:1, phase 3, 2-arm randomized controlled trial PARTICIPANTS: The study population includes hospitalized adults admitted for COVID-19 prior to the development of critical illness."
      },
      {
        "text": "Excluded individuals are those where the bleeding risk or risk of transfusion would generally be considered unacceptable, those already therapeutically anticoagulated and those who have already have any component of the primary composite outcome."
      },
      {
        "text": "Participants are recruited from hospital sites in Brazil, Canada, Ireland, Saudi Arabia, United Arab Emirates, and the United States of America."
      },
      {
        "text": "The inclusion criteria are: 1) Laboratory confirmed COVID-19 (diagnosis of SARS-CoV-2 via reverse transcriptase polymerase chain reaction as per the World Health Organization protocol or by nucleic acid based isothermal amplification) prior to hospital admission OR within first 5 days (i.e. 120 hours) after hospital admission; 2) Admitted to hospital for COVID-19; 3) One D-dimer value above the upper limit of normal (ULN) (within 5 days (i.e. 120 hours) of hospital admission) AND EITHER: a. D-Dimer â¥2 times ULN OR b. D-Dimer above ULN and Oxygen saturation â¤ 93% on room air; 4) > 18 years of age; 5) Informed consent from the patient (or legally authorized substitute decision maker)."
      },
      {
        "text": "The exclusion criteria are: 1) pregnancy; 2) hemoglobin <80 g/L in the last 72 hours; 3) platelet count <50 x 109/L in the last 72 hours; 4) known fibrinogen <1.5 g/L (if testing deemed clinically indicated by the treating physician prior to the initiation of anticoagulation); 5) known INR >1.8 (if testing deemed clinically indicated by the treating physician prior to the initiation of anticoagulation); 6) patient already prescribed intermediate dosing of LMWH that cannot be changed (determination of what constitutes an intermediate dose is to be at the discretion of the treating clinician taking the local institutional thromboprophylaxis protocol for high risk patients into consideration); 7) patient already prescribed therapeutic anticoagulation at the time of screening [low or high dose nomogram UFH, LMWH, warfarin, direct oral anticoagulant (any dose of dabigatran, apixaban, rivaroxaban, edoxaban)]; 8) patient prescribed dual antiplatelet therapy, when one of the agents cannot be stopped safely; 9) known bleeding within the last 30 days requiring emergency room presentation or hospitalization; 10) known history of a bleeding disorder of an inherited or active acquired bleeding disorder; 11) known history of heparin-induced thrombocytopenia; 12) known allergy to UFH or LMWH; 13) admitted to the intensive care unit at the time of screening; 14) treated with non-invasive positive pressure ventilation or invasive mechanical ventilation at the time of screening; 15) Imminent death according to the judgement of the most responsible physician; 16) enrollment in another clinical trial of antithrombotic therapy involving hospitalized patients."
      },
      {
        "text": "INTERVENTION AND COMPARATOR Intervention: Therapeutic dose of LMWH (dalteparin, enoxaparin, tinzaparin) or high dose nomogram of UFH."
      },
      {
        "text": "The choice of LMWH versus UFH will be at the clinician's discretion and dependent on local institutional supply."
      },
      {
        "text": "Comparator: Standard care [thromboprophylactic doses of LMWH (dalteparin, enoxaparin, tinzaparin, fondaparinux)] or UFH."
      },
      {
        "text": "Administration of LMWH, UFH or fondaparinux at thromboprophylactic doses for acutely ill hospitalized medical patients, in the absence of contraindication, is generally considered standard care."
      },
      {
        "text": "MAIN OUTCOMES The primary composite outcome of ICU admission, non-invasive positive pressure ventilation, invasive mechanical ventilation or death at 28 days."
      },
      {
        "text": "Secondary outcomes include (evaluated up to day 28): 1."
      },
      {
        "text": "All-cause death 2."
      },
      {
        "text": "Composite of ICU admission or all-cause death 3."
      },
      {
        "text": "Composite of mechanical ventilation or all-cause death 4."
      },
      {
        "text": "Major bleeding as defined by the ISTH Scientific and Standardization Committee (ISTH-SSC) recommendation; 5."
      },
      {
        "text": "Red blood cell transfusion (>1 unit); 6."
      },
      {
        "text": "Transfusion of platelets, frozen plasma, prothrombin complex concentrate, cryoprecipitate and/or fibrinogen concentrate; 7."
      },
      {
        "text": "Renal replacement therapy; 8."
      },
      {
        "text": "Hospital-free days alive; 9."
      },
      {
        "text": "ICU-free days alive; 10."
      },
      {
        "text": "Ventilator-free days alive; 11."
      },
      {
        "text": "Organ support-free days alive; 12."
      },
      {
        "text": "Venous thromboembolism (defined as symptomatic or incidental, suspected or confirmed via diagnostic imaging and/or electrocardiogram where appropriate); 13."
      },
      {
        "text": "Arterial thromboembolism (defined as suspected or confirmed via diagnostic imaging and/or electrocardiogram where appropriate); 14."
      },
      {
        "text": "Heparin induced thrombocytopenia; 15."
      },
      {
        "text": "Trajectories of COVID-19 disease-related coagulation and inflammatory biomarkers."
      },
      {
        "text": "RANDOMISATION Randomisation will be stratified by site and age (>65 versus â¤65 years) using a 1:1 computer-generated random allocation sequence with variable block sizes."
      },
      {
        "text": "Randomization will occur within the first 5 days (i.e. 120 hours) of participant hospital admission."
      },
      {
        "text": "However, it is recommended that randomization occurs as early as possible after hospital admission."
      },
      {
        "text": "Central randomization using an interactive web response system will ensure allocation concealment."
      },
      {
        "text": "BLINDING (MASKING) No blinding involved."
      },
      {
        "text": "This is an open-label trial."
      },
      {
        "text": "NUMBERS TO BE RANDOMISED (SAMPLE SIZE) 462 patients (231 per group) are needed to detect a 15% risk difference, from 50% in the control group to 35% in the experimental group, with power of 90% at a two-sided alpha of 0.05."
      },
      {
        "text": "TRIAL STATUS Protocol Version Number 1.4."
      },
      {
        "text": "Recruitment began on May 11th, 2020."
      },
      {
        "text": "Recruitment is expected to be completed March 2022."
      },
      {
        "text": "Recruitment is ongoing."
      },
      {
        "text": "TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT04362085 Date of Trial Registration: April 24, 2020 FULL PROTOCOL: The full protocol is attached as an additional file, accessible from the Trials website (Additional file 1)."
      },
      {
        "text": "In the interest of expediting dissemination of this material, the familiar formatting has been eliminated; this Letter serves as a summary of the key elements of the full protocol."
      }
    ]
  },
  "33691172": {
    "title": "Contribution of STAT3 to the pathogenesis of COVID-19.",
    "sentences": [
      {
        "text": "Hyper-inflammatory responses, lymphopenia, unbalanced immune responses, cytokine storm, large viral replication and massive cell death play fundamental roles in the pathogenesis of COVID-19."
      },
      {
        "text": "Extreme production of many kinds of pro-inflammatory cytokines and chemokines occur in severe COVID-19 that called cytokine storm."
      },
      {
        "text": "Signal transducer and activator of transcription-3 (STAT-3) present in the cytoplasm in an inactive form and can be stimulated by a vast range of cytokines, chemokines and growth factors."
      },
      {
        "text": "Thus, STAT-3 can participate in the induction of inflammatory responses during coronavirus infections."
      },
      {
        "text": "STAT-3 can also suppress anti-virus interferon response and induce unbalanced anti-virus adaptive immune response, through influencing Th17-, Th1-, Treg-, and B cell-mediated functions."
      },
      {
        "text": "Furthermore, STAT-3 can contribute to the M2 macrophage polarization, lung fibrosis and thrombosis."
      },
      {
        "text": "Moreover, STAT-3 may be directly targeted by some virus-derived protein and operate as a pro-viral or anti-viral element in a virus-specific process."
      },
      {
        "text": "Here, the possible contribution of STAT-3 to the pathogenesis of COVID-19 was explained, while providing potential approaches to target this transcription factor in an attempt for COVID-19 treatment."
      }
    ]
  },
  "33691089": {
    "title": "Metabolic programs define dysfunctional immune responses in severe COVID-19 patients.",
    "sentences": [
      {
        "text": "It is unclear why some SARS-CoV-2 patients readily resolve infection while others develop severe disease."
      },
      {
        "text": "By interrogating metabolic programs of immune cells in severe and recovered coronavirus disease 2019 (COVID-19) patients compared with other viral infections, we identify a unique population of TÂ cells."
      },
      {
        "text": "These TÂ cells express increased Voltage-Dependent Anion Channel 1 (VDAC1), accompanied by gene programs and functional characteristics linked to mitochondrial dysfunction and apoptosis."
      },
      {
        "text": "The percentage of these cells increases in elderly patients and correlates with lymphopenia."
      },
      {
        "text": "Importantly, TÂ cell apoptosis is inhibited inÂ vitro by targeting the oligomerization of VDAC1 or blocking caspase activity."
      },
      {
        "text": "We also observe an expansion of myeloid-derived suppressor cells with unique metabolic phenotypes specific to COVID-19, and their presence distinguishes severe from mild disease."
      },
      {
        "text": "Overall, the identification of these metabolic phenotypes provides insight into the dysfunctional immune response in acutely ill COVID-19 patients and provides a means to predict and track disease severity and/or design metabolic therapeutic regimens."
      }
    ]
  },
  "33558851": {
    "title": "SUMO pathway, blood coagulation and oxidative stress in SARS-CoV-2 infection.",
    "sentences": [
      {
        "text": "Severe Acute Respiratory Syndrome Corona Virus 2 (SARS CoV-2) is currently an international pandemic causing coronavirus disease 19 (COVID-19)."
      },
      {
        "text": "Viral entry requires ACE2 and transmembrane protease serine 2 (TMPRSS2) for membrane fusion or through endosomal pathway."
      },
      {
        "text": "This Study aims to assess transcriptomic changes and differentially expressed genes (DFGs) in COVID-19."
      },
      {
        "text": "Methods Transcriptomic data of the publicly available dataset (GSE147507) was quantile normalized and analysed for DFGs, network analysis and pathway analysis."
      },
      {
        "text": "Results DFG sets showed that 8 genes (SAE1, AEBP2, ATP1A1, DKK3, MAFF, NUDC, TRAP1, and VAV1) were significantly dysregulated in all studied groups."
      },
      {
        "text": "Functional analysis revealed that negative regulation of glucocorticoid biosynthesis, protein SUMOylation (SAE1), blood coagulation (VAV1) and cellular response to stress were affected by SARS CoV-2 infection."
      },
      {
        "text": "Cell line transduction with ACE2 vector didn't show significant changes in the dysregulated pathways."
      },
      {
        "text": "Also, no significant change was observed in expression levels of ACE2 or TMPRSS2 in response to SARS CoV-2 infection."
      },
      {
        "text": "Further analysis showed dysregulation of several genes in the SUMOylation pathway and blood coagulation process in human and cell lines transcriptome."
      },
      {
        "text": "Also, several Cathepsins proteases were significantly dysregulated in case of SARS CoV-2 infection."
      },
      {
        "text": "Genes related to cellular response to stress such as TRAP-1 and NOX were dysregulated in cases of SARS CoV-2 infection."
      },
      {
        "text": "Conclusion Dysregulation in genes of protein SUMOylation, blood coagulation and response to oxidative stress pathways in SARS CoV-2 infection could be critical for disease progression."
      },
      {
        "text": "Drugs acting on SUMO pathway, VAV1, NOX genes could be studied for potential benefit to COVID-19 patients."
      }
    ]
  },
  "33532792": {
    "title": "Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19.",
    "sentences": [
      {
        "text": "Although T cells are likely players in SARS-CoV-2 immunity, little is known about the phenotypic features of SARS-CoV-2-specific T cells associated with recovery from severe COVID-19."
      },
      {
        "text": "We analyzed T cells from longitudinal specimens of 34 COVID-19 patients with severities ranging from mild (outpatient) to critical culminating in death."
      },
      {
        "text": "Relative to patients that succumbed, individuals that recovered from severe COVID-19 harbored elevated and increasing numbers of SARS-CoV-2-specific T cells capable of homeostatic proliferation."
      },
      {
        "text": "In contrast, fatal COVID-19 displayed elevated numbers of SARS-CoV-2-specific regulatory T cells and a time-dependent escalation in activated bystander CXCR4+ T cells."
      },
      {
        "text": "Together with the demonstration of increased proportions of inflammatory CXCR4+ T cells in the lungs of severe COVID-19 patients, these results support a model whereby lung-homing T cells activated through bystander effects contribute to immunopathology, while a robust, non-suppressive SARS-CoV-2-specific T cell response limits pathogenesis and promotes recovery from severe COVID-19."
      },
      {
        "text": "HIGHLIGHTS Dysfunctional spike-specific T cells are characteristic of severe COVID-19Spike-specific CD127+ Th1 cells are increased in survivors of severe COVID-19Spike-specific Tregs and IL6+ CD8+ T cells are increased in fatal COVID-19Escalation of activated lung-homing CXCR4+ T cells associates with fatal COVID-19."
      },
      {
        "text": "BRIEF SUMMARY By conducting CyTOF on total and SARS-CoV-2-specific T cells from longitudinal specimens spanning the entire spectrum of COVID-19 diseases, Neidleman et al."
      },
      {
        "text": "demonstrate that spike-specific Th1 cells capable of IL7-dependent homeostatic proliferation predict survival from severe COVID-19, while Tregs and IL6+ CD8+ T cells recognizing spike predict fatal outcome."
      },
      {
        "text": "Fatal COVID-19 is characterized by escalating activation of bystander CXCR4+ T cells in the lungs."
      },
      {
        "text": "Boosting SARS-CoV-2-specific CD4+ T effector responses while diminishing CXCR4-mediated homing may help recovery from severe disease."
      }
    ]
  },
  "33497931": {
    "title": "Increased placental expression of angiotensin-converting enzyme 2, the receptor of SARS-CoV-2, associated with hypoxia in twin anemia-polycythemia sequence (TAPS).",
    "sentences": [
      {
        "text": "INTRODUCTION Recent reports suggest SARS-CoV-2, the virus causing COVID-19, may be transmittable from pregnant mother to placenta and fetus, albeit rarely."
      },
      {
        "text": "The efficacy of vertical transmission of SARS-CoV-2 critically depends on the availability of its receptor, ACE2, in the placenta."
      },
      {
        "text": "In the present study, we tested the hypothesis that placental ACE2 expression is oxygenation-dependent by studying the expression of ACE2 and associated cell entry regulators in the monochorionic twin anemia-polycythemia (TAPS) placenta, a model of discordant placental oxygenation."
      },
      {
        "text": "METHODS We performed a retrospective comparative immunohistochemical, immunofluorescence and Western blot analysis of ACE2, TMPRSS2 and Cathepsin B expression in anemic and polycythemic territories of TAPS placentas (NÂ =Â 14)."
      },
      {
        "text": "RESULTS ACE2 protein levels were significantly higher in the anemic twin territories than in the corresponding polycythemic territories, associated with upregulation of the key ACE2-related cell entry regulators, TMPRSS2 and Cathepsin B, immunolocalized to villous trophoblastic and stromal cells."
      },
      {
        "text": "Cellular colocalization of ACE2 and TMPRSS2, suggestive of functionality of this cell entry axis, was demonstrated by double immunofluorescence studies."
      },
      {
        "text": "DISCUSSION Placental hypoxia is associated with upregulation of ACE2 expression, concomitant with increased expression of its key cell entry proteases."
      },
      {
        "text": "ACE2-regulated placental functions, both infection- and non-infection related, may be highly oxygenation-dependent."
      }
    ]
  },
  "33688573": {
    "title": "Neurological complications of COVID19 during March 2020 at LCMC health university medical center: Dataset.",
    "sentences": [
      {
        "text": "We reviewed the electronic medical records (EMR) of patients hospitalized during the peak of the pandemic, March 1st through March 31st, to document the type and frequency of neurological problems seen in patients with COVID-19 at presentation to the emergency room."
      },
      {
        "text": "Secondary aims were to determine: 1) the frequency of neurological complaints during the hospital stay; 2) whether the presence of any neurological complaint at presentation or any of the individual types of neurological complaints at admission predicted three separate outcomes: death, length of hospital stay, or the need for intubation; and 3) if the presence of any neurological complaint or any of the individual types of neurological complaints developed during hospital stay predicted the previous three outcomes."
      },
      {
        "text": "Setting The Louisiana Health Sciences Center - New Orleans Institutional Review Board and the University Medical Center Clinical Research Review Committee approved the study protocol."
      },
      {
        "text": "Data acquisition We reviewed the electronic medical records (EMR) of patients hospitalized during March (March 1st through March 31st) 2020 at the University Medical Center New Orleans (UMCNO), who tested positive for SARS-CoV-2 during the same hospitalization."
      },
      {
        "text": "The EMR team generated a list of 257 patients admitted for COVID-19."
      },
      {
        "text": "We excluded seven patients because of a negative COVID-19 test result or incomplete medical record documentation."
      },
      {
        "text": "Three neurology residents (DC, MS, DB) reviewed the EMR in detail to capture the relevant medical history, clinical course, and laboratory test results and abstracted data into an electronic data collection spreadsheet."
      },
      {
        "text": "We recorded the presentation or development of the following neurological complaints: headache, syncope, altered mental status, seizure, status epilepticus, and ischemic or hemorrhagic stroke."
      },
      {
        "text": "Statistical analysis We used \"R\" (statistics software) and Microsoft Excel to generate summary tables."
      },
      {
        "text": "To analyze hospital length of stay or death, we fitted a competing risks proportional hazards model for time to discharge or death using the crr() function in R version 4.0."
      },
      {
        "text": "0."
      },
      {
        "text": "The competing risks model allowed the analysis of hospital stay, taking into account that the censoring of cases due to death was not random."
      },
      {
        "text": "To predict the likelihood of intubation, we used the glm() function in R to fit a logistic regression model."
      },
      {
        "text": "For each model, we determined baseline demographic variables predictive of the outcomes and generated adjusted models."
      },
      {
        "text": "For variables with less than five cases per cell, we reported the p-values for Fisher's Exact Test."
      },
      {
        "text": "The analyses and results are published in:Chachkhiani, David etÂ al."
      },
      {
        "text": "\"Neurological complications in a predominantly African American population of COVID-19 predict worse outcomes during hospitalization\"."
      },
      {
        "text": "Clinical Neurology and Neurosurgery (in press)."
      },
      {
        "text": "These data will be useful for researchers trying to build larger datasets regarding COVID19 neurological complications for metanalysis or to answer other questions requiring larger sample sizes."
      }
    ]
  },
  "33596494": {
    "title": "Randomized placebo-controlled pilot clinical trial on the efficacy of ayurvedic treatment regime on COVID-19 positive patients.",
    "sentences": [
      {
        "text": "BACKGROUND Specific treatment for COVID-19 is still an unmet need."
      },
      {
        "text": "Outcomes of clinical trials on repurposed drugs have not been yielding success."
      },
      {
        "text": "Therefore, it is necessary to include complementary approaches of medicine against COVID-19."
      },
      {
        "text": "PURPOSE This study was designed to evaluate the impact of traditional Indian Ayurvedic treatment regime on asymptomatic patients with COVID-19 infection."
      },
      {
        "text": "STUDY DESIGN It is a placebo controlled randomized double-blind pilot clinical trial."
      },
      {
        "text": "METHODS The study was registered with Clinical Trial Registry-India (vide Registration No."
      },
      {
        "text": "CTRI/2020/05/025273) and conducted at the Department of Medicine in National Institute of Medical Sciences and Research, Jaipur, India."
      },
      {
        "text": "1 g of Giloy Ghanvati (Tinospora cordifolia) and 2 g of Swasari Ras (traditional herbo-mineral formulation) and 0.5 g each of Ashwagandha (Withania somnifera) and Tulsi Ghanvati (Ocimum sanctum) were given orally to the patients in treatment group twice per day for 7 days."
      },
      {
        "text": "Medicines were given in the form of tablets and each tablet weighed 500 mg."
      },
      {
        "text": "While, Swasari Ras was administered in powdered form, 30 min before breakfasts and dinners, rest were scheduled for 30 min post-meals."
      },
      {
        "text": "Patients in the treatment group also received 4 drops of Anu taila (traditional nasal drop) in each nostril every day 1 h before breakfast."
      },
      {
        "text": "Patients in the placebo group received identical-looking tablets and drops, post randomization and double blinded assortments."
      },
      {
        "text": "RT-qPCR test was used for the detection of viral load in the nasopharyngeal and oropharyngeal swab samples of study participants during the study."
      },
      {
        "text": "Chemiluminescent immunometric assay was used to quantify serum levels of interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-Î±) and high sensitivity C-reactive protein (hs-CRP) on day 1 and day 7 of the study."
      },
      {
        "text": "RESULTS By day 3, 71.1Â % and 50.0Â % patients recovered in the treatment and placebo groups, respectively."
      },
      {
        "text": "Treatment group witnessed 100Â % recovery by day 7, while it was 60.0Â % in the placebo group."
      },
      {
        "text": "Average fold changes in serum levels of hs-CRP, IL-6 and TNF-Î± in treatment group were respectively, 12.4, 2.5 and 20 times lesser than those in the placebo group at day 7."
      },
      {
        "text": "There was 40Â % absolute reduction in the risk of delayed recovery from infection in the treatment group."
      },
      {
        "text": "CONCLUSIONS Ayurvedic treatment can expedite virological clearance, help in faster recovery and concomitantly reduce the risk of viral dissemination."
      },
      {
        "text": "Reduced inflammation markers suggested less severity of SARS-CoV-2 infection in the treatment group."
      },
      {
        "text": "Moreover, there was no adverse effect observed to be associated with this treatment."
      }
    ]
  },
  "33686492": {
    "title": "Association between ABO blood types and coronavirus disease 2019 (COVID-19), genetic associations, and underlying molecular mechanisms: a literature review of 23 studies.",
    "sentences": [
      {
        "text": "An association of various blood types and the 2019 novel coronavirus disease (COVID-19) has been found in a number of publications."
      },
      {
        "text": "The aim of this literature review is to summarize key findings related to ABO blood types and COVID-19 infection rate, symptom presentation, and outcome."
      },
      {
        "text": "Summarized findings include associations between ABO blood type and higher infection susceptibility, intubation duration, and severe outcomes, including death."
      },
      {
        "text": "The literature suggests that blood type O may serve as a protective factor, as individuals with blood type O are found COVID-19 positive at far lower rates."
      },
      {
        "text": "This could suggest that blood type O individuals are less susceptible to infection, or that they are asymptomatic at higher rates and therefore do not seek out testing."
      },
      {
        "text": "We also discuss genetic associations and potential molecular mechanisms that drive the relationship between blood type and COVID-19."
      },
      {
        "text": "Studies have found a strong association between a locus on a specific gene cluster on chromosome three (chr3p21.31) and outcome severity, such as respiratory failure."
      },
      {
        "text": "Cellular models have suggested an explanation for blood type modulation of infection, evidencing that spike protein/Angiotensin-converting enzyme 2 (ACE2)-dependent adhesion to ACE2-expressing cell lines was specifically inhibited by monoclonal or natural human anti-A antibodies, so individuals with non-A blood types, specifically O, or B blood types, which produce anti-A antibodies, may be less susceptible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection due to the inhibitory effects of anti-A antibodies."
      }
    ]
  },
  "33684527": {
    "title": "Mesenchymal stem cell alongside exosomes as a novel cell-based therapy for COVID-19: A review study.",
    "sentences": [
      {
        "text": "In the past year, an emerging disease called Coronavirus disease 2019 (COVID-19), caused by Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been discovered in Wuhan, China, which has become a worrying pandemic and has challenged the world health system and economy."
      },
      {
        "text": "SARS-CoV-2 enters the host cell through a specific receptor (Angiotensin-converting enzyme 2) expressed on epithelial cells of various tissues."
      },
      {
        "text": "The virus, by inducing cell apoptosis and production of pro-inflammatory cytokines, generates as cytokine storm, which is the major cause of mortality in the patients."
      },
      {
        "text": "This type of response, along with responses by other immune cell, such as alveolar macrophages and neutrophils causes extensive damage to infected tissue."
      },
      {
        "text": "Newly, a novel cell-based therapy by Mesenchymal stem cell (MSC) as well as by their exosomes has been developed for treatment of COVID-19 that yielded promising outcomes."
      },
      {
        "text": "In this review study, we discuss the characteristics and benefits of MSCs therapy as well as MSC-secreted exosome therapy in treatment of COVID-19 patients."
      }
    ]
  },
  "33679760": {
    "title": "Cyclic-di-GMP Induces STING-Dependent ILC2 to ILC1 Shift During Innate Type 2 Lung Inflammation.",
    "sentences": [
      {
        "text": "Type 2 inflammation is found in most forms of asthma, which may co-exist with recurrent viral infections, bacterial colonization, and host cell death."
      },
      {
        "text": "These processes drive the accumulation of intracellular cyclic-di-nucleotides such as cyclic-di-GMP (CDG)."
      },
      {
        "text": "Group 2 innate lymphoid cells (ILC2s) are critical drivers of type 2 lung inflammation during fungal allergen exposure in mice; however, it is unclear how CDG regulates lung ILC responses during lung inflammation."
      },
      {
        "text": "Here, we show that intranasal CDG induced early airway type 1 interferon (IFN) production and dramatically suppressed CD127+ST2+ ILC2s and type 2 lung inflammation during Alternaria and IL-33 exposure."
      },
      {
        "text": "Further, CD127-ST2-Thy1.2+ lung ILCs, which showed a transcriptomic signature consistent with ILC1s, were expanded and activated by CDG combined with either Alternaria or IL-33."
      },
      {
        "text": "CDG-mediated suppression of type 2 inflammation occurred independent of IL-18R, IL-12, and STAT6 but required the stimulator of interferon genes (STING) and type 1 IFN signaling."
      },
      {
        "text": "Thus, CDG potently suppresses ILC2-driven lung inflammation and promotes ILC1 responses."
      },
      {
        "text": "These results suggest potential therapeutic modulation of STING to suppress type 2 inflammation and/or increase anti-viral responses during respiratory infections."
      }
    ]
  },
  "33655248": {
    "title": "An Autoantigen Profile of Human A549 Lung Cells Reveals Viral and Host Etiologic Molecular Attributes of Autoimmunity in COVID-19.",
    "sentences": [
      {
        "text": "We aim to establish a comprehensive COVID-19 autoantigen atlas in order to understand autoimmune diseases caused by SARS-CoV-2 infection."
      },
      {
        "text": "Based on the unique affinity between dermatan sulfate and autoantigens, we identified 348 proteins from human lung A549 cells, of which 198 are known targets of autoantibodies."
      },
      {
        "text": "Comparison with current COVID data identified 291 proteins that are altered at protein or transcript level in SARS-CoV-2 infection, with 191 being known autoantigens."
      },
      {
        "text": "These known and putative autoantigens are significantly associated with viral replication and trafficking processes, including gene expression, ribonucleoprotein biogenesis, mRNA metabolism, translation, vesicle and vesicle-mediated transport, and apoptosis."
      },
      {
        "text": "They are also associated with cytoskeleton, platelet degranulation, IL-12 signaling, and smooth muscle contraction."
      },
      {
        "text": "Host proteins that interact with and that are perturbed by viral proteins are a major source of autoantigens."
      },
      {
        "text": "Orf3 induces the largest number of protein alterations, Orf9 affects the mitochondrial ribosome, and they and E, M, N, and Nsp proteins affect protein localization to membrane, immune responses, and apoptosis."
      },
      {
        "text": "Phosphorylation and ubiquitination alterations by viral infection define major molecular changes in autoantigen origination."
      },
      {
        "text": "This study provides a large list of autoantigens as well as new targets for future investigation, e.g., UBA1, UCHL1, USP7, CDK11A, PRKDC, PLD3, PSAT1, RAB1A, SLC2A1, platelet activating factor acetylhydrolase, and mitochondrial ribosomal proteins."
      },
      {
        "text": "This study illustrates how viral infection can modify host cellular proteins extensively, yield diverse autoantigens, and trigger a myriad of autoimmune sequelae."
      }
    ]
  },
  "33655239": {
    "title": "Expression of SARS-CoV-2-related Receptors in Cells of the Neurovascular Unit: Implications for HIV-1 Infection.",
    "sentences": [
      {
        "text": "Background."
      },
      {
        "text": "Neurological complications are common in patients affected by COVID-19 due to the ability of SARS-CoV-2 to infect brains."
      },
      {
        "text": "While the mechanisms of this process are not fully understood, it has been proposed that SARS-CoV-2 can infect the cells of the neurovascular units (NVU), which form the blood-brain barrier (BBB)."
      },
      {
        "text": "The aim of the current study was to analyze the expression pattern of the main SARS-CoV-2 receptors in naÃ¯ve and HIV-1-infected cells of the NVU in order to elucidate a possible pathway of the virus entry into the brain and a potential modulatory impact of HIV-1 in this process."
      },
      {
        "text": "Methods."
      },
      {
        "text": "The gene and protein expression profile of ACE2, TMPRSS2, ADAM17, BSG, DPP4, AGTR2, ANPEP, cathepsin B and cathepsin L was assessed by qPCR and immunoblotting, respectively."
      },
      {
        "text": "In addition, we investigated if brain endothelial cells can be affected by the exposure to the S1 subunit of the S protein, the domain responsible for the direct binding of SARS-CoV-2 to the ACE2 receptors."
      },
      {
        "text": "Results."
      },
      {
        "text": "The receptors involved in SARS-CoV-2 infection are coexpressed in the cells of the NVU, especially in astrocytes and microglial cells."
      },
      {
        "text": "These receptors are functionally active as exposure of endothelial cells to the SARS CoV-2 S1 protein subunit altered the expression pattern of tight junction proteins, such as claudin-5 and ZO-1."
      },
      {
        "text": "Additionally, HIV-1 infection upregulated ACE2 and TMPRSS2 expression in brain astrocytes and microglia cells."
      },
      {
        "text": "Conclusions."
      },
      {
        "text": "These findings provide key insight into SARS-CoV-2 recognition by cells of the NVU and may help to develop possible treatment of CNS complications of COVID-19."
      }
    ]
  },
  "33518850": {
    "title": "Electrochemical sensing: A prognostic tool in the fight against COVID-19.",
    "sentences": [
      {
        "text": "The COVID-19 pandemic has devastated the world, despite all efforts in infection control and treatment/vaccine development."
      },
      {
        "text": "Hospitals are currently overcrowded, with health statuses of patients often being hard to gauge."
      },
      {
        "text": "Therefore, methods for determining infection severity need to be developed so that high-risk patients can be prioritized, resources can be efficiently distributed, and fatalities can be prevented."
      },
      {
        "text": "Electrochemical prognostic biosensing of various biomarkers may hold promise in solving these problems as they are low-cost and provide timely results."
      },
      {
        "text": "Therefore, we have reviewed the literature and extracted the most promising biomarkers along with their most favourable electrochemical sensors."
      },
      {
        "text": "The biomarkers discussed in this paper are C-reactive protein (CRP), interleukins (ILs), tumour necrosis factor alpha (TNFÎ±), interferons (IFNs), glutamate, breath pH, lymphocytes, platelets, neutrophils and D-dimer."
      },
      {
        "text": "Metabolic syndrome is also discussed as comorbidity for COVID-19 patients, as it increases infection severity and raises chances of becoming infected."
      },
      {
        "text": "Cannabinoids, especially cannabidiol (CBD), are discussed as a potential adjunct therapy for COVID-19 as their medicinal properties may be desirable in minimizing the neurodegenerative or severe inflammatory damage caused by severe COVID-19 infection."
      },
      {
        "text": "Currently, hospitals are struggling to provide adequate care; thus, point-of-care electrochemical sensor development needs to be prioritized to provide an approximate prognosis for hospital patients."
      },
      {
        "text": "During and following the immediate aftermath of the pandemic, electrochemical sensors can also be integrated into wearable and portable devices to help patients monitor recovery while returning to their daily lives."
      },
      {
        "text": "Beyond the COVID-19 pandemic, these sensors will also prove useful for monitoring inflammation-based diseases such as cancer and cardiovascular disease."
      }
    ]
  },
  "33682075": {
    "title": "A comparative review of pathogenesis and host innate immunity evasion strategies among the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV).",
    "sentences": [
      {
        "text": "COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has put the global public health at its highest threat around the world."
      },
      {
        "text": "Previous epidemic caused by the acute respiratory syndrome coronavirus (SARS-CoV) in 2002 is also considered since both the coronaviruses resulted in the similar clinical complications."
      },
      {
        "text": "The outbreak caused by the Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012 had a low rate of disease transmission and death cases."
      },
      {
        "text": "Modes of entry by MERS and SARS coronaviruses are similar to that of SARS-CoV-2, except MERS-CoV utilize different receptor."
      },
      {
        "text": "They all belong to the lineage C of Î²-coronavirus."
      },
      {
        "text": "Based on the information from the previous reports, the present review is mainly focused on the mechanisms of disease progression by each of these viruses in association to their strategies to escape the host immunity."
      },
      {
        "text": "The viral entry is the first step of pathogenesis associated with attachment of viral spike protein with host receptor help releasing the viral RNA into the host cell."
      },
      {
        "text": "Models of molecular pathogenesis are outlined with virus strategies escaping the host immunity along with the role of various inflammatory cytokines and chemokines in the process."
      },
      {
        "text": "The molecular aspects of pathogenesis have also been discussed."
      }
    ]
  },
  "33681537": {
    "title": "SARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis.",
    "sentences": [
      {
        "text": "There is ongoing debate as to whether cardiac complications of coronavirus disease 2019 (COVID-19) result from myocardial viral infection or are secondary to systemic inflammation and/or thrombosis."
      },
      {
        "text": "We provide evidence that cardiomyocytes are infected in patients with COVID-19 myocarditis and are susceptible to severe acute respiratory syndrome coronavirus 2."
      },
      {
        "text": "We establish an engineered heart tissue model of COVID-19 myocardial pathology, define mechanisms of viral pathogenesis, and demonstrate that cardiomyocyte severe acute respiratory syndrome coronavirus 2 infection results in contractile deficits, cytokine production, sarcomere disassembly, and cell death."
      },
      {
        "text": "These findings implicate direct infection of cardiomyocytes in the pathogenesis of COVID-19 myocardial pathology and provides a model system to study this emerging disease."
      }
    ]
  },
  "33681266": {
    "title": "New Insights Into the Physiopathology of COVID-19: SARS-CoV-2-Associated Gastrointestinal Illness.",
    "sentences": [
      {
        "text": "Although SARS-CoV-2 is considered a lung-tropic virus that infects the respiratory tract through binding to the ACE2 cell-surface molecules present on alveolar lungs epithelial cells, gastrointestinal symptoms have been frequently reported in COVID-19 patients."
      },
      {
        "text": "What can be considered an apparent paradox is that these symptoms (e.g., diarrhea), sometimes precede the development of respiratory tract illness as if the breathing apparatus was not its first target during viral dissemination."
      },
      {
        "text": "Recently, evidence was reported that the gut is an active site of replication for SARS-CoV-2."
      },
      {
        "text": "This replication mainly occurs in mature enterocytes expressing the ACE2 viral receptor and TMPRSS4 protease."
      },
      {
        "text": "In this review we question how SARS-CoV-2 can cause intestinal disturbances, whether there are pneumocyte-tropic, enterocyte-tropic and/or dual tropic strains of SARS-CoV-2."
      },
      {
        "text": "We examine two major models: first, that of a virus directly causing damage locally (e.g., by inducing apoptosis of infected enterocytes); secondly, that of indirect effect of the virus (e.g., by inducing changes in the composition of the gut microbiota followed by the induction of an inflammatory process), and suggest that both situations probably occur simultaneously in COVID-19 patients."
      },
      {
        "text": "We eventually discuss the consequences of the virus replication in brush border of intestine on long-distance damages affecting other tissues/organs, particularly lungs."
      }
    ]
  },
  "33679775": {
    "title": "C-Reactive Protein Triggers Cell Death in Ischemic Cells.",
    "sentences": [
      {
        "text": "C-reactive protein (CRP) is the best-known acute phase protein."
      },
      {
        "text": "In humans, almost every type of inflammation is accompanied by an increase of CRP concentration."
      },
      {
        "text": "Until recently, the only known physiological function of CRP was the marking of cells to initiate their phagocytosis."
      },
      {
        "text": "This triggers the classical complement pathway up to C4, which helps to eliminate pathogens and dead cells."
      },
      {
        "text": "However, vital cells with reduced energy supply are also marked, which is useful in the case of a classical external wound because an important substrate for pathogens is disposed of, but is counterproductive at internal wounds (e.g., heart attack or stroke)."
      },
      {
        "text": "This mechanism negatively affects clinical outcomes since it is established that CRP levels correlate with the prognosis of these indications."
      },
      {
        "text": "Here, we summarize what we can learn from a clinical study in which CRP was adsorbed from the bloodstream by CRP-apheresis."
      },
      {
        "text": "Recently, it was shown that CRP can have a direct effect on blood pressure in rabbits."
      },
      {
        "text": "This is interesting in regard to patients with high inflammation, as they often become tachycardic and need catecholamines."
      },
      {
        "text": "These two physiological effects of CRP apparently also occur in COVID-19."
      },
      {
        "text": "Parts of the lung become ischemic due to intra-alveolar edema and hemorrhage and in parallel CRP increases dramatically, hence it is assumed that CRP is also involved in this ischemic condition."
      },
      {
        "text": "It is meanwhile considered that most of the damage in COVID-19 is caused by the immune system."
      },
      {
        "text": "The high amounts of CRP could have an additional influence on blood pressure in severe COVID-19."
      }
    ]
  },
  "33679753": {
    "title": "Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia.",
    "sentences": [
      {
        "text": "Hyper-inflammatory responses induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are a major cause of disease severity and death."
      },
      {
        "text": "Predictive prognosis biomarkers to guide therapeutics are critically lacking."
      },
      {
        "text": "Several studies have indicated a \"cytokine storm\" with the release of interleukin-1 (IL-1), IL-6, and IL-8, along with tumor necrosis factor alpha (TNFÎ±) and other inflammatory mediators."
      },
      {
        "text": "Here, we proposed to assess the relationship between IL-6 and outcomes of patients with coronavirus disease 2019 (COVID-19)."
      },
      {
        "text": "Our cohort consisted of 46 adult patients with PCR-proven SARS-CoV-2 infection admitted in a COVID-19 ward of the Hospital de Braga (HB) from April 7 to May 7, 2020, whose IL-6 levels were followed over time."
      },
      {
        "text": "We found that IL-6 levels were significantly different between the disease stages."
      },
      {
        "text": "Also, we found a significant negative correlation between IL-6 levels during stages IIb and III, peripheral oxygen saturation (SpO2), and partial pressure of oxygen in arterial blood (PaO2), showing that IL-6 correlates with respiratory failure."
      },
      {
        "text": "Compared to the inflammatory markers available in the clinic routine, we found a positive correlation between IL-6 and C-reactive protein (CRP)."
      },
      {
        "text": "However, when we assessed the predictive value of these two markers, IL-6 behaves as a better predictor of disease progression."
      },
      {
        "text": "In a binary logistic regression, IL-6 level was the most significant predictor of the non-survivors group, when compared to age and CRP."
      },
      {
        "text": "Herein, we present IL-6 as a relevant tool for prognostic evaluation, mainly as a predictor of outcome."
      }
    ]
  },
  "33679437": {
    "title": "In vitro and In silico Models to Study SARS-CoV-2 Infection: Integrating Experimental and Computational Tools to Mimic \"COVID-19 Cardiomyocyte\".",
    "sentences": [
      {
        "text": "The rapid dissemination of SARS-CoV-2 has made COVID-19 a tremendous social, economic, and health burden."
      },
      {
        "text": "Despite the efforts to understand the virus and treat the disease, many questions remain unanswered about COVID-19 mechanisms of infection and progression."
      },
      {
        "text": "Severe Acute Respiratory Syndrome (SARS) infection can affect several organs in the body including the heart, which can result in thromboembolism, myocardial injury, acute coronary syndromes, and arrhythmias."
      },
      {
        "text": "Numerous cardiac adverse events, from cardiomyocyte death to secondary effects caused by exaggerated immunological response against the virus, have been clinically reported."
      },
      {
        "text": "In addition to the disease itself, repurposing of treatments by using \"off label\" drugs can also contribute to cardiotoxicity."
      },
      {
        "text": "Over the past several decades, animal models and more recently, stem cell-derived cardiomyocytes have been proposed for studying diseases and testing treatments in vitro."
      },
      {
        "text": "In addition, mechanistic in silico models have been widely used for disease and drug studies."
      },
      {
        "text": "In these models, several characteristics such as gender, electrolyte imbalance, and comorbidities can be implemented to study pathophysiology of cardiac diseases and to predict cardiotoxicity of drug treatments."
      },
      {
        "text": "In this Mini Review, we (1) present the state of the art of in vitro and in silico cardiomyocyte modeling currently in use to study COVID-19, (2) review in vitro and in silico models that can be adopted to mimic the effects of SARS-CoV-2 infection on cardiac function, and (3) provide a perspective on how to combine some of these models to mimic \"COVID-19 cardiomyocytes environment\"."
      },
      {
        "text": "."
      }
    ]
  },
  "33679136": {
    "title": "The Implications of Zinc Therapy in Combating the COVID-19 Global Pandemic.",
    "sentences": [
      {
        "text": "The global pandemic from COVID-19 infection has generated significant public health concerns, both health-wise and economically."
      },
      {
        "text": "There is no specific pharmacological antiviral therapeutic option to date available for COVID-19 management."
      },
      {
        "text": "Also, there is an urgent need to discover effective medicines, prevention, and control methods because of the harsh death toll from this novel coronavirus infection."
      },
      {
        "text": "Acute respiratory tract infections, significantly lower respiratory tract infections, and pneumonia are the primary cause of millions of deaths worldwide."
      },
      {
        "text": "The role of micronutrients, including trace elements, boosted the human immune system and was well established."
      },
      {
        "text": "Several vitamins such as vitamin A, B6, B12, C, D, E, and folate; microelement including zinc, iron, selenium, magnesium, and copper; omega-3 fatty acids as eicosapentaenoic acid and docosahexaenoic acid plays essential physiological roles in promoting the immune system."
      },
      {
        "text": "Furthermore, zinc is an indispensable microelement essential for a thorough enzymatic physiological process."
      },
      {
        "text": "It also helps regulate gene-transcription such as DNA replication, RNA transcription, cell division, and cell activation in the human biological system."
      },
      {
        "text": "Subsequently, zinc, together with natural scavenger cells and neutrophils, are also involved in developing cells responsible for regulating nonspecific immunity."
      },
      {
        "text": "The modern food habit often promotes zinc deficiency; as such, quite a few COVID-19 patients presented to hospitals were frequently diagnosed as zinc deficient."
      },
      {
        "text": "Earlier studies documented that zinc deficiency predisposes patients to a viral infection such as herpes simplex, common cold, hepatitis C, severe acute respiratory syndrome coronavirus (SARS-CoV-1), the human immunodeficiency virus (HIV) because of reducing antiviral immunity."
      },
      {
        "text": "This manuscript aimed to discuss the various roles played by zinc in the management of COVID-19 infection."
      }
    ]
  },
  "33677468": {
    "title": "Dynamic blood single-cell immune responses in patients with COVID-19.",
    "sentences": [
      {
        "text": "The 2019 coronavirus disease (COVID-19) outbreak caused by the SARS-CoV-2 virus is an ongoing global health emergency."
      },
      {
        "text": "However, the virus' pathogenesis remains unclear, and there is no cure for the disease."
      },
      {
        "text": "We investigated the dynamic changes of blood immune response in patients with COVID-19 at different stages by using 5' gene expression, T cell receptor (TCR), and B cell receptors (BCR) V(D)J transcriptome analysis at a single-cell resolution."
      },
      {
        "text": "We obtained single-cell mRNA sequencing (scRNA-seq) data of 341,420 peripheral blood mononuclear cells (PBMCs) and 185,430 clonotypic T cells and 28,802 clonotypic B cells from 25 samples of 16 patients with COVID-19 for dynamic studies."
      },
      {
        "text": "In addition, we used three control samples."
      },
      {
        "text": "We found expansion of dendritic cells (DCs), CD14+ monocytes, and megakaryocytes progenitor cells (MP)/platelets and a reduction of naÃ¯ve CD4+ T lymphocytes in patients with COVID-19, along with a significant decrease of CD8+ T lymphocytes, and natural killer cells (NKs) in patients in critical condition."
      },
      {
        "text": "The type I interferon (IFN-I), mitogen-activated protein kinase (MAPK), and ferroptosis pathways were activated while the disease was active, and recovered gradually after patient conditions improved."
      },
      {
        "text": "Consistent with this finding, the mRNA level of IFN-I signal-induced gene IFI27 was significantly increased in patients with COVID-19 compared with that of the controls in a validation cohort that included 38 patients and 35 controls."
      },
      {
        "text": "The concentration of interferon-Î± (IFN-Î±) in the serum of patients with COVID-19 increased significantly compared with that of the controls in an additional cohort of 215 patients with COVID-19 and 106 controls, further suggesting the important role of the IFN-I pathway in the immune response of COVID-19."
      },
      {
        "text": "TCR and BCR sequences analyses indicated that patients with COVID-19 developed specific immune responses against SARS-CoV-2 antigens."
      },
      {
        "text": "Our study reveals a dynamic landscape of human blood immune responses to SARS-CoV-2 infection, providing clues for therapeutic potentials in treating COVID-19."
      }
    ]
  },
  "33676105": {
    "title": "Acute SARS-CoV-2 pneumonitis with cytotoxic CD8 positive T-lymphocytes: Case report and review of the literature.",
    "sentences": [
      {
        "text": "As of October 2020, there are over 40 million confirmed cases, and more than 1 million confirmed deaths of Covid-19 worldwide."
      },
      {
        "text": "The main cause of death in hospitalized patients is a respiratory failure due to acute respiratory distress syndrome."
      },
      {
        "text": "It has been suggested that the very intense immune response induces diffuse alveolar damage that far exceeds the harm that would have been caused by virus replication per se, resulting in lethal tissue destruction."
      },
      {
        "text": "We present a detailed report of the histopathological findings on cryo transbronchial biopsy in the patient with persistent (3 months) interstitial pneumonitis and severe CD8 positive cell infiltration in the lungs due to SARS-CoV-2 infection."
      },
      {
        "text": "CD8 positive T-lymphocytes have a great potential to damage tissue either through direct cytotoxicity or through cytokines release."
      }
    ]
  },
  "33390762": {
    "title": "Exogenous pulmonary surfactant: A review focused on adjunctive therapy for severe acute respiratory syndrome coronavirus 2 including SP-A and SP-D as added clinical marker.",
    "sentences": [
      {
        "text": "Type I and type II pneumocytes are two forms of epithelial cells found lining the alveoli in the lungs."
      },
      {
        "text": "Type II pneumocytes exclusively secrete 'pulmonary surfactants,'Â a lipoprotein complex made up of 90% lipids (mainly phospholipids) and 10% surfactant proteins (SP-A, SP-B, SP-C, and SP-D)."
      },
      {
        "text": "Respiratory diseases such as influenza, severe acute respiratory syndrome coronavirus infection, and severe acute respiratory syndrome coronavirus 2 infection are reported to preferentially attack type II pneumocytes of the lungs."
      },
      {
        "text": "After viral invasion, consequent viral propagation and destruction of type II pneumocytes causes altered surfactant production, resulting in dyspnea and acute respiratory distress syndrome in patients with coronavirus disease 2019."
      },
      {
        "text": "Exogenous animal-derived or synthetic pulmonary surfactant therapy has already shown immense success in the treatment of neonatal respiratory distress syndrome and has the potential to contribute efficiently toward repair of damaged alveoli and preventing severe acute respiratory syndrome coronavirus 2-associated respiratory failure."
      },
      {
        "text": "Furthermore, early detection of surfactant collectins (SP-A and SP-D) in the circulatory system can be a significant clinical marker for disease prognosis in the near future."
      }
    ]
  },
  "33674950": {
    "title": "Characteristics of COVID-19 patients with preexisting CKD history.",
    "sentences": [
      {
        "text": "PURPOSE This paper was intended to describe the characteristics of coronavirus disease 2019 (COVID-19) patients with known chronic kidney disease (CKD) history."
      },
      {
        "text": "METHODS Clinical information of 20 COVID-19 pneumonia patients with CKD history diagnosed between January 20th and March 1st, 2020 were collected in Tongji Hospital, Wuhan."
      },
      {
        "text": "We listed the clinical baseline data, laboratory findings, chest computed tomography (CT) changes and processed a short period of follow-up of these 20 patients."
      },
      {
        "text": "RESULTS Based on the estimated glomerular filtration rate (eGFR) on admission, 6 patients were classified as stage 2 of CKD, 5 were as 3a, 2 were as 3b, 3 were as 4 and 4 were as 5, respectively."
      },
      {
        "text": "COVID-19 patients with CKD history were elder and hypertension was the most common comorbidity."
      },
      {
        "text": "Cough and fever accounted for more than 80% of the infectious cases."
      },
      {
        "text": "Lymphopenia, increased D-dimer and elevated infectious indications such as hypersensitive C response protein (hsCRP), interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-Î±) were also common among these patients."
      },
      {
        "text": "Ground-glass opacity (GGO) and consolidation were the major manifestations in CT scans."
      },
      {
        "text": "4 patients died and 7 patients underwent acute kidney injury (AKI) during observation."
      },
      {
        "text": "Among 16 discharged patients, 12 were with stable renal function and 4 had deteriorating renal function compared with that of admission."
      },
      {
        "text": "CONCLUSION Compared to general population infected with SARS-CoV-2, COVID-19 patients with CKD history had a preference to develop to severity with higher fatality rate."
      }
    ]
  },
  "33673529": {
    "title": "Demystifying Excess Immune Response in COVID-19 to Reposition an Orphan Drug for Down-Regulation of NF-ÎºB: A Systematic Review.",
    "sentences": [
      {
        "text": "The immunological findings from autopsies, biopsies, and various studies in COVID-19 patients show that the major cause of morbidity and mortality in COVID-19 is excess immune response resulting in hyper-inflammation."
      },
      {
        "text": "With the objective to review various mechanisms of excess immune response in adult COVID-19 patients, Pubmed was searched for free full articles not related to therapeutics or co-morbid sub-groups, published in English until 27.10.2020, irrespective of type of article, country, or region."
      },
      {
        "text": "Joanna Briggs Institute's design-specific checklists were used to assess the risk of bias."
      },
      {
        "text": "Out of 122 records screened for eligibility, 42 articles were included in the final review."
      },
      {
        "text": "The review found that eventually, most mechanisms result in cytokine excess and up-regulation of Nuclear Factor-ÎºB (NF-ÎºB) signaling as a common pathway of excess immune response."
      },
      {
        "text": "Molecules blocking NF-ÎºB or targeting downstream effectors like Tumour Necrosis Factor Î± (TNFÎ±) are either undergoing clinical trials or lack specificity and cause unwanted side effects."
      },
      {
        "text": "Neutralization of upstream histamine by histamine-conjugated normal human immunoglobulin has been demonstrated to inhibit the nuclear translocation of NF-ÎºB, thereby preventing the release of pro-inflammatory cytokines Interleukin (IL) 1Î², TNF-Î±, and IL-6 and IL-10 in a safer manner."
      },
      {
        "text": "The authors recommend repositioning it in COVID-19."
      }
    ]
  },
  "33671651": {
    "title": "sFasL-The Key to a Riddle: Immune Responses in Aging Lung and Disease.",
    "sentences": [
      {
        "text": "By dint of the aging population and further deepened with the Covid-19 pandemic, lung disease has turned out to be a major cause of worldwide morbidity and mortality."
      },
      {
        "text": "The condition is exacerbated when the immune system further attacks the healthy, rather than the diseased, tissue within the lung."
      },
      {
        "text": "Governed by unremittingly proliferating mesenchymal cells and increased collagen deposition, if inflammation persists, as frequently occurs in aging lungs, the tissue develops tumors and/or turns into scars (fibrosis), with limited regenerative capacity and organ failure."
      },
      {
        "text": "Fas ligand (FasL, a ligand of the Fas cell death receptor) is a key factor in the regulation of these processes."
      },
      {
        "text": "FasL is primarily found in two forms: full length (membrane, or mFasL) and cleaved (soluble, or sFasL)."
      },
      {
        "text": "We and others found that T-cells expressing the mFasL retain autoimmune surveillance that controls mesenchymal, as well as tumor cell accumulation following an inflammatory response."
      },
      {
        "text": "However, mesenchymal cells from fibrotic lungs, tumor cells, or cells from immune-privileged sites, resist FasL+ T-cell-induced cell death."
      },
      {
        "text": "The mechanisms involved are a counterattack of immune cells by FasL, by releasing a soluble form of FasL that competes with the membrane version, and inhibits their cell death, promoting cell survival."
      },
      {
        "text": "This review focuses on understanding the previously unrecognized role of FasL, and in particular its soluble form, sFasL, in the serum of aged subjects, and its association with the evolution of lung disease, paving the way to new methods of diagnosis and treatment."
      }
    ]
  },
  "33671255": {
    "title": "Multivalent Display of SARS-CoV-2 Spike (RBD Domain) of COVID-19 to Nanomaterial, Protein Ferritin Nanocages.",
    "sentences": [
      {
        "text": "SARS-CoV-2, or COVID-19, has a devastating effect on our society, both in terms of quality of life and death rates; hence, there is an urgent need for developing safe and effective therapeutics against SARS-CoV-2."
      },
      {
        "text": "The most promising strategy to fight against this deadly virus is to develop an effective vaccine."
      },
      {
        "text": "Internalization of SARS-CoV-2 into the human host cell mainly occurs through the binding of the coronavirus spike protein (a trimeric surface glycoprotein) to the human angiotensin-converting enzyme 2 (ACE2) receptor."
      },
      {
        "text": "The spike-ACE2 protein-protein interaction is mediated through the receptor-binding domain (RBD) of the spike protein."
      },
      {
        "text": "Mutations in the spike RBD can significantly alter interactions with the ACE2 host receptor."
      },
      {
        "text": "Due to its important role in virus transmission, the spike RBD is considered to be one of the key molecular targets for vaccine development."
      },
      {
        "text": "In this study, a spike RBD-based subunit vaccine was designed by utilizing a ferritin protein nanocage as a scaffold."
      },
      {
        "text": "Several fusion protein constructs were designed in silico by connecting the spike RBD via a synthetic linker (different sizes) to different ferritin subunits (H-ferritin and L-ferritin)."
      },
      {
        "text": "The stability and the dynamics of the engineered nanocage constructs were tested by extensive molecular dynamics simulation (MDS)."
      },
      {
        "text": "Based on our MDS analysis, a five amino acid-based short linker (S-Linker) was the most effective for displaying the spike RBD over the surface of ferritin."
      },
      {
        "text": "The behavior of the spike RBD binding regions from the designed chimeric nanocages with the ACE2 receptor was highlighted."
      },
      {
        "text": "These data propose an effective multivalent synthetic nanocage, which might form the basis for new vaccine therapeutics designed against viruses such as SARS-CoV-2."
      }
    ]
  },
  "33670490": {
    "title": "Mitochondriopathies as a Clue to Systemic Disorders-Analytical Tools and Mitigating Measures in Context of Predictive, Preventive, and Personalized (3P) Medicine.",
    "sentences": [
      {
        "text": "The mitochondrial respiratory chain is the main site of reactive oxygen species (ROS) production in the cell."
      },
      {
        "text": "Although mitochondria possess a powerful antioxidant system, an excess of ROS cannot be completely neutralized and cumulative oxidative damage may lead to decreasing mitochondrial efficiency in energy production, as well as an increasing ROS excess, which is known to cause a critical imbalance in antioxidant/oxidant mechanisms and a \"vicious circle\" in mitochondrial injury."
      },
      {
        "text": "Due to insufficient energy production, chronic exposure to ROS overproduction consequently leads to the oxidative damage of life-important biomolecules, including nucleic acids, proteins, lipids, and amino acids, among others."
      },
      {
        "text": "Different forms of mitochondrial dysfunction (mitochondriopathies) may affect the brain, heart, peripheral nervous and endocrine systems, eyes, ears, gut, and kidney, among other organs."
      },
      {
        "text": "Consequently, mitochondriopathies have been proposed as an attractive diagnostic target to be investigated in any patient with unexplained progressive multisystem disorder."
      },
      {
        "text": "This review article highlights the pathomechanisms of mitochondriopathies, details advanced analytical tools, and suggests predictive approaches, targeted prevention and personalization of medical services as instrumental for the overall management of mitochondriopathy-related cascading pathologies."
      }
    ]
  },
  "33670304": {
    "title": "Drugs, Metabolites, and Lung Accumulating Small Lysosomotropic Molecules: Multiple Targeting Impedes SARS-CoV-2 Infection and Progress to COVID-19.",
    "sentences": [
      {
        "text": "Lysosomotropism is a biological characteristic of small molecules, independently present of their intrinsic pharmacological effects."
      },
      {
        "text": "Lysosomotropic compounds, in general, affect various targets, such as lipid second messengers originating from lysosomal enzymes promoting endothelial stress response in systemic inflammation; inflammatory messengers, such as IL-6; and cathepsin L-dependent viral entry into host cells."
      },
      {
        "text": "This heterogeneous group of drugs and active metabolites comprise various promising candidates with more favorable drug profiles than initially considered (hydroxy) chloroquine in prophylaxis and treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections/Coronavirus disease 2019 (COVID-19) and cytokine release syndrome (CRS) triggered by bacterial or viral infections."
      },
      {
        "text": "In this hypothesis, we discuss the possible relationships among lysosomotropism, enrichment in lysosomes of pulmonary tissue, SARS-CoV-2 infection, and transition to COVID-19."
      },
      {
        "text": "Moreover, we deduce further suitable approved drugs and active metabolites based with a more favorable drug profile on rational eligibility criteria, including readily available over-the-counter (OTC) drugs."
      },
      {
        "text": "Benefits to patients already receiving lysosomotropic drugs for other pre-existing conditions underline their vital clinical relevance in the current SARS-CoV2/COVID-19 pandemic."
      }
    ]
  },
  "33669738": {
    "title": "Computational Selectivity Assessment of Protease Inhibitors against SARS-CoV-2.",
    "sentences": [
      {
        "text": "The pandemic of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a serious global health threat."
      },
      {
        "text": "Since no specific therapeutics are available, researchers around the world screened compounds to inhibit various molecular targets of SARS-CoV-2 including its main protease (Mpro) essential for viral replication."
      },
      {
        "text": "Due to the high urgency of these discovery efforts, off-target binding, which is one of the major reasons for drug-induced toxicity and safety-related drug attrition, was neglected."
      },
      {
        "text": "Here, we used molecular docking, toxicity profiling, and multiple molecular dynamics (MD) protocols to assess the selectivity of 33 reported non-covalent inhibitors of SARS-CoV-2 Mpro against eight proteases and 16 anti-targets."
      },
      {
        "text": "The panel of proteases included SARS-CoV Mpro, cathepsin G, caspase-3, ubiquitin carboxy-terminal hydrolase L1 (UCHL1), thrombin, factor Xa, chymase, and prostasin."
      },
      {
        "text": "Several of the assessed compounds presented considerable off-target binding towards the panel of proteases, as well as the selected anti-targets."
      },
      {
        "text": "Our results further suggest a high risk of off-target binding to chymase and cathepsin G. Thus, in future discovery projects, experimental selectivity assessment should be directed toward these proteases."
      },
      {
        "text": "A systematic selectivity assessment of SARS-CoV-2 Mpro inhibitors, as we report it, was not previously conducted."
      }
    ]
  },
  "33669408": {
    "title": "The Role of Bcl-xL Protein in Viral Infections.",
    "sentences": [
      {
        "text": "Bcl-xL represents a family of proteins responsible for the regulation of the intrinsic apoptosis pathway."
      },
      {
        "text": "Due to its anti-apoptotic activity, Bcl-xL co-determines the viability of various virally infected cells."
      },
      {
        "text": "Their survival may determine the effectiveness of viral replication and spread, dynamics of systemic infection, and viral pathogenesis."
      },
      {
        "text": "In this paper, we have reviewed the role of Bcl-xL in the context of host infection by eight different RNA and DNA viruses: hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), influenza A virus (IAV), Epstein-Barr virus (EBV), human T-lymphotropic virus type-1 (HTLV-1), Maraba virus (MRBV), Schmallenberg virus (SBV) and coronavirus (CoV)."
      },
      {
        "text": "We have described an influence of viral infection on the intracellular level of Bcl-xL and discussed the impact of Bcl-xL-dependent cell survival control on infection-accompanying pathogenic events such as tissue damage or oncogenesis."
      },
      {
        "text": "We have also presented anti-viral treatment strategies based on the pharmacological regulation of Bcl-xL expression or activity."
      }
    ]
  },
  "33669218": {
    "title": "The Rheumatology Drugs for COVID-19 Management: Which and When?",
    "sentences": [
      {
        "text": "While waiting for the development of specific antiviral therapies and vaccines to effectively neutralize the SARS-CoV2, a relevant therapeutic strategy is to counteract the hyperinflammatory status, characterized by an increase mainly of interleukin (IL)-1Î², IL-2, IL-6, IL-7, IL-8, and tumor necrosis factor (TNF)-Î±, which hallmarks the most severe clinical cases."
      },
      {
        "text": "'Repurposing' immunomodulatory drugs and applying clinical management approved for rheumatic diseases represents a game-changer option."
      },
      {
        "text": "In this article, we will review the drugs that have indication in patients with COVID-19, including corticosteroids, antimalarials, anti-TNF, anti-IL-1, anti-IL-6, baricitinib, intravenous immunoglobulins, and colchicine."
      },
      {
        "text": "The PubMed, Medline, and Cochrane Library databases were searched for English-language papers concerning COVID-19 treatment published between January 2020 and October 2020."
      },
      {
        "text": "Results were summarized as a narrative review due to large heterogeneity among studies."
      },
      {
        "text": "In the absence of specific treatments, the use of immunomodulatory drugs could be advisable in severe COVID-19 patients, but clinical outcomes are still suboptimal."
      },
      {
        "text": "An early detection and treatment of the complications combined with a multidisciplinary approach could allow a better recovery of these patients."
      }
    ]
  },
  "33668602": {
    "title": "Covid-19 Symptomatic Patients with Oral Lesions: Clinical and Histopathological Study on 123 Cases of the University Hospital Policlinic of Bari with a Purpose of a New Classification.",
    "sentences": [
      {
        "text": "The aim of this study is to report on the oral lesions detected in 123 patients diagnosed at the University Hospital of Bari from October 2020 to December 2020, focusing on the correlation of clinical and pathological features in order to purpose a new classification."
      },
      {
        "text": "METHODS General and specialistic anamnesis were achieved and oral examination was performed."
      },
      {
        "text": "The following data were collected: age/gender, general symptoms and form of Covid-19, presence and features of taste disorders, day of appearance of the oral lesions, type and features of oral lesions and day of beginning of therapies."
      },
      {
        "text": "If ulcerative lesions did not heal, biopsy was performed."
      },
      {
        "text": "RESULTS Many types of oral lesions were found and classified into four groups considering the timing of appearance and the start of the therapies."
      },
      {
        "text": "Early lesions in the initial stages of Covid-19 before the start of therapies was observed in 65.9% of the patients."
      },
      {
        "text": "In the histopathological analysis of four early lesions, thrombosis of small and middle size vessels was always noticed with necrosis of superficial tissues."
      },
      {
        "text": "CONCLUSION The presence of oral lesions in early stages of Covid-19 could represent an initial sign of peripheral thrombosis, a warning sign of possible evolution to severe illness."
      },
      {
        "text": "This suggests that anticoagulant therapies should start as soon as possible."
      }
    ]
  },
  "33668493": {
    "title": "Obesity, Nutrients and the Immune System in the Era of COVID-19.",
    "sentences": [
      {
        "text": "The past year has shown that obesity is a risk factor for severe complications of SARS-CoV-2 infection."
      },
      {
        "text": "Excess fat mass during obesity is known to be a risk factor for chronic diseases but also for severe infections and infectious complications."
      },
      {
        "text": "We have focused here on the elements responsible for this particular susceptibility to infections and more specifically to COVID-19."
      },
      {
        "text": "Excess fat is, in itself, responsible for alterations of the immune system by disrupting the production and function of immune cells."
      },
      {
        "text": "Indeed, hypertrophic adipocytes produce more pro-inflammatory adipokines (including cytokines)."
      },
      {
        "text": "The increase in their apoptosis induces a release of pro-inflammatory compounds into the circulation and a recruitment of pro-inflammatory macrophages into the adipose tissue."
      },
      {
        "text": "A chronic systemic inflammatory state is then observed."
      },
      {
        "text": "In addition, diet, apart from its role in the development of adipose tissue, can also affect the immune system, with excess simple sugars and saturated fats exerting pro-inflammatory effects."
      },
      {
        "text": "This inflammation, the adipokines released by the adipocytes, and the infiltration of lipids into the lymphoid organs affects the production of immune cells and, directly, the functions of these cells."
      },
      {
        "text": "The alteration of the immune system increases the risk of infection as well as complications, including secondary bacterial infections and septic states, and increases infection-related mortality."
      },
      {
        "text": "During COVID-19, the chronic inflammatory state promotes the cytokine shock, characteristic of severe forms, caused in particular by excessive activation of the NLRP3 inflammasome."
      },
      {
        "text": "Furthermore, in obese subjects, the already present endothelial dysfunction will render endothelial inflammation (endotheliitis) due to viral infiltration all the more severe."
      },
      {
        "text": "Added to this is a state of hypercoagulability and a decrease in respiratory capacity, leading to a risk of severe COVID-19 with cardiovascular complications, acute respiratory distress syndrome, and disseminated intravascular coagulation, which can lead to multiple organ failure and even death."
      }
    ]
  },
  "33668405": {
    "title": "Comparative Transcriptome Profiling of Human and Pig Intestinal Epithelial Cells after Porcine Deltacoronavirus Infection.",
    "sentences": [
      {
        "text": "Porcine deltacoronavirus (PDCoV) is an emerging infectious disease of swine with zoonotic potential."
      },
      {
        "text": "Phylogenetic analysis suggests that PDCoV originated recently from a host-switching event between birds and mammals."
      },
      {
        "text": "Little is known about how PDCoV interacts with its differing hosts."
      },
      {
        "text": "Human-derived cell lines are susceptible to PDCoV infection."
      },
      {
        "text": "Herein, we compare the gene expression profiles of an established host swine cells to potential emerging host human cells after infection with PDCoV."
      },
      {
        "text": "Cell lines derived from intestinal lineages were used to reproduce the primary sites of viral infection in the host."
      },
      {
        "text": "Porcine intestinal epithelial cells (IPEC-J2) and human intestinal epithelial cells (HIEC) were infected with PDCoV."
      },
      {
        "text": "RNA-sequencing was performed on total RNA extracted from infected cells."
      },
      {
        "text": "Human cells exhibited a more pronounced response to PDCoV infection in comparison to porcine cells with more differentially expressed genes (DEGs) in human, 7486, in comparison to pig cells, 1134."
      },
      {
        "text": "On the transcriptional level, the adoptive host human cells exhibited more DEGs in response to PDCoV infection in comparison to the primary pig host cells, where different types of cytokines can control PDCoV replication and virus production."
      },
      {
        "text": "Key immune-associated DEGs and signaling pathways are shared between human and pig cells during PDCoV infection."
      },
      {
        "text": "These included genes related to the NF-kappa-B transcription factor family, the interferon (IFN) family, the protein-kinase family, and signaling pathways such as the apoptosis signaling pathway, JAK-STAT signaling pathway, inflammation/cytokine-cytokine receptor signaling pathway."
      },
      {
        "text": "MAP4K4 was unique in up-regulated DEGs in humans in the apoptosis signaling pathway."
      },
      {
        "text": "While similarities exist between human and pig cells in many pathways, our research suggests that the adaptation of PDCoV to the porcine host required the ability to down-regulate many response pathways including the interferon pathway."
      },
      {
        "text": "Our findings provide an important foundation that contributes to an understanding of the mechanisms of PDCoV infection across different hosts."
      },
      {
        "text": "To our knowledge, this is the first report of transcriptome analysis of human cells infected by PDCoV."
      }
    ]
  },
  "33665704": {
    "title": "Infectivity of deceased COVID-19 patients.",
    "sentences": [
      {
        "text": "The duration of infectivity of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) in living patients has been demarcated."
      },
      {
        "text": "In contrast, a possible SARS-CoV-2 infectivity of corpses and subsequently its duration under post mortem circumstances remain to be elucidated."
      },
      {
        "text": "The aim of this study was to investigate the infectivity and its duration of deceased COVID-19 (coronavirus disease) patients."
      },
      {
        "text": "Four SARS-CoV-2 infected deceased patients were subjected to medicolegal autopsy."
      },
      {
        "text": "Post mortem intervals (PMI) of 1, 4, 9 and 17 days, respectively, were documented."
      },
      {
        "text": "During autopsy, swabs and organ samples were taken and examined by RT-qPCR (real-time reverse transcription-polymerase chain reaction) for the detection of SARS-CoV-2 ribonucleic acid (RNA)."
      },
      {
        "text": "Determination of infectivity was performed by means of virus isolation in cell culture."
      },
      {
        "text": "In two cases, virus isolation was successful for swabs and tissue samples of the respiratory tract (PMI 4 and 17 days)."
      },
      {
        "text": "The two infectious cases showed a shorter duration of COVID-19 until death than the two non-infectious cases (2 and 11 days, respectively, compared to > 19 days), which correlates with studies of living patients, in which infectivity could be narrowed to about 6 days before to 12 days after symptom onset."
      },
      {
        "text": "Most notably, infectivity was still present in one of the COVID-19 corpses after a post-mortem interval of 17 days and despite already visible signs of decomposition."
      },
      {
        "text": "To prevent SARS-CoV-2 infections in all professional groups involved in the handling and examination of COVID-19 corpses, adequate personal safety standards (reducing or avoiding aerosol formation and wearing FFP3 [filtering face piece class 3] masks) have to be enforced for routine procedures."
      }
    ]
  },
  "33664446": {
    "title": "Polyunsaturated Ï-3 fatty acids inhibit ACE2-controlled SARS-CoV-2 binding and cellular entry.",
    "sentences": [
      {
        "text": "The strain SARS-CoV-2, newly emerged in late 2019, has been identified as the cause of COVID-19 and the pandemic declared by WHO in early 2020."
      },
      {
        "text": "Although lipids have been shown to possess antiviral efficacy, little is currently known about lipid compounds with anti-SARS-CoV-2 binding and entry properties."
      },
      {
        "text": "To address this issue, we screened, overall, 17 polyunsaturated fatty acids, monounsaturated fatty acids and saturated fatty acids, as wells as lipid-soluble vitamins."
      },
      {
        "text": "In performing target-based ligand screening utilizing the RBD-SARS-CoV-2 sequence, we observed that polyunsaturated fatty acids most effectively interfere with binding to hACE2, the receptor for SARS-CoV-2."
      },
      {
        "text": "Using a spike protein pseudo-virus, we also found that linolenic acid and eicosapentaenoic acid significantly block the entry of SARS-CoV-2."
      },
      {
        "text": "In addition, eicosapentaenoic acid showed higher efficacy than linolenic acid in reducing activity of TMPRSS2 and cathepsin L proteases, but neither of the fatty acids affected their expression at the protein level."
      },
      {
        "text": "Also, neither reduction of hACE2 activity nor binding to the hACE2 receptor upon treatment with these two fatty acids was observed."
      },
      {
        "text": "Although further in vivo experiments are warranted to validate the current findings, our study provides a new insight into the role of lipids as antiviral compounds against the SARS-CoV-2 strain."
      }
    ]
  },
  "33664395": {
    "title": "COVID-19 engages clinical markers for the management of cancer and cancer-relevant regulators of cell proliferation, death, migration, and immune response.",
    "sentences": [
      {
        "text": "Clinical reports show that the management of cancer patients infected with SARS-CoV-2 requires modifications."
      },
      {
        "text": "Understanding of cancer-relevant mechanisms engaged by the virus is essential for the evidence-based management of cancer."
      },
      {
        "text": "The network of SARS-CoV-2 regulatory mechanisms was used to study potential engagement of oncogenes, tumor suppressors, other regulators of tumorigenesis and clinical markers used in the management of cancer patients."
      },
      {
        "text": "Our network analysis confirms links between COVID-19 and tumorigenesis that were predicted in epidemiological reports."
      },
      {
        "text": "The COVID-19 network shows the involvement of tumorigenesis regulators and clinical markers."
      },
      {
        "text": "Regulators of cell proliferation, death, migration, and the immune system were retrieved."
      },
      {
        "text": "Examples are pathways initiated by EGF, VEGF, TGFÎ² and FGF."
      },
      {
        "text": "The SARS-CoV-2 network engages markers for diagnosis, prognosis and selection of treatment."
      },
      {
        "text": "Intersection with cancer diagnostic signatures supports a potential impact of the virus on tumorigenesis."
      },
      {
        "text": "Clinical observations show the diversity of symptoms correlating with biological processes and types of cells engaged by the virus, e.g. epithelial, endothelial, smooth muscle, glial and immune system cells."
      },
      {
        "text": "Our results describe an extensive engagement of cancer-relevant mechanisms and clinical markers by COVID-19."
      },
      {
        "text": "Engagement by the virus of clinical markers provides a rationale for clinical decisions based on these markers."
      }
    ]
  },
  "33664168": {
    "title": "COVID-19-associated coagulopathy: a concise review on pathogenesis and clinical implications.",
    "sentences": [
      {
        "text": "In this review, we summarize the possible mechanisms of COVID-19-associated coagulopathy and compare its features to other similar conditions."
      },
      {
        "text": "The recent COVID-19 pandemic has caused enormous mortality and morbidity worldwide."
      },
      {
        "text": "It is important to note that COVID-19-associated thrombotic events play a huge role in the morbidity of this disease."
      },
      {
        "text": "Interestingly, it has been observed that this complication may occur despite prophylactic anticoagulant therapy."
      },
      {
        "text": "Recent studies on COVID-19-associated coagulopathy revealed that the COVID-19-associated hypercoagulability is more frequently observed among those with a severe course of the disease."
      },
      {
        "text": "Various mechanisms have been suggested as explanations for this condition and possible underlying etiologies."
      }
    ]
  },
  "33662681": {
    "title": "Network pharmacology and RNA-sequencing reveal the molecular mechanism of Xuebijing injection on COVID-19-induced cardiac dysfunction.",
    "sentences": [
      {
        "text": "BACKGROUND Coronavirus disease 2019 (COVID-19) is an emerging infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)."
      },
      {
        "text": "Up to 20%-30% of patients hospitalized with COVID-19 have evidence of cardiac dysfunction."
      },
      {
        "text": "Xuebijing injection is a compound injection containing five traditional Chinese medicine ingredients, which can protect cells from SARS-CoV-2-induced cell death and improve cardiac function."
      },
      {
        "text": "However, the specific protective mechanism of Xuebijing injection on COVID-19-induced cardiac dysfunction remains unclear."
      },
      {
        "text": "METHODS The therapeutic effect of Xuebijing injection on COVID-19 was validated by the TCM Anti COVID-19 (TCMATCOV) platform."
      },
      {
        "text": "RNA-sequencing (RNA-seq) data from GSE150392 was used to find differentially expressed genes (DEGs) from human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) infected with SARS-CoV-2."
      },
      {
        "text": "Data from GSE151879 was used to verify the expression of Angiotensin I Converting Enzyme 2 (ACE2) and central hub genes in both human embryonic-stem-cell-derived cardiomyocytes (hESC-CMs) and adult human CMs with SARS-CoV-2 infection."
      },
      {
        "text": "RESULTS A total of 97 proteins were identified as the therapeutic targets of Xuebijing injection for COVID-19."
      },
      {
        "text": "There were 22 DEGs in SARS-CoV-2 infected hiPSC-CMs overlapped with the 97 therapeutic targets, which might be the therapeutic targets of Xuebijing injection on COVID-19-induced cardiac dysfunction."
      },
      {
        "text": "Based on the bioinformatics analysis, 7 genes (CCL2, CXCL8, FOS, IFNB1, IL-1A, IL-1B, SERPINE1) were identified as central hub genes and enriched in pathways including cytokines, inflammation, cell senescence and oxidative stress."
      },
      {
        "text": "ACE2, the receptor of SARS-CoV-2, and the 7 central hub genes were differentially expressed in at least two kinds of SARS-CoV-2 infected CMs. Besides, FOS and quercetin exhibited the tightest binding by molecular docking analysis."
      },
      {
        "text": "CONCLUSION Our study indicated the underlying protective effect of Xuebijing injection on COVID-19, especially on COVID19-induced cardiac dysfunction, which provided the theoretical basis for exploring the potential protective mechanism of Xuebijing injection on COVID19-induced cardiac dysfunction."
      }
    ]
  },
  "33662449": {
    "title": "SARS-CoV-2 and other coronaviruses negatively influence mitochondrial quality control: beneficial effects of melatonin.",
    "sentences": [
      {
        "text": "Coronaviruses (CoVs) are a group of single stranded RNA viruses, of which some of them such as SARS-CoV, MERS-CoV, and SARS-CoV-2 are associated with deadly worldwide human diseases."
      },
      {
        "text": "Coronavirus disease-2019 (COVID-19), a condition caused by SARS-CoV-2, results in acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) associated with high mortality in the elderly and in people with underlying comorbidities."
      },
      {
        "text": "Results from several studies suggest that CoVs localize in mitochondria and interact with mitochondrial protein translocation machinery to target their encoded products to mitochondria."
      },
      {
        "text": "Coronaviruses encode a number of proteins; this process is essential for viral replication through inhibiting degradation of viral proteins and host misfolded proteins including those in mitochondria."
      },
      {
        "text": "These viruses seem to maintain their replication by altering mitochondrial dynamics and targeting mitochondrial-associated antiviral signaling (MAVS), allowing them to evade host innate immunity."
      },
      {
        "text": "Coronaviruses infections such as COVID-19 are more severe in aging patients."
      },
      {
        "text": "Since endogenous melatonin levels are often dramatically reduced in the aged and because it is a potent anti-inflammatory agent, melatonin has been proposed to be useful in CoVs infections by altering proteasomal and mitochondrial activities."
      },
      {
        "text": "Melatonin inhibits mitochondrial fission due to its antioxidant and inhibitory effects on cytosolic calcium overload."
      },
      {
        "text": "The collective data suggests that melatonin may mediate mitochondrial adaptations through regulating both mitochondrial dynamics and biogenesis."
      },
      {
        "text": "We propose that melatonin may inhibit SARS-CoV-2-induced cell damage by regulating mitochondrial physiology."
      }
    ]
  },
  "33659858": {
    "title": "SARS-CoV-2 and endothelial cell interaction in COVID-19: molecular perspectives.",
    "sentences": [
      {
        "text": "SARS-CoV-2 is the agent responsible for the coronavirus disease (COVID-19), which has been declared a pandemic by the World Health Organization."
      },
      {
        "text": "The clinical evolution of COVID-19 ranges from asymptomatic infection to death."
      },
      {
        "text": "Older people and patients with underlying medical conditions, particularly diabetes, cardiovascular and chronic respiratory diseases are more susceptible to develop severe forms of COVID-19."
      },
      {
        "text": "Significant endothelial damage has been reported in COVID-19 and growing evidence supports the key pathophysiological role of this alteration in the onset and the progression of the disease."
      },
      {
        "text": "In particular, the impaired vascular homeostasis secondary to the structural and functional damage of the endothelium and its main component, the endothelial cells, contributes to the systemic proinflammatory state and the multiorgan involvement observed in COVID-19 patients."
      },
      {
        "text": "This review summarizes the current evidence supporting the proposition that the endothelium is a key target of SARS-CoV-2, with a focus on the molecular mechanisms involved in the interaction between SARS-CoV-2 and endothelial cells."
      }
    ]
  },
  "33521687": {
    "title": "Human eggs, zygotes, and embryos express the receptor angiotensin 1-converting enzyme 2 and transmembrane serine protease 2 protein necessary for severe acute respiratory syndrome coronavirus 2 infection.",
    "sentences": [
      {
        "text": "Objective To study messenger ribonucleic acid (mRNA) and protein expressions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) entry receptors (angiotensin 1-converting enzyme 2 [ACE2] and CD147) and proteases (transmembrane serine protease 2 [TMPRSS2] and cathepsin L [CTSL]) in human oocytes, embryos, and cumulus (CCs) and granulosa cells (GCs)."
      },
      {
        "text": "Design Research study."
      },
      {
        "text": "Setting Clinical inÂ vitro fertilization (IVF) treatment center."
      },
      {
        "text": "Patients Patients undergoing IVF were treated at the Colorado Center for Reproductive Medicine."
      },
      {
        "text": "Interventions Oocytes (germinal vesicle and metaphase II [MII]) and embryos (1-cell [1C] and blastocyst [BL]) were donated for research at the disposition by the patients undergoing IVF."
      },
      {
        "text": "Follicular cells (CC and GC) were collected from women undergoing egg retrieval after ovarian stimulation without an ovulatory trigger for inÂ vitro maturation/IVF treatment cycles."
      },
      {
        "text": "Main Outcome Measures Presence or absence of ACE2, CD147, TMPRSS2, and CTSL mRNAs detected using quantitative reverse transcription polymerase chain reaction and proteins detected using capillary Western blotting in human oocytes, embryos, and ovarian follicular cells."
      },
      {
        "text": "Results The quantitative reverse transcription polymerase chain reaction analysis revealed high abundance of ACE2 gene transcripts in germinal vesicle and MII oocytes than in CC, GC, and BL."
      },
      {
        "text": "ACE2 protein was present only in the MII oocytes, and 1C and BL embryos, but other ACE2 protein variants were observed in all the samples."
      },
      {
        "text": "TMPRSS2 protein was present in all the samples, whereas mRNA was observed only in the BL stage."
      },
      {
        "text": "All the samples were positive for CD147 and CTSL mRNA expressions."
      },
      {
        "text": "However, CCs and GCs were the only samples that showed coexpression of both CD147 and CTSL proteins in low abundance."
      },
      {
        "text": "Conclusions CCs and GCs are the least susceptible to SARS-CoV-2 infection because of lack of the required combination of receptors and proteases (ACE2/TMPRSS2 or CD147/CTSL) in high abundance."
      },
      {
        "text": "The coexpression of ACE2 and TMPRSS2 proteins in the MII oocytes, zygotes, and BLs demonstrated that these gametes and embryos have the cellular machinery required and, thus, are potentially susceptible to SARS-CoV-2 infection if exposed to the virus."
      },
      {
        "text": "However, we do not know whether the infection occurs inÂ vivo or inÂ vitro in an assisted reproductive technology setting yet."
      }
    ]
  },
  "33660566": {
    "title": "Host Defence RNases as Antiviral Agents against Enveloped Single Stranded RNA Viruses.",
    "sentences": [
      {
        "text": "Owing to the recent outbreak of Coronavirus Disease of 2019 (COVID-19), it is urgent to develop effective and safe drugs to treat the present pandemic and prevent other viral infections that might come in the future."
      },
      {
        "text": "Proteins from our own innate immune system can serve as ideal sources of novel drug candidates thanks to their safety and immune regulation versatility."
      },
      {
        "text": "Some host defense RNases equipped with antiviral activity have been reported over time."
      },
      {
        "text": "Here, we try to summarize the currently available information on human RNases that can target viral pathogens, with special focus on enveloped single-stranded RNA (ssRNA) viruses."
      },
      {
        "text": "Overall, host RNases can fight viruses by a combined multifaceted strategy, including the enzymatic target of the viral genome, recognition of virus unique patterns, immune modulation, control of stress granule formation, and induction of autophagy/apoptosis pathways."
      },
      {
        "text": "The review also includes a detailed description of representative enveloped ssRNA viruses and their strategies to interact with the host and evade immune recognition."
      },
      {
        "text": "For comparative purposes, we also provide an exhaustive revision of the currently approved or experimental antiviral drugs."
      },
      {
        "text": "Finally, we sum up the current perspectives of drug development to achieve successful eradication of viral infections."
      }
    ]
  },
  "33658066": {
    "title": "The important herbal pair for the treatment of COVID-19 and its possible mechanisms.",
    "sentences": [
      {
        "text": "BACKGROUND Coronavirus Disease 2019 (COVID-19) is an unprecedented disaster for people around the world."
      },
      {
        "text": "Many studies have shown that traditional Chinese medicine (TCM) are effective in treating COVID-19."
      },
      {
        "text": "However, it is difficult to find the most effective combination herbal pair among numerous herbs, as well as identifying its potential mechanisms."
      },
      {
        "text": "Herbal pair is the main form of a combination of TCM herbs, which is widely used for the treatment of diseases."
      },
      {
        "text": "It can also help us to better understand the compatibility of TCM prescriptions, thus improving the curative effects."
      },
      {
        "text": "The purpose of this article is to explore the compatibility of TCM prescriptions and identify the most important herbal pair for the treatment of COVID-19, and then analyze the active components and potential mechanisms of this herbal pair."
      },
      {
        "text": "METHODS We first systematically sorted the TCM prescriptions recommended by the leading experts for treating COVID-19, and the specific herbs contained in these prescriptions across different stages of the disease."
      },
      {
        "text": "Next, the association rule approach was employed to examine the distribution and compatibility among these TCM prescriptions, and then identify the most important herbal pair."
      },
      {
        "text": "On this basis, we further investigated the active ingredients and potential targets in the selected herbal pair by a network pharmacology approach, and analyzed the potential mechanisms against COVID-19."
      },
      {
        "text": "Finally, the main active compounds in the herbal pair were selected for molecular docking with severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) 3CLpro and angiotensin converting enzyme II (ACE2) for further verification."
      },
      {
        "text": "RESULT We obtained 32 association rules for the herbal combinations in the selection of TCM treatment for COVID-19."
      },
      {
        "text": "The results showed that the combination of Amygdalus Communis Vas (ACV) and Ephedra sinica Stapf (ESS) had the highest confidence degree and lift value, as well as high support degree, which can be used in almost all the stages of COVID-19, so ACV and ESS (AE) were selected as the most important herbal pair."
      },
      {
        "text": "There were 26 active ingredients and 44 potential targets, which might be related to the herbal pair of AE against COVID-19."
      },
      {
        "text": "The main active ingredients of AE against COVID-19 were quercetin, kaempferol, luteolin, while the potential targets were Interleukin 6 (IL-6), Mitogen-activated Protein Kinase 1 (MAPK)1, MAPK8, Interleukin-1Î² (IL-1Î²), and Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) p65 subunit (RELA)."
      },
      {
        "text": "The protein-protein interaction (PPI) cluster demonstrated that IL-6 was the seed in the cluster, which plays an important role in connecting other nodes in the PPI network."
      },
      {
        "text": "The potential pathways mainly involved tumor necrosis factor (TNF), Toll-like receptor (TLR), hypoxia-inducible factor-1 (HIF-1), and nucleotide-binding oligomerization domain (NOD)-like receptor (NLRs)."
      },
      {
        "text": "The molecular docking results showed that the main active ingredients of AE have good affinity with SARS-COV-2 3CLpro and ACE2, which are consistent with the above analysis."
      },
      {
        "text": "CONCLUSIONS There were 32 association rules in the TCM prescriptions recommended by experts for COVID-19."
      },
      {
        "text": "The combination of ACV and EAS was the most important herbal pair for the treatment of COVID-19."
      },
      {
        "text": "AE might have therapeutic effects against COVID-19 by affecting the inflammatory and immune responses, cell apoptosis, hypoxia damage and other pathological processes through multiple components, targets and pathways."
      }
    ]
  },
  "33657418": {
    "title": "SARS-CoV-2 Infects Human Pluripotent Stem Cell-Derived Cardiomyocytes, Impairing Electrical and Mechanical Function.",
    "sentences": [
      {
        "text": "COVID-19 patients often develop severe cardiovascular complications, but it remains unclear if these are caused directly by viral infection or are secondary to a systemic response."
      },
      {
        "text": "Here, we examine the cardiac tropism of SARS-CoV-2 in human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) and smooth muscle cells (hPSC-SMCs)."
      },
      {
        "text": "We find that that SARS-CoV-2 selectively infects hPSC-CMs through the viral receptor ACE2, whereas in hPSC-SMCs there is minimal viral entry or replication."
      },
      {
        "text": "After entry into cardiomyocytes, SARS-CoV-2 is assembled in lysosome-like vesicles and egresses via bulk exocytosis."
      },
      {
        "text": "The viral transcripts become a large fraction of cellular mRNA while host gene expression shifts from oxidative to glycolytic metabolism and upregulates chromatin modification and RNA splicing pathways."
      },
      {
        "text": "Most importantly, viral infection of hPSC-CMs progressively impairs both their electrophysiological and contractile function, and causes widespread cell death."
      },
      {
        "text": "These data support the hypothesis that COVID-19-related cardiac symptoms can result from a direct cardiotoxic effect of SARS-CoV-2."
      }
    ]
  },
  "33643308": {
    "title": "Immunomodulatory Effects of Azithromycin Revisited: Potential Applications to COVID-19.",
    "sentences": [
      {
        "text": "The rapid advancement of the COVID-19 pandemic has prompted an accelerated pursuit to identify effective therapeutics."
      },
      {
        "text": "Stages of the disease course have been defined by viral burden, lung pathology, and progression through phases of the immune response."
      },
      {
        "text": "Immunological factors including inflammatory cell infiltration and cytokine storm have been associated with severe disease and death."
      },
      {
        "text": "Many immunomodulatory therapies for COVID-19 are currently being investigated, and preliminary results support the premise of targeting the immune response."
      },
      {
        "text": "However, because suppressing immune mechanisms could also impact the clearance of the virus in the early stages of infection, therapeutic success is likely to depend on timing with respect to the disease course."
      },
      {
        "text": "Azithromycin is an immunomodulatory drug that has been shown to have antiviral effects and potential benefit in patients with COVID-19."
      },
      {
        "text": "Multiple immunomodulatory effects have been defined for azithromycin which could provide efficacy during the late stages of the disease, including inhibition of pro-inflammatory cytokine production, inhibition of neutrophil influx, induction of regulatory functions of macrophages, and alterations in autophagy."
      },
      {
        "text": "Here we review the published evidence of these mechanisms along with the current clinical use of azithromycin as an immunomodulatory therapeutic."
      },
      {
        "text": "We then discuss the potential impact of azithromycin on the immune response to COVID-19, as well as caution against immunosuppressive and off-target effects including cardiotoxicity in these patients."
      },
      {
        "text": "While azithromycin has the potential to contribute efficacy, its impact on the COVID-19 immune response requires additional characterization so as to better define its role in individualized therapy."
      }
    ]
  },
  "33634266": {
    "title": "First and Second Waves of Coronavirus Disease 2019 in Madrid, Spain: Clinical Characteristics and Hematological Risk Factors Associated With Critical/Fatal Illness.",
    "sentences": [
      {
        "text": "Objectives This study aims to determine similarities and differences in clinical characteristics between the patients from two waves of severe acute respiratory syndrome coronavirus-2 infection at the time of hospital admission, as well as to identify risk biomarkers of coronavirus disease 2019 severity."
      },
      {
        "text": "Design Retrospective observational study."
      },
      {
        "text": "Setting A single tertiary-care center in Madrid."
      },
      {
        "text": "Patients Coronavirus disease 2019 adult patients admitted to hospital from March 4, 2020, to March 25, 2020 (first infection wave), and during July 18, 2020, and August 20, 2020 (second infection wave)."
      },
      {
        "text": "Interventions Treatment with a hospital-approved drug cocktail during hospitalization."
      },
      {
        "text": "Measurements and Main Results Demographic, clinical, and laboratory data were compared between the patients with moderate and critical/fatal illness across both infection waves."
      },
      {
        "text": "The median age of patients with critical/fatal coronavirus disease 2019 was 67.5 years (interquartile range, 56.75-78.25 yr; 64.5% male) in the first wave and 59.0 years (interquartile range, 48.25-80.50 yr; 70.8% male) in the second wave."
      },
      {
        "text": "Hypertension and dyslipidemia were major comorbidities in both waves."
      },
      {
        "text": "Body mass index over 25 and presence of bilateral pneumonia were common findings."
      },
      {
        "text": "Univariate logistic regression analyses revealed an association of a number of blood parameters with the subsequent illness progression and severity in both waves."
      },
      {
        "text": "However, some remarkable differences were detected between both waves that prevented an accurate extrapolation of prediction models from the first wave into the second wave."
      },
      {
        "text": "Interleukin-6 and d-dimer concentrations at the time of hospital admission were remarkably higher in patients who developed a critical/fatal condition only during the first wave (p < 0.001), although both parameters significantly increased with disease worsening in follow-up studies from both waves."
      },
      {
        "text": "Multivariate analyses from wave 1 rendered a predictive signature for critical/fatal illness upon hospital admission that comprised six blood biomarkers: neutrophil-to-lymphocyte ratio (â¥ 5; odds ratio, 2.684 [95% CI, 1.143-6.308]), C-reactive protein (â¥ 15.2âmg/dL; odds ratio, 2.412 [95% CI, 1.006-5.786]), lactate dehydrogenase (â¥ 411.96 U/L; odds ratio, 2.875 [95% CI, 1.229-6.726]), interleukin-6 (â¥ 78.8 pg/mL; odds ratio, 5.737 [95% CI, 2.432-13.535]), urea (â¥ 40âmg/dL; odds ratio, 1.701 [95% CI, 0.737-3.928]), and d-dimer (â¥ 713âng/mL; odds ratio, 1.903 [95% CI, 0.832-4.356])."
      },
      {
        "text": "The predictive accuracy of the signature was 84% and the area under the receiver operating characteristic curve was 0.886."
      },
      {
        "text": "When the signature was validated with data from wave 2, the accuracy was 81% and the area under the receiver operating characteristic curve value was 0.874, albeit most biomarkers lost their independent significance."
      },
      {
        "text": "Follow-up studies reassured the importance of monitoring the biomarkers included in the signature, since dramatic increases in the levels of such biomarkers occurred in critical/fatal patients over disease progression."
      },
      {
        "text": "Conclusions Most parameters analyzed behaved similarly in the two waves of coronavirus disease 2019."
      },
      {
        "text": "However, univariate logistic regression conducted in both waves revealed differences in some parameters associated with poor prognosis in wave 1 that were not found in wave 2, which may reflect a different disease stage of patients on arrival to hospital."
      },
      {
        "text": "The six-biomarker predictive signature reported here constitutes a helpful tool to classify patient's prognosis on arrival to hospital."
      }
    ]
  },
  "33655266": {
    "title": "Endothelium-protective, histone-neutralizing properties of the polyanionic agent defibrotide.",
    "sentences": [
      {
        "text": "Neutrophil-mediated activation and injury of the endothelium play a role in the pathogenesis of diverse disease states ranging from autoimmunity to cancer to COVID-19."
      },
      {
        "text": "Neutralization of cationic proteins (such as neutrophil extracellular trap/NET-derived histones) with polyanionic compounds has been suggested as a potential strategy for protecting the endothelium from such insults."
      },
      {
        "text": "Here, we report that the FDA-approved polyanionic agent defibrotide (a pleotropic mixture of oligonucleotides) directly engages histones and thereby blocks their pathological effects on endothelium."
      },
      {
        "text": "In vitro , defibrotide counteracted endothelial cell activation and cell death, whether triggered by purified NETs, COVID-19 serum containing high levels of NETs, or recombinant histone H4."
      },
      {
        "text": "In vivo , defibrotide stabilized the endothelium and protected against histone-accelerated inferior vena cava thrombosis in mice."
      },
      {
        "text": "Mechanistically, defibrotide demonstrated direct and tight binding to histone H4 as detected by both electrophoretic mobility shift assay and surface plasmon resonance."
      },
      {
        "text": "Taken together, these data provide insights into the potential role of polyanionic compounds in protecting the endothelium from thromboinflammation with potential implications for myriad NET- and histone-accelerated disease states."
      }
    ]
  },
  "33652988": {
    "title": "SARS-CoV-2 Infection and Disease Modelling Using Stem Cell Technology and Organoids.",
    "sentences": [
      {
        "text": "In this Review, we briefly describe the basic virology and pathogenesis of SARS-CoV-2, highlighting how stem cell technology and organoids can contribute to the understanding of SARS-CoV-2 cell tropisms and the mechanism of disease in the human host, supporting and clarifying findings from clinical studies in infected individuals."
      },
      {
        "text": "We summarize here the results of studies, which used these technologies to investigate SARS-CoV-2 pathogenesis in different organs."
      },
      {
        "text": "Studies with in vitro models of lung epithelia showed that alveolar epithelial type II cells, but not differentiated lung alveolar epithelial type I cells, are key targets of SARS-CoV-2, which triggers cell apoptosis and inflammation, while impairing surfactant production."
      },
      {
        "text": "Experiments with human small intestinal organoids and colonic organoids showed that the gastrointestinal tract is another relevant target for SARS-CoV-2."
      },
      {
        "text": "The virus can infect and replicate in enterocytes and cholangiocytes, inducing cell damage and inflammation."
      },
      {
        "text": "Direct viral damage was also demonstrated in in vitro models of human cardiomyocytes and choroid plexus epithelial cells."
      },
      {
        "text": "At variance, endothelial cells and neurons are poorly susceptible to viral infection, thus supporting the hypothesis that neurological symptoms and vascular damage result from the indirect effects of systemic inflammatory and immunological hyper-responses to SARS-CoV-2 infection."
      }
    ]
  },
  "33652685": {
    "title": "Animal Coronaviruses Induced Apoptosis.",
    "sentences": [
      {
        "text": "Apoptosis is a form of programmed death that has also been observed in cells infected by several viruses."
      },
      {
        "text": "It is considered one of the most critical innate immune mechanisms that limits pathogen proliferation and propagation before the initiation of the adaptive immune response."
      },
      {
        "text": "Recent studies investigating the cellular responses to SARS-CoV and SARS-CoV-2 infection have revealed that coronaviruses can alter cellular homeostasis and promote cell death, providing evidence that the modulation of apoptotic pathways is important for viral replication and propagation."
      },
      {
        "text": "Despite the genetic diversity among different coronavirus clades and the infection of different cell types and several hosts, research studies in animal coronaviruses indicate that apoptosis in host cells is induced by common molecular mechanisms and apoptotic pathways."
      },
      {
        "text": "We summarize and critically review current knowledge on the molecular aspects of cell-death regulation during animal coronaviruses infection and the viral-host interactions to this process."
      },
      {
        "text": "Future research is expected to lead to a better understanding of the regulation of cell death during coronavirus infection."
      },
      {
        "text": "Moreover, investigating the role of viral proteins in this process will help us to identify novel antiviral targets related to apoptotic signaling pathways."
      }
    ]
  },
  "33564760": {
    "title": "Discovery of re-purposed drugs that slow SARS-CoV-2 replication in human cells.",
    "sentences": [
      {
        "text": "Background The SARS-CoV-2 virus has caused the death of over 2 million people worldwide during the COVID-19 pandemic."
      },
      {
        "text": "Whilst effective vaccines have been developed and vaccination schedules are being rolled out, the identification of safe and inexpensive drugs to slow the replication of SARS-CoV-2 could help thousands of people worldwide whilst awaiting vaccination."
      },
      {
        "text": "Methods Using SARS-CoV-2 tagged with nano-luciferase (SARS-CoV-2-ÎOrf7a-NLuc) we screened a variety of cells under optimised cell culture conditions for their ability to be infected by, and support the replication of, SARS-CoV-2."
      },
      {
        "text": "Electron microscopy was used to demonstrate generation of infectious virus particles."
      },
      {
        "text": "We assessed a library of 1971 FDA-approved drugs for their ability to inhibit or enhance viral replication in Vero (simian kidney cells) but also in the human hepatocyte cell, HUH7."
      },
      {
        "text": "Initial hits were further tested to identify compounds that could suppress viral replication, post-viral infection."
      },
      {
        "text": "Dose response curves were obtained for a shortlist of 9 compounds of interest (COI)."
      },
      {
        "text": "Findings Our SARS-CoV-2-ÎOrf7a-NLuc virus was as effective as wild-type SARS-CoV-2 in inducing CPE and replicating in Vero cells."
      },
      {
        "text": "Conventional electron microscopy showed the NLuc-tagged virus to be structurally indistinguishable from the wild-type virus, and both could be identified within the endosomal system of infected cells."
      },
      {
        "text": "SARS-CoV-2-ÎOrf7a-NLuc was used in experiments to robustly quantitate virus infection and replication."
      },
      {
        "text": "A wide variety of human cells including lung fibroblasts and epithelial cells were susceptible to infection but were not effective in supporting SARS-CoV-2-ÎOrf7a-NLuc replication."
      },
      {
        "text": "In contrast, human kidney epithelial cells and human hepatic cells were particularly susceptible and supported SARS-CoV-2-replication, which is in-line with reported proteinuria and liver damage in patients with COVID-19."
      },
      {
        "text": "Our screening of FDA approved compounds identified 35 COI that inhibited virus infection and replication in either Vero or human cell lines."
      },
      {
        "text": "Nine of these also inhibited SARS-CoV-2 replication when treatment commenced after virus infection."
      },
      {
        "text": "Therapeutics approved for treatment of cancer, malaria, hypertension and viral infection were identified with atovaquone, manidipine, vitamin D3 and ebastine being well tolerated with minimal side effects."
      },
      {
        "text": "Only two COI were consistently found to enhance SARS-CoV-2 replication, aliskiren and lithocholic acid."
      },
      {
        "text": "Interpretation Re-purposing of safe, well-tolerated FDA-approved drugs that inhibit SARS-CoV-2 replication is an attractive strategy to reduce the risk of COVID-19 infection prior to receiving an effective vaccine."
      },
      {
        "text": "The COI identified here hold potential to contain COVID-19 whilst wide-scale vaccination proceeds."
      },
      {
        "text": "The identification of FDA-approved drugs that enhance SARS-CoV-2 replication in human cells suggests that entry routes into cells can be made more accessible to the virus by certain medications."
      },
      {
        "text": "The information provided in this research paper is for information only and is not meant to be a substitute for advice provided by a doctor or other qualified health care professional."
      },
      {
        "text": "Funding The research was funded by a grant from the Wellcome Trust (110126/Z/15/Z) to KEK."
      },
      {
        "text": "The Cat 3 facilities were made possible by an award from the BBSRC (BB/T00083X/1) to Jennifer Cavet."
      }
    ]
  },
  "33651717": {
    "title": "Cell-free DNA maps COVID-19 tissue injury and risk of death and can cause tissue injury.",
    "sentences": [
      {
        "text": "INTRODUCTIONThe clinical course of coronavirus 2019 (COVID-19) is heterogeneous, ranging from mild to severe multiorgan failure and death."
      },
      {
        "text": "In this study, we analyzed cell-free DNA (cfDNA) as a biomarker of injury to define the sources of tissue injury that contribute to such different trajectories."
      },
      {
        "text": "METHODSWe conducted a multicenter prospective cohort study to enroll patients with COVID-19 and collect plasma samples."
      },
      {
        "text": "Plasma cfDNA was subject to bisulfite sequencing."
      },
      {
        "text": "A library of tissue-specific DNA methylation signatures was used to analyze sequence reads to quantitate cfDNA from different tissue types."
      },
      {
        "text": "We then determined the correlation of tissue-specific cfDNA measures to COVID-19 outcomes."
      },
      {
        "text": "Similar analyses were performed for healthy controls and a comparator group of patients with respiratory syncytial virus and influenza."
      },
      {
        "text": "RESULTSWe found markedly elevated levels and divergent tissue sources of cfDNA in COVID-19 patients compared with patients who had influenza and/or respiratory syncytial virus and with healthy controls."
      },
      {
        "text": "The major sources of cfDNA in COVID-19 were hematopoietic cells, vascular endothelium, hepatocytes, adipocytes, kidney, heart, and lung."
      },
      {
        "text": "cfDNA levels positively correlated with COVID-19 disease severity, C-reactive protein, and D-dimer."
      },
      {
        "text": "cfDNA profile at admission identified patients who subsequently required intensive care or died during hospitalization."
      },
      {
        "text": "Furthermore, the increased cfDNA in COVID-19 patients generated excessive mitochondrial ROS (mtROS) in renal tubular cells in a concentration-dependent manner."
      },
      {
        "text": "This mtROS production was inhibited by a TLR9-specific antagonist."
      },
      {
        "text": "CONCLUSIONcfDNA maps tissue injury that predicts COVID-19 outcomes and may mechanistically propagate COVID-19-induced tissue injury."
      },
      {
        "text": "FUNDINGIntramural Targeted Anti-COVID-19 grant, NIH."
      }
    ]
  },
  "33649297": {
    "title": "SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes.",
    "sentences": [
      {
        "text": "Infection by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been associated with leukopenia and uncontrolled inflammatory response in critically ill patients."
      },
      {
        "text": "A better comprehension of SARS-CoV-2-induced monocyte death is essential for the identification of therapies capable to control the hyper-inflammation and reduce viral replication in patients with 2019 coronavirus disease (COVID-19)."
      },
      {
        "text": "Here, we show that SARS-CoV-2 engages inflammasome and triggers pyroptosis in human monocytes, experimentally infected, and from patients under intensive care."
      },
      {
        "text": "Pyroptosis associated with caspase-1 activation, IL-1Ã production, gasdermin D cleavage, and enhanced pro-inflammatory cytokine levels in human primary monocytes."
      },
      {
        "text": "At least in part, our results originally describe mechanisms by which monocytes, a central cellular component recruited from peripheral blood to respiratory tract, succumb to control severe COVID-19."
      }
    ]
  },
  "33648924": {
    "title": "Extensive longitudinal immune profiling reveals sustained innate immune activation in COVID-19 patients with unfavorable outcome",
    "sentences": [
      {
        "text": "COVID-19 differs substantially between individuals, ranging from mild to severe or even fatal."
      },
      {
        "text": "Heterogeneity in the immune response against SARS-COV-2 likely contributes to this."
      },
      {
        "text": "Therefore, we explored the temporal dynamics of key cellular and soluble mediators of innate and adaptive immune activation in relation to COVID-19 severity and progression."
      },
      {
        "text": "Forty-four patients with a PCR-proven diagnosis of COVID-19 were included."
      },
      {
        "text": "Extensive cellular (leukocytes and T-lymphocyte subsets) and serological immune profiling (cytokines, soluble cell surface molecules, and SARS-CoV-2 antibodies) was performed at hospital admission and every 3-4 days during hospitalization."
      },
      {
        "text": "Measurements and disease outcome were compared between patients with an unfavorable (IC admission and/or death) and favorable (all others) outcome."
      },
      {
        "text": "Patients with an unfavorable outcome had higher leukocyte numbers at baseline, mostly due to increased neutrophils, whereas lymphocyte and monocyte numbers were reduced."
      },
      {
        "text": "CRP, IL-6, CCL2, CXCL10, and GM-CSF levels were higher at baseline in the unfavorable group, whereas IL-7 levels were lower."
      },
      {
        "text": "SARS-CoV-2 antibodies were more frequently absent in the unfavorable group."
      },
      {
        "text": "Longitudinal analysis revealed delayed kinetics of activated CD4 and CD8 T-lymphocyte subsets in the unfavorable group."
      },
      {
        "text": "Furthermore, whereas CRP, IL-6, CXCL10, and GM-CSF declined in the favorable group, these cytokines declined with delayed kinetics, remained increased, or even increased further in the unfavorable group."
      },
      {
        "text": "Our data indicate a state of increased innate immune activation in COVID19-patients with an unfavorable outcome at hospital admission, which remained over time, as compared with patients with a favorable outcome."
      }
    ]
  },
  "33645977": {
    "title": "Boceprevir, Calpain Inhibitors II and XII, and GC-376 Have Broad-Spectrum Antiviral Activity against Coronaviruses.",
    "sentences": [
      {
        "text": "As the COVID-19 pandemic continues to unfold, the morbidity and mortality are increasing daily."
      },
      {
        "text": "Effective treatment for SARS-CoV-2 is urgently needed."
      },
      {
        "text": "We recently discovered four SARS-CoV-2 main protease (Mpro) inhibitors including boceprevir, calpain inhibitors II and XII, and GC-376 with potent antiviral activity against infectious SARS-CoV-2 in cell culture."
      },
      {
        "text": "In this study, we further characterized the mechanism of action of these four compounds using the SARS-CoV-2 pseudovirus neutralization assay."
      },
      {
        "text": "It was found that GC-376 and calpain inhibitors II and XII have a dual mechanism of action by inhibiting both viral Mpro and host cathepsin L in Vero cells."
      },
      {
        "text": "To rule out the cell-type dependent effect, the antiviral activity of these four compounds against SARS-CoV-2 was also confirmed in type 2 transmembrane serine protease-expressing Caco-2 cells using the viral yield reduction assay."
      },
      {
        "text": "In addition, we found that these four compounds have broad-spectrum antiviral activity in inhibiting not only SARS-CoV-2 but also SARS-CoV, and MERS-CoV, as well as human coronaviruses (CoVs) 229E, OC43, and NL63."
      },
      {
        "text": "The mechanism of action is through targeting the viral Mpro, which was supported by the thermal shift-binding assay and enzymatic fluorescence resonance energy transfer assay."
      },
      {
        "text": "We further showed that these four compounds have additive antiviral effect when combined with remdesivir."
      },
      {
        "text": "Altogether, these results suggest that boceprevir, calpain inhibitors II and XII, and GC-376 might be promising starting points for further development against existing human coronaviruses as well as future emerging CoVs."
      }
    ]
  },
  "33644724": {
    "title": "Abnormal liver tests in patients with SARS-CoV-2 or influenza - prognostic similarities and temporal disparities.",
    "sentences": [
      {
        "text": "Background & Aims Abnormal liver tests are common in patients with severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) infection, but a possible direct role of the virus in liver injury and its association with short-term outcomes are controversial."
      },
      {
        "text": "Therefore, we aimed to compare the pattern of abnormal liver tests in SARS-CoV-2 patients with those of patients infected with influenza, a non-hepatotropic respiratory virus, and their association with worse outcomes during hospitalization."
      },
      {
        "text": "Methods A retrospective cohort study of 1737 hospitalized patients (865 with influenza and 872 with SARS-Cov-2) in a tertiary medical center."
      },
      {
        "text": "We defined abnormal liver tests as GPT or GOT â¥40IU/ML at any time-point during hospitalization."
      },
      {
        "text": "Results Abnormal liver tests were mild-moderate in the majority of patients regardless of infection type, but the majority of patients with influenza had a transaminases peak earlier during hospitalization compared to patients with SARS-Cov-2."
      },
      {
        "text": "Abnormal liver tests correlated with markers of severe disease in either influenza or SARS-Cov-2 infections, and were associated with death, occurring mainly in patients with severe liver tests abnormalities (>200IU/L) (38.7% and 60% of patients with influenza or SARS-Cov-2, respectively)."
      },
      {
        "text": "In multivariate analysis, controlling for age, gender, lymphopenia and CRP, liver tests abnormalities remained significantly associated with death for influenza (OR= 4.344, 95% CI 2.218-8.508) and SARS-Cov-2 (OR= 3.898, 95% CI 2.203-6.896)."
      },
      {
        "text": "These results were confirmed upon propensity score matching."
      },
      {
        "text": "Conclusions Abnormal liver tests during hospitalization with SARS-Cov-2 or influenza infections are common, may differ in their time-course and reflect disease severity."
      },
      {
        "text": "They are associated with worse outcomes, mainly in patients with severe liver test abnormalities, regardless of infection type."
      }
    ]
  },
  "33642886": {
    "title": "Smoking and COVID-19: A Scoping Review.",
    "sentences": [
      {
        "text": "Smoking affects a person's overall health and damages nearly every organ of the body."
      },
      {
        "text": "Since smoking tobacco affects and damages the lungs, it increases the risk of respiratory infections and makes it easier for the coronavirus disease (COVID-19) to invade the lung tissue, causing more severe symptoms and increasing the risk of death."
      },
      {
        "text": "However, debates are still ongoing as to the effect of cigarette smoking on vulnerability to COVID-19."
      },
      {
        "text": "Some studies, where active smokers were underrepresented among patients with COVID-19, claimed that a \"smoker's paradox\" may exist in COVID-19 and that smokers are protected from infection and severe complications of COVID-19."
      },
      {
        "text": "However, other studies reported the opposite trend."
      },
      {
        "text": "The objective of this study is to review the findings of epidemiological and in vitro studies about the association between smoking and the risk of contracting COVID-19, taking into account disease severity."
      },
      {
        "text": "Several epidemiological studies have found a higher smoking prevalence among COVID-19 infected patients."
      },
      {
        "text": "Also, studies had shown that people with respiratory diseases caused by tobacco use are at higher risk of developing severe COVID-19 symptoms."
      },
      {
        "text": "Studies have shown that in vitro, the acute exposure allows for more severe proximal airway epithelial disease from SARS-CoV-2 by reducing the mucosal innate immune response and the proliferation of airway basal stem cells and has implications for disease spread and severity in people exposed to cigarette smoke, with a more severe viral infection and cell death."
      },
      {
        "text": "Smoker patients with different comorbidities are at higher risk of contracting the COVID-19 virus and have a worse prognosis for the virus as well as for their comorbidities."
      },
      {
        "text": "Further investigations of the interaction between smoking and COVID-19 are warranted to accurately assess the risk of contracting COVID-19 among smokers, and the progression to mechanical ventilation or death in patients who suffer from it."
      }
    ]
  },
  "33641657": {
    "title": "Challenges of Hematopoietic Stem Cell Transplantation in the Era of COVID-19.",
    "sentences": [
      {
        "text": "The coronavirus disease 2019 (COVID-19) pandemic raised unprecedented concerns in the hematopoietic stem cell transplant community."
      },
      {
        "text": "The diagnosis of COVID-19 in these transplant recipients may require extensive laboratory testing and high clinical suspicion, as atypical clinical manifestations or other respiratory viral infections are common in this patient population."
      },
      {
        "text": "The underlying malignancies, immunosuppressed state, frequently observed coinfections, and advanced age in some patients may also predispose them to worse clinical outcomes."
      },
      {
        "text": "Similar outcomes have been previously described with other human coronaviruses, including the severe acute respiratory syndrome coronavirus and the Middle East respiratory syndrome coronavirus."
      },
      {
        "text": "Many hematopoietic stem cell transplant organizations have issued elaborative guidelines that aim to prevent transmission and hence adverse patient outcomes."
      },
      {
        "text": "All potential donors are thoroughly screened, and donated products are cryopreserved in advance."
      },
      {
        "text": "Potential hematopoietic stem cell transplant recipients are also screened, and most nonurgent transplant cases with low risk of progression and/or death are deferred."
      },
      {
        "text": "Current hematopoietic stem cell transplant recipients should adhere to precaution and isolation measures, while their transplant units should also follow strict safety protocols, similar to other infectious outbreaks."
      },
      {
        "text": "The prolonged susceptibility of hematopoietic stem cell transplant recipients to respiratory viral infections might necessitate extending these measures even after the peak of the outbreak until a gradually return to normality is possible."
      }
    ]
  },
  "33641587": {
    "title": "COVID-19: Immunology, Immunopathogenesis and Potential Therapies.",
    "sentences": [
      {
        "text": "The Coronavirus Disease-2019 (COVID-19) imposed public health emergency and affected millions of people around the globe."
      },
      {
        "text": "As of January 2021, 100 million confirmed cases of COVID-19 along with more than 2 million deaths were reported worldwide."
      },
      {
        "text": "SARS-CoV-2 infection causes excessive production of pro-inflammatory cytokines thereby leading to the development of \"Cytokine Storm Syndrome\"."
      },
      {
        "text": "This condition results in uncontrollable inflammation that further imposes multiple-organ-failure eventually leading to death."
      },
      {
        "text": "SARS-CoV-2 induces unrestrained innate immune response and impairs adaptive immune responses thereby causing tissue damage."
      },
      {
        "text": "Thus, understanding the foremost features and evolution of innate and adaptive immunity to SARS-CoV-2 is crucial in anticipating COVID-19 outcomes and in developing effective strategies to control the viral spread."
      },
      {
        "text": "In the present review, we exhaustively discuss the sequential key immunological events that occur during SARS-CoV-2 infection and are involved in the immunopathogenesis of COVID-19."
      },
      {
        "text": "In addition to this, we also highlight various therapeutic options already in use such as immunosuppressive drugs, plasma therapy and intravenous immunoglobulins along with various novel potent therapeutic options that should be considered in managing COVID-19 infection such as traditional medicines and probiotics."
      }
    ]
  },
  "33640537": {
    "title": "Inflammation, immunity and potential target therapy of SARS-COV-2: A total scale analysis review.",
    "sentences": [
      {
        "text": "Coronavirus disease-19 (COVID-19) is a complex disease that causes illness ranging from mild to severe respiratory problems."
      },
      {
        "text": "It is caused by a novel coronavirus SARS-CoV-2 (Severe acute respiratory syndrome coronavirus-2) that is an enveloped positive-sense single-stranded RNA (+ssRNA) virus belongs to coronavirus CoV family."
      },
      {
        "text": "It has a fast-spreading potential worldwide, which leads to high mortality regardless of lows death rates."
      },
      {
        "text": "Now some vaccines or a specific drug are approved but not available for every country for disease prevention and/or treatment."
      },
      {
        "text": "Therefore, it is a high demand to identify the known drugs and test them as a possible therapeutic approach."
      },
      {
        "text": "In this critical situation, one or more of these drugs may represent the only option to treat or reduce the severity of the disease, until some specific drugs or vaccines will be developed and/or approved for everyone in this pandemic."
      },
      {
        "text": "In this updated review, the available repurpose immunotherapeutic treatment strategies are highlighted, elucidating the crosstalk between the immune system and SARS-CoV-2."
      },
      {
        "text": "Despite the reasonable data availability, the effectiveness and safety of these drugs against SARS-CoV-2 needs further studies and validations aiming for a better clinical outcome."
      }
    ]
  },
  "33640208": {
    "title": "Administration of high titer convalescent anti-SARS-CoV-2 plasma: From donor selection to monitoring recipient outcomes.",
    "sentences": [
      {
        "text": "Early in the SARS-CoV-2 pandemic, convalescent plasma (CP) therapy was proposed as a treatment for severely ill patients."
      },
      {
        "text": "We conducted a CP treatment protocol under the Mayo Clinic Extended Access Program at University Hospital Brooklyn (UHB)."
      },
      {
        "text": "Potential donors were screened with a lateral flow assay (LFA) for IgM and IgG antibodies against the SARS-CoV-2 S1 receptor-binding domain (RBD)."
      },
      {
        "text": "Volunteers that were LFA positive were tested with an ELISA to measure IgG titers against the RBD."
      },
      {
        "text": "Subjects with titers of at least 1:1024 were selected to donate."
      },
      {
        "text": "Most donors with positive LFA had acceptable titers and were eligible to donate."
      },
      {
        "text": "Out of 171 volunteers, only 65 tested positive in the LFA (38.0%), and 55 (32.2%) had titers of at least 1:1024."
      },
      {
        "text": "Before our donation program started, 31 CP units were procured from the New York Blood Center (NYBC)."
      },
      {
        "text": "Among the 31 CP units that were obtained from the NYBC, 25 units (80.6%) were positive in the LFA but only 12 units (38.7%) had titers of at least 1:1024."
      },
      {
        "text": "CP was administered to 28 hospitalized COVID-19 patients."
      },
      {
        "text": "Patients who received low titer CP, high titer CP and patients who did not receive CP were followed for 45Â days after presentation."
      },
      {
        "text": "Severe adverse events were not associated with CP transfusion."
      },
      {
        "text": "Death was a less frequent outcome for patients that received high titer CP (>1:1024) 38.6% mortality, than patients that received low titer CP (â¤1:1024) 77.8% mortality."
      }
    ]
  },
  "33619510": {
    "title": "Prediction of Mortality in hospitalized COVID-19 patients in a statewide health network.",
    "sentences": [
      {
        "text": "Importance A predictive model to automatically identify the earliest determinants of both hospital discharge and mortality in hospitalized COVID-19 patients could be of great assistance to caregivers if the predictive information is generated and made available in the immediate hours following admission."
      },
      {
        "text": "Objective To identify the most important predictors of hospital discharge and mortality from measurements at admission for hospitalized COVID-19 patients."
      },
      {
        "text": "Design Observational cohort study."
      },
      {
        "text": "Setting Electronic records from hospitalized patients."
      },
      {
        "text": "Participants Patients admitted between March 3 rd and August 24 th with COVID-19 in Johns Hopkins Health System hospitals."
      },
      {
        "text": "Exposures 216 phenotypic variables collected within 48 hours of admission."
      },
      {
        "text": "Main Outcomes We used age-stratified (<60 and >=60 years) random survival forests with competing risks to identify the most important predictors of death and discharge."
      },
      {
        "text": "Fine-Gray competing risk regression (FGR) models were then constructed based on the most important RSF-derived covariates."
      },
      {
        "text": "Results Of 2212 patients, 1913 were discharged (age 57Â±19, time-to-discharge 9Â±11 days) while 279 died (age 75Â±14, time to death 14Â±15 days)."
      },
      {
        "text": "Patients >= 60 years were nearly 10 times as likely to die within 60 days of admission as those <60."
      },
      {
        "text": "As the pandemic evolved, the rate of hospital discharge increased in both older and younger patients."
      },
      {
        "text": "Incident death and hospital discharge were accurately predicted by measures of respiratory distress, inflammation, infection, renal function, red cell turn over and cardiac stress."
      },
      {
        "text": "FGR models for each of hospital discharge and mortality as outcomes based on these variables performed well in the older (AUC 0.80-0.85 at 60-days) and younger populations (AUC >0.90 at 60-days)."
      },
      {
        "text": "Conclusions and Relevance We identified markers collected within 2 days of admission that predict hospital discharge and mortality in COVID-19 patients and provide prediction models that may be used to guide patient care."
      },
      {
        "text": "Our proposed model suggests that hospital discharge and mortality can be forecasted with high accuracy based on 8-10 variables at this stage of the COVID-19 pandemic."
      },
      {
        "text": "Our findings also point to several specific pathways that could be the focus of future investigations directed at reducing mortality and expediting hospital discharge among COVID-19 patients."
      },
      {
        "text": "Probability of hospital discharge increased over the course of the pandemic."
      },
      {
        "text": "K ey P oints Question: Can we predict the likelihood of hospital discharge as well as mortality from data obtained in the first 48 hours from admission in hospitalized COVID-19 patients?"
      },
      {
        "text": "Findings: Models based on extensive phenotyping mined directly from electronic medical records followed by variable selection, accounted for the competing events of hospital death versus discharge, predicted both death and discharge with area under the receiver operating characteristic curves of >0.80."
      },
      {
        "text": "Meaning: Hospital discharge and mortality can be forecasted with high accuracy based on just 8-10 variables, and the probability of hospital discharge increased over the course of the pandemic."
      }
    ]
  },
  "33639632": {
    "title": "Interpretation of Hematological, Biochemical, and Immunological Findings of COVID-19 Disease: Biomarkers Associated with Severity and Mortality.",
    "sentences": [
      {
        "text": "The severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) spread rapidly all over the world in late 2019 and caused critical illness and death in some infected patients."
      },
      {
        "text": "This study aimed at examining several laboratory factors, especially inflammatory and immunological mediators, to identify severity and mortality associated biomarkers."
      },
      {
        "text": "Ninety-three hospitalized patients with confirmed coronavirus disease 2019 (COVID-19) were classified based on disease severity."
      },
      {
        "text": "The levels of biochemical, hematological, immunological, and inflammatory mediators were assessed, and their association with severity and mortality were evaluated."
      },
      {
        "text": "Hospitalized patients were mostly men (77.4%) with an average (standard deviation) age of 59.14 (14.81) years."
      },
      {
        "text": "The mortality rate was significantly higher in critical patients (85.7%)."
      },
      {
        "text": "Increased serum levels of blood sugar, urea, creatinine, uric acid, phosphorus, total bilirubin, serum glutamic-oxaloacetic transaminase, serum glutamic-oxaloacetic transaminase, lactic dehydrogenase, C-reactive protein, ferritin, and procalcitonin were significantly prevalent (p=0.002, p<0.001, p<0.001, p=0.014, p=0.047, p=0.003, p<0.001, p<0.001, p<0.001, p<0.001, P<0.001, and p<0.001, respectively) in COVID-19 patients."
      },
      {
        "text": "Decreased red blood cell, hemoglobin, and hematocrit were significantly prevalent among COVID-19 patients than healthy control subjects (p<0.001 for all)."
      },
      {
        "text": "Troponin-I, interleukin-6, neutrophil/lymphocyte ratio (NLR), procalcitonin, and D-dimer showed a significant association with the mortality of patients with specificity and sensitivity more than 60%."
      },
      {
        "text": "Age, sex, underlying diseases, blood oxygen pressure, complete blood count along with C-reactive protein, lactic dehydrogenase, procalcitonin, D-dimer, and interleukin-6 evaluation help to predict the severity and required management for COVID-19 patients."
      },
      {
        "text": "Further investigations are highly recommended in a larger cohort study for validation of the present findings."
      }
    ]
  },
  "33638807": {
    "title": "MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19.",
    "sentences": [
      {
        "text": "Coronaviruses, such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) responsible for the coronavirus disease 2019 (COVID-19) pandemic, present a significant threat to human health by inflicting a wide variety of health complications and even death."
      },
      {
        "text": "While conventional therapeutics often involve administering small molecules to fight viral infections, small non-coding RNA sequences, known as microRNAs (miRNAs/miR-), may present a novel antiviral strategy."
      },
      {
        "text": "We can take advantage of their ability to modulate host-virus interactions through mediating RNA degradation or translational inhibition."
      },
      {
        "text": "Investigations into miRNA and SARS-CoV-2 interactions can reveal novel therapeutic approaches against this virus."
      },
      {
        "text": "The viral genomes of SARS-CoV-2, severe acute respiratory syndrome coronavirus (SARS-CoV), and Middle East respiratory syndrome coronavirus (MERS-CoV) were searched using the Nucleotide Basic Local Alignment Search Tool (BLASTn) for highly similar sequences, to identify potential binding sites for miRNAs hypothesized to play a role in SARS-CoV-2 infection."
      },
      {
        "text": "miRNAs that target angiotensin-converting enzyme 2 (ACE2), the receptor used by SARS-CoV-2 and SARS-CoV for host cell entry, were also predicted."
      },
      {
        "text": "Several relevant miRNAs were identified, and their potential roles in regulating SARS-CoV-2 infections were further assessed."
      },
      {
        "text": "Current treatment options for SARS-CoV-2 are limited and have not generated sufficient evidence on safety and efficacy for treating COVID-19."
      },
      {
        "text": "Therefore, by investigating the interactions between miRNAs and SARS-CoV-2, miRNA-based antiviral therapies, including miRNA mimics and inhibitors, may be developed as an alternative strategy to fight COVID-19."
      }
    ]
  },
  "33527073": {
    "title": "Placental pathology and fetal demise at 35Â weeks of gestation in a woman with SARS-CoV-2 infection: A case report.",
    "sentences": [
      {
        "text": "The consequences of SARS-CoV-2 infection in pregnancy have not been well defined."
      },
      {
        "text": "However, there have been a number of reports of poor maternal and fetal outcomes worldwide."
      },
      {
        "text": "This report presents a case of stillbirth with associated placental pathology during week 35 in an otherwise healthy pregnant woman with SARS-CoV-2 infection."
      },
      {
        "text": "Placental findings in this case showed patchy acute chorionitis and diffuse infarction/villous necrosis of the placental parenchyma resulting in extensive vascular malperfusion."
      },
      {
        "text": "Fetal autopsy was most significant for placental findings and no congenital malformations were discovered."
      },
      {
        "text": "The findings in this case are consistent with reports in the literature of pathological placental changes associated with COVID-19."
      },
      {
        "text": "This case of fetal demise in a woman with confirmed SARS-CoV-2 infection without any other medical or obstetric disorders and no alternate cause suggests that fetal death can be an outcome of COVID-19 during pregnancy."
      },
      {
        "text": "This outcome was supported by the histopathological findings in the placenta."
      },
      {
        "text": "Continued research is imperative to confirm the findings in this case and multiple similar cases."
      },
      {
        "text": "Additionally, increased screening and collection of COVID-19 data specific to pregnant women and their fetuses and infants is needed to increase knowledge, support research efforts, and create guidelines for clinical practice that will prevent potential negative outcomes and loss of life."
      }
    ]
  },
  "33633925": {
    "title": "Membranous nephropathy in a patient with coronavirus disease 2019 (COVID-19): AÂ caseÂ report.",
    "sentences": [
      {
        "text": "INTRODUCTION Though respiratory, immune, and coagulation systems are major targets of coronavirus disease 2019 (COVID-19), kidney dysfunction, presenting with acute kidney injury (AKI), is also common."
      },
      {
        "text": "Most AKI cases in COVID-19 manifest as acute tubular injury (ATI) in conjunction with multiorgan failure."
      },
      {
        "text": "While initial renal pathological findings were limited to acute tubular necrosis and collapsing glomerulopathy, a recent case series reported a larger spectrum of findings."
      },
      {
        "text": "CASE REPORT Here, we report a case of membranous nephropathy (MN) in an 81-year-old Hispanic man with underlying chronic kidney disease (CKD) stage 3 who developed ATI in the setting of COVID-19."
      },
      {
        "text": "The patient was hospitalized for hypoxic respiratory failure in the setting of AKI stage 3 with serum creatinine 7.1Â mg/dL 6Â days after a positive-SARS-CoV-2 screening."
      },
      {
        "text": "He was found to have nephrotic range proteinuria, glycosuria (with normal serum glucose), anemia, and hypoalbuminemia."
      },
      {
        "text": "Kidney biopsy showed ATI and early MN."
      },
      {
        "text": "Workup for primary and secondary MN was unrevealing, and serum PLA2R antibody was negative."
      },
      {
        "text": "No viral particles were observed in podocytes."
      },
      {
        "text": "CONCLUSION Although the MN could be incidental, this observation raises the question of whether SARS-CoV-2 infection can trigger or worsen an underlying MN from an exaggerated immune response associated with COVID-19."
      }
    ]
  },
  "33633121": {
    "title": "Elevation in viral entry genes and innate immunity compromise underlying increased infectivity and severity of COVID-19 in cancer patients.",
    "sentences": [
      {
        "text": "Multiple studies have reported a doubling in risk of Coronavirus Disease-2019 (COVID-19) among cancer patients."
      },
      {
        "text": "Here, we examine the potential biological rationale behind this recurrent epidemiological observation."
      },
      {
        "text": "By leveraging large-scale genome-wide transcriptional data of normal and malignant tissues from adults and children, we found evidence of increased expression of SARS-CoV-2 viral entry genes in the cancer state, particularly in respiratory, gastrointestinal, and genitourinary tract tissues, with decreased expression in pediatric vs."
      },
      {
        "text": "adult samples."
      },
      {
        "text": "Additionally, by interrogating the temporal effects of radiotherapy on human peripheral blood mononuclear and mucosal cells, we observed important treatment-related alterations in host innate immunity, specifically type I interferon responses."
      },
      {
        "text": "Overall, cancers enhance expression of critical viral entry genes, and innate viral defenses can be dysregulated transiently during radiation treatments."
      },
      {
        "text": "These factors may contribute to the observed increased susceptibility to SARS-CoV-2 entry and severity of COVID-19 in cancer patients."
      }
    ]
  },
  "33632295": {
    "title": "Comorbidities and inflammation associated with ovarian cancer and its influence on SARS-CoV-2 infection.",
    "sentences": [
      {
        "text": "Coronavirus disease 2019 (COVID-19) caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) worldwide is a major public health concern."
      },
      {
        "text": "Cancer patients are considered a vulnerable population to SARS-CoV-2 infection and may develop several COVID-19 symptoms."
      },
      {
        "text": "The heightened immunocompromised state, prolonged chronic pro-inflammatory milieu coupled with comorbid conditions are shared in both disease conditions and may influence patient outcome."
      },
      {
        "text": "Although ovarian cancer (OC) and COVID-19 are diseases of entirely different primary organs, both diseases share similar molecular and cellular characteristics in their microenvironment suggesting a potential cooperativity leading to poor outcome."
      },
      {
        "text": "In COVID-19 related cases, hospitalizations and deaths worldwide are lower in women than in males; however, comorbidities associated with OC may increase the COVID-19 risk in women."
      },
      {
        "text": "The women at the age of 50-60 years are at greater risk of developing OC as well as SARS-CoV-2 infection."
      },
      {
        "text": "Increased levels of gonadotropin and androgen, dysregulated renin-angiotensin-aldosterone system (RAAS), hyper-coagulation and chronic inflammation are common conditions observed among OC and severe cases of COVID-19."
      },
      {
        "text": "The upregulation of common inflammatory cytokines and chemokines such as tumor necrosis factor Î± (TNF-Î±), interleukin (IL)-1Î², IL-2, IL-6, IL-10, interferon-Î³-inducible protein 10 (IP-10), granulocyte colony-stimulating factor (G-CSF), monocyte chemoattractant protein-1 (MCP-1), macrophage colony-stimulating factor (M-CSF), among others in the sera of COVID-19 and OC subjects suggests potentially similar mechanism(s) involved in the hyper-inflammatory condition observed in both disease states."
      },
      {
        "text": "Thus, it is conceivable that the pathogenesis of OC may significantly contribute to the potential infection by SARS-CoV-2."
      },
      {
        "text": "Our understanding of the influence and mechanisms of SARS-CoV-2 infection on OC is at an early stage and in this article, we review the underlying pathogenesis presented by various comorbidities of OC and correlate their influence on SARS-CoV-2 infection."
      }
    ]
  },
  "33631512": {
    "title": "Serum cytokine levels of COVID-19 patients after 7Â days of treatment with Favipiravir or Kaletra.",
    "sentences": [
      {
        "text": "BACKGROUND Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes coronavirus disease 2019 (COVID-19) has infected 86,4 M patients and resulted in 1,86Â M deaths worldwide."
      },
      {
        "text": "Severe COVID-19 patients have elevated blood levels of interleukin-6 (IL-6), IL-1Î², tumor necrosis factor (TNF)Î±, IL-8 and interferon (IFN)Î³."
      },
      {
        "text": "OBJECTIVE To investigate the effect of antiviral treatment serum cytokines in severe COVID-19 patients."
      },
      {
        "text": "METHODS Blood was obtained from 29 patients (aged 32-79Â yr) with laboratory-confirmed COVID-19 upon admission and 7Â days after antiviral (Favipiravir or Lopinavir/Ritonavir) treatment."
      },
      {
        "text": "Patients also received standard supportive treatment in this retrospective observational study."
      },
      {
        "text": "Chest computed tomography (CT) scans were evaluated to investigate lung manifestations of COVID-19."
      },
      {
        "text": "Serum was also obtained and cytokines levels were evaluated."
      },
      {
        "text": "19 age- and gender-matched healthy controls were studied."
      },
      {
        "text": "RESULTS Anti-viral therapy significantly reduced CT scan scores and the elevated serum levels of C-reactive protein (CRP) and lactate dehydrogenase (LDH)."
      },
      {
        "text": "In contrast, serum levels of IL-6, IL-8 and IFNÎ³ were elevated at baseline in COVID-19 subjects compared to healthy subjects with IL-6 (pÂ =Â 0.006) and IL-8 (pÂ =Â 0.011) levels being further elevated after antiviral therapy."
      },
      {
        "text": "IL-1Î² (pÂ =Â 0.01) and TNFÎ± (pÂ =Â 0.069) levels were also enhanced after treatment but baseline levels were similar to those of healthy controls."
      },
      {
        "text": "These changes occurred irrespective of whether patients were admitted to the intensive care unit."
      },
      {
        "text": "CONCLUSION Antiviral treatments did not suppress the inflammatory phase of COVID-19 after 7Â days treatment although CT, CRP and LDH suggest a decline in lung inflammation."
      },
      {
        "text": "There was limited evidence for a viral-mediated cytokine storm in these COVID-19 subjects."
      }
    ]
  },
  "33630167": {
    "title": "Cutaneous Manifestations Related to COVID-19 Immune Dysregulation in the Pediatric Age Group.",
    "sentences": [
      {
        "text": "PURPOSE OF REVIEW At the juncture of the COVID-19 pandemic, the world is currently in an early phase of collecting clinical data and reports of its skin manifestations, and its pathophysiology is still highly conjectural."
      },
      {
        "text": "We reviewed cutaneous manifestations associated with COVID-19 in the pediatric age group."
      },
      {
        "text": "RECENT FINDINGS Children infected by SARS-CoV-2 usually develop milder respiratory symptoms, but cutaneous manifestations seem a little more prevalent than in adults."
      },
      {
        "text": "These skin features of infection by the coronavirus can be similar to those produced by other common viruses, but there are also reports of cases with more heterogeneous clinical pictures, which have made their classification difficult."
      },
      {
        "text": "To date, the more frequently reported skin variants featured in pediatric cases are purpuric (pseudo-chilblain, necrotic-acral ischemia, hemorrhagic macules, and/or cutaneous necrosis), morbilliform/maculopapular, erythema multiforme, urticarial, vesicular, Kawasaki-like, and miscellaneous (highly variable in both frequency and severity)."
      },
      {
        "text": "Their pathophysiological mechanism is still elusive and is likely to be the result of the complex involvement of one or more mechanisms, like direct virus-induced skin damage, vasculitis-like reactions, and/or indirect injury as a consequence of a systemic inflammatory reaction."
      },
      {
        "text": "In this review, we presented and discussed clinical cases as examples of different cutaneous responses reported in some children with SARS-CoV-2 infection, differential diagnosis considerations, and a preliminary conceptual approach to some of their probable associated pathologic mechanisms."
      }
    ]
  },
  "33629342": {
    "title": "The clinical warning index of severe COVID-19: discussion based on the clinical features and outcomes of 4 patients.",
    "sentences": [
      {
        "text": "OBJECTIVE Coronavirus disease 2019 (COVID-19) is spreading worldwide."
      },
      {
        "text": "The onset of severe COVID-19 could lead to multiple organ damage and even death."
      },
      {
        "text": "It is worth paying attention to the warning index of the onset for severe COVID-19 so that patients can be identified and monitored carefully."
      },
      {
        "text": "PATIENTS AND METHODS The report is a retrospective study that describes and analyzes the clinical features during the treatment of COVID-19."
      },
      {
        "text": "Four patients with COVID-19 were involved in this study, who were father-and-son pairs from two families."
      },
      {
        "text": "All patients were treated with the same combination of anti-microbial and anti-viral agents for 10-14 days, adjusting for the disease status."
      },
      {
        "text": "The primary outcome measure was SARS-CoV-2 detection using RT-qPCR with oropharyngeal swabs."
      },
      {
        "text": "Chest CT imaging served as a secondary outcome measure."
      },
      {
        "text": "RESULTS One of the four patients progressed to severe disease, while the remaining patients recovered with the same treatment."
      },
      {
        "text": "A persistent decrease in the lymphocyte ratio and increase in the C-reactive protein (CRP) level were observed in the severe patient, along with other typical symptoms of COVID-19."
      },
      {
        "text": "CONCLUSIONS The cases we described indicate that blood cell and CRP tests could be useful risk warnings of severe onset of COVID-19."
      }
    ]
  },
  "33629341": {
    "title": "Differential expression and immune correlation analysis of COVID-19 receptor ACE2 and TMPRSS2 genes in all normal and tumor tissues.",
    "sentences": [
      {
        "text": "The outbreak of COVID-19 seriously affected people's life and safety, and it has not been effectively controlled all over the world at present."
      },
      {
        "text": "The binding of S protein of SARS-COV-2 virus to ACE2 receptor requires the assistance of Transmembrane Serine Protease 2 (TMPRSS2), which can activate the S protein on the surface of virus and promote its binding to the ACE2 receptor."
      },
      {
        "text": "With the continuous accumulation of experience in the treatment of COVID-19 patients and the experimental studies of a large number of scientific researchers, it was found that COVID-19 patients had a higher mortality rate in patients with underlying diseases."
      },
      {
        "text": "Therefore, for COVID-19 patients with tumors, the mortality rate may be significantly higher than other people."
      },
      {
        "text": "Clinical studies had found that some patients were complicated with cytokine storm in clinical treatment, which was also the direct cause of death for some patients."
      },
      {
        "text": "The infiltration of immune cells and the release of a variety of cytokines were important factors causing cytokine storm."
      },
      {
        "text": "Therefore, for COVID-19 patients with tumors, it was of great clinical significance to explore the relationship between COVID-19 virus receptor ACE2, TMPRSS2 and immune cell infiltration, which can help clinicians to make some more appropriate treatment plans."
      }
    ]
  },
  "33629254": {
    "title": "CIGB-258, a peptide derived from human heat-shock protein 60, decreases hyperinflammation in COVID-19 patients.",
    "sentences": [
      {
        "text": "Hyperinflammation distinguishes COVID-19 patients who develop a slight disease or none, from those progressing to severe and critical conditions."
      },
      {
        "text": "CIGB-258 is a therapeutic option for the latter group of patients."
      },
      {
        "text": "This drug is an altered peptide ligand (APL) derived from the cellular stress protein 60 (HSP60)."
      },
      {
        "text": "In preclinical models, this peptide developed anti-inflammatory effects and increased regulatory T cell (Treg) activity."
      },
      {
        "text": "Results from a phase I clinical trial with rheumatoid arthritis (RA) patients indicated that CIGB-258 was safe and reduced inflammation."
      },
      {
        "text": "The aim of this study was to examine specific biomarkers associated with hyperinflammation, some cytokines linked to the cytokine storm granzyme B and perforin in a cohort of COVID-19 patients treated with this peptide."
      },
      {
        "text": "All critically ill patients were under invasive mechanical ventilation and received the intravenous administration of 1 or 2 mg of CIGB-258 every 12 h. Seriously ill patients were treated with oxygen therapy receiving 1 mg of CIGB-258 every 12 h and all patients recovered from their severe condition."
      },
      {
        "text": "Biomarker levels associated with hyperinflammation, such as interleukin (IL)-6, IL-10, tumor necrosis factor (TNF-Î±), granzyme B, and perforin, significantly decreased during treatment."
      },
      {
        "text": "Furthermore, we studied the ability of CIGB-258 to induce Tregs in COVID-19 patients and found that Tregs were induced in all patients studied."
      },
      {
        "text": "Altogether, these results support the therapeutic potential of CIGB-258 for diseases associated with hyperinflammation."
      },
      {
        "text": "Clinical trial registry: RPCEC00000313."
      }
    ]
  },
  "33628371": {
    "title": "Oxidative Imbalance as a Crucial Factor in Inflammatory Lung Diseases: Could Antioxidant Treatment Constitute a New Therapeutic Strategy?",
    "sentences": [
      {
        "text": "Inflammatory lung disease results in a high global burden of death and disability."
      },
      {
        "text": "There are no effective treatments for the most severe forms of many inflammatory lung diseases, such as chronic obstructive pulmonary disease, emphysema, corticosteroid-resistant asthma, and coronavirus disease 2019; hence, new treatment options are required."
      },
      {
        "text": "Here, we review the role of oxidative imbalance in the development of difficult-to-treat inflammatory lung diseases."
      },
      {
        "text": "The inflammation-induced overproduction of reactive oxygen species (ROS) means that endogenous antioxidants may not be sufficient to prevent oxidative damage, resulting in an oxidative imbalance in the lung."
      },
      {
        "text": "In turn, intracellular signaling events trigger the production of proinflammatory mediators that perpetuate and aggravate the inflammatory response and may lead to tissue damage."
      },
      {
        "text": "The production of high levels of ROS in inflammatory lung diseases can induce the phosphorylation of mitogen-activated protein kinases, the inactivation of phosphoinositide 3-kinase (PI3K) signaling and histone deacetylase 2, a decrease in glucocorticoid binding to its receptor, and thus resistance to glucocorticoid treatment."
      },
      {
        "text": "Hence, antioxidant treatment might be a therapeutic option for inflammatory lung diseases."
      },
      {
        "text": "Preclinical studies have shown that antioxidants (alone or combined with anti-inflammatory drugs) are effective in the treatment of inflammatory lung diseases, although the clinical evidence of efficacy is weaker."
      },
      {
        "text": "Despite the high level of evidence for the efficacy of antioxidants in the treatment of inflammatory lung diseases, the discovery and clinical investigation of safer, more efficacious compounds are now a priority."
      }
    ]
  },
  "33628044": {
    "title": "Clinical Characteristics and Short-Term Outcomes of Chronic Dialysis Patients Admitted for COVID-19 in Metro Manila, Philippines.",
    "sentences": [
      {
        "text": "Aim Data published on COVID-19 in the Filipino population, particularly those with end stage kidney disease (ESKD) are still lacking."
      },
      {
        "text": "Methods We performed a retrospective, observational study of 68 ESKD patients admitted with COVID-19 infection at a tertiary hospital in Metro Manila, Philippines from April 1, 2020 to July 31, 2020."
      },
      {
        "text": "We compared the clinical features, baseline laboratory data, treatment strategies and short-term outcomes between those who survived and those who died."
      },
      {
        "text": "We also determined the risk factors associated with mortality from COVID-19."
      },
      {
        "text": "Results Mean age was 54.5 years old, 66% were male."
      },
      {
        "text": "All patients admitted were on maintenance hemodialysis (HD)."
      },
      {
        "text": "The most common presenting symptoms were dyspnea (57%), fever (47%) and cough (38%)."
      },
      {
        "text": "There was an equal number of patients on high flow nasal cannula (17.7%) and invasive mechanical ventilation (17.7%)."
      },
      {
        "text": "ICU admission was required in 17.7% of the cohort."
      },
      {
        "text": "In-hospital death occurred in 25% of the patients."
      },
      {
        "text": "Admission PaO2/FiO2 (PF) ratios (162 Â± 134 versus 356 Â± 181; p=0.0009) were lower, and procalcitonin (6.07 Â± 10.5ng/mL versus 0.73 Â± 3.61 ng/mL; p=0.02), lactate dehydrogenase (396 Â± 274U/L versus 282 Â± 148 U/L; p=0.03), and white blood cell counts (10 Â± 7.3 x 109/L versus 6.3 Â± 4.2 x 109/L; p= 0.0039) were significantly higher among those who died compared to those who survived."
      },
      {
        "text": "After adjusting for confounders, only low PF ratio (HR 1.01 for every unit decrease, 95% CI 1-1.01) and need for ventilation (HR 6.45, 95% CI 1.16-35.97) conferred a significant risk for in-hospital mortality."
      },
      {
        "text": "Conclusion Short-term, in-hospital mortality is high among patients on chronic hemodialysis admitted for COVID-19 infection."
      },
      {
        "text": "They present similarly with the general population."
      },
      {
        "text": "Low PF ratio on admission and need for ventilation are independent risk factors for in-hospital mortality."
      }
    ]
  },
  "33626098": {
    "title": "Association of SARS-CoV-2 viral load at admission with in-hospital acute kidney injury: A retrospective cohort study.",
    "sentences": [
      {
        "text": "BACKGROUND Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the associated Coronavirus Disease 2019 (COVID-19) is a public health emergency."
      },
      {
        "text": "Acute kidney injury (AKI) is a common complication in hospitalized patients with COVID-19 although mechanisms underlying AKI are yet unclear."
      },
      {
        "text": "There may be a direct effect of SARS-CoV-2 virus on the kidney; however, there is currently no data linking SARS-CoV-2 viral load (VL) to AKI."
      },
      {
        "text": "We explored the association of SARS-CoV-2 VL at admission to AKI in a large diverse cohort of hospitalized patients with COVID-19."
      },
      {
        "text": "METHODS AND FINDINGS We included patients hospitalized between March 13th and May 19th, 2020 with SARS-CoV-2 in a large academic healthcare system in New York City (N = 1,049) with available VL at admission quantified by real-time RT-PCR."
      },
      {
        "text": "We extracted clinical and outcome data from our institutional electronic health records (EHRs)."
      },
      {
        "text": "AKI was defined by KDIGO guidelines."
      },
      {
        "text": "We fit a Fine-Gray competing risks model (with death as a competing risk) using demographics, comorbidities, admission severity scores, and log10 transformed VL as covariates and generated adjusted hazard ratios (aHR) and 95% Confidence Intervals (CIs)."
      },
      {
        "text": "VL was associated with an increased risk of AKI (aHR = 1.04, 95% CI: 1.01-1.08, p = 0.02) with a 4% increased hazard for each log10 VL change."
      },
      {
        "text": "Patients with a viral load in the top 50th percentile had an increased adjusted hazard of 1.27 (95% CI: 1.02-1.58, p = 0.03) for AKI as compared to those in the bottom 50th percentile."
      },
      {
        "text": "CONCLUSIONS VL is weakly but significantly associated with in-hospital AKI after adjusting for confounders."
      },
      {
        "text": "This may indicate the role of VL in COVID-19 associated AKI."
      },
      {
        "text": "This data may inform future studies to discover the mechanistic basis of COVID-19 associated AKI."
      }
    ]
  },
  "33622611": {
    "title": "Cheap and simple, could it get even cooler? Mild hypothermia and COVID-19.",
    "sentences": [
      {
        "text": "PURPOSE The pathophysiology theories of COVID-19 attach the injury of target organs to faulty immune responses and occasionally hyper-inflammation."
      },
      {
        "text": "The damage frequently extends beyond the respiratory system, accompanying cardiovascular, renal, central nervous system, and/or coagulation derangements."
      },
      {
        "text": "Tumor necrosis factor-Î± (TNF-Î±) and interleukins (IL)-1 andÂ -Â 6 suppression may improve outcomes, as experimentally shown."
      },
      {
        "text": "Targeted therapies have been proposed, but mild therapeutic hypothermia-a more multifaceted approach-could be suitable."
      },
      {
        "text": "FINDINGS According to evidence derived from previous applications, therapeutic hypothermia diminishes the release of IL-1, IL-6, and TNF-Î± in serum and at the tissue level."
      },
      {
        "text": "PaCO2 is reduced and the PaO2/FiO2 ratio is increased, possibly lasting after rewarming."
      },
      {
        "text": "Cooling might mitigate both ventilator and infectious-induced lung injury, and suppress microthrombi development, enhancing V/Q mismatch."
      },
      {
        "text": "Improvements in microhemodynamics and tissue O2 diffusion, along with the ischemia-tolerance heightening of tissues, could be reached."
      },
      {
        "text": "Arrhythmia incidence diminishes."
      },
      {
        "text": "Moreover, hypothermia may address the coagulopathy, promoting normalization of both hypo- and hyper-coagulability patterns, which are apparently sustained after a return to normothermia."
      },
      {
        "text": "CONCLUSIONS As per prior therapeutic hypothermia literature, the benefits regarding inflammatory response and organic damage might be seen."
      },
      {
        "text": "Following the safety-cornerstones of the technique, the overall infection rate and infection-related mortality are not expected to rise, and increased viral replication does not seem to be a concern."
      },
      {
        "text": "Therefore, the possibility of a low cost and widely available therapy being capable of improving COVID-19 outcomes deserves further study."
      }
    ]
  },
  "33622218": {
    "title": "Severe Acute Respiratory Syndrome Coronavirus Type 2: Insight Into Challenges for Cell Therapy.",
    "sentences": [
      {
        "text": "Coronavirus disease 2019 has affected more than 4 million people throughout the world since December 2019."
      },
      {
        "text": "It seems this infection has been the most insidious virus of the coronavirus family."
      },
      {
        "text": "This virus causes severe respiratory failure and symptoms in patients and can result in death."
      },
      {
        "text": "Designing a restrict protocol to deal with infections from severe acute respiratory syndrome coronavirus type 2 is critical in cell therapy institutes."
      },
      {
        "text": "In this review, we present the important aspects related to this virus in cell therapy protocols."
      }
    ]
  },
  "33621488": {
    "title": "Autophagosome maturation stymied by SARS-CoV-2.",
    "sentences": [
      {
        "text": "Many pathogens are capable of disrupting autophagy within host cells."
      },
      {
        "text": "In this issue of Developmental Cell, Miao etÂ al."
      },
      {
        "text": "discover that the SARS-CoV-2 protein ORF3a inhibits autophagosome-lysosome fusion by dysregulating the HOPS complex."
      }
    ]
  },
  "33594364": {
    "title": "Bifurcated monocyte states are predictive of mortality in severe COVID-19.",
    "sentences": [
      {
        "text": "Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 infection presents with varied clinical manifestations 1 , ranging from mild symptoms to acute respiratory distress syndrome (ARDS) with high mortality 2,3 ."
      },
      {
        "text": "Despite extensive analyses, there remains an urgent need to delineate immune cell states that contribute to mortality in severe COVID-19."
      },
      {
        "text": "We performed high-dimensional cellular and molecular profiling of blood and respiratory samples from critically ill COVID-19 patients to define immune cell genomic states that are predictive of outcome in severe COVID-19 disease."
      },
      {
        "text": "Critically ill patients admitted to the intensive care unit (ICU) manifested increased frequencies of inflammatory monocytes and plasmablasts that were also associated with ARDS not due to COVID-19."
      },
      {
        "text": "Single-cell RNAseq (scRNAseq)-based deconvolution of genomic states of peripheral immune cells revealed distinct gene modules that were associated with COVID-19 outcome."
      },
      {
        "text": "Notably, monocytes exhibited bifurcated genomic states, with expression of a cytokine gene module exemplified by CCL4 (MIP-1Î²) associated with survival and an interferon signaling module associated with death."
      },
      {
        "text": "These gene modules were correlated with higher levels of MIP-1Î² and CXCL10 levels in plasma, respectively."
      },
      {
        "text": "Monocytes expressing genes reflective of these divergent modules were also detectable in endotracheal aspirates."
      },
      {
        "text": "Machine learning algorithms identified the distinctive monocyte modules as part of a multivariate peripheral immune system state that was predictive of COVID-19 mortality."
      },
      {
        "text": "Follow-up analysis of the monocyte modules on ICU day 5 was consistent with bifurcated states that correlated with distinct inflammatory cytokines."
      },
      {
        "text": "Our data suggests a pivotal role for monocytes and their specific inflammatory genomic states in contributing to mortality in life-threatening COVID-19 disease and may facilitate discovery of new diagnostics and therapeutics."
      }
    ]
  },
  "33398263": {
    "title": "SARS-CoV-2 Receptors are Expressed on Human Platelets and the Effect of Aspirin on Clinical Outcomes in COVID-19 Patients.",
    "sentences": [
      {
        "text": "Coronavirus disease-2019 (COVID-19) caused by SARS-CoV-2 is an ongoing viral pandemic marked by increased risk of thrombotic events."
      },
      {
        "text": "However, the role of platelets in the elevated observed thrombotic risk in COVID-19 and utility of anti-platelet agents in attenuating thrombosis is unknown."
      },
      {
        "text": "We aimed to determine if human platelets express the known SARS-CoV-2 receptor-protease axis on their cell surface and assess whether the anti-platelet effect of aspirin may mitigate risk of myocardial infarction (MI), cerebrovascular accident (CVA), and venous thromboembolism (VTE) in COVID-19."
      },
      {
        "text": "Expression of ACE2 and TMPRSS2 on human platelets were detected by immunoblotting and confirmed by confocal microscopy."
      },
      {
        "text": "We evaluated 22,072 symptomatic patients tested for COVID-19."
      },
      {
        "text": "Propensity-matched analyses were performed to determine if treatment with aspirin or non-steroidal anti-inflammatory drugs (NSAIDs) affected thrombotic outcomes in COVID-19."
      },
      {
        "text": "Neither aspirin nor NSAIDs affected mortality in COVID-19."
      },
      {
        "text": "However, both aspirin and NSAID therapies were associated with increased risk of the combined thrombotic endpoint of (MI), (CVA), and (VTE)."
      },
      {
        "text": "Thus, while platelets clearly express ACE2-TMPRSS2 receptor-protease axis for SARS-CoV-2 infection, aspirin does not prevent thrombosis and death in COVID-19."
      },
      {
        "text": "The mechanisms of thrombosis in COVID-19, therefore, appears distinct and the role of platelets as direct mediators of SARS-CoV-2-mediated thrombosis warrants further investigation."
      }
    ]
  },
  "33621211": {
    "title": "Comorbid illnesses are associated with altered adaptive immune responses to SARS-CoV-2.",
    "sentences": [
      {
        "text": "Comorbid medical illnesses, such as obesity and diabetes, are associated with more severe COVID-19, hospitalization, and death."
      },
      {
        "text": "However, the role of the immune system in mediating these clinical outcomes has not been determined."
      },
      {
        "text": "We used multiparameter flow cytometry and systems serology to comprehensively profile the functions of T cells and antibodies targeting spike, nucleocapsid, and envelope proteins in a convalescent cohort of COVID-19 subjects who were either hospitalized (n = 20) or not hospitalized (n = 40)."
      },
      {
        "text": "To avoid confounding, subjects were matched by age, sex, ethnicity, and date of symptom onset."
      },
      {
        "text": "Surprisingly, we found that the magnitude and functional breadth of virus-specific CD4+ T cell and antibody responses were consistently higher among hospitalized subjects, particularly those with medical comorbidities."
      },
      {
        "text": "However, an integrated analysis identified more coordination between polyfunctional CD4+ T cells and antibodies targeting the S1 domain of spike among subjects who were not hospitalized."
      },
      {
        "text": "These data reveal a functionally diverse and coordinated response between T cells and antibodies targeting SARS-CoV-2, which is reduced in the presence of comorbid illnesses that are known risk factors for severe COVID-19."
      }
    ]
  },
  "33621190": {
    "title": "Improving the Understanding of the Immunopathogenesis of Lymphopenia as a Correlate of SARS-CoV-2 Infection Risk and Disease Progression in African Patients: Protocol for a Cross-sectional Study.",
    "sentences": [
      {
        "text": "BACKGROUND The COVID-19 pandemic, caused by SARS-CoV-2, continues to impact health systems throughout the world with serious medical challenges being imposed on many African countries like Nigeria."
      },
      {
        "text": "Although emerging studies have identified lymphopenia as a driver of cytokine storm, disease progression, and poor outcomes in infected patients, its immunopathogenesis, as well as environmental and genetic determinants, remain unclear."
      },
      {
        "text": "Understanding the interplay of these determinants in the context of lymphopenia and COVID-19 complications in patients in Africa may help with risk stratification and appropriate deployment of targeted treatment regimens with repurposed drugs to improve prognosis."
      },
      {
        "text": "OBJECTIVE This study is designed to investigate the role of vitamin D status, vasculopathy, apoptotic pathways, and vitamin D receptor (VDR) gene polymorphisms in the immunopathogenesis of lymphopenia among African people infected with SARS-CoV-2."
      },
      {
        "text": "METHODS This cross-sectional study will enroll 230 participants, categorized as \"SARS-CoV-2 negative\" (n=69), \"COVID-19 mild\" (n=32), \"hospitalized\" (n=92), and \"recovered\" (n=37), from two health facilities in Lagos, Nigeria."
      },
      {
        "text": "Sociodemographic data, travel history, and information on comorbidities will be obtained from case files and through a pretested, interview-based structured questionnaire."
      },
      {
        "text": "Venous blood samples (5 mL) collected between 8 AM and 10 AM and aliquoted into EDTA (ethylenediaminetetraacetic acid) and plain tubes will be used for complete blood count and CD4 T cell assays to determine lymphopenia (lymphocyte count <1000 cells/ÂµL) and CD4 T lymphocyte levels, as well as to measure the concentrations of vitamin D, caspase 3, soluble vascular cell adhesion molecule-1 (sVCAM-1), and soluble Fas ligand (sFasL) using an autoanalyzer, flow cytometry, and ELISA (enzyme-linked immunosorbent assay) techniques."
      },
      {
        "text": "Genomic DNA will be extracted from the buffy coat and used as a template for the amplification of apoptosis-related genes (Bax, Bcl-2, BCL2L12) by polymerase chain reaction (PCR) and genotyping of VDR (Apa1, Fok1, and Bsm1) gene polymorphisms by the PCR restriction fragment length polymorphism method and capillary sequencing."
      },
      {
        "text": "Total RNA will also be extracted, reverse transcribed, and subsequently quantitated by reverse transcription PCR (RT-PCR) to monitor the expression of apoptosis genes in the four participant categories."
      },
      {
        "text": "Data analyses, which include a test of association between VDR gene polymorphisms and study outcomes (lymphopenia and hypovitaminosis D prevalence, mild/moderate and severe infections) will be performed using the R statistical software."
      },
      {
        "text": "Hardy-Weinberg equilibrium and linkage disequilibrium analyses for the alleles, genotypes, and haplotypes of the genotyped VDR gene will also be carried out."
      },
      {
        "text": "RESULTS A total of 45 participants comprising 37 SARS-CoV-2-negative and 8 COVID-19-recovered individuals have been enrolled so far."
      },
      {
        "text": "Their complete blood counts and CD4 T lymphocyte counts have been determined, and their serum samples and genomic DNA and RNA samples have been extracted and stored at -20 Â°C until further analyses."
      },
      {
        "text": "Other expected outcomes include the prevalence and distribution of lymphopenia and hypovitaminosis D in the control (SARS-CoV-2 negative), confirmed, hospitalized, and recovered SARS-CoV-2-positive participants; association of lymphopenia with CD4 T lymphocyte level, serum vitamin D, sVCAM-1, sFasL, and caspase 3 levels in hospitalized patients with COVID-19; expression levels of apoptosis-related genes among hospitalized participants with COVID-19, and those with lymphopenia compared to those without lymphopenia; and frequency distribution of the alleles, genotypes, and haplotypes of VDR gene polymorphisms in COVID-19-infected participants."
      },
      {
        "text": "CONCLUSIONS This study will aid in the genotypic and phenotypic stratification of COVID-19-infected patients in Nigeria with and without lymphopenia to enable biomarker discovery and pave the way for the appropriate and timely deployment of patient-centered treatments to improve prognosis."
      },
      {
        "text": "INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID) DERR1-10.2196/21242."
      }
    ]
  },
  "33620066": {
    "title": "Lysosome activation in peripheral blood mononuclear cells and prognostic significance of circulating LC3B in COVID-19.",
    "sentences": [
      {
        "text": "Coronavirus disease 2019 (COVID-19) has spread rapidly worldwide, causing significant mortality."
      },
      {
        "text": "There is a mechanistic relationship between intracellular coronavirus replication and deregulated autophagosome-lysosome system."
      },
      {
        "text": "We performed transcriptome analysis of peripheral blood mononuclear cells (PBMCs) from COVID-19 patients and identified the aberrant upregulation of genes in the lysosome pathway."
      },
      {
        "text": "We further determined the capability of two circulating markers, namely microtubule-associated proteins 1A/1B light chain 3B (LC3B) and (p62/SQSTM1) p62, both of which depend on lysosome for degradation, in predicting the emergence of moderate-to-severe disease in COVID-19 patients requiring hospitalization for supplemental oxygen therapy."
      },
      {
        "text": "Logistic regression analyses showed that LC3B was associated with moderate-to-severe COVID-19, independent of age, sex and clinical risk score."
      },
      {
        "text": "A decrease in LC3B concentrationâ<5.5Â ng/ml increased the risk of oxygen and ventilatory requirement (adjusted odds ratio: 4.6; 95% CI: 1.1-22.0; Pâ=â0.04)."
      },
      {
        "text": "Serum concentrations of p62 in the moderate-to-severe group were significantly lower in patients aged 50 or below."
      },
      {
        "text": "In conclusion, lysosome function is deregulated in PBMCs isolated from COVID-19 patients, and the related biomarker LC3B may serve as a novel tool for stratifying patients with moderate-to-severe COVID-19 from those with asymptomatic or mild disease."
      },
      {
        "text": "COVID-19 patients with a decrease in LC3B concentrationâ<5.5Â ng/ml will require early hospital admission for supplemental oxygen therapy and other respiratory support."
      }
    ]
  },
  "33618677": {
    "title": "Bowel necrosis in patient with severe case of COVID-19: a case report.",
    "sentences": [
      {
        "text": "BACKGROUND In patients who are critically ill with COVID-19, multiple extrapulmonary manifestations of the disease have been observed, including gastrointestinal manifestations."
      },
      {
        "text": "CASE PRESENTATION We present a case of a 65Â year old man with severe COVID-19 pneumonia that developed hypercoagulation and peritonitis."
      },
      {
        "text": "Emergent laparotomy was performed and we found bowel necrosis in two sites."
      },
      {
        "text": "CONCLUSIONS Although rare, the presentation of COVID-19 with bowel necrosis requires emergency treatments, and it has high mortality rate."
      }
    ]
  },
  "33618659": {
    "title": "Effects of Cell Proteostasis Network on the Survival of SARS-CoV-2.",
    "sentences": [
      {
        "text": "The proteostasis network includes all the factors that control the function of proteins in their native state and minimize their non-functional or harmful reactions."
      },
      {
        "text": "The molecular chaperones, the important mediator in the proteostasis network can be considered as any protein that contributes to proper folding and assembly of other macromolecules, through maturating of unfolded or partially folded macromolecules, refolding of stress-denatured proteins, and modifying oligomeric assembly, otherwise it leads to their proteolytic degradation."
      },
      {
        "text": "Viruses that use the hosts' gene expression tools and protein synthesis apparatus to survive and replicate, are obviously protected by such a host chaperone system."
      },
      {
        "text": "This means that many viruses use members of the hosts' chaperoning system to infect the target cells, replicate, and spread."
      },
      {
        "text": "During viral infection, increase in endoplasmic reticulum (ER) stress due to high expression of viral proteins enhances the level of heat shock proteins (HSPs) and induces cell apoptosis or necrosis."
      },
      {
        "text": "Indeed, evidence suggests that ER stress and the induction of unfolded protein response (UPR) may be a major aspect of the corona-host virus interaction."
      },
      {
        "text": "In addition, several clinical reports have confirmed the autoimmune phenomena in COVID-19-patients, and a strong association between this autoimmunity and severe SARS-CoV-2 infection."
      },
      {
        "text": "Part of such autoimmunity is due to shared epitopes among the virus and host."
      },
      {
        "text": "This article reviews the proteostasis network and its relationship to the immune system in SARS-CoV-2 infection."
      }
    ]
  },
  "33617948": {
    "title": "In silico identification of available drugs targeting cell surface BiP to disrupt SARS-CoV-2 binding and replication: Drug repurposing approach.",
    "sentences": [
      {
        "text": "AIMS Cell surface binding immunoglobin protein (csBiP) is predicted to be susceptible to SARS-CoV-2 binding."
      },
      {
        "text": "With a substrate-binding domain (SBD) that binds to polypeptides and a nucleotide-binding domain (NBD) that can initiate extrinsic caspase-dependent apoptosis, csBiP may be a promising therapeutic target for COVID-19."
      },
      {
        "text": "This study aims to identify FDA-approved drugs that can neutralize viral binding and prevent viral replication by targeting the functional domains of csBiP."
      },
      {
        "text": "METHODS In silico screening of 1999 FDA-approved drugs against the functional domains of BiP were performed using three molecular docking programs to avoid bias from individual docking programs."
      },
      {
        "text": "Top ligands were selected by averaging the ligand rankings from three programs."
      },
      {
        "text": "Interactions between top ligands and functional domains of BiP were analyzed."
      },
      {
        "text": "KEY FINDINGS The top 10 SBD-binding candidates are velpatasvir, irinotecan, netupitant, lapatinib, doramectin, conivaptan, fenoverine, duvelisib, irbesartan, and pazopanib."
      },
      {
        "text": "The top 10 NBD-binding candidates are nilotinib, eltrombopag, grapiprant, topotecan, acetohexamide, vemurafenib, paritaprevir, pixantrone, azosemide, and piperaquine-phosphate."
      },
      {
        "text": "Among them, Velpatasvir and paritaprevir are antiviral agents that target the protease of hepatitis C virus."
      },
      {
        "text": "Netupitant is an anti-inflammatory drug that inhibits neurokinin-1 receptor, which contributes to acute inflammation."
      },
      {
        "text": "Grapiprant is an anti-inflammatory drug that inhibits the prostaglandin E2 receptor protein subtype 4, which is expressed on immune cells and triggers inflammation."
      },
      {
        "text": "These predicted SBD-binding drugs could disrupt SARS-CoV-2 binding to csBiP, and NBD-binding drugs may falter viral attachment and replication by locking the SBD in closed conformation and triggering apoptosis in infected cells."
      },
      {
        "text": "SIGNIFICANCE csBiP appears to be a novel therapeutic target against COVID-19 by preventing viral attachment and replication."
      },
      {
        "text": "These identified drugs could be repurposed to treat COVID-19 patients."
      }
    ]
  },
  "33614627": {
    "title": "Targeting Lipid Rafts as a Strategy Against Coronavirus.",
    "sentences": [
      {
        "text": "Lipid rafts are functional membrane microdomains containing sphingolipids, including gangliosides, and cholesterol."
      },
      {
        "text": "These regions are characterized by highly ordered and tightly packed lipid molecules."
      },
      {
        "text": "Several studies revealed that lipid rafts are involved in life cycle of different viruses, including coronaviruses."
      },
      {
        "text": "Among these recently emerged the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)."
      },
      {
        "text": "The main receptor for SARS-CoV-2 is represented by the angiotensin-converting enzyme-2 (ACE-2), although it also binds to sialic acids linked to host cell surface gangliosides."
      },
      {
        "text": "A new type of ganglioside-binding domain within the N-terminal portion of the SARS-CoV-2 spike protein was identified."
      },
      {
        "text": "Lipid rafts provide a suitable platform able to concentrate ACE-2 receptor on host cell membranes where they may interact with the spike protein on viral envelope."
      },
      {
        "text": "This review is focused on selective targeting lipid rafts components as a strategy against coronavirus."
      },
      {
        "text": "Indeed, cholesterol-binding agents, including statins or methyl-Î²-cyclodextrin (MÎ²CD), can affect cholesterol, causing disruption of lipid rafts, consequently impairing coronavirus adhesion and binding."
      },
      {
        "text": "Moreover, these compounds can block downstream key molecules in virus infectivity, reducing the levels of proinflammatory molecules [tumor necrosis factor alpha (TNF-Î±), interleukin (IL)-6], and/or affecting the autophagic process involved in both viral replication and clearance."
      },
      {
        "text": "Furthermore, cyclodextrins can assemble into complexes with various drugs to form host-guest inclusions and may be used as pharmaceutical excipients of antiviral compounds, such as lopinavir and remdesivir, by improving bioavailability and solubility."
      },
      {
        "text": "In conclusion, the role of lipid rafts-affecting drugs in the process of coronavirus entry into the host cells prompts to introduce a new potential task in the pharmacological approach against coronavirus."
      }
    ]
  },
  "33552069": {
    "title": "Delving Into the Origin of Destructive Inflammation in COVID-19: A Betrayal of Natural Host Defense Peptides?",
    "sentences": [
      {
        "text": "In contrast to other pathogenic agents that directly destroy host cells and tissues, the lethal power of SARS-CoV-2 resides in the over-reactive immune response triggered by this virus."
      },
      {
        "text": "Based on numerous evidences indicating that the lipid composition of host membranes is dramatically affected by COVID-19, and in the fact that our endogenous antimicrobial peptides (AMPs) are sensitive to the membrane composition of pathogenic agents, we propose that such destructive immune response is due to the direct action of AMPs."
      },
      {
        "text": "In a scenario where most host cell membranes are dressed by a pathogenic lipid composition, AMPs can indiscriminately attack them."
      },
      {
        "text": "This is why we use the \"AMP betrayal\" term to describe this mechanism."
      },
      {
        "text": "Previously proposed cytokine/bradykinin storm mechanisms are not incompatible with this new proposal."
      },
      {
        "text": "Interestingly, the harmful action of AMPs could be prevented by new therapies aimed to reestablish the lipid composition or to inhibit the action of specific peptides."
      }
    ]
  },
  "33615814": {
    "title": "Dynamic changes in serum IL-6, IL-8, and IL-10 predict the outcome of ICU patients with severe COVID-19.",
    "sentences": [
      {
        "text": "BACKGROUND Biomarkers to prognosticate the outcomes and guide the treatment of patients with severe coronavirus disease 2019 (COVID-19) are currently required."
      },
      {
        "text": "We aimed to investigate whether the dynamic variation of cytokines was associated with the survival of patients admitted to the intensive care unit (ICU)."
      },
      {
        "text": "METHODS A retrospective study was performed on 40 patients with COVID-19 admitted to the ICU in Wuhan, China."
      },
      {
        "text": "Demographic, clinical, and laboratory variables were collected, and serum cytokines were kinetically assessed."
      },
      {
        "text": "A multivariable-adjusted generalized linear regression model was used to analyze the differences in serum cytokine levels between survivors and non-survivors."
      },
      {
        "text": "RESULTS Among the 40 patients included, we found a positive correlation between multiple cytokines."
      },
      {
        "text": "Serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor alpha (TNFÎ±) in non-survivors were consistently elevated compared to those in the survivors."
      },
      {
        "text": "Kinetic variations in IL-6, IL-8, and IL-10 were associated with a fatal outcome in patients with severe COVID-19, independent of sex, age, absolute lymphocyte count, direct bilirubin, hypertension, chronic obstructive pulmonary disease, and cancer as well as the use of glucocorticoids and tocilizumab."
      },
      {
        "text": "CONCLUSIONS Dynamic changes in serum IL-6, IL-8, and IL-10 levels were associated with survival in patients in the ICU, and could serve as a predictive biomarker to determine the therapeutic options for patients with severe COVID-19."
      }
    ]
  },
  "33615756": {
    "title": "Gastrointestinal toxicities associated with immune checkpoint inhibitors: a disproportionality analysis leveraging VigiBase, the WHO Adverse Drug Reaction Database.",
    "sentences": []
  },
  "33597956": {
    "title": "Cytokine Storm as a Cellular Response to dsDNA Breaks: A New Proposal.",
    "sentences": [
      {
        "text": "Pathogenesis of cytokine storm is poorly understood."
      },
      {
        "text": "In this article we propose a new mechanism and suggest innovative therapeutic avenues for its prevention."
      },
      {
        "text": "We have reported that particles of cell-free chromatin (cfCh) that are released from the billions of cells that die in the body everyday can illegitimately integrate into genomes of healthy cells to trigger dsDNA breaks."
      },
      {
        "text": "The latter leads to apoptosis and/or intense activation of inflammatory cytokines in the affected cells."
      },
      {
        "text": "We hypothesise that a similar phenomenon of dsDNA breaks and inflammation is involved in cytokine storm."
      },
      {
        "text": "The abundant cfCh particles that are released from dying host cells following viral/microbial invasion initiate a cascading effect of more cell death resulting in a vicious cycle of further DNA damage, apoptosis and hyper-inflammation which culminate in cytokine storm."
      },
      {
        "text": "We propose that this unrelenting vicious cycle of cellular DNA damage and cytokine storm may be the underlying cause of high mortality from severe COVID-19."
      },
      {
        "text": "We discuss results of our preclinical studies wherein we have shown that endotoxin induced cytokine storm in mice can be reversed by three different agents that have the ability to inactivate cfCh."
      },
      {
        "text": "These agents may be worthy of investigation in clinical trials to reduce mortality from COVID-19."
      }
    ]
  },
  "33609773": {
    "title": "Tocilizumab treatment in critically ill patients with COVID-19: A retrospective observational study.",
    "sentences": [
      {
        "text": "OBJECTIVE Elevated levels of pro-inflammatory cytokines are observed in severe COVID-19 infections, and cytokine storm is associated with disease severity."
      },
      {
        "text": "Tocilizumab, an interleukin-6 receptor antagonist, is used to treat chimeric antigen receptor T cell-induced cytokine release syndrome and may attenuate the dysregulated immune response in COVID-19."
      },
      {
        "text": "We compared outcomes among tocilizumab-treated and non-tocilizumab-treated critically ill COVID-19 patients."
      },
      {
        "text": "DESIGN, SETTING, AND PARTICIPANTS This was a retrospective observational study conducted at a tertiary referral center investigating all patients admitted to the intensive care unit for COVID-19 who had a disposition from the hospital because of death or hospital discharge between March 1 and May 18, 2020 (n = 96)."
      },
      {
        "text": "The percentages of death and secondary infections were compared between patients treated with tocilizumab (n = 55) and those who were not (n = 41)."
      },
      {
        "text": "MEASUREMENTS AND MAIN RESULTS More tocilizumab-treated patients required mechanical ventilation (44/55, 80%) compared to non-treated patients (15/41, 37%; P < 0.001)."
      },
      {
        "text": "Of 55 patients treated with tocilizumab, 32 (58%) were on mechanical ventilation at the time of administration, and 12 (22%) progressed to mechanical ventilation after treatment."
      },
      {
        "text": "Of patients treated with tocilizumab requiring mechanical ventilation, 30/44 (68%) were intubated within 1 day of administration."
      },
      {
        "text": "Fewer deaths were observed among tocilizumab-treated patients, both in the overall population (15% vs 37%; P = 0.02) and among the subgroup of patients requiring mechanical ventilation (14% vs 60%; P = 0.001)."
      },
      {
        "text": "Secondary infections were not different between the 2 groups (tocilizumab: 31%, non-tocilizumab: 17%; P = 0.16) and were predominantly related to invasive devices, such as urinary and central venous catheters."
      },
      {
        "text": "CONCLUSIONS Tocilizumab treatment was associated with fewer deaths compared to non-treatment despite predominantly being used in patients with more advanced respiratory disease."
      }
    ]
  },
  "33608333": {
    "title": "Bilateral liquefactive corneal necrosis: a rare and devastating complication of vitamin A deficiency in the adult.",
    "sentences": [
      {
        "text": "A 34year-old man presented with diminution of vision, pain and whitish opacity in both eyes (right eye followed by left eye) since 1âweek."
      },
      {
        "text": "He is a known case of chronic alcoholic abuse."
      },
      {
        "text": "He had multiple episodes of haemoptysis in the past."
      },
      {
        "text": "On general physical examination, he was severely malnourished with multiple oral ulcers."
      },
      {
        "text": "Visual acuity at presentation was light perception in both eyes with projection of rays accurate in all quadrants."
      },
      {
        "text": "Slit-lamp biomicroscopy revealed bilateral total corneal melt with diffuse conjunctival congestion."
      },
      {
        "text": "Corneal scrapings and blood investigations were done and he was started on empirical topical and systemic therapy followed by surgical intervention, with large corneal grafts in both the eyes (right eye followed by left eye) with 1âday interval."
      },
      {
        "text": "The visual gain in both the eyes were 20/400 at first postoperative day."
      },
      {
        "text": "The right eye developed severe fibrinous reaction on the second postoperative day which resolved with topical antibiotics, topical steroids and systemic steroids."
      },
      {
        "text": "The patient was followed up via telemedicine (due to COVID-19 outbreak) and he is able to carry out his daily routine work independently."
      }
    ]
  },
  "33607766": {
    "title": "Novel signaling pathways regulate SARS-CoV and SARS-CoV-2 infectious disease.",
    "sentences": [
      {
        "text": "Severe acute respiratory syndrome coronavirus (SARS-CoV)-2 induces severe infection, and it is responsible for a worldwide disease outbreak starting in late 2019."
      },
      {
        "text": "Currently, there are no effective medications against coronavirus."
      },
      {
        "text": "In the present study, we utilized a holistic bioinformatics approach to study gene signatures of SARS-CoV- and SARS-CoV-2-infected Calu-3 lung adenocarcinoma cells."
      },
      {
        "text": "Through the Gene Ontology platform, we determined that several cytokine genes were up-regulated after SARS-CoV-2 infection, including TNF, IL6, CSF2, IFNL1, IL-17C, CXCL10, and CXCL11."
      },
      {
        "text": "Differentially regulated pathways were detected by the Kyoto Encyclopedia of Genes and Genomes, gene ontology, and Hallmark platform, including chemokines, cytokines, cytokine receptors, cytokine metabolism, inflammation, immune responses, and cellular responses to the virus."
      },
      {
        "text": "A Venn diagram was utilized to illustrate common overlapping genes from SARS-CoV- and SARS-CoV-2-infected datasets."
      },
      {
        "text": "An Ingenuity pathway analysis discovered an enrichment of tumor necrosis factor- (TNF-) and interleukin (IL)-17-related signaling in a gene set enrichment analysis."
      },
      {
        "text": "Downstream networks were predicted by the Database for Annotation, Visualization, and Integrated Discovery platform also revealed that TNF and TNF receptor 2 signaling elicited leukocyte recruitment, activation, and survival of host cells after coronavirus infection."
      },
      {
        "text": "Our discovery provides essential evidence for transcript regulation and downstream signaling of SARS-CoV and SARS-CoV-2 infection."
      }
    ]
  },
  "33604401": {
    "title": "Pretest Symptom Duration and Cycle Threshold Values for Severe Acute Respiratory Syndrome Coronavirus 2 Reverse-Transcription Polymerase Chain Reaction Predict Coronavirus Disease 2019 Mortality.",
    "sentences": [
      {
        "text": "Background The relationship between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load and patient symptom duration in both in- and outpatients, and the impact of these factors on patient outcomes, are currently unknown."
      },
      {
        "text": "Understanding these associations is important to clinicians caring for patients with coronavirus disease 2019 (COVID-19)."
      },
      {
        "text": "Methods We conducted an observational study between March 10 and May 30, 2020 at a large quaternary academic medical center in New York City."
      },
      {
        "text": "Patient characteristics, laboratory values, and clinical outcomes were abstracted from the electronic medical records."
      },
      {
        "text": "Of all patients tested for SARS-CoV-2 during this time (Nâ=â16 384), there were 5467 patients with positive tests, 4254 of which had available cycle threshold (Ct) values and were included in further analysis."
      },
      {
        "text": "Univariable and multivariable logistic regression models were used to test associations between Ct values, duration of symptoms before testing, patient characteristics, and mortality."
      },
      {
        "text": "The primary outcome is defined as death or discharge to hospice."
      },
      {
        "text": "Results Lower Ct values at diagnosis (ie, higher viral load) were associated with significantly higher mortality among both in- and outpatients."
      },
      {
        "text": "It is interesting to note that patients with a shorter time since the onset of symptoms to testing had a worse prognosis, with those presenting less than 3 days from symptom onset having 2-fold increased odds of death."
      },
      {
        "text": "After adjusting for time since symptom onset and other clinical covariates, Ct values remained a strong predictor of mortality."
      },
      {
        "text": "Conclusions Severe acute respiratory syndrome coronavirus 2 reverse-transcription polymerase chain reaction Ct value and duration of symptoms are strongly associated with mortality."
      },
      {
        "text": "These 2 factors add useful information for clinicians to risk stratify patients presenting with COVID-19."
      }
    ]
  },
  "33602326": {
    "title": "Development and validation of an online model to predict critical COVID-19 with immune-inflammatory parameters.",
    "sentences": [
      {
        "text": "BACKGROUND Immune and inflammatory dysfunction was reported to underpin critical COVID-19(coronavirus disease 2019)."
      },
      {
        "text": "We aim to develop a machine learning model that enables accurate prediction of critical COVID-19 using immune-inflammatory features at admission."
      },
      {
        "text": "METHODS We retrospectively collected 2076 consecutive COVID-19 patients with definite outcomes (discharge or death) between January 27, 2020 and March 30, 2020 from two hospitals in China."
      },
      {
        "text": "Critical illness was defined as admission to intensive care unit, receiving invasive ventilation, or death."
      },
      {
        "text": "Least Absolute Shrinkage and Selection Operator (LASSO) was applied for feature selection."
      },
      {
        "text": "Five machine learning algorithms, including Logistic Regression (LR), Support Vector Machine (SVM), Gradient Boosted Decision Tree (GBDT), K-Nearest Neighbor (KNN), and Neural Network (NN) were built in a training dataset, and assessed in an internal validation dataset and an external validation dataset."
      },
      {
        "text": "RESULTS Six features (procalcitonin, [T + B + NK cell] count, interleukin 6, C reactive protein, interleukin 2 receptor, T-helper lymphocyte/T-suppressor lymphocyte) were finally used for model development."
      },
      {
        "text": "Five models displayed varying but all promising predictive performance."
      },
      {
        "text": "Notably, the ensemble model, SPMCIIP (severity prediction model for COVID-19 by immune-inflammatory parameters), derived from three contributive algorithms (SVM, GBDT, and NN) achieved the best performance with an area under the curve (AUC) of 0.991 (95% confidence interval [CI] 0.979-1.000) in internal validation cohort and 0.999 (95% CI 0.998-1.000) in external validation cohort to identify patients with critical COVID-19."
      },
      {
        "text": "SPMCIIP could accurately and expeditiously predict the occurrence of critical COVID-19 approximately 20âdays in advance."
      },
      {
        "text": "CONCLUSIONS The developed online prediction model SPMCIIP is hopeful to facilitate intensive monitoring and early intervention of high risk of critical illness in COVID-19 patients."
      },
      {
        "text": "TRIAL REGISTRATION This study was retrospectively registered in the Chinese Clinical Trial Registry ( ChiCTR2000032161 )."
      },
      {
        "text": "vv."
      }
    ]
  },
  "33600292": {
    "title": "Low Vitamin D Status at Admission as a Risk Factor for Poor Survival in Hospitalized Patients With COVID-19: An Italian Retrospective Study.",
    "sentences": [
      {
        "text": "OBJECTIVE Preliminary findings suggest a relationship between lower serum 25-hydroxyvitamin D [25(OH)D] levels and incidence and severity of COVID-19."
      },
      {
        "text": "The aim of this study was to evaluate the relationship between vitamin D status at admission and different markers of inflammation, coagulation, and sepsis in hospitalized patients with COVID-19."
      },
      {
        "text": "METHOD We conducted a retrospective study on 137 consecutive patients with SARS-CoV-2 infection and available data on serum 25(OH)D levels, who were admitted to our Institution between March 1 and April 30, 2020."
      },
      {
        "text": "Patients were divided into two groups: survivors (nâ=â78; 57%) and non-survivors (nâ=â59; 43%)."
      },
      {
        "text": "RESULTS At admission, all patients showed hypovitaminosis D. Median total serum 25(OH)D levels at admission were significantly higher in survivors than non-survivors (12âng/mL vs 8âng/mL; pâ<â0.01)."
      },
      {
        "text": "Non-survivors exhibited significantly higher median levels of white blood cell (WBC) count, neutrophil-to-lymphocyte count ratio (NLR), high-sensitivity C-reactive protein (hsCRP), ferritin, interleukin 6 (IL-6), D-dimer, fibrinogen, and procalcitonin (PCT) compared to survivors at three different time points during hospitalization."
      },
      {
        "text": "In a multivariate analysis performed by a logistic regression model, serum 25(OH)D levels were significantly inversely associated with risk of COVID-19-related in-hospital mortality (odds ratio, 0.91; 95% confidence interval, 0.85-0.98; pâ=â0.01)."
      },
      {
        "text": "According to receiver operating characteristic curve analysis, hsCRP, NLR, ferritin, and D-dimer were the best predictive biomarkers for poor prognosis of COVID-19, whereas IL-6, PCT, fibrinogen, 25(OH)D, WBC count, and tumor necrosis factor alpha (TNF-Î±) may serve as supportive biomarkers for worse clinical course of the disease."
      },
      {
        "text": "CONCLUSIONS We found a markedly high prevalence (100%) of hypovitaminosis D in patients admitted to hospital with COVID-19, suggesting a possible role of low vitamin D status in increasing the risk of SARS-CoV-2 infection and subsequent hospitalization."
      },
      {
        "text": "The inverse association between serum 25(OH)D levels and risk of in-hospital mortality observed in our cohort suggests that a lower vitamin D status upon admission may represent a modifiable and independent risk factor for poor prognosis in COVID-19."
      }
    ]
  },
  "33600286": {
    "title": "Dexamethasone and Trans-Dehydroandrosterone Significantly Reduce Pulmonary Epithelial Cell Injuries Associated with Mechanical Ventilation.",
    "sentences": [
      {
        "text": "Many patients who suffer from pulmonary diseases cannot inflate their lungs normally as they need Mechanical Ventilation (MV) to assist them."
      },
      {
        "text": "The stress associated with MV can damage delicate epithelium in small airways and alveoli which can cause complications in many cases resulting in Ventilation Induced Lungs injuries (VILI) especially in patients with Acute Respiratory Distress Syndrome (ARDS)."
      },
      {
        "text": "Therefore, efforts have been used to developed safe modes for its use."
      },
      {
        "text": "In our work, we propose a different approach to decrease injuries of Epithelial Cells (EpCs) upon MV."
      },
      {
        "text": "We alter EpCs' cytoskeletal structure to increase their survival rate during airway reopening conditions associated with MV."
      },
      {
        "text": "We tested two anti-inflammatory drugs Dexamethasone (DEX) and Trans-Dehydroandrosterone (DHEA) to alter the cytoskeleton."
      },
      {
        "text": "Cultured rat L2 alveolar EpCs were exposed to airway reopening conditions using a parallel plate perfusion chamber."
      },
      {
        "text": "Cells were exposed to a single bubble propagation to simulate stresses associated with mechanical ventilation in both control and study groups."
      },
      {
        "text": "Cellular injury and cytoskeleton reorganization were assessed via fluorescent microscopy while cell topography was studied via Atomic Force Microscopy (AFM)."
      },
      {
        "text": "Our results indicate that cells in cultured media, DEX, or DHEA solutions did not lead to cell death (static cultures)."
      },
      {
        "text": "Bubble flows caused significant cell injury."
      },
      {
        "text": "Pre-exposure with DEX or DHEA decreased cell death significantly."
      },
      {
        "text": "The AFM verified cells' mechanics' alteration due to actin fibers depolymerization."
      },
      {
        "text": "These results suggest potential beneficial effects of DEX and DHEA for ARRDS treatment for COVID-19 patients."
      },
      {
        "text": "They are also critical for VILI and applicable to future clinical studies."
      }
    ]
  },
  "33599800": {
    "title": "Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study.",
    "sentences": [
      {
        "text": "AIMS/HYPOTHESIS This is an update of the results from the previous report of the CORONADO (Coronavirus SARS-CoV-2 and Diabetes Outcomes) study, which aims to describe the outcomes and prognostic factors in patients with diabetes hospitalised for coronavirus disease-2019 (COVID-19)."
      },
      {
        "text": "METHODS The CORONADO initiative is a French nationwide multicentre study of patients with diabetes hospitalised for COVID-19 with a 28-day follow-up."
      },
      {
        "text": "The patients were screened after hospital admission from 10 March to 10 April 2020."
      },
      {
        "text": "We mainly focused on hospital discharge and death within 28Â days."
      },
      {
        "text": "RESULTS We included 2796 participants: 63.7% men, mean age 69.7âÂ±â13.2Â years, median BMI (25th-75th percentile) 28.4 (25.0-32.4) kg/m2."
      },
      {
        "text": "Microvascular and macrovascular diabetic complications were found in 44.2% and 38.6% of participants, respectively."
      },
      {
        "text": "Within 28Â days, 1404 (50.2%; 95% CI 48.3%, 52.1%) were discharged from hospital with a median duration of hospital stay of 9 (5-14) days, while 577 participants died (20.6%; 95% CI 19.2%, 22.2%)."
      },
      {
        "text": "In multivariable models, younger age, routine metformin therapy and longer symptom duration on admission were positively associated with discharge."
      },
      {
        "text": "History of microvascular complications, anticoagulant routine therapy, dyspnoea on admission, and higher aspartate aminotransferase, white cell count and C-reactive protein levels were associated with a reduced chance of discharge."
      },
      {
        "text": "Factors associated with death within 28Â days mirrored those associated with discharge, and also included routine treatment by insulin and statin as deleterious factors."
      },
      {
        "text": "CONCLUSIONS/INTERPRETATION In patients with diabetes hospitalised for COVID-19, we established prognostic factors for hospital discharge and death that could help clinicians in this pandemic period."
      },
      {
        "text": "TRIAL REGISTRATION Clinicaltrials.gov identifier: NCT04324736."
      }
    ]
  },
  "33599738": {
    "title": "Network meta-analysis of infliximab biosimilars for the treatment of rheumatoid arthritis.",
    "sentences": [
      {
        "text": "PURPOSE This article assesses the relative efficacy and safety of infliximab biosimilars in treatment of patients with rheumatoid arthritis (RA)."
      },
      {
        "text": "METHODS A frequentist, random-effects network meta-analysis was performed to evaluate evidence from randomized controlled trials that examined the use of infliximab biosimilars for treatment of patients with RA."
      },
      {
        "text": "PubMed/MEDLINE and other sources were searched for reports evaluating rates of response to treatment with the reference product (infliximab) vs an infliximab biosimilar."
      },
      {
        "text": "The primary efficacy outcome of interest was the rate of attainment of ACR20 (ie, 20% improvement in American College of Rheumatology core measures)."
      },
      {
        "text": "The primary safety outcome was the rate of treatment-related serious adverse events (SAEs)."
      },
      {
        "text": "Data were extracted by the primary author, and an assessment for risks of methodological bias was performed for each evaluated study."
      },
      {
        "text": "RESULTS Five studies that enrolled a total of 2,499 patients were included."
      },
      {
        "text": "Overall comparisons using odds ratios and 95% confidence intervals (CIs) did not indicate statistically significant differences in response to treatment with biosimilar agents relative to each other or the infliximab reference product."
      },
      {
        "text": "ORs for ACR20 response for biosimilars vs infliximab were as follows: 1.475 (95% CI, 0.940-2.315) for infliximab-axxq, 1.259 (95% CI, 0.854-1.855) for infliximab-dyyb, 0.865 (95% CI, 0.5511.358) for infliximab-qbtx, and 0.832 (95% CI, 0.506-1.367) for infliximab-abda."
      },
      {
        "text": "Similar findings were observed in reported SAE rates among patients treated with the various biosimilars."
      },
      {
        "text": "CONCLUSION ACR20 response appears to be comparable and nonsignificantly different between infliximab biosimilars."
      },
      {
        "text": "In the absence of any meaningful differences in safety or efficacy, biosimilar cost may be the deciding factor in choosing a treatment or agent for formulary inclusion."
      }
    ]
  },
  "33585798": {
    "title": "Viral Respiratory Infections: An Ounce of Prevention Is Worth a Pound of Cure.",
    "sentences": [
      {
        "text": "The sudden outbreak and global spread of COVID-19 demanded a tremendous amount of attention for viral respiratory infections (VRIs) in modern times."
      },
      {
        "text": "Evidence accumulated over the past few decades increasingly suggests the importance of recognizing the background and context of lifestyle factors in the prevention of VRIs recurrence."
      },
      {
        "text": "The focus of attention has specifically been on how to optimize respiratory barrier function and immune function during the period of the pandemic outbreak."
      },
      {
        "text": "This viewpoint discusses the impact of a healthy lifestyle on VRIs and demonstrates a practical approach to preventing the occurrence of VRIs based on contemporary evidence."
      }
    ]
  },
  "33585554": {
    "title": "SARS-CoV-2 Proteins Exploit Host's Genetic and Epigenetic Mediators for the Annexation of Key Host Signaling Pathways.",
    "sentences": [
      {
        "text": "The constant rise of the death toll and cases of COVID-19 has made this pandemic a serious threat to human civilization."
      },
      {
        "text": "Understanding of host-SARS-CoV-2 interaction in viral pathogenesis is still in its infancy."
      },
      {
        "text": "In this study, we utilized a blend of computational and knowledgebase approaches to model the putative virus-host interplay in host signaling pathways by integrating the experimentally validated host interactome proteins and differentially expressed host genes in SARS-CoV-2 infection."
      },
      {
        "text": "While searching for the pathways in which viral proteins interact with host proteins, we discovered various antiviral immune response pathways such as hypoxia-inducible factor 1 (HIF-1) signaling, autophagy, retinoic acid-inducible gene I (RIG-I) signaling, Toll-like receptor signaling, fatty acid oxidation/degradation, and IL-17 signaling."
      },
      {
        "text": "All these pathways can be either hijacked or suppressed by the viral proteins, leading to improved viral survival and life cycle."
      },
      {
        "text": "Aberration in pathways such as HIF-1 signaling and relaxin signaling in the lungs suggests the pathogenic lung pathophysiology in COVID-19."
      },
      {
        "text": "From enrichment analysis, it was evident that the deregulated genes in SARS-CoV-2 infection might also be involved in heart development, kidney development, and AGE-RAGE signaling pathway in diabetic complications."
      },
      {
        "text": "Anomalies in these pathways might suggest the increased vulnerability of COVID-19 patients with comorbidities."
      },
      {
        "text": "Moreover, we noticed several presumed infection-induced differentially expressed transcription factors and epigenetic factors, such as miRNAs and several histone modifiers, which can modulate different immune signaling pathways, helping both host and virus."
      },
      {
        "text": "Our modeling suggests that SARS-CoV-2 integrates its proteins in different immune signaling pathways and other cellular signaling pathways for developing efficient immune evasion mechanisms while leading the host to a more complicated disease condition."
      },
      {
        "text": "Our findings would help in designing more targeted therapeutic interventions against SARS-CoV-2."
      }
    ]
  },
  "33585111": {
    "title": "Neutrophil-to-Lymphocyte, Lymphocyte-to-Monocyte, and Platelet-to-Lymphocyte Ratios: Prognostic Significance in COVID-19.",
    "sentences": [
      {
        "text": "Background and objective Neutrophils are primarily responsible for activating the immune system, and systemic inflammation destroys CD4+ T lymphocytes and increases suppressor CD8+ T lymphocytes, thereby leading to an increased neutrophil-to-lymphocyte ratio (NLR)."
      },
      {
        "text": "An increase in the apoptosis of lymphocytes leads to lymphopenia and elevated thrombopoietin (THPO) promotes megakaryocyte production."
      },
      {
        "text": "The reflections of these inflammatory changes can be vital in gauging the progression of the disease."
      },
      {
        "text": "This study aimed at examining the prognostic value of normal and derived neutrophil-to-lymphocyte, lymphocyte-to-monocyte, platelet-to-lymphocyte, and mean platelet volume (MPV)-to-platelet count ratios in patients with coronavirus disease 2019 (COVID-19)."
      },
      {
        "text": "Methodology This was a retrospective cross-sectional study conducted in the wards of Chigateri General Hospital, Davangere for a period of two months."
      },
      {
        "text": "Complete blood count was ordered for all patients at the time of admission along with confirmation of the disease by reverse transcription-polymerase chain reactionÂ (RT-PCR)."
      },
      {
        "text": "Results The final study population consisted of 100 patients."
      },
      {
        "text": "The mean age of patients who survived (43 years) was significantly lower than the mean age of non-survivors (59.1 years), with a p-value of <0.001."
      },
      {
        "text": "NLR was raised in 60% of the population and was significantly higher in patients who survived the disease, with a p-value of 0.004."
      },
      {
        "text": "The platelet-to-lymphocyte ratio (PLR) also followed a similar trend with a p-value of 0.017."
      },
      {
        "text": "Even though the lymphocyte-to-monocyte ratio (LMR) also mimicked the trend,Â the statistical association was not significant (p-value: 0.09)."
      },
      {
        "text": "The derived NLR and MPV-to-platelets ratios were not found to be significantly associated with mortality in this study."
      },
      {
        "text": "Discussion Younger patients had better clinical outcomes in our study population compared to the geriatric age group."
      },
      {
        "text": "A significant correlation between LMR and mortality was observed when a cut-off of 2.5 was considered as a differentiating benchmark."
      },
      {
        "text": "Conflicting trends were observed in NLR and PLR in our study; however, LMR was in accordance with most other studies."
      },
      {
        "text": "The phase that a patient is in with regard to the natural history of the disease also influences the blood cell ratios."
      },
      {
        "text": "Nonetheless, all three ratios can be used as crucial screening and prognostic tools as they are readily available with the help of a complete hemogram."
      },
      {
        "text": "This is an investigation modality that is widely accessible even in remote areas and resource-limited settings."
      },
      {
        "text": "Conclusion These hematological ratios can facilitate in categorizing the disease severity and progression in patients, thereby enabling us to make appropriate and informed clinical decisions."
      },
      {
        "text": "Since the second wave of the novel coronavirus is on the verge of arrival, it is imperative to channel resources for the patients early in their disease course toÂ ultimatelyÂ prevent complications and reduce mortality."
      }
    ]
  },
  "33584656": {
    "title": "Key Components of Inflammasome and Pyroptosis Pathways Are Deficient in Canines and Felines, Possibly Affecting Their Response to SARS-CoV-2 Infection.",
    "sentences": [
      {
        "text": "SARS-CoV-2 causes the ongoing COVID-19 pandemic."
      },
      {
        "text": "Natural SARS-COV-2 infection has been detected in dogs, cats and tigers."
      },
      {
        "text": "However, the symptoms in canines and felines were mild."
      },
      {
        "text": "The underlying mechanisms are unknown."
      },
      {
        "text": "Excessive activation of inflammasome pathways can trigger cytokine storm and severe damage to host."
      },
      {
        "text": "In current study, we performed a comparative genomics study of key components of inflammasome and pyroptosis pathways in dogs, cats and tigers."
      },
      {
        "text": "Cats and tigers do not have AIM2 and NLRP1."
      },
      {
        "text": "Dogs do not contain AIM2, and encode a short form of NLRC4."
      },
      {
        "text": "The activation sites in GSDMB were absent in dogs, cats and tigers, while GSDME activation sites in cats and tigers were abolished."
      },
      {
        "text": "We propose that deficiencies of inflammasome and pyroptosis pathways might provide an evolutionary advantage against SARS-CoV-2 by reducing cytokine storm-induced host damage."
      },
      {
        "text": "Our findings will shed important lights on the mild symptoms in canines and felines infected with SARS-CoV-2."
      }
    ]
  },
  "33584530": {
    "title": "Case Report: Myopathy in Critically Ill COVID-19 Patients: A Consequence of Hyperinflammation?",
    "sentences": [
      {
        "text": "Introduction: COVID-19-associated muscular complications may comprise myalgia, weakness, wasting, and rhabdomyolysis."
      },
      {
        "text": "Skeletal muscle damage in COVID-19 may be due to direct infection by the virus SARS-CoV-2 through interaction with the ACE2 receptor, systemic hyper-inflammatory state with cytokine release and homeostatic perturbation, an autoimmune process, or myotoxic drugs."
      },
      {
        "text": "Disclosing the cause of weakness in an individual patient is therefore difficult."
      },
      {
        "text": "Case Description: We report two patients, who survived typical COVID-19 pneumonia requiring intensive care treatment and who developed early on myalgia and severe proximal weakness in all four limbs."
      },
      {
        "text": "Laboratory exams revealed elevated serum creatine kinase and markedly increased C-reactive protein and interleukin 6, concurring with a systemic inflammatory response."
      },
      {
        "text": "On admission in neurorehabilitation (4 and 7 weeks after COVID-19 onset, respectively), the patients presented with proximal flaccid tetraparesis and limb-girdle muscle atrophy."
      },
      {
        "text": "Motor nerve conduction studies showed decreased amplitude and prolonged duration of compound muscle action potentials (CMAPs) with normal distal motor latencies and normal conduction velocities in median and ulnar nerves."
      },
      {
        "text": "Needle electromyography in proximal muscles revealed spontaneous activity in one and myopathic changes in both patients."
      },
      {
        "text": "Discussion: Clinical, laboratory, and electrodiagnostic findings in these patients were unequivocally consistent with myopathy."
      },
      {
        "text": "Interestingly, increased distal CMAP duration has been described in patients with critical illness myopathy (CIM) and reflects slow muscle fiber conduction velocity due to membrane hypo-excitability, possibly induced by inflammatory cytokines."
      },
      {
        "text": "By analogy with CIM, the pathogenesis of COVID-19-related myopathy might also depend on hyperinflammation and metabolic pathways that may affect muscles in a pathophysiological continuum from hypo-excitability to necrosis."
      }
    ]
  },
  "33584306": {
    "title": "HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons.",
    "sentences": [
      {
        "text": "The review analyzes the potential advantages and problems associated with using HIF prolyl hydroxylase inhibitors as a treatment for COVID-19."
      },
      {
        "text": "HIF prolyl hydroxylase inhibitors are known to boost endogenous erythropoietin (Epo) and activate erythropoiesis by stabilizing and activating the hypoxia inducible factor (HIF)."
      },
      {
        "text": "Recombinant Epo treatment has anti-inflammatory and healing properties, and thus, very likely, will be beneficial for moderate to severe cases of COVID-19."
      },
      {
        "text": "However, HIF PHD inhibition may have a significantly broader effect, in addition to stimulating the endogenous Epo production."
      },
      {
        "text": "The analysis of HIF target genes reveals that some HIF-targets, such as furin, could play a negative role with respect to viral entry."
      },
      {
        "text": "On the other hand, HIF prolyl hydroxylase inhibitors counteract ferroptosis, the process recently implicated in vessel damage during the later stages of COVID-19."
      },
      {
        "text": "Therefore, HIF prolyl hydroxylase inhibitors may serve as a promising treatment of COVID-19 complications, but they are unlikely to aid in the prevention of the initial stages of infection."
      }
    ]
  },
  "33574756": {
    "title": "Potential of Immune-Related Therapy in COVID-19.",
    "sentences": [
      {
        "text": "At the beginning of 2020, a sudden outbreak of new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), infections led to anxiety, panic, and crisis among people worldwide."
      },
      {
        "text": "The outbreak first occurred in Wuhan, China, in late December 2019 and then spread rapidly across the globe, thus becoming a major public health emergency."
      },
      {
        "text": "Although the current epidemic situation in China tends to be stable, coronavirus disease 2019 (COVID-19) continues to spread globally."
      },
      {
        "text": "At present, no specific therapeutic drugs and vaccines are available against COVID-19."
      },
      {
        "text": "Also, the pathogenesis of the SARS-CoV-2 is not fully clear."
      },
      {
        "text": "Human immunity is important in SARS-CoV-2 infection."
      },
      {
        "text": "Studies have shown that excessive inflammation caused by SARS-CoV-2 infection and subsequent induced uncontrolled cytokine storm are the main causes of disease deterioration and death of severe patients."
      },
      {
        "text": "Therefore, immune-related research is of great significance for the prevention, control, and prognosis of COVID-19."
      },
      {
        "text": "This study aimed to review the latest research on immune-related treatment of COVID-19."
      }
    ]
  },
  "33569525": {
    "title": "COVID-19 related thrombi in ascending and descending thoracic aorta with peripheral embolization: a case report.",
    "sentences": [
      {
        "text": "Background COVID-19 (severe acute respiratory syndrome coronavirus 2) infected patients have increased risk for thrombotic events, which initially may have been under recognized."
      },
      {
        "text": "The existence of cardiovascular emboli can be directly life threatening when obstructing the blood flow to vital organs such as the brain or other parts of the body."
      },
      {
        "text": "The exact mechanism for this hypercoagulable state in COVID-19 patients yet remains to be elucidated."
      },
      {
        "text": "Case summary A 72-year-old man critically ill with COVID-19 was diagnosed with a free-floating and mural thrombus in the thoracic aorta."
      },
      {
        "text": "Subsequent distal embolization to the limbs led to ischaemia and necrosis of the right foot."
      },
      {
        "text": "Treatment with heparin and anticoagulants reduced thrombus load in the ascending and thoracic aorta."
      },
      {
        "text": "Discussion One-third of COVID-19 patients show major thrombotic events, mostly pulmonary emboli."
      },
      {
        "text": "The endothelial expression of angiotensin-converting enzyme-2 receptors makes it feasible that in patients with viraemia direct viral-toxicity to the endothelium of also the large arteries results in local thrombus formation."
      },
      {
        "text": "Up to date, prophylactic anticoagulants are recommended in all patients that are hospitalized with COVID-19 infections to prevent venous and arterial thrombotic complications."
      }
    ]
  },
  "33392213": {
    "title": "Clinical Characteristics and Neonatal Outcomes of Pregnant Patients With COVID-19: A Systematic Review.",
    "sentences": [
      {
        "text": "Background and Objective: Coronavirus disease 2019 (COVID-19) characterized by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has created serious concerns about its potential adverse effects."
      },
      {
        "text": "There are limited data on clinical, radiological, and neonatal outcomes of pregnant women with COVID-19 pneumonia."
      },
      {
        "text": "This study aimed to assess clinical manifestations and neonatal outcomes of pregnant women with COVID-19."
      },
      {
        "text": "Methods: We conducted a systematic article search of PubMed, EMBASE, Scopus, Google Scholar, and Web of Science for studies that discussed pregnant patients with confirmed COVID-19 between January 1, 2020, and April 20, 2020, with no restriction on language."
      },
      {
        "text": "Articles were independently evaluated by two expert authors."
      },
      {
        "text": "We included all retrospective studies that reported the clinical features and outcomes of pregnant patients with COVID-19."
      },
      {
        "text": "Results: Forty-seven articles were assessed for eligibility; 13 articles met the inclusion criteria for the systematic review."
      },
      {
        "text": "Data is reported for 235 pregnant women with COVID-19."
      },
      {
        "text": "The age range of patients was 25-40 years, and the gestational age ranged from 8 to 40 weeks plus 6 days."
      },
      {
        "text": "Clinical characteristics were fever [138/235 (58.72%)], cough [111/235 (47.23%)], and sore throat [21/235 (8.93%)]."
      },
      {
        "text": "One hundred fifty six out of 235 (66.38%) pregnant women had cesarean section, and 79 (33.62%) had a vaginal delivery."
      },
      {
        "text": "All the patients showed lung abnormalities in CT scan images, and none of the patients died."
      },
      {
        "text": "Neutrophil cell count, C-reactive protein (CRP) concentration, ALT, and AST were increased but lymphocyte count and albumin levels were decreased."
      },
      {
        "text": "Amniotic fluid, neonatal throat swab, and breastmilk samples were taken to test for SARS-CoV-2 but all found negativ results."
      },
      {
        "text": "Recent published evidence showed the possibility of vertical transmission up to 30%, and neonatal death up to 2.5%."
      },
      {
        "text": "Pre-eclampsia, fetal distress, PROM, pre-mature delivery were the major complications of pregnant women with COVID-19."
      },
      {
        "text": "Conclusions: Our study findings show that the clinical, laboratory and radiological characteristics of pregnant women with COVID-19 were similar to those of the general populations."
      },
      {
        "text": "The possibility of vertical transmission cannot be ignored but C-section should not be routinely recommended anymore according to latest evidences and, in any case, decisions should be taken after proper discussion with the family."
      },
      {
        "text": "Future studies are needed to confirm or refute these findings with a larger number of sample sizes and a long-term follow-up period."
      }
    ]
  },
  "33596266": {
    "title": "SARS-CoV-2 tropism, entry, replication, and propagation: Considerations for drug discovery and development.",
    "sentences": [
      {
        "text": "Since the initial report of the novel Coronavirus Disease 2019 (COVID-19) emanating from Wuhan, China, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has spread globally."
      },
      {
        "text": "While the effects of SARS-CoV-2 infection are not completely understood, there appears to be a wide spectrum of disease ranging from mild symptoms to severe respiratory distress, hospitalization, and mortality."
      },
      {
        "text": "There are no Food and Drug Administration (FDA)-approved treatments for COVID-19 aside from remdesivir; early efforts to identify efficacious therapeutics for COVID-19 have mainly focused on drug repurposing screens to identify compounds with antiviral activity against SARS-CoV-2 in cellular infection systems."
      },
      {
        "text": "These screens have yielded intriguing hits, but the use of nonhuman immortalized cell lines derived from non-pulmonary or gastrointestinal origins poses any number of questions in predicting the physiological and pathological relevance of these potential interventions."
      },
      {
        "text": "While our knowledge of this novel virus continues to evolve, our current understanding of the key molecular and cellular interactions involved in SARS-CoV-2 infection is discussed in order to provide a framework for developing the most appropriate in vitro toolbox to support current and future drug discovery efforts."
      }
    ]
  },
  "33592322": {
    "title": "Role of arachidonic cascade in COVID-19 infection: A review.",
    "sentences": [
      {
        "text": "The World Health Organization has described the 2019 Coronavirus disease caused by an influenza-like virus called SARS-CoV-2 as a pandemic."
      },
      {
        "text": "Millions of people worldwide are already infected by this virus, and severe infection causes hyper inflammation, thus disrupting lung function, exacerbating breath difficulties, and death."
      },
      {
        "text": "Various inflammatory mediators bio-synthesized through the arachidonic acid pathway play roles in developing cytokine storms, injuring virus-infected cells."
      },
      {
        "text": "Since pro-inflammatory eicosanoids, including prostaglandins, and leukotrienes, are key brokers for physiological processes such as inflammation, fever, allergy, and pain but, their function in COVID-19 is not well defined."
      },
      {
        "text": "This study addresses eicosanoid's crucial role through the arachidonic pathway in inflammatory cascading and recommends using bioactive lipids, NSAIDs, steroids, cell phospholipase A2 (cPLA2) inhibitors, and specialized pro-resolving mediators (SPMs) to treat COVID-19 disease."
      },
      {
        "text": "The role of soluble epoxide hydrolase inhibitors (SEHIs) in promoting the activity of epoxyeicosatrienoic acids (EETs) and 17-hydroxide-docosahexaenoic acid (17-HDHA) is also discussed."
      },
      {
        "text": "Additional research that assesses the eicosanoid profile in COVID-19 patients or preclinical models generates novel insights into coronavirus-host interaction and inflammation regulation."
      }
    ]
  },
  "33588321": {
    "title": "Biological responses to COVID-19: Insights from physiological and blood biomarker profiles.",
    "sentences": [
      {
        "text": "BACKGROUND Understanding the spectrum and course of biological responses to coronavirus disease 2019 (COVID-19) may have important therapeutic implications."
      },
      {
        "text": "We sought to characterise biological responses among patients hospitalised with severe COVID-19 based on serial, routinely collected, physiological and blood biomarker values."
      },
      {
        "text": "METHODS AND FINDINGS We performed a retrospective cohort study of 1335 patients hospitalised with laboratory-confirmed COVID-19 (median age 70 years, 56 % male), between 1st March and 30th April 2020."
      },
      {
        "text": "Latent profile analysis was performed on serial physiological and blood biomarkers."
      },
      {
        "text": "Patient characteristics, comorbidities and rates of death and admission to intensive care, were compared between the latent classes."
      },
      {
        "text": "A five class solution provided the best fit."
      },
      {
        "text": "Class 1 \"Typical response\" exhibited a moderately elevated and rising C-reactive protein (CRP), stable lymphopaenia, and the lowest rates of 14-day adverse outcomes."
      },
      {
        "text": "Class 2 \"Rapid hyperinflammatory response\" comprised older patients, with higher admission white cell and neutrophil counts, which declined over time, accompanied by a very high and rising CRP and platelet count, and exibited the highest mortality risk."
      },
      {
        "text": "Class 3 \"Progressive inflammatory response\" was similar to the typical response except for a higher and rising CRP, though similar mortality rate."
      },
      {
        "text": "Class 4 \"Inflammatory response with kidney injury\" had prominent lymphopaenia, moderately elevated (and rising) CRP, and severe renal failure."
      },
      {
        "text": "Class 5 \"Hyperinflammatory response with kidney injury\" comprised older patients, with a very high and rising CRP, and severe renal failure that attenuated over time."
      },
      {
        "text": "Physiological measures did not substantially vary between classes at baseline or early admission."
      },
      {
        "text": "CONCLUSIONS AND RELEVANCE Our identification of five distinct classes of biomarker profiles provides empirical evidence for heterogeneous biological responses to COVID-19."
      },
      {
        "text": "Early hyperinflammatory responses and kidney injury may signify unique pathophysiology that requires targeted therapy."
      }
    ]
  },
  "33587448": {
    "title": "Risk of adverse coronavirus disease 2019 outcomes for people living with HIV.",
    "sentences": [
      {
        "text": "OBJECTIVE To assess whether people living with HIV (PLWH) are at increased risk of coronavirus disease 2019 (COVID-19) mortality or adverse outcomes, and whether antiretroviral therapy (ART) influences this risk."
      },
      {
        "text": "DESIGN Rapid review with meta-analysis and narrative synthesis."
      },
      {
        "text": "METHODS We searched databases including Embase, Medline, medRxiv and Google Scholar up to 26 August 2020 for studies describing COVID-19 outcomes in PLWH and conducted a meta-analysis of higher quality studies."
      },
      {
        "text": "RESULTS We identified 1908 studies and included 19 in the review."
      },
      {
        "text": "In a meta-analysis of five studies, PLWH had a higher risk of COVID-19 mortality [hazard ratio 1.95, 95% confidence interval (CI): 1.62-2.34] compared with people without HIV."
      },
      {
        "text": "Risk of death remained elevated for PLWH in a subgroup analysis of hospitalized cohorts (hazard ratio 1.60, 95% CI: 1.12-2.27) and studies of PLWH across all settings (hazard ratio 2.08, 95% CI: 1.69-2.56)."
      },
      {
        "text": "Eight other studies assessed the association between HIV and COVID-19 outcomes, but provided inconclusive, lower quality evidence due to potential confounding and selection bias."
      },
      {
        "text": "There were insufficient data on the effect of CD4+ T-cell count and HIV viral load on COVID-19 outcomes."
      },
      {
        "text": "Eleven studies reported COVID-19 outcomes by ART-regimen."
      },
      {
        "text": "In the two largest studies, tenofovir disoproxil fumarate-based regimens were associated with a lower risk of adverse COVID-19 outcomes, although these analyses are susceptible to confounding by co-morbidities."
      },
      {
        "text": "CONCLUSION Emerging evidence suggests a moderately increased risk of COVID-19 mortality among PLWH."
      },
      {
        "text": "Further investigation into the relationship between COVID-19 outcomes and CD4+ T-cell count, HIV viral load, ART and the use of tenofovir disoproxil fumarate is warranted."
      }
    ]
  },
  "33586810": {
    "title": "Non-canonical autophagy functions of ATG16L1 in epithelial cells limit lethal infection by influenza A virus.",
    "sentences": [
      {
        "text": "Influenza A virus (IAV) and SARS-CoV-2 (COVID-19) cause pandemic infections where cytokine storm syndrome and lung inflammation lead to high mortality."
      },
      {
        "text": "Given the high social and economic cost of respiratory viruses, there is an urgent need to understand how the airways defend against virus infection."
      },
      {
        "text": "Here we use mice lacking the WD and linker domains of ATG16L1 to demonstrate that ATG16L1-dependent targeting of LC3 to single-membrane, non-autophagosome compartments - referred to as non-canonical autophagy - protects mice from lethal IAV infection."
      },
      {
        "text": "Mice with systemic loss of non-canonical autophagy are exquisitely sensitive to low-pathogenicity IAV where extensive viral replication throughout the lungs, coupled with cytokine amplification mediated by plasmacytoid dendritic cells, leads to fulminant pneumonia, lung inflammation and high mortality."
      },
      {
        "text": "IAV was controlled within epithelial barriers where non-canonical autophagy reduced IAV fusion with endosomes and activation of interferon signalling."
      },
      {
        "text": "Conditional mouse models and ex vivo analysis showed that protection against IAV infection of lung was independent of phagocytes and other leucocytes."
      },
      {
        "text": "This establishes non-canonical autophagy in airway epithelial cells as a novel innate defence that restricts IAV infection and lethal inflammation at respiratory surfaces."
      }
    ]
  },
  "33586274": {
    "title": "Four Cycles of Etoposide plus Cisplatin for Patients with Good-Risk Advanced Germ Cell Tumors.",
    "sentences": [
      {
        "text": "BACKGROUND The National Comprehensive Cancer Network recommends either three cycles of bleomycin, etoposide, and cisplatin or four cycles of etoposide and cisplatin (EPx4) as initial chemotherapy for the treatment of good-risk germ cell tumors (GCTs)."
      },
      {
        "text": "To assess the response, toxicity, and survival outcomes of EPx4, we analyzed our experience."
      },
      {
        "text": "MATERIAL AND METHODS Response and survival outcomes, selected toxicities, and adherence to chemotherapy dose and schedule were assessed in patients with good-risk GCT who received EPx4 at Memorial Sloan Kettering Cancer Center between 1982 and 2016."
      },
      {
        "text": "The results were compared with our past results and published data."
      },
      {
        "text": "RESULTS Between 1982 and 2016, 944 patients with GCT were treated with EPx4, 289 who were previously reported plus 655 treated between January 2000 and August 2016."
      },
      {
        "text": "A favorable response was achieved in 928 of 944 patients (98.3%)."
      },
      {
        "text": "Five-year progression-free, disease-specific, and overall survival rates were 93.9%, 98.6%, and 97.9%, respectively."
      },
      {
        "text": "Median follow-up was 7.3âyears (range, 2.8 months to 35.5âyears)."
      },
      {
        "text": "Viable, nonteratomatous malignant GCT was present in 3.5% of 432 postchemotherapy retroperitoneal lymph node dissection specimens from patients with nonseminomatous GCT."
      },
      {
        "text": "Febrile neutropenia and thromboembolic events occurred in 16.0% and 8.9%, respectively, with one treatment-related death."
      },
      {
        "text": "In the more recent 655-patient cohort, full-dose EPx4 was administered to 631 (96.3%), with deviations from planned treatment driven mainly by vascular (n =â13), hematologic (n =â11), renal (n =â7), or infectious (n =â5) events."
      },
      {
        "text": "CONCLUSION EPx4 is highly effective and well tolerated in patients with good-risk GCTs and remains a standard of care."
      },
      {
        "text": "IMPLICATIONS FOR PRACTICE Four cycles of etoposide and cisplatin (EPx4) is a standard-of-care regimen for all patients with good-risk germ cell tumors with a favorable response rate and disease-specific survival of 98%."
      },
      {
        "text": "Full-dose administration of etoposide and cisplatin and complete resection of residual disease lead to optimal outcomes."
      },
      {
        "text": "EPx4 should be the recommended regimen in active smokers, patients with reduced or borderline kidney function, and patients aged 50 years or older, which are patient groups at increased risk for bleomycin pulmonary toxicity."
      },
      {
        "text": "Because of a risk of acquired severe pulmonary illness, EPx4 may also be favored for patients who vape or use e-cigarettes and during ongoing transmission of severe acute respiratory syndrome coronavirus 2."
      }
    ]
  },
  "33582156": {
    "title": "Hyper-Inflammatory Response Involves in Cardiac Injury among Patients with Coronavirus Disease 2019.",
    "sentences": [
      {
        "text": "BACKGROUND Coronavirus disease 2019 (COVID-19) is still ongoing throughout the world and has resulted in considerable fatality."
      },
      {
        "text": "Inflammation and cardiac injury are commonly observed in these cases."
      },
      {
        "text": "However, the association between the hyper-inflammatory response and cardiac injury among patients with COVID-19 remains unknown."
      },
      {
        "text": "METHODS The study was designed based on severe and critically ill patients with COVID-19."
      },
      {
        "text": "Information on demographics and baseline clinical characteristics as well as laboratory examinations were collected from the electronic medical records and analyzed."
      },
      {
        "text": "RESULTS There were 32.4% (nâ¯=â¯107) of patients presenting with cardiac injury."
      },
      {
        "text": "The median age was 67 years, and 48.8% (nâ¯=â¯161) of patients were men."
      },
      {
        "text": "Hypertension was the most common in 161 (48.8%) patients, followed by diabetes (16.7%, nâ¯=â¯55) and coronary heart disease (13.3%, nâ¯=â¯44)."
      },
      {
        "text": "Moreover, compared to cases without cardiac injury, those with cardiac injury were older, had higher proportions of coronary heart disease, had significantly elevated leukocyte counts and concentrations of N-terminal pro-B-Type natriuretic peptide, high-sensitivity C-reactive protein (hs-CRP), tumor necrosis factor (TNF)-Î±, interleukin-2 receptor (IL-2R), IL-6, and IL-8, but lower lymphocyte counts."
      },
      {
        "text": "A significant positive correlation was observed between high-sensitivity troponin I and hs-CRP, TNF-Î±, IL-2R, IL-6 and IL-8."
      },
      {
        "text": "Stepwise logistic regression analysis showed that hs-CRP, TNF-Î± and IL-6 were independent risk factors for cardiac injury."
      },
      {
        "text": "CONCLUSIONS Pro-inflammatory cytokines were associated with cardiac injury among severe and critically ill patients with COVID-19, suggesting that hyper-inflammatory response may involve in cardiac injury."
      }
    ]
  },
  "33580949": {
    "title": "Autopsy and Histologic Findings of Patients with New Coronavirus Pneumonia: The Pathologic Associations with Hypoxemia.",
    "sentences": [
      {
        "text": "BACKGROUND Coronavirus 2 (SARS-CoV-2) was declared a pandemic by the World Health Organization (WHO) in March 2020."
      },
      {
        "text": "To further reveal the pathologic associations between coronavirus and hypoxemia, we report the findings of 4 complete systematic autopsies of severe acute respiratory syndrome coronavirus 2-positive individuals who died of multiple organ failure caused by severe hypoxemia."
      },
      {
        "text": "MATERIAL AND METHODS We examined the donated corpses of 4 deceased patients who had been diagnosed with severe acute respiratory syndrome coronavirus 2."
      },
      {
        "text": "A complete post-mortem examination was carried out on each corpse, and multiple organs were macroscopically examined."
      },
      {
        "text": "RESULTS The 4 corpses were 2 males and 2 females, with an average age of 69 years."
      },
      {
        "text": "Bilateral lungs showed various degrees of atrophy and consolidation, with diffusely tough and solid texture in the sections."
      },
      {
        "text": "A thromboembolism was found in the main pulmonary artery extending into the atrium in 1 corpse, and significant atherosclerotic plaques tagged in the inner wall of the aortic arch were found in 2 corpses."
      },
      {
        "text": "Two corpses were found to have slightly atrophied bilateral renal parenchyma."
      },
      {
        "text": "Atrophic changes in the spleen were found in 2 corpses."
      },
      {
        "text": "Notably, there were significantly expanded alveolar septa and prominent fibroblastic proliferation."
      },
      {
        "text": "CONCLUSIONS The laboratory data of these corpses showed a progressive decrease in blood oxygen saturation, followed by refractory and irreversible hypoxemia."
      },
      {
        "text": "Clinical and laboratory information and autopsy and histologic presentations of multiple organs showed insufficient air exchange due to abnormalities in the respiratory system, and reduced erythropoiesis in bone marrow may play a role."
      }
    ]
  },
  "33580566": {
    "title": "Background to new treatments for COVID-19, including its chronicity, through altering elements of the cytokine storm.",
    "sentences": [
      {
        "text": "Anti-tumour necrosis factor (TNF) biologicals, Dexamethasone and rIL-7 are of considerable interest in treating COVID-19 patients who are in danger of, or have become, seriously ill."
      },
      {
        "text": "Yet reducing sepsis mortality by lowering circulating levels of TNF lost favour when positive endpoints in earlier simplistic models could not be reproduced in well-conducted human trials."
      },
      {
        "text": "Newer information with anti-TNF biologicals has encouraged reintroducing this concept for treating COVID-19."
      },
      {
        "text": "Viral models have had encouraging outcomes, as have the effects of anti-TNF biologicals on community-acquired COVID-19 during their long-term use to treat chronic inflammatory states."
      },
      {
        "text": "The positive outcome of a large scale trial of dexamethasone, and its higher potency late in the disease, harmonises well with its capacity to enhance levels of IL-7RÎ±, the receptor for IL-7, a cytokine that enhances lymphocyte development and is increased during the cytokine storm."
      },
      {
        "text": "Lymphoid germinal centres required for antibody-based immunity can be harmed by TNF, and restored by reducing TNF."
      },
      {
        "text": "Thus the IL-7- enhancing activity of dexamethasone may explain its higher potency when lymphocytes are depleted later in the infection, while employing anti-TNF, for several reasons, is much more logical earlier in the infection."
      },
      {
        "text": "This implies dexamethasone could prove to be synergistic with rIL-7, currently being trialed as a COVID-19 therapeutic."
      },
      {
        "text": "The principles behind these COVID-19 therapies are consistent with the observed chronic hypoxia through reduced mitochondrial function, and also the increased severity of this disease in ApoE4-positive individuals."
      },
      {
        "text": "Many of the debilitating persistent aspects of this disease are predictably susceptible to treatment with perispinal etanercept, since they have cerebral origins."
      }
    ]
  },
  "33578926": {
    "title": "Fruits and Vegetables in the Management of Underlying Conditions for COVID-19 High-Risk Groups.",
    "sentences": [
      {
        "text": "SARS-CoV-2 or COVID-19 is a novel coronavirus, which is the cause of the current pandemic with 107,411,561 infections and 2,351,195 death worldwide so far."
      },
      {
        "text": "There are multiple symptoms that are linked with the infection of COVID-19 such as coughing, shortness of breath, congestion together with fatigue, fever, loss of taste or smell, headaches, diarrhea, vomiting, and loss of appetite."
      },
      {
        "text": "The lack of or early stage of development of a cure for COVID-19 illness, there is need for insuring the best possible position of health to be able to fight the virus naturally through a robust immune system to limit severe complication."
      },
      {
        "text": "In this article, we have discussed the role of fruits and vegetables consumption to boost the immune system and major emphasis has been given to high risk group."
      },
      {
        "text": "We have taken into consideration a number of underlying conditions such as people with cardiovascular diseases, obesity, diabetes, chronic obstructive pulmonary disease, chronic kidney disease, hemoglobin disorder such as sickle cell disease, weakened immune system due to organ transplant."
      },
      {
        "text": "Furthermore, factors to improve the immune system, risks associated with quarantine and lifestyle and food handling during COVID-19 has been discussed."
      }
    ]
  },
  "33578295": {
    "title": "Age-dependent effects of the recombinant spike protein/SARS-CoV-2 on the M-CSF- and IL-34-differentiated macrophages inÂ vitro.",
    "sentences": [
      {
        "text": "The SARS-CoV-2 virus causes elevated production of senescence-associated secretory phenotype (SASP) markers by macrophages."
      },
      {
        "text": "SARS-CoV-2 enters macrophages through its Spike-protein aided by cathepsin (Cat) B and L, which also mediate SASP production."
      },
      {
        "text": "Since M-CSF and IL-34 control macrophage differentiation, we investigated the age-dependent effects of the Spike-protein on SASP-related pro-inflammatory-cytokines and nuclear-senescence-regulatory-factors, and CatB, L and K, in mouse M-CSF- and IL-34-differentiated macrophages."
      },
      {
        "text": "The Spike-protein upregulated SASP expression in young and aged male M-CSF-macrophages."
      },
      {
        "text": "In contrast, only young and aged male IL-34-macrophages demonstrated significantly reduced pro-inflammatory cytokine expression in response to the Spike-protein inÂ vitro."
      },
      {
        "text": "Furthermore, the S-protein elevated CatB expression in young male M-CSF-macrophages and young female IL-34-macrophages, whereas CatL was overexpressed in young male IL-34- and old male M-CSF-macrophages."
      },
      {
        "text": "Surprisingly, the S-protein increased CatK activity in young and aged male M-CSF-macrophages, indicating that CatK may be also involved in the COVID-19 pathology."
      },
      {
        "text": "Altogether, we demonstrated the age- and sex-dependent effects of the Spike-protein on M-CSF and IL-34-macrophages using a novel inÂ vitro mouse model of SARS-CoV-2/COVID-19."
      }
    ]
  },
  "33576584": {
    "title": "SARS-CoV-2 associated rhabdomyolysis in 32 patients.",
    "sentences": [
      {
        "text": "none , letter to the Editor."
      }
    ]
  },
  "33575962": {
    "title": "P2Y14 Receptor as a Target for Neutrophilia Attenuation in Severe COVID-19 Cases: From Hematopoietic Stem Cell Recruitment and Chemotaxis to Thrombo-inflammation.",
    "sentences": [
      {
        "text": "The global SARS-CoV-2 pandemic starting in 2019 has already reached more than 2.3Â million deaths."
      },
      {
        "text": "Despite the scientific community's efforts to investigate the COVID-19 disease, a drug for effectively treating or curing patients yet needs to be discovered."
      },
      {
        "text": "Hematopoietic stem cells (HSC) differentiating into immune cells for defense express COVID-19 entry receptors, and COVID-19Â infection hinders their differentiation."
      },
      {
        "text": "The importance of purinergic signaling in HSC differentiation and innate immunity has been recognized."
      },
      {
        "text": "The metabotropic P2Y14 receptor subtype, activated by UDP-glucose, controls HSC differentiation and mobilization."
      },
      {
        "text": "Thereon, the exacerbated activation of blood immune cells amplifies the inflammatory state observed in COVID-19 patients, specially through the continuous release of reactive oxygen species and extracellular neutrophil traps (NETs)."
      },
      {
        "text": "Further, the P2Y14 subtype, robustly inhibits the infiltration of neutrophils into various epithelial tissues, including lungs and kidneys."
      },
      {
        "text": "Here we discuss findings suggesting that antagonism of the P2Y14 receptor could prevent the progression of COVID-19-induced systemic inflammation, which often leads to severe illness and death cases."
      },
      {
        "text": "Considering the modulation of neutrophil recruitment of extreme relevance for respiratory distress and lung failure prevention, we propose that P2Y14 receptor inhibition by its selective antagonist PPTN could limit neutrophil recruitment and NETosis, hence limiting excessive formation of oxygen reactive species and proteolytic activation of the kallikrein-kinin system and subsequent bradykinin storm in the alveolar septa of COVID-19 patients."
      }
    ]
  },
  "33574054": {
    "title": "COVID-19 lung injury as a primer for immune checkpoint inhibitors (ICIs)-related pneumonia in a patient affected by squamous head and neck carcinoma treated with PD-L1 blockade: a case report.",
    "sentences": [
      {
        "text": "By the beginning of the global pandemic, SARS-CoV-2 infection has dramatically impacted on oncology daily practice."
      },
      {
        "text": "In the current oncological landscape, where immunotherapy has revolutionized the treatment of several malignancies, distinguishing between COVID-19 and immune-mediated pneumonitis can be hard because of shared clinical, radiological and pathological features."
      },
      {
        "text": "Indeed, their common mechanism of aberrant inflammation could lead to a mutual and amplifying interaction."
      },
      {
        "text": "We describe the case of a 65-year-old patient affected by metastatic squamous head and neck cancer and candidate to an experimental therapy including an anti-PD-L1 agent."
      },
      {
        "text": "COVID-19 ground-glass opacities under resolution were an incidental finding during screening procedures and worsened after starting immunotherapy."
      },
      {
        "text": "The diagnostic work-up was consistent with ICIs-related pneumonia and it is conceivable that lung injury by SARS-CoV-2 has acted as an inflammatory primer for the development of the immune-related adverse event."
      },
      {
        "text": "Patients recovered from COVID-19 starting ICIs could be at greater risk of recall immune-mediated pneumonitis."
      },
      {
        "text": "Nasopharyngeal swab and chest CT scan are recommended before starting immunotherapy."
      },
      {
        "text": "The awareness of the phenomenon could allow an easier interpretation of radiological changes under treatment and a faster diagnostic work-up to resume ICIs."
      },
      {
        "text": "In the presence of clinical benefit, for asymptomatic ICIs-related pneumonia a watchful-waiting approach and immunotherapy prosecution are suggested."
      }
    ]
  },
  "33570644": {
    "title": "Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection.",
    "sentences": [
      {
        "text": "We aimed to identify predictors of outcomes and survival in patients living in 4 major metropolitan areas who had sickle cell disease (SCD) and COVID-19 to inform best approaches to prevention and care."
      },
      {
        "text": "Data were collected at baseline and during the clinical course in SCD patients diagnosed with COVID-19 in four COVID-19 epicenters."
      },
      {
        "text": "Patients were followed up posthospital discharge for up to 3 months."
      },
      {
        "text": "Of sixty-six SCD patients with COVID-19, fifty patients (75%) required hospitalization, and seven died (10.6%)."
      },
      {
        "text": "Patients with preexisting kidney disease (chronic kidney disease) were more likely to be hospitalized."
      },
      {
        "text": "The most common presenting symptom was vaso-occlusive pain."
      },
      {
        "text": "Acute chest syndrome occurred in 30 (60%) of the 50 hospitalized patients and in all who died."
      },
      {
        "text": "Older age and histories of pulmonary hypertension, congestive heart failure, chronic kidney disease, and stroke were more prevalent in patients who died, as were higher creatinine, lactate dehydrogenase, and D-dimer levels."
      },
      {
        "text": "Anticoagulation use while inpatient was twice less common in patients who died."
      },
      {
        "text": "All deaths occurred in individuals not taking hydroxyurea or any other SCD-modifying therapy."
      },
      {
        "text": "Patients with SCD and COVID-19 exhibited a broad range of disease severity."
      },
      {
        "text": "We cannot definitively state that the overall mortality is higher in patients with SCD, although our case fatality rate was â¼10% compared with â¼3% in the general population, despite a median age of 34 years."
      },
      {
        "text": "Individuals with SCD aged >50 years, with preexisting cardiopulmonary, renal disease, and/or stroke not receiving hydroxyurea, who present with high serum creatinine, lactate dehydrogenase, and D-dimer levels, are at higher risk of death, irrespective of genotype or sex."
      }
    ]
  },
  "33570381": {
    "title": "Challenges for Targeting SARS-CoV-2 Proteases as a Therapeutic Strategy for COVID-19.",
    "sentences": [
      {
        "text": "Two proteases produced by the SARS-CoV-2 virus, the main protease and papain-like protease, are essential for viral replication and have become the focus of drug development programs for treatment of COVID-19."
      },
      {
        "text": "We screened a highly focused library of compounds containing covalent warheads designed to target cysteine proteases to identify new lead scaffolds for both Mpro and PLpro proteases."
      },
      {
        "text": "These efforts identified a small number of hits for the Mpro protease and no viable hits for the PLpro protease."
      },
      {
        "text": "Of the Mpro hits identified as inhibitors of the purified recombinant protease, only two compounds inhibited viral infectivity in cellular infection assays."
      },
      {
        "text": "However, we observed a substantial drop in antiviral potency upon expression of TMPRSS2, a transmembrane serine protease that acts in an alternative viral entry pathway to the lysosomal cathepsins."
      },
      {
        "text": "This loss of potency is explained by the fact that our lead Mpro inhibitors are also potent inhibitors of host cell cysteine cathepsins."
      },
      {
        "text": "To determine if this is a general property of Mpro inhibitors, we evaluated several recently reported compounds and found that they are also effective inhibitors of purified human cathepsins L and B and showed similar loss in activity in cells expressing TMPRSS2."
      },
      {
        "text": "Our results highlight the challenges of targeting Mpro and PLpro proteases and demonstrate the need to carefully assess selectivity of SARS-CoV-2 protease inhibitors to prevent clinical advancement of compounds that function through inhibition of a redundant viral entry pathway."
      }
    ]
  },
  "33567252": {
    "title": "COVID-19 immune signatures reveal stable antiviral TÂ cell function despite declining humoral responses.",
    "sentences": [
      {
        "text": "Cellular and humoral immunity to SARS-CoV-2 is critical to control primary infection and correlates with severity of disease."
      },
      {
        "text": "The role of SARS-CoV-2-specific TÂ cell immunity, its relationship to antibodies, and pre-existing immunity against endemic coronaviruses (huCoV), which has been hypothesized to be protective, were investigated in 82 healthy donors (HDs), 204 recovered (RCs), and 92 active COVID-19 patients (ACs)."
      },
      {
        "text": "ACs had high amounts of anti-SARS-CoV-2 nucleocapsid and spike IgG but lymphopenia and overall reduced antiviral TÂ cell responses due to the inflammatory milieu, expression of inhibitory molecules (PD-1, Tim-3) as well as effector caspase-3, -7, and -8 activity in TÂ cells."
      },
      {
        "text": "SARS-CoV-2-specific TÂ cell immunity conferred by polyfunctional, mainly interferon-Î³-secreting CD4+ TÂ cells remained stable throughout convalescence, whereas humoral responses declined."
      },
      {
        "text": "Immune responses toward huCoV in RCs with mild disease and strong cellular SARS-CoV-2 TÂ cell reactivity imply a protective role of pre-existing immunity against huCoV."
      }
    ]
  },
  "33565034": {
    "title": "Baseline characteristics and changes of biomarkers in disease course predict prognosis of patients with COVID-19.",
    "sentences": [
      {
        "text": "The outbreak of coronavirus disease (COVID-19) has brought great challenges to the world."
      },
      {
        "text": "The objectives of this study were to describe the baseline characteristics and changes of biomarkers of these COVID-19 patients and identify predictive value of the above markers for patient death."
      },
      {
        "text": "Using patient death as the observational endpoints, clinical data of inpatients in a special ward for COVID-19 in Wuhan, China were retrospectively collected."
      },
      {
        "text": "Univariate and multivariate Cox regression analyses were used to evaluate prognostic value of baseline characteristics and laboratory data changes."
      },
      {
        "text": "This study included clinical data of 75 patients."
      },
      {
        "text": "Age, c-reactive protein (CRP) and interleukin-6 levels were independent predictors of patient death."
      },
      {
        "text": "Survivors were characterized as having declining neutrophil counts, D-dimer, N-terminal pronatriuretic peptide, troponin I (TnI) and c-reactive protein levels, while counts of lymphocyte gradually came back."
      },
      {
        "text": "Non-survivors were characterized with increasing white blood cell counts (WBC) and neutrophil counts."
      },
      {
        "text": "Changes of WBC, TnI and interleukin-6 were also independently associated with patient death."
      },
      {
        "text": "Older age, baseline CRP and IL-6 levels may be used as meaningful predictors to identify patients with poor prognosis."
      },
      {
        "text": "Changes of biomarkers should be closely monitored in the management of patients with COVID-19, while constantly increasing levels of WBC, TnI and interleukin-6 in the disease course also predict patient death."
      }
    ]
  },
  "33564990": {
    "title": "Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and Other Coronaviruses: A Genome-wide Comparative Annotation and Analysis.",
    "sentences": [
      {
        "text": "Novel strain of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) causes mild to severe respiratory illness."
      },
      {
        "text": "The early symptoms may be fever, dry cough, sour throat, and difficulty in breathing which may lead to death in severe cases."
      },
      {
        "text": "Compared to previous outbreaks like SARS-CoV and Middle East Respiratory Syndrome (MERS), SARS-CoV2 disease (COVID-19) outbreak has been much distressing due to its high rate of infection but low infection fatality rate (IFR) with 1.4% around the world."
      },
      {
        "text": "World Health Organization (WHO) has declared (COVID-19) a pandemic on March 11, 2020."
      },
      {
        "text": "In the month of January 2020, the whole genome of SARS-CoV2 was sequenced which made work easy for researchers to develop diagnostic kits and to carry out drug repurposing to effectively alleviate the pandemic situation in the world."
      },
      {
        "text": "Now, it is important to understand why this virus has high rate of infectivity or is there any factor involved at the genome level which actually facilitates this virus infection globally?"
      },
      {
        "text": "In this study, we have extensively analyzed the whole genomes of different coronaviruses infecting humans and animals in different geographical locations around the world."
      },
      {
        "text": "The main aim of the study is to identify the similarity and the mutational adaptation of the coronaviruses from different host and geographical locations to the SARS-CoV2 and provide a better strategy to understand the mutational rate for specific target-based drug designing."
      },
      {
        "text": "This study is focused to every annotation in a comparative manner which includes SNPs, repeat analysis with the different categorization of the short-sequence repeats and long-sequence repeats, different UTR's, transcriptional factors, and the predicted matured peptides with the specific length and positions on the genomes."
      },
      {
        "text": "The extensive analysis on SNPs revealed that Wuhan SARS-CoV2 and Indian SARS-CoV2 are having only eight SNPs."
      },
      {
        "text": "Collectively, phylogenetic analysis, repeat analysis, and the polymorphism revealed the genomic conserveness within the SARS-CoV2 and few other coronaviruses with very less mutational chances and the huge distance and mutations from the few other species."
      }
    ]
  },
  "33564481": {
    "title": "Can COVID-19 Cause Flare-Ups of Acute Hepatitis B? An Atypical Presentation of COVID-19 with Acute Hepatitis B.",
    "sentences": [
      {
        "text": "We report a case of fulminant liver failure in a patient with acute active hepatitis B infection who was found to have COVID-19 without lung involvement."
      },
      {
        "text": "A 24-year-old male was brought by ambulance service to Hamad General Hospital, Emergency Department (ED), in Doha on April 8, 2020, with chief complaints of fever and cough for 3 days."
      },
      {
        "text": "Upon initial evaluation, the patient was febrile (39.4Â°C), jaundiced, and disoriented regarding time, place, and person, with an unremarkable past medical history."
      },
      {
        "text": "Initial blood tests showed severely elevated urea, creatinine, transaminases, and ammonium in addition to an impaired coagulation profile consistent with fulminant liver failure."
      },
      {
        "text": "A swab was taken for COVID-19 PCR testing and found to be positive."
      },
      {
        "text": "Serological tests revealed hepatitis B surface antigen positivity and other serology indicating acute hepatitis B. Initial X-ray and repeat chest X-rays did not show lung infiltrates."
      },
      {
        "text": "On the 6th day after admission, the patient developed fixed dilated pupils, with brain edema on CT; cardiac arrest occurred on the 10th day after admission, and the patient died."
      },
      {
        "text": "Although it is still largely unclear, HBV0-activated sudden-onset strong cytotoxic T lymphocyte response and enhanced viral replication and/or retention of the viral capsid in infected hepatocytes may cause the pathogenesis of FH."
      },
      {
        "text": "These pathophysiological events cause extensive hepatocyte apoptosis and necrosis, which results in deadly severe liver failure."
      },
      {
        "text": "Our findings support that the liver damage occurring in COVID-19 is caused by an impaired innate immune system rather than by direct cell damage caused by SARS-CoV-2."
      },
      {
        "text": "We think that more consideration should be given to the presence of acute hepatitis B, especially in COVID-19 patients."
      }
    ]
  },
  "33563901": {
    "title": "Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19.",
    "sentences": [
      {
        "text": "In a multicenter European retrospective study including 162 patients with COVID-19 occurring in essential thrombocythemia (ET, nâ=â48), polycythemia vera (PV, nâ=â42), myelofibrosis (MF, nâ=â56), and prefibrotic myelofibrosis (pre-PMF, nâ=â16), 15 major thromboses (3 arterial and 12 venous) were registered in 14 patients, of whom all, but one, were receiving LMW-heparin prophylaxis."
      },
      {
        "text": "After adjustment for the competing risk of death, the cumulative incidence of arterial and venous thromboembolic events (VTE) reached 8.5% after 60 days follow-up."
      },
      {
        "text": "Of note, 8 of 12 VTE were seen in ET."
      },
      {
        "text": "Interestingly, at COVID-19 diagnosis, MPN patients had significantly lower platelet count (pâ<â0.0001) than in the pre-COVID last follow-up."
      },
      {
        "text": "This decline was remarkably higher in ET (-23.3%, pâ<â0.0001) than in PV (-16.4%, pâ=â0.1730) and was associated with higher mortality rate (pâ=â0.0010) for pneumonia."
      },
      {
        "text": "The effects of possible predictors of thrombosis, selected from those clinically relevant and statistically significant in univariate analysis, were examined in a multivariate model."
      },
      {
        "text": "Independent risk factors were transfer to ICU (SHRâ=â3.73, pâ=â0.029), neutrophil/lymphocyte ratio (SHRâ=â1.1, pâ=â0.001) and ET phenotype (SHRâ=â4.37, pâ=â0.006)."
      },
      {
        "text": "The enhanced susceptibility to ET-associated VTE and the associated higher mortality for pneumonia may recognize a common biological plausibility and deserve to be delved to tailor new antithrombotic regimens including antiplatelet drugs."
      }
    ]
  },
  "33563656": {
    "title": "The polybasic cleavage site in the SARS-CoV-2 spike modulates viral sensitivity to Type I interferon and IFITM2.",
    "sentences": [
      {
        "text": "The cellular entry of severe acute respiratory syndrome-associated coronaviruses types 1 and 2 (SARS-CoV-1 and -2) requires sequential protease processing of the viral spike glycoprotein."
      },
      {
        "text": "The presence of a polybasic cleavage site in SARS-CoV-2 spike at the S1/S2 boundary has been suggested to be a factor in the increased transmissibility of SARS-CoV-2 compared to SARS-CoV-1 by facilitating maturation of the spike precursor by furin-like proteases in the producer cells rather than endosomal cathepsins in the target."
      },
      {
        "text": "We investigate the relevance of the polybasic cleavage site in the route of entry of SARS-CoV-2 and the consequences this has for sensitivity to interferons (IFNs), and more specifically, the IFN-induced transmembrane (IFITM) protein family that inhibit entry of diverse enveloped viruses."
      },
      {
        "text": "We found that SARS-CoV-2 is restricted predominantly by IFITM2, rather than IFITM3, and the degree of this restriction is governed by route of viral entry."
      },
      {
        "text": "Importantly, removal of the cleavage site in the spike protein renders SARS-CoV-2 entry highly pH- and cathepsin-dependent in late endosomes where, like SARS-CoV-1 spike, it is more sensitive to IFITM2 restriction."
      },
      {
        "text": "Furthermore, we found that potent inhibition of SARS-CoV-2 replication by type I but not type II IFNs is alleviated by targeted depletion of IFITM2 expression."
      },
      {
        "text": "We propose that the polybasic cleavage site allows SARS-CoV-2 to mediate viral entry in a pH-independent manner, in part to mitigate against IFITM-mediated restriction and promote replication and transmission."
      },
      {
        "text": "This suggests therapeutic strategies that target furin-mediated cleavage of SARS-CoV-2 spike may reduce viral replication through the activity of type I IFNs."
      },
      {
        "text": "IMPORTANCE The furin cleavage site in the spike protein is a distinguishing feature of SARS-CoV-2 and has been proposed to be a determinant for the higher transmissibility between individuals, compared to SARS-CoV-1."
      },
      {
        "text": "One explanation for this is that it permits more efficient activation of fusion at or near the cell surface rather than requiring processing in the endosome of the target cell."
      },
      {
        "text": "Here we show that SARS-CoV-2 is inhibited by antiviral membrane protein IFITM2 and that the sensitivity is exacerbated by deletion of the furin cleavage site, which restricts viral entry to low pH compartments."
      },
      {
        "text": "Furthermore, we find that IFITM2 is a significant effector of the antiviral activity of type I interferons against SARS-CoV-2 replication."
      },
      {
        "text": "We suggest one role of the furin cleavage site is to reduce SARS-CoV-2 sensitivity to innate immune restriction, and thus may represent a potential therapeutic target for COVID-19 treatment development."
      }
    ]
  },
  "33557911": {
    "title": "Carboxypeptidase B blocks ex vivo activation of the anaphylatoxin-neutrophil extracellular trap axis in neutrophils from COVID-19 patients.",
    "sentences": [
      {
        "text": "BACKGROUND Thrombosis and coagulopathy are highly prevalent in critically ill patients with COVID-19 and increase the risk of death."
      },
      {
        "text": "Immunothrombosis has recently been demonstrated to contribute to the thrombotic events in COVID-19 patients with coagulopathy."
      },
      {
        "text": "As the primary components of immunothrombosis, neutrophil extracellular traps (NETs) could be induced by complement cascade components and other proinflammatory mediators."
      },
      {
        "text": "We aimed to explore the clinical roles of NETs and the regulation of complement on the NET formation in COVID-19."
      },
      {
        "text": "METHODS We recruited 135 COVID-19 patients and measured plasma levels of C5, C3, cell-free DNA and myeloperoxidase (MPO)-DNA."
      },
      {
        "text": "Besides, the formation of NETs was detected by immunofluorescent staining and the cytotoxicity to vascular endothelial HUVEC cells was evaluated by CCK-8 assay."
      },
      {
        "text": "RESULTS We found that the plasma levels of complements C3 and MPO-DNA were positively related to coagulation indicator fibrin(-ogen) degradation products (C3: râ=â0.300, pâ=â0.005; MPO-DNA: râ=â0.316, pâ=â0.002) in COVID-19 patients."
      },
      {
        "text": "Besides, C3 was positively related to direct bilirubin (râ=â0.303, pâ=â0.004) and total bilirubin (râ=â0.304, pâ=â0.005), MPO-DNA was positively related to lactate dehydrogenase (râ=â0.306, pâ=â0.003) and creatine kinase (râ=â0.308, pâ=â0.004)."
      },
      {
        "text": "By using anti-C3a and anti-C5a antibodies, we revealed that the complement component anaphylatoxins in the plasma of COVID-19 patients strongly induced NET formation."
      },
      {
        "text": "The pathological effect of the anaphylatoxin-NET axis on the damage of vascular endothelial cells could be relieved by recombinant carboxypeptidase B (CPB), a stable homolog of enzyme CPB2 which can degrade anaphylatoxins to inactive products."
      },
      {
        "text": "CONCLUSIONS Over-activation in anaphylatoxin-NET axis plays a pathological role in COVID-19."
      },
      {
        "text": "Early intervention in anaphylatoxins might help prevent thrombosis and disease progression in COVID-19 patients."
      }
    ]
  },
  "33437096": {
    "title": "Statins as inhibitors of voltage-gated potassium channels Kv1.3 in cancer cells.",
    "sentences": [
      {
        "text": "Voltage-gated potassium channels are integral membrane proteins selectively permeable for potassium ions and activated upon change of membrane potential."
      },
      {
        "text": "Voltage-gated potassium channels of the Kv1.3 type were discovered both in plasma membrane and in inner mitochondrial membrane (mito Kv1.3 channels)."
      },
      {
        "text": "For some time Kv1.3 channels located both in plasma membrane and in mitochondria are considered as a potentially new molecular target in several pathologies including some cancer disorders."
      },
      {
        "text": "Lipophilic nontoxic organic inhibitors of Kv1.3 channels may potentially find a clinical application to support therapy of some cancer diseases such as breast, pancreas and lung cancer, melanoma or chronic lymphocytic leukaemia (B-CLL)."
      },
      {
        "text": "Inhibition of T lymphocyte Kv1.3 channels may be also important in treatment of chronic and acute respiratory diseases including severe pulmonary complication in corona virus disease Covid 19, however further studies are needed to confirm this supposition."
      },
      {
        "text": "Statins are small-molecule organic compounds, which are lipophilic and are widely used in treatment of hypercholesterolemia and atherosclerosis."
      },
      {
        "text": "Electrophysiological studies performed in our laboratory showed that statins: pravastatin, mevastatin and simvastatin are effective inhibitors of Kv1.3 channels in cancer cells of human T cell line Jurkat."
      },
      {
        "text": "We showed that application of the statins in the concentration range from 1.5Â Î¼M to 50Â Î¼M inhibited the channels in a concentration-dependent manner."
      },
      {
        "text": "The inhibitory effect was the most potent in case of simvastatin and the least potent in case of pravastatin."
      },
      {
        "text": "The inhibition was partially irreversible in case of simvastatin and fully reversible in case of pravastatin and mevastatin."
      },
      {
        "text": "It was accompanied by a significant acceleration of the current inactivation rate without any significant change of the activation rate."
      },
      {
        "text": "Mechanism of the inhibition is probably complex, including a direct interaction with the channel protein and perturbation of lipid bilayer structure, leading to stabilization of the inactivated state of the channels."
      }
    ]
  },
  "33424034": {
    "title": "Pyrrolo[2,3-b]quinoxalines in attenuating cytokine storm in COVID-19: their sonochemical synthesis and in silico / in vitro assessment.",
    "sentences": [
      {
        "text": "In view of the recent global pandemic caused by COVID-19 intense efforts have been devoted worldwide towards the development of an effective treatment for this disease."
      },
      {
        "text": "Recently, PDE4 inhibitors have been suggested to attenuate the cytokine storm in COVID-19 especially tumour necrosis factor alpha (TNF-Î±)."
      },
      {
        "text": "In our effort we have explored the 2-substituted pyrrolo[2,3-b]quinoxalines for this purpose because of their potential inhibitory properties of PDE-4 / TNF-Î±."
      },
      {
        "text": "Moreover, several of these compounds appeared to be promising in silico when assessed for their binding affinities via docking into the N-terminal RNA-binding domain (NTD) of N-protein of SARS-CoV-2."
      },
      {
        "text": "A rapid and one-pot synthesis of this class of molecules was achieved via the Cu-catalyzed coupling-cyclization-desulfinylation of 3-alkynyl-2-chloroquinoxalines with t-butyl sulfinamide as the ammonia surrogate under ultrasound irradiation."
      },
      {
        "text": "Most of these compounds showed good to significant inhibition of TNF-Î± in vitro establishing a SAR (Structure Activity Relationship) within the series."
      },
      {
        "text": "One compound e.g. 3i was identified as a promising hit for which the desirable ADME and acceptable toxicity profile was predicted in silico."
      }
    ]
  },
  "33556768": {
    "title": "COVID-19 as an independent risk factor for subclinical placental dysfunction.",
    "sentences": [
      {
        "text": "BACKGROUND The pandemic of the severe acute respiratory distress syndrome-associated Coronavirus-2 (SARS-CoV-2) has affected millions around the world."
      },
      {
        "text": "In pregnancy the dangers to the mother and fetus are still being explored."
      },
      {
        "text": "SARS-CoV2 can potentially compromise maternal and neonatal outcomes and this may be dependent on the pregnancy stage during which the infection occurs."
      },
      {
        "text": "OBJECTIVE The present study was done to find the histopathological alterations in the placenta of SARS-CoV-2 positive pregnancies with either no symptoms or mild coronavirus disease (COVID)-19 related symptoms and its association with neonatal outcomes."
      },
      {
        "text": "STUDY DESIGN This was a prospective analytical study."
      },
      {
        "text": "Twenty seven asymptomatic or mildly symptomatic SARS-CoV-2 positive pregnant women with a singleton pregnancy delivered between 1st July 2020 and 15th September 2020, were included as cases."
      },
      {
        "text": "An equal number of SARS-CoV-2 negative singleton pregnancies matched for maternal and gestational age during the same period were included as controls."
      },
      {
        "text": "After delivery the histopathological examination of the placenta of these women was done and the findings recorded on a predesigned proforma based on the Amsterdam consensus criteria for evidence of maternal and fetal vascular malperfusion changes."
      },
      {
        "text": "RESULTS The baseline characteristics were comparable between the cases and controls."
      },
      {
        "text": "The following features of maternal vascular malperfusion (MVM) were significantly higher in the placentae of COVID-19 positive pregnancies: retroplacental hematomas (RPH), accelerated villous maturation (AVM), distal villous hyperplasia (DVH), atherosis, fibrinoid necrosis, mural hypertrophy of membrane arterioles (MHMA), vessel ectasia and persistence of intramural endovascular trophoblast (PIEVT)."
      },
      {
        "text": "Fetal vascular malperfusion (FVM) significantly associated with the positive pregnancies were chorioangiosis, thrombosis of the fetal chorionic plate (TFCP), intramural fibrin deposition (IMFD) and vascular ectasia."
      },
      {
        "text": "Additionally, perivillous fibrin deposition was also significantly higher in the placentae of cases."
      },
      {
        "text": "The percentage of spontaneously delivered women was comparable in the two groups."
      },
      {
        "text": "The sex and weight of the newborn and the number of live births were comparable between the two groups."
      },
      {
        "text": "CONCLUSIONS Asymptomatic or mildly symptomatic SARS-CoV-2 positive pregnant women, with otherwise uncomplicated pregnancies, show evidence of placental injury at a microscopic level."
      },
      {
        "text": "Similar findings have been demonstrated in other studies too."
      },
      {
        "text": "This placental injury apparently does not lead to poor pregnancy outcomes."
      },
      {
        "text": "The extent of this injury in symptomatic cases of COVID-19 pregnancies and its consequences on the outcomes need to be analysed."
      }
    ]
  },
  "33556379": {
    "title": "Susceptibility of neuroblastoma and glioblastoma cell lines to SARS-CoV-2 infection.",
    "sentences": [
      {
        "text": "Modelling cell infection in-a-dish can represent a useful tool to understand the susceptibility of different cell types towards severe acute respiratory coronavirus-2 (SARS-CoV-2) and to decipher its neurotropism."
      },
      {
        "text": "In this perspective, retinoic acid (RA)-differentiated neuroblastoma cell lines, SH-SY5Y and SK-N-BE(2) and glioblastoma cell lines, U-87 MG and U-373 MG, were infected with a SARS-CoV-2 strain, at various multiplicity-of-infection (MOI)."
      },
      {
        "text": "We first demonstrated that the common entry genes - needed for invading epithelial cells - were expressed."
      },
      {
        "text": "RA-differentiation induced an upregulation of ace2 and tmprss2 gene expression while inducing downregulation of ctsb and ctsl."
      },
      {
        "text": "Using in situ hybridization and confocal analysis, SARS-CoV-2 gene S RNA was detected intracellularly at MOI 5.0, and localized in both soma and neuritic-like or glial-like processes."
      },
      {
        "text": "The infection was confirmed by quantification of viral gene E RNA and showed a dose-dependency, with few infected cells at MOI 0.1."
      },
      {
        "text": "After 24Â h of infection, no cytopathic effect was observed in SH-SY5Y abilities to maintain neuritic processes or in U-373 MG for the uptake of glutamate."
      },
      {
        "text": "Unlike the permissive Vero E6 cells, no significant apoptosis death was detected following SARS-CoV-2 infection of neuroblastoma or glioblastoma cells."
      },
      {
        "text": "This study demonstrates the susceptibility of neuronal- and glial-like cell lines towards SARS-CoV-2 infection at high MOIs."
      },
      {
        "text": "Once inside the cells, the virus does not seem to rapidly replicate nor exert major cytopathic effect."
      },
      {
        "text": "Overall, our results strengthen the idea that SARS-CoV-2 has a tropism for nervous cells that express commonly described entry genes."
      }
    ]
  },
  "33553219": {
    "title": "Can GPR4 Be a Potential Therapeutic Target for COVID-19?",
    "sentences": [
      {
        "text": "Coronavirus disease 19 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first emerged in late 2019 and has since rapidly become a global pandemic."
      },
      {
        "text": "SARS-CoV-2 infection causes damages to the lung and other organs."
      },
      {
        "text": "The clinical manifestations of COVID-19 range widely from asymptomatic infection, mild respiratory illness to severe pneumonia with respiratory failure and death."
      },
      {
        "text": "Autopsy studies demonstrate that diffuse alveolar damage, inflammatory cell infiltration, edema, proteinaceous exudates, and vascular thromboembolism in the lung as well as extrapulmonary injuries in other organs represent key pathological findings."
      },
      {
        "text": "Herein, we hypothesize that GPR4 plays an integral role in COVID-19 pathophysiology and is a potential therapeutic target for the treatment of COVID-19."
      },
      {
        "text": "GPR4 is a pro-inflammatory G protein-coupled receptor (GPCR) highly expressed in vascular endothelial cells and serves as a \"gatekeeper\" to regulate endothelium-blood cell interaction and leukocyte infiltration."
      },
      {
        "text": "GPR4 also regulates vascular permeability and tissue edema under inflammatory conditions."
      },
      {
        "text": "Therefore, we hypothesize that GPR4 antagonism can potentially be exploited to mitigate the hyper-inflammatory response, vessel hyper-permeability, pulmonary edema, exudate formation, vascular thromboembolism and tissue injury associated with COVID-19."
      }
    ]
  },
  "33552855": {
    "title": "Caffeine-Operated Synthetic Modules for Chemogenetic Control of Protein Activities by Life Style.",
    "sentences": [
      {
        "text": "A genetically encoded caffeine-operated synthetic module (COSMO) is introduced herein as a robust chemically induced dimerization (CID) system."
      },
      {
        "text": "COSMO enables chemogenetic manipulation of biological processes by caffeine and its metabolites, as well as caffeinated beverages, including coffee, tea, soda, and energy drinks."
      },
      {
        "text": "This CID tool, evolved from an anti-caffeine nanobody via cell-based high-throughput screening, permits caffeine-inducible gating of calcium channels, tumor killing via necroptosis, growth factors-independent activation of tyrosine receptor kinase signaling, and enhancement of nanobody-mediated antigen recognition for the severe acute respiratory distress coronavirus 2 (SARS-CoV-2) spike protein."
      },
      {
        "text": "Further rationalized engineering of COSMO leads to 34-217-fold enhancement in caffeine sensitivity (EC50 = 16.9Â nanomolar), which makes it among the most potent CID systems like the FK506 binding protein (FKBP)-FKBP rapamycin binding domain (FRB)-rapamycin complex."
      },
      {
        "text": "Furthermore, bivalent COSMO (biCOMSO) connected with a long linker favors intramolecular dimerization and acts as a versatile precision switch when inserted in host proteins to achieve tailored function."
      },
      {
        "text": "Given the modularity and high transferability of COMSO and biCOSMO, these chemical biology tools are anticipated to greatly accelerate the development of therapeutic cells and biologics that can be switched on and off by caffeinated beverages commonly consumed in the daily life."
      }
    ]
  },
  "33551316": {
    "title": "Sick Euthyroid Syndrome on Presentation of Patients With COVID-19: A Potential Marker for Disease Severity.",
    "sentences": [
      {
        "text": "OBJECTIVE Precise risk stratification and triage of coronavirus disease 2019 (COVID-19) patients are essential in the setting of an overwhelming pandemic burden."
      },
      {
        "text": "Clinical observation has shown a somewhat high prevalence of sick euthyroid syndrome among patients with COVID-19."
      },
      {
        "text": "This study aimed to evaluate the predictive value of free triiodothyronine (FT3) at the clinical presentation of COVID-19 for disease severity and death."
      },
      {
        "text": "METHODS This retrospective cohort study was based on electronic medical records."
      },
      {
        "text": "The study was conducted at Sheba Medical Centre, a tertiary hospital where several acute and chronic wards have been dedicated to the treatment of patients with COVID-19."
      },
      {
        "text": "The primary outcome measure was death during hospitalization; secondary outcomes included hospitalization in intensive care, mechanical ventilation, and length of hospitalization."
      },
      {
        "text": "RESULTS Of a total of 577 polymerase chain reaction-positive patients with COVID-19 hospitalized between February 27 and July 30, 2020, 90 had at least 1 measurement of thyroid-stimulating hormone, free thyroxine, and FT3 within 3 days of presentation."
      },
      {
        "text": "After applying strict exclusion criteria, 54 patients were included in the study."
      },
      {
        "text": "Patients in the lowest tertile of FT3 had significantly higher rates of mortality (40%, 5.9%, and 5.9%, PÂ = ."
      },
      {
        "text": "008), mechanical ventilation (45%, 29.4%, and 0.0%; PÂ = ."
      },
      {
        "text": "007) and intensive care unit admission (55%, 29.4%, and 5.9%, PÂ = ."
      },
      {
        "text": "006)."
      },
      {
        "text": "In multivariate analyses adjusted for age, Charlson comorbidity index, creatinine, albumin, and white blood cell count."
      },
      {
        "text": "FT3 remained a significant independent predictor of death."
      },
      {
        "text": "CONCLUSION FT3 levels can serve as a prognostic tool for disease severity in the early presentation of COVID-19."
      }
    ]
  },
  "33550983": {
    "title": "COVID-19 and cytokine storm syndrome: can what we know about interleukin-6 in ovarian cancer be applied?",
    "sentences": [
      {
        "text": "Improving early diagnosis along with timely and effective treatment of COVID-19 are urgently needed."
      },
      {
        "text": "However, at present, the mechanisms underlying disease spread and development, defined prognosis, and immune status of patients with COVID-19 remain to be determined."
      },
      {
        "text": "Patients with severe disease state exhibit a hyperinflammatory response associated with cytokine storm syndrome, hypercoagulability, and depressed cell-mediated immunity."
      },
      {
        "text": "These clinical manifestations, sharing similar pathogenesis, have been well-studied in patients with advanced ovarian cancer."
      },
      {
        "text": "The present review suggests treatment approaches for COVID-19 based on strategies used against ovarian cancer, which shares similar immunopathology and associated coagulation disorders."
      },
      {
        "text": "The chronicization of the hyperinflammatory cytokine storm in patients with severe COVID-19 highlights a defective resistance phase that leads to aspecific chronic inflammation, associated with oxidative stress, which impairs specific T-cell response, induces tissue and endothelial damage, and thrombosis associated with systemic effects that lead to severe multi-organ failure and death."
      },
      {
        "text": "These events are similar to those observed in advanced ovarian cancer which share similar pathogenesis mediated primarily by Interleukin-6, which is, as well demonstrated in ovarian cancer, the key cytokine driving the immunopathology, related systemic symptoms, and patient prognosis."
      },
      {
        "text": "Consistent with findings in other disease models with similar immunopathology, such as advanced ovarian cancer, treatment of severe COVID-19 infection should target inflammation, oxidative stress, coagulation disorders, and immunodepression to improve patient outcome."
      },
      {
        "text": "Correctly identifying disease stages, based on available laboratory data, and developing a specific protocol for each phase is essential for effective treatment."
      }
    ]
  },
  "33550165": {
    "title": "Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19.",
    "sentences": [
      {
        "text": "Accumulating evidence supports that the viral-induced hyper-inflammatory immune response plays a central role in COVID-19 pathogenesis."
      },
      {
        "text": "It might be involved in the progression to acute respiratory distress syndrome (ARDS), multi-organ failure leading to death."
      },
      {
        "text": "In this study, we aimed to evaluate the prognostic value of the immune-inflammatory biomarkers in COVID-19, then determine optimal thresholds for assessing severe and fatal forms of this disease."
      },
      {
        "text": "153 patients with confirmed COVID-19 were included in this study, and classified into non-severe and severe groups."
      },
      {
        "text": "Plasmatic levels of interleukin 6 (IL6), C-reactive protein (CRP), soluble-IL2 receptor (IL2RÎ±), procalcitonin (PCT) and ferritin were measured using chemiluminescence assay."
      },
      {
        "text": "Complete blood count was performed by Convergys 3XÂ® hematology analyzer."
      },
      {
        "text": "Our results demonstrated that the peripheral blood levels of IL6, PCT, CRP, ferritin, IL2RÎ±, white blood cell count (WBC), neutrophil count (NEU), neutrophil-to-lymphocyte ratio (NLR), derived neutrophil-to-lymphocyte ratio (d-NLR) were significantly higher in severe forms of COVID-19."
      },
      {
        "text": "The ROC curve analysis showed that IL6 was the most accurate inflammatory biomarker."
      },
      {
        "text": "The calculated cutoff of IL6 (42Â pg/ml) could correctly classifyÂ >Â 90% of patients regarding their risk of severity (area under ROC curve (AUROC)Â =Â 0.972) and the threshold value of 83Â pg/ml was highly predictive of the progression to death (AUROCÂ =Â 0.94, ORÂ =Â 184) after a median of 3Â days."
      },
      {
        "text": "Besides, IL-6 was positively correlated with other inflammatory markers and the kinetic analysis highlighted its value for monitoring COVID-19 patients."
      },
      {
        "text": "PCT and NLR had also a high prognostic relevance to assess severe forms of COVID-19 with corresponding AUROC of 0.856, 0.831 respectively."
      },
      {
        "text": "Furthermore the cut-off values of PCT (0.16Â ng/ml) and NLR (7.4) allowed to predict mortality with high accuracy (seÂ =Â 96.3%, spÂ =Â 70.5%,ORÂ =Â 61.2)' (seÂ =Â 75%, spÂ =Â 84%, ORÂ =Â 14.6)."
      },
      {
        "text": "The levels of these parameters were not influenced by corticosteroid treatment, which make them potential prognostic markers when patients are already undergoing steroid therapy."
      }
    ]
  },
  "33549831": {
    "title": "Common hematological values predict unfavorable outcomes in hospitalized COVID-19 patients.",
    "sentences": [
      {
        "text": "COVID-19 can range from asymptomatic to life-threatening."
      },
      {
        "text": "Early identification of patients who will develop severe disease is crucial."
      },
      {
        "text": "A number of scores and indexes have been developed to predict severity."
      },
      {
        "text": "However, most rely on measurements not readily available."
      },
      {
        "text": "We evaluated hematological and biochemical markers taken on admission and determined how predictive they were of development of critical illness or death."
      },
      {
        "text": "We observed that higher values of readily available tests, including neutrophil:lymphocyte ratio; derived neutrophil index; and troponin I were associated with a higher risk of death or critical care admission (PÂ <Â 0.001)."
      },
      {
        "text": "We show that common hematological tests can be helpful in determining early in the course of illness which patients are likely to develop severe forms, as well as allocating resources to those patients early, while avoiding overuse of limited resources in patients with reduced risk of progression to severe disease."
      }
    ]
  },
  "33549005": {
    "title": "Clinical risk factors for mortality of hospitalized patients with COVID-19: systematic review and meta-analysis.",
    "sentences": [
      {
        "text": "BACKGROUND New evidence from retrospective cohort studies on risk of death from COVID-19 infection became available."
      },
      {
        "text": "We aimed to systematically review the clinical risk factors for fatal outcome of COVID-19."
      },
      {
        "text": "METHODS We performed meta-analysis, using PubMed, EMBASE and Cochrane databases from December 1 2019 to June 10 2020."
      },
      {
        "text": "The meta-analysis summarized clinical, laboratory, radiological features, and complications of non-survivors with confirmed COVID-19."
      },
      {
        "text": "In addition, a fixed- or random-effects model was adopted based on the heterogeneity among studies."
      },
      {
        "text": "We also used funnel-plot with Egger's tests to screen potential publication bias."
      },
      {
        "text": "RESULTS In total, twenty studies with 15,408 COVID-19 cases were included in our meta-analysis."
      },
      {
        "text": "Male, current smoking, and older age were associated with in-hospital death."
      },
      {
        "text": "Patients aged 60 years or over had the highest pooled ORs [OR 4.94 (2.89, 8.44)]."
      },
      {
        "text": "Non-survivors were more likely to have diabetes, hypertension, cardiovascular disease (CVD), respiratory disease, or chronic kidney disease (CKD)."
      },
      {
        "text": "Respiratory disease had the highest pooled ORs [OR 2.55 (2.14, 3.05)]."
      },
      {
        "text": "Dyspnea [OR 3.31 (1.78, 6.16); I2 : 83%] and fatigue [OR 1.36 (1.07, 1.73); I2 : 0%] were associated with increased risk of death."
      },
      {
        "text": "Increased white blood cell count, decreased lymphocyte and platelet counts, were also associated with increased risk of death."
      },
      {
        "text": "Biomarkers of coagulation function, inflammation, liver and kidney function, cardiac and muscle injury were also elevated in nonsurvivors."
      },
      {
        "text": "CONCLUSIONS Male, current smoking patients aged 60 years or over might face a greater risk of in-hospital death and the comorbidities such as diabetes, hypertension, CVD, respiratory disease, and CKD could also influence the prognosis of the COVID-19."
      },
      {
        "text": "Clinical feature such as dyspnea and fatigue could imply the exacerbation and even death."
      },
      {
        "text": "Our findings highlighted early markers of mortality which were beneficial to identify fatal COVID-19."
      }
    ]
  },
  "33548481": {
    "title": "Pronounce expression of Tim-3 and CD39 but not PD1 defines CD8 T cells in critical Covid-19 patients.",
    "sentences": [
      {
        "text": "BACKGROUND During viral infection, inhibitory receptors play a key role in regulating CD8 T-cell activity."
      },
      {
        "text": "The objective of this research was to investigate programmed cell death protein 1 (PD-1), T-cell immunoglobulin and mucin domain-containing protein-3 (TIM-3), and CD39 exhaustion markers in CD8 T cells of new coronavirus disease-2019 (COVID-19) patients."
      },
      {
        "text": "METHODS A total of 44 patients with COVID-19 (17 subjects in a critical group and 27 patients in a non-critical group) and 14 healthy controls, who were admitted to Hospitals in Babol, were recruited to the study."
      },
      {
        "text": "In subjects' peripheral blood mononuclear cells (PBMCs), we compared the phenotype of CD8 T lymphocytes, expressing PD-1, TIM-3, or CD39, both alone and in various combinations."
      },
      {
        "text": "RESULTS The findings showed that the percentage of CD8+ cells was significantly lower in patients."
      },
      {
        "text": "Critical and non-critical patients were more likely than healthy controls to have an escalated frequency of CD8+ TIM-3+, CD8+ CD39+, and CD8+ TIM-3+ CD39+ cells."
      },
      {
        "text": "No significant differences were observed between all groups in the CD8+ PD-1+ cell counts."
      },
      {
        "text": "There was also no difference between three groups regarding the counts of CD8+ TIM-3+ PD-1+, CD8+ PD-1+ CD39+, and CD8+ TIM-3+ PD-1+ CD39+ cells."
      },
      {
        "text": "The counts of non-exhausted cells were significantly lower in critical and non-critical individuals compared to the healthy individuals' value."
      },
      {
        "text": "CONCLUSION Patients, infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), altered exhausted CD8 T lymphocytes with CD39 and TIM-3 exhaustion markers, which may account the dysregulated immune response found in COVID-19."
      }
    ]
  },
  "33547221": {
    "title": "COVID-19 pandemic is associated with mechanical complications in patients with ST-elevation myocardial infarction.",
    "sentences": [
      {
        "text": "OBJECTIVE Although there are regional reports that the COVID-19 pandemic is associated with a reduction in acute myocardial infarction presentations and primary percutaneous coronary intervention (PCI) procedures, little is known about the impact of the COVID-19 pandemic on mechanical complications resulting from ST-segment elevation myocardial infarction (STEMI) and mortality."
      },
      {
        "text": "METHODS This single-centre retrospective cohort study analysed presentations, incidence of mechanical complications, and mortality in patients with STEMI before and after a state of emergency was declared due to the COVID-19 pandemic by the Japanese government on 7 April 2020."
      },
      {
        "text": "RESULTS We analysed 359 patients with STEMI hospitalised before the declaration and 63 patients hospitalised after the declaration."
      },
      {
        "text": "The proportion of patients with late presentation was significantly higher after the declaration than before (25.4% vs 14.2%, p=0.03)."
      },
      {
        "text": "The incidence of late presentation was significantly higher during the COVID-19 pandemic than before (incidence rate ratio (IRR), 2.41; 95% CI, 1.37 to 4.05; p=0.001, even after adjusting for month (IRR, 2.61; 95%âCI, 1.33 to 5.13; p<0.01)."
      },
      {
        "text": "Primary PCI was performed significantly less often after the declaration than before (68.3% vs 82.5%, p=0.009)."
      },
      {
        "text": "The mechanical complication resulting from STEMI occurred in 13 of 359 (3.6%) patients before the declaration and 9 of 63 (14.3%) patients after the declaration (p<0.001)."
      },
      {
        "text": "However, the incidence of in-hospital death (before, 6.2% vs after, 6.4%, p=0.95) was comparable."
      },
      {
        "text": "CONCLUSIONS Following the COVID-19 pandemic, an increased incidence of mechanical complications resulting from STEMI was observed."
      },
      {
        "text": "Instructing people to stay at home, without effectively educating them to immediately seek medical attention when suffering symptoms of a heart attack, may worsen outcomes in patients with STEMI."
      }
    ]
  },
  "33546958": {
    "title": "COVID-19 in patients with cancer: Risks and precautions.",
    "sentences": [
      {
        "text": "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a member of the coronavirus family, which causes coronavirus disease 2019 (COVID-19)."
      },
      {
        "text": "The phenotype of the disease varies from asymptomatic, to a mild phenotype, through to the severe form of acute respiratory distress syndrome (ARDS), which often leads to death, especially in those with underlying diseases."
      },
      {
        "text": "It has been reported that those who suffer from cancer (especially lung cancer and hematological malignancies) are at higher risk of serious complications and death from COVID-19."
      },
      {
        "text": "Some cancer treatments such as CAR T cell therapy can produce a cytokine storm, which is also a hallmark of severe COVID-19."
      },
      {
        "text": "Therefore, patients receiving CAR T cells are at higher risk if they become infected with COVID-19, and could be treated with anti-cytokine approaches."
      }
    ]
  },
  "33546489": {
    "title": "Mucosal-Associated Invariant T (MAIT) Cells Are Highly Activated and Functionally Impaired in COVID-19 Patients.",
    "sentences": [
      {
        "text": "Coronavirus disease 2019 (COVID-19), caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), comprises mild courses of disease as well as progression to severe disease, characterised by lung and other organ failure."
      },
      {
        "text": "The immune system is considered to play a crucial role for the pathogenesis of COVID-19, although especially the contribution of innate-like T cells remains poorly understood."
      },
      {
        "text": "Here, we analysed the phenotype and function of mucosal-associated invariant T (MAIT) cells, innate-like T cells with potent antimicrobial effector function, in patients with mild and severe COVID-19 by multicolour flow cytometry."
      },
      {
        "text": "Our data indicate that MAIT cells are highly activated in patients with COVID-19, irrespective of the course of disease, and express high levels of proinflammatory cytokines such as IL-17A and TNFÎ± ex vivo."
      },
      {
        "text": "Of note, expression of the activation marker HLA-DR positively correlated with SAPS II score, a measure of disease severity."
      },
      {
        "text": "Upon MAIT cell-specific in vitro stimulation, MAIT cells however failed to upregulate expression of the cytokines IL-17A and TNFÎ±, as well as cytolytic proteins, that is, granzyme B and perforin."
      },
      {
        "text": "Thus, our data point towards an altered cytokine expression profile alongside an impaired antibacterial and antiviral function of MAIT cells in COVID-19 and thereby contribute to the understanding of COVID-19 immunopathogenesis."
      }
    ]
  },
  "33545796": {
    "title": "The features comparison between patients in the ICU and general wards and between patients with different outcomes: a 2020 COVID-19 study.",
    "sentences": [
      {
        "text": "BACKGROUND The novel 2019 coronavirus (COVID-19) has largely abated in China; however, sporadic or imported cases are still a concern, while in other countries, the COVID-19 pandemic persists as a major health crisis."
      },
      {
        "text": "METHODS All patients enrolled in this study were diagnosed with COVID-19 from February 21, 2020 to April 14, 2020 in Wuhan."
      },
      {
        "text": "We retrospectively analyzed the patients admitted to the ICU (137 patients) and general wards (114 patients) of Wuhan Leishenshan Hospital in China."
      },
      {
        "text": "The population characteristics, symptoms, and laboratory examination results between the patients in the ICU and those in the general wards were compared."
      },
      {
        "text": "Furthermore, the differences between the deceased patients in the ICU and those discharged from the ICU were compared."
      },
      {
        "text": "RESULTS There were significant differences between the two groups in terms of symptoms, including fever, shortness of breath, no presence of complications, presence of 1 complication, and presence of 3 or more complications (P<0.05)."
      },
      {
        "text": "There were also significant differences between the patients in terms of the laboratory examination results including elevated urea nitrogen, creatinine, direct bilirubin, aspartate aminotransferase, total protein, albumin, creatine kinase, lactate dehydrogenase, procalcitonin, erythrocyte sedimentation rate, white blood cells, C-reactive protein, prothrombin time, activated partial thromboplastin time, fibrinogen, D-dimer, interleukin 6, interleukin 8, interleukin 10, interleukin 2 receptor, tumor necrosis factor-Î±, troponin I, phosphokinase isoenzyme-MB, and B-type natriuretic peptide; and decreased platelets, lymphocyte absolute value, and eosinophil absolute value (<0.05)."
      },
      {
        "text": "There were 45 patients who died in ICU and 57 improved and discharged patients."
      },
      {
        "text": "There were significant differences between the two groups in the number of patients that had 1 complication and 3 or more complications (P<0.05)."
      },
      {
        "text": "There were also significant differences in the laboratory examination results between the patients including elevated urea nitrogen, total bilirubin, direct bilirubin, aspartate aminotransferase, procalcitonin, white blood cells, interleukin 8, interleukin 10, phosphokinase isoenzyme-MB, and B-type natriuretic peptide; and decreased platelets and eosinophil absolute value (P<0.05)."
      },
      {
        "text": "CONCLUSIONS Our findings highlight that the identified determinants may help to improve treatment of COVID-19 patients, to predict the risk of developing severe illness and to optimizing arrangement of health resources."
      }
    ]
  },
  "33545161": {
    "title": "Chloroquine: Autophagy inhibitor, antimalarial, bitter taste receptor agonist in fight against COVID-19, a reality check?",
    "sentences": [
      {
        "text": "The recent SARS-CoV-2 pandemic poses one of the greatest challenges to modern medicine."
      },
      {
        "text": "Therefore, identification of new therapeutic strategies seems essential either based on novel vaccines or drugs or simply repurposing existing drugs."
      },
      {
        "text": "Notably, due to their known safety profile, repurposing of existing drugs is the fastest and highly efficient approach to bring a therapeutic to a clinic for any new indication."
      },
      {
        "text": "One such drug that has been used extensively for decades is chloroquine (CQ, with its derivatives) either for malaria, lupus and rheumatoid arthritis."
      },
      {
        "text": "Accumulating body of evidence from experimental pharmacology suggests that CQ and related analogues also activate certain pathways that can potentially be exploited for therapeutic gain."
      },
      {
        "text": "For example, in the airways, this has opened an attractive avenue for developing novel bitter taste ligands as a new class of bronchodilators for asthma."
      },
      {
        "text": "While CQ and its derivatives have been proposed as a therapy in COVID-19, it remains to be seen whether it really work in the clinic?"
      },
      {
        "text": "To this end, our perspective aims to provide a timely yet brief insights on the existing literature on CQ and the controversies surrounding its use in COVID-19."
      },
      {
        "text": "Further, we also highlight some of cell-based mechanism(s) that CQ and its derivatives affect in mediating variety of physiological responses in the cell."
      },
      {
        "text": "We believe, data emanating from the clinical studies and continual understanding of the fundamental mechanisms may potentially help in designing effective therapeutic strategies that meets both efficacy and safety criteria for COVID-19."
      }
    ]
  },
  "33542974": {
    "title": "Cardiac arrest and COVID-19: inflammation, angiotensin-converting enzyme 2, and the destabilization of non-significant coronary artery disease-a case report.",
    "sentences": [
      {
        "text": "Background The new Î²-coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) appears to exhibit cardiovascular pathogenicity through use of angiotensin-converting enzyme 2 (ACE2) for cell entry and the development of a major systemic inflammation."
      },
      {
        "text": "Furthermore, cardiovascular comorbidities increase susceptibility to SARS-CoV-2 infection and the development of a severe form of COronaVIrus Disease 2019 (COVID-19)."
      },
      {
        "text": "Case summary We describe the case of a COVID-19 patient whose inaugural presentation was a refractory cardiac arrest secondary to the destabilization of known, non-significant coronary artery disease."
      },
      {
        "text": "Patient was supported by venoarterial extracorporeal life support."
      },
      {
        "text": "After 12âh of support, cardiac function remained stable on low vasopressor support but the patient remained in a coma and brainstem death was diagnosed."
      },
      {
        "text": "Discussion Myocardial injury is frequently seen among critically unwell COVID-19 patients and increases the risk of mortality."
      },
      {
        "text": "This case illustrates several potential mechanisms that are thought to drive the cardiac complications seen in COVID-19."
      },
      {
        "text": "We present the potential role of inflammation and ACE2 in the pathophysiology of COVID-19."
      }
    ]
  },
  "33542929": {
    "title": "Peripheral Inflammatory Cytokines and Lymphocyte Subset Features of Deceased COVID-19 Patients.",
    "sentences": [
      {
        "text": "Objective To compare the difference of inflammatory cytokines and lymphocyte subsets between deceased patients and survivors with COVID-19."
      },
      {
        "text": "Methods This retrospective study included 254 confirmed patients from 10 January to 11 March, 2020, at Tongji Hospital of Wuhan, China."
      },
      {
        "text": "Laboratory and immunologic features were collected and analyzed, and the main outcomes focused on inflammatory cytokines and lymphocyte subsets."
      },
      {
        "text": "Results A trend of markedly higher levels of inflammatory cytokines as well as lower lymphocyte subset levels in deceased patients was observed compared with survivors."
      },
      {
        "text": "ROC curve analyses indicated that inflammatory cytokines and the decrease levels of T cell, Th (helper T cells) cell, Ts (suppressor T cells) cell, B cell, and NK cell along with Th/Ts ratio increase could be used to predict the death of COVID-19."
      },
      {
        "text": "Multivariate analyses showed that higher levels of IL-6, IL-8, and IL-10 remained significantly correlated with shorter survival time and that the amount of Ts cells was negatively associated with the possibility of death in COVID-19 patients."
      },
      {
        "text": "In conclusion, SARS-CoV-2 would cause lymphopenia and result in decreased lymphocyte subset cells, particularly in Ts cell counts, which further induces hyperinflammatory response and cytokine storm."
      },
      {
        "text": "IL-6, IL-8, IL-10, and Ts cell might be independent predictors for the poor outcome of COVID-19."
      }
    ]
  },
  "33542047": {
    "title": "Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial.",
    "sentences": [
      {
        "text": "OBJECTIVE To evaluate whether the addition of colchicine to standard treatment for COVID-19 results in better outcomes."
      },
      {
        "text": "DESIGN We present the results of a randomised, double-blinded, placebo-controlled clinical trial of colchicine for the treatment of moderate to severe COVID-19, with 75 patients allocated 1:1 from 11 April to 30 August 2020."
      },
      {
        "text": "Colchicine regimen was 0.5âmg thrice daily for 5âdays, then 0.5âmg twice daily for 5âdays."
      },
      {
        "text": "The primary endpoints were the need for supplemental oxygen, time of hospitalisation, need for admission and length of stay in intensive care unit and death rate."
      },
      {
        "text": "RESULTS Seventy-two patients (36 for placebo and 36 for colchicine) completed the study."
      },
      {
        "text": "Median (and IQR) time of need for supplemental oxygen was 4.0 (2.0-6.0)âdays for the colchicine group and 6.5 (4.0-9.0)âdays for the placebo group (p<0.001)."
      },
      {
        "text": "Median (IQR) time of hospitalisation was 7.0 (5.0-9.0)âdays for the colchicine group and 9.0 (7.0-12.0)âdays for the placebo group (p=0.003)."
      },
      {
        "text": "At day 2, 67% versus 86% of patients maintained the need for supplemental oxygen, while at day 7, the values were 9% versus 42%, in the colchicine and the placebo groups, respectively (log rank; p=0.001)."
      },
      {
        "text": "Two patients died, both in placebo group."
      },
      {
        "text": "Diarrhoea was more frequent in the colchicine group (p=0.26)."
      },
      {
        "text": "CONCLUSION Colchicine reduced the length of both, supplemental oxygen therapy and hospitalisation."
      },
      {
        "text": "The drug was safe and well tolerated."
      },
      {
        "text": "Once death was an uncommon event, it is not possible to ensure that colchicine reduced mortality of COVID-19."
      },
      {
        "text": "TRIAL REGISTRATION NUMBER RBR-8jyhxh."
      }
    ]
  },
  "33540625": {
    "title": "Thymoquinone: A Tie-Breaker in SARS-CoV2-Infected Cancer Patients?",
    "sentences": [
      {
        "text": "Since the beginning of the SARS-CoV-2(severe acute respiratory syndrome-coronavirus-2) pandemic, arace to develop a vaccine has been initiated, considering the massive and rather significant economic and healthcare hits that this virus has caused."
      },
      {
        "text": "The pathophysiology occurring following COVID-19(coronavirus disease-2019) infection has givenhints regarding the supportive and symptomatic treatments to establish for patients, as no specific anti-SARS-CoV-2 is available yet."
      },
      {
        "text": "Patient symptoms vary greatly and range from mild symptoms to severe fatal complications."
      },
      {
        "text": "Supportive treatments include antipyretics, antiviral therapies, different combinations of broad-spectrum antibiotics, hydroxychloroquine and plasma transfusion."
      },
      {
        "text": "Unfortunately, cancer patients are at higher risk of viral infection and more likely to develop serious complications due to their immunocompromised state, the fact that they are already administering multiple medications, as well as combined comorbidity compared to the general population."
      },
      {
        "text": "It may seem impossible to find a drug that possesses both potent antiviral and anticancer effects specifically against COVID-19 infection and its complications and the existing malignancy, respectively."
      },
      {
        "text": "Thymoquinone (TQ) is the most pharmacologically active ingredient in Nigella sativa seeds (black seeds); it is reported to have anticancer, anti-inflammatory and antioxidant effects in various settings."
      },
      {
        "text": "In this review, we will discuss the multiple effects of TQ specifically against COVID-19, its beneficial effects against COVID-19 pathophysiology and multiple-organ complications, its use as an adjuvant for supportive COVID-19 therapy and cancer therapy, and finally, its anticancer effects."
      }
    ]
  },
  "33537060": {
    "title": "The Dynamic Expression of Potential Mediators of Severe Acute Respiratory Syndrome Coronavirus 2 Cellular Entry in Fetal, Neonatal, and Adult Rhesus Monkeys.",
    "sentences": [
      {
        "text": "The coronavirus disease 2019 (COVID-19) pandemic, induced by the pathogenic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread rapidly all over the world."
      },
      {
        "text": "There is considerable variability among neonates, children, and adults in the incidence of infection and severe disease following exposure to SARS-CoV-2."
      },
      {
        "text": "In our study, we analyzed the transcriptome data of primate animal model of Rhesus monkeys to evaluate the expression levels of possible SARS-CoV-2 receptors and proteases and immunologic features in the lungs, colons, livers, and brains at different developmental stages."
      },
      {
        "text": "Our results revealed that ACE2 and TMPRSS2 were highly expressed in neonates compared with other populations, which imply the high incidence of infection."
      },
      {
        "text": "Other potential receptors and Type II transmembrane serine proteases (TTSPs) and cathepsin of endosomal proteases also exhibited dynamic and differential expression patterns."
      },
      {
        "text": "The expression of receptors (ACE2, BSG, and DPP4) and proteases (TMPRSS2, TMPRSS9, CTSL, and CTSB) were highly correlated during lung development, suggesting the high susceptibility of the lungs."
      },
      {
        "text": "TMPRSS9 was specifically highly expressed in the lungs and reached the highest level in neonates, similar to TMPRSS2."
      },
      {
        "text": "Moreover, the immune cell infiltration analysis revealed immunity immaturity in neonates, implying the association with the mild or moderate type of COVID-19."
      },
      {
        "text": "The results might help researchers design protective and therapeutic strategies for COVID-19 in populations at different ages."
      }
    ]
  },
  "33520227": {
    "title": "Total gastric necrosis following acute pancreatitis in a patient with COVID -19: Case report and literature review.",
    "sentences": [
      {
        "text": "The Coronavirus Disease Pandemic - 2019 (COVID-19) has spread to more than 200 countries worldwide, affecting more than 2 million people and >120,000 deaths, Acute pancreatitis of infectious origin can be caused by different viruses but currently no study has concluded that COVID-19 is directly responsible for acute pancreatitis."
      },
      {
        "text": "We report the case of a COVID-19 patient admitted to the emergency room in a state of respiratory distress associated with stage E pancreatitis according to the classification of balthazar whose surgical exploration found total necrosis of the stomach."
      },
      {
        "text": "A total gastrectomy was performed with an esophagostomy and a wide drainage of the abdominal cavity, the postoperative sequelae were marked by the death of the patient at D6 postoperatively by cardiorespiratory arrest."
      }
    ]
  },
  "33520197": {
    "title": "In silico prediction of structure and function for a large family of transmembrane proteins that includes human Tmem41b.",
    "sentences": [
      {
        "text": "Background: Recent strides in computational structural biology have opened up an opportunity to understand previously uncharacterised proteins."
      },
      {
        "text": "The under-representation of transmembrane proteins in the Protein Data Bank highlights the need to apply new and advanced bioinformatics methods to shed light on their structure and function."
      },
      {
        "text": "This study focuses on a family of transmembrane proteins containing the Pfam domain PF09335 ('SNARE_ASSOC'/ 'VTT '/'Tvp38')."
      },
      {
        "text": "One prominent member, Tmem41b, has been shown to be involved in early stages of autophagosome formation and is vital in mouse embryonic development as well as being identified as a viral host factor of SARS-CoV-2."
      },
      {
        "text": "Methods: We used evolutionary covariance-derived information to construct and validate ab initio models, make domain boundary predictions and infer local structural features."
      },
      {
        "text": "Results: The results from the structural bioinformatics analysis of Tmem41b and its homologues showed that they contain a tandem repeat that is clearly visible in evolutionary covariance data but much less so by sequence analysis."
      },
      {
        "text": "Furthermore, cross-referencing of other prediction data with covariance analysis showed that the internal repeat features two-fold rotational symmetry."
      },
      {
        "text": "Ab initio modelling of Tmem41b and homologues reinforces these structural predictions."
      },
      {
        "text": "Local structural features predicted to be present in Tmem41b were also present in Cl -/H + antiporters."
      },
      {
        "text": "Conclusions: The results of this study strongly point to Tmem41b and its homologues being transporters for an as-yet uncharacterised substrate and possibly using H + antiporter activity as its mechanism for transport."
      }
    ]
  },
  "33520046": {
    "title": "Bowel necrosis associated with COVID-19 pneumonia: A report of two cases.",
    "sentences": [
      {
        "text": "A novel coronavirus, called as SARS-CoV-2, caused multiple typical and atypical respiratory symptoms with several reported abdominal findings."
      },
      {
        "text": "We have described 2 cases of an unusual presentation of Covid-19."
      },
      {
        "text": "For patient 1, a woman aged 59-year-old had pneumonia and new onset abdominal pain."
      },
      {
        "text": "In patient 2, a 60-year-old man admitted with positive polymerase chain reaction test and abdominal pain from 2 weeks ago."
      },
      {
        "text": "Both lung and abdominal computed tomography (CT) were achieved in a few days."
      },
      {
        "text": "Acute ischemic mesenteritis and other abdominal complications were observed in the CT scan."
      },
      {
        "text": "Bowel necrosis in combination with peritonitis founded by laparotomy."
      },
      {
        "text": "Early diagnosis of abdominal complications in Covid-19 pneumonia can improve patient outcomes."
      }
    ]
  },
  "33538960": {
    "title": "Potential Effects of COVID-19 on Cytochrome P450-Mediated Drug Metabolism and Disposition in Infected Patients.",
    "sentences": [
      {
        "text": "Coronavirus Disease 2019 (COVID-19) has been a global health crisis since it was first identified in December 2019."
      },
      {
        "text": "In addition to fever, cough, headache, and shortness of breath, an intense increase in immune response-based inflammation has been the hallmark of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) virus infection."
      },
      {
        "text": "This narrative review summarizes and critiques pathophysiology of COVID-19Â and its plausible effects on drug metabolism and disposition."
      },
      {
        "text": "The release of inflammatory cytokines (e.g., interleukins, tumor necrosis factor Î±), also known as 'cytokine storm', leads to altered molecular pathophysiology and eventually organ damage in the lung, heart, and liver."
      },
      {
        "text": "The laboratory values for various liver function tests (e.g., alanine aminotransferase, aspartate aminotransferase, total bilirubin, albumin) have indicated potential hepatocellular injury in COVID-19 patients."
      },
      {
        "text": "Since the liver is the powerhouse of protein synthesis and the primary site of cytochrome P450 (CYP)-mediated drug metabolism, even a minor change in the liver function status has the potential to affect the hepatic clearance of xenobiotics."
      },
      {
        "text": "It has now been well established that extreme increases in cytokine levels are common in COVID-19 patients, and previous studies with patients infected with non-SARS-CoV-2 virus have shown that CYP enzymes can be suppressed by an infection-related cytokine increase and inflammation."
      },
      {
        "text": "Alongside the investigational COVID-19 drugs, the patients may also be on therapeutics for comorbidities; especially epidemiological studies have indicated that individuals with hypertension, hyperglycemia, and obesity are more vulnerable to COVID-19 than the average population."
      },
      {
        "text": "This complicates the drug-disease interaction profile of the patients as both the investigational drugs (e.g., remdesivir, dexamethasone) and the agents for comorbidities can be affected by compromised CYP-mediated hepatic metabolism."
      },
      {
        "text": "Overall, it is imperative that healthcare professionals pay attention to the COVID-19 and CYP-driven drug metabolism interactions with the goal to adjust the dose or discontinue the affected drugs as appropriate."
      }
    ]
  },
  "33535779": {
    "title": "Acute Ischemic Stroke and COVID-19: An Analysis of 27â676 Patients.",
    "sentences": [
      {
        "text": "BACKGROUND AND PURPOSE Acute ischemic stroke may occur in patients with coronavirus disease 2019 (COVID-19), but risk factors, in-hospital events, and outcomes are not well studied in large cohorts."
      },
      {
        "text": "We identified risk factors, comorbidities, and outcomes in patients with COVID-19 with or without acute ischemic stroke and compared with patients without COVID-19 and acute ischemic stroke."
      },
      {
        "text": "METHODS We analyzed the data from 54 health care facilities using the Cerner deidentified COVID-19 dataset."
      },
      {
        "text": "The dataset included patients with an emergency department or inpatient encounter with discharge diagnoses codes that could be associated to suspicion of or exposure to COVID-19 or confirmed COVID-19."
      },
      {
        "text": "RESULTS A total of 103 (1.3%) patients developed acute ischemic stroke among 8163 patients with COVID-19."
      },
      {
        "text": "Among all patients with COVID-19, the proportion of patients with hypertension, diabetes, hyperlipidemia, atrial fibrillation, and congestive heart failure was significantly higher among those with acute ischemic stroke."
      },
      {
        "text": "Acute ischemic stroke was associated with discharge to destination other than home or death (relative risk, 2.1 [95% CI, 1.6-2.4]; P<0.0001) after adjusting for potential confounders."
      },
      {
        "text": "A total of 199 (1.0%) patients developed acute ischemic stroke among 19â513 patients without COVID-19."
      },
      {
        "text": "Among all ischemic stroke patients, COVID-19 was associated with discharge to destination other than home or death (relative risk, 1.2 [95% CI, 1.0-1.3]; P=0.03) after adjusting for potential confounders."
      },
      {
        "text": "CONCLUSIONS Acute ischemic stroke was infrequent in patients with COVID-19 and usually occurs in the presence of other cardiovascular risk factors."
      },
      {
        "text": "The risk of discharge to destination other than home or death increased 2-fold with occurrence of acute ischemic stroke in patients with COVID-19."
      }
    ]
  },
  "33533933": {
    "title": "COVID-19 Outcomes Among Persons Living With or Without Diagnosed HIV Infection in New York State.",
    "sentences": [
      {
        "text": "Importance New York State has been an epicenter for both the US coronavirus disease 2019 (COVID-19) and HIV/AIDS epidemics."
      },
      {
        "text": "Persons living with diagnosed HIV may be more prone to COVID-19 infection and severe outcomes, yet few studies have assessed this possibility at a population level."
      },
      {
        "text": "Objective To evaluate the association between HIV diagnosis and COVID-19 diagnosis, hospitalization, and in-hospital death in New York State."
      },
      {
        "text": "Design, Setting, and Participants This cohort study, conducted in New York State, including New York City, between March 1 and June 15, 2020, matched data from HIV surveillance, COVID-19 laboratory-confirmed diagnoses, and hospitalization databases to provide a full population-level comparison of COVID-19 outcomes between persons living with diagnosed HIV and persons living without diagnosed HIV."
      },
      {
        "text": "Exposures Diagnosis of HIV infection through December 31, 2019."
      },
      {
        "text": "Main Outcomes and Measures The main outcomes were COVID-19 diagnosis, hospitalization, and in-hospital death."
      },
      {
        "text": "COVID-19 diagnoses, hospitalizations, and in-hospital death rates comparing persons living with diagnosed HIV with persons living without dianosed HIV were computed, with unadjusted rate ratios and indirect standardized rate ratios (sRR), adjusting for sex, age, and region."
      },
      {
        "text": "Adjusted rate ratios (aRRs) for outcomes specific to persons living with diagnosed HIV were assessed by age, sex, region, race/ethnicity, transmission risk, and CD4+ T-cell count-defined HIV disease stage, using Poisson regression models."
      },
      {
        "text": "Results A total of 2988 persons living with diagnosed HIV (2109 men [70.6%]; 2409 living in New York City [80.6%]; mean [SD] age, 54.0 [13.3] years) received a diagnosis of COVID-19."
      },
      {
        "text": "Of these persons living with diagnosed HIV, 896 were hospitalized and 207 died in the hospital through June 15, 2020."
      },
      {
        "text": "After standardization, persons living with diagnosed HIV and persons living without diagnosed HIV had similar diagnosis rates (sRR, 0.94 [95% CI, 0.91-0.97]), but persons living with diagnosed HIV were hospitalized more than persons living without diagnosed HIV, per population (sRR, 1.38 [95% CI, 1.29-1.47]) and among those diagnosed (sRR, 1.47 [95% CI, 1.37-1.56])."
      },
      {
        "text": "Elevated mortality among persons living with diagnosed HIV was observed per population (sRR, 1.23 [95% CI, 1.07-1.40]) and among those diagnosed (sRR, 1.30 [95% CI, 1.13-1.48]) but not among those hospitalized (sRR, 0.96 [95% CI, 0.83-1.09])."
      },
      {
        "text": "Among persons living with diagnosed HIV, non-Hispanic Black individuals (aRR, 1.59 [95% CI, 1.40-1.81]) and Hispanic individuals (aRR, 2.08 [95% CI, 1.83-2.37]) were more likely to receive a diagnosis of COVID-19 than White individuals, but they were not more likely to be hospitalized once they received a diagnosis or to die once hospitalized."
      },
      {
        "text": "Hospitalization risk increased with disease progression to HIV stage 2 (aRR, 1.29 [95% CI, 1.11-1.49]) and stage 3 (aRR, 1.69 [95% CI, 1.38-2.07]) relative to stage 1."
      },
      {
        "text": "Conclusions and Relevance In this cohort study, persons living with diagnosed HIV experienced poorer COVID-related outcomes relative to persons living without diagnosed HIV; Previous HIV diagnosis was associated with higher rates of severe disease requiring hospitalization, and hospitalization risk increased with progression of HIV disease stage."
      }
    ]
  },
  "33530272": {
    "title": "Simultaneous cardio-cerebral infarction in the coronavirus disease pandemic era: A case series.",
    "sentences": [
      {
        "text": "INTRODUCTION Simultaneous occurrence of acute ischemic stroke and myocardial infarction is reported to have variable precipitating causes."
      },
      {
        "text": "This occurrence has been rarely reported in the literature and described only in very few case reports."
      },
      {
        "text": "During the surge of coronavirus disease (COVID-19) in our region, we noted an increase in the simultaneous occurrence of cardio-cerebral infarction."
      },
      {
        "text": "This led us to explore the possible mechanisms and pathophysiology that could contribute to this increase."
      },
      {
        "text": "The retrospective nature of the study limited us from drawing any conclusion about causation."
      },
      {
        "text": "Rather, we aimed to formulate a hypothesis for future, more rigorous studies."
      },
      {
        "text": "PATIENT CONCERNS We present an overview of 5 cases of simultaneous cardio-cerebral infarction that we encountered in our emergency department within 1 month."
      },
      {
        "text": "DIAGNOSIS In all cases, diagnosis was confirmed using an electrocardiogram, assessment of laboratory cardiac markers, and imaging."
      },
      {
        "text": "INTERVENTIONS In all cases, dual antiplatelet therapy was started and thrombolysis was held, as the condition was considered high risk in most of the patients."
      },
      {
        "text": "Cardiac catheterization lab was not activated either because the patient was unstable or the risk of COVID-19 in staff outweighed the benefit added in patient treatment."
      },
      {
        "text": "OUTCOMES Two out of 5 patients died because of early complications that lasted for few days."
      },
      {
        "text": "The remaining 3 were discharged from the hospital in moderate functionality for extensive therapy and rehabilitation."
      },
      {
        "text": "CONCLUSION Early recognition and immediate treatment is important in different scenarios leading to thrombosis as the outcome."
      },
      {
        "text": "Additionally, addressing the unknown risks that could contribute to our traditional understanding of these causative mechanisms is important."
      },
      {
        "text": "The hypothesis of exacerbated damage caused by inflammatory and immunological endothelial systemic damage should further be explored to be able to delineate new possibilities in managing these conditions."
      }
    ]
  },
  "33530084": {
    "title": "Genetic Variation, Diet, Inflammation, and the Risk for COVID-19.",
    "sentences": [
      {
        "text": "COVID-19, which is caused by SARS-CoV-2, is characterized by various symptoms, ranging from mild fatigue to life-threatening pneumonia, \"cytokine storm,\" and multiorgan failure."
      },
      {
        "text": "The manifestation of COVID-19 may lead to a cytokine storm, i.e., it facilitates viral replication that triggers a strong release of cytokines, which then modulates the immune system and results in hyperinflammation."
      },
      {
        "text": "Today's diet is high in omega-6 fatty acids and deficient in omega-3 fatty acids; this, along with a high fructose intake, leads to obesity, which is a chronic state of low-grade inflammation."
      },
      {
        "text": "Omega-6 fatty acids are proinflammatory and prothrombotic whereas omega-3 fatty acids are less proinflammatory and thrombotic."
      },
      {
        "text": "Furthermore, omega-3 fatty acids make specialized lipid mediators, namely resolvins, protectins, and maresins, that are potent anti-inflammatory agents."
      },
      {
        "text": "Throughout evolution there was a balance between omega-6 and omega-3 fatty acids with a ratio of 1-2/1 omega-6/omega-3, but today this ratio is 16-20/1 omega-6/omega-3, leading to a proinflammatory state."
      },
      {
        "text": "In addition, genetic variants in FADS1, FADS2, ELOV-2, and ELOV-5 lead to a more efficient biosynthesis of long-chain polyunsaturated fatty acids (PUFAs), e.g., of linoleic acid (LA) to arachidonic acid (ARA), and (alpha-linolenic acid) (ALA) to eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), leading to higher ARA levels."
      },
      {
        "text": "Because the US diet is already high in omega-6 fatty acids, the increased biosynthesis of ARA in people with the derived FADS haplotype (haplotype D) leads to an increased production of leukotrienes, thromboxanes, C-reactive protein (CRP), and eventually elevated levels of cytokines, like interleukin (IL)-1, IL-6, and tumor necrosis factor (TNF), which may increase susceptibility to COVID-19."
      },
      {
        "text": "About 80% of African Americans, 50% of Hispanics, and 45% of European Americans have the FADS haplotype D and are thus efficient metabolizers, which could account for the higher vulnerability of these populations to COVID-19."
      },
      {
        "text": "Therefore, another reason that African Americans and Hispanics are more susceptible to COVID-19 is that they have a higher frequency of haplotype D, which is no longer beneficial in today's environment and diet."
      },
      {
        "text": "Genetic variation must be considered in all studies of disease development and therapy because it is important to the practice of precision nutrition by physicians and other health professionals."
      },
      {
        "text": "The objective of this commentary is to emphasize the importance of genetic variation within populations and its interaction with diet in the development of disease."
      },
      {
        "text": "Differences in the frequency of genes and their interactions with nutrients in various population groups must be considered among the factors contributing to health disparities in the development of COVID-19."
      },
      {
        "text": "A balanced omega-6/omega-3 ratio is essential to health."
      },
      {
        "text": "Physicians should measure their patients' fatty acids and recommend decreasing the intake of foods rich in omega-6 fatty acids and increasing the intake of omega-3 fatty acids along with fruits and vegetables."
      }
    ]
  },
  "33527080": {
    "title": "Virtual screening of phytochemical compounds as potential inhibitors against SARS-CoV-2 infection.",
    "sentences": [
      {
        "text": "Background The present pandemic situation due to coronavirus has led to the search for newer prevention, diagnostic, and treatment methods."
      },
      {
        "text": "The onset of the corona infection in a human results in acute respiratory illness followed by death if not diagnosed and treated with suitable antiretroviral drugs."
      },
      {
        "text": "With the unavailability of the targeted drug treatment, several repurposed drugs are being used for treatment."
      },
      {
        "text": "However, the side-effects of the drugs urges us to move to a search for newer synthetic- or phytochemical-based drugs."
      },
      {
        "text": "The present study investigates the use of various phytochemicals virtually screened from various plant sources in Western Ghats, India, and subsequently molecular docking studies were performed to identify the efficacy of the drug in retroviral infection particularly coronavirus infection."
      },
      {
        "text": "Results Out of 57 phytochemicals screened initially based on the structural and physicochemical properties, 39 were effectively used for the docking analysis."
      },
      {
        "text": "Finally, 5 lead compounds with highest hydrophobic interaction and number of H-bonds were screened."
      },
      {
        "text": "Results from the interaction analysis suggest Piperolactam A to be pocketed well with good hydrophobic interaction with the residues in the binding region R1."
      },
      {
        "text": "ADME and toxicity profiling also reveals Piperolactam A with higher LogS values indicating higher permeation and hydrophilicity."
      },
      {
        "text": "Toxicity profiling suggests that the 5 screened compounds to be relatively safe."
      },
      {
        "text": "Conclusion The in silico methods used in this study suggests that the compound Piperolactam A to be the most effective inhibitor of S-protein from binding to the GRP78 receptor."
      },
      {
        "text": "By blocking the binding of the S-protein to the CS-GRP78 cell surface receptor, they can inhibit the binding of the virus to the host."
      },
      {
        "text": "Supplementary Information The online version contains supplementary material available at 10.1186/s43088-021-00095-x."
      }
    ]
  },
  "33437916": {
    "title": "Case report of severe PCR-confirmed COVID-19 myocarditis in a European patient manifesting in mid January 2020.",
    "sentences": [
      {
        "text": "Background Viral genesis is the most common cause of myocarditis."
      },
      {
        "text": "COVID-19-associated myocarditis seems to be a notable extrapulmonary manifestation, which may result in the need for a different treatment."
      },
      {
        "text": "There has been no positive polymerase chain reaction (PCR) testing of SARS-CoV-2 in heart specimens, thus far."
      },
      {
        "text": "Case summary A 48-year-old male patient presented with fever, dyspnoea, and haemoptysis."
      },
      {
        "text": "Laboratory findings showed highly elevated inflammatory and cardiac damage markers."
      },
      {
        "text": "Thoracic computed tomography (CT) revealed bilateral, patchy peripheral ground-glass opacities with a crazy-paving pattern, focal consolidations, and mild pleural effusions."
      },
      {
        "text": "Cardiac imaging with echocardiography and magnetic resonance imaging (MRI) detected a reduced biventricular function."
      },
      {
        "text": "MRI additionally showed myocardial oedema and late gadolinium enhancement."
      },
      {
        "text": "Lung and heart biopsies were performed, revealing alveolitis with necrosis and acute lymphocytic myocarditis."
      },
      {
        "text": "Testing for usual cardiotropic viruses was negative, and no aspects of vasculitis or granuloma could be found."
      },
      {
        "text": "Due to fulfilling the criteria, the patient was diagnosed with rheumatic vasculitis."
      },
      {
        "text": "Treatment with cyclophosphamide and steroids was initiated."
      },
      {
        "text": "Later, the patient reported a history of travel to Tyrol in mid January."
      },
      {
        "text": "Consequently, PCR testing for SARS-CoV-2 was performed, which was positive in the heart specimen."
      },
      {
        "text": "Immunosuppressive treatment was discontinued."
      },
      {
        "text": "During a follow-up visit at the end of April, the patient's recovery was stable."
      },
      {
        "text": "Discussion In COVID-19 infections, myocardial inflammation can be present as an extrapulmonary manifestation."
      },
      {
        "text": "Positive PCR testing confirms myocardial invasion of the virus."
      },
      {
        "text": "Imaging and laboratory studies correlate with the histopathological findings, and thus should be performed in COVID-19 patients who are suspicious for myocarditis."
      },
      {
        "text": "Supportive treatment with steroids may be useful in these patients."
      }
    ]
  },
  "33526326": {
    "title": "The protective effect of rheumatic disease agents in COVID-19.",
    "sentences": [
      {
        "text": "Several immunosuppressive therapies have been investigated as potential treatments for patients with severe and critical coronavirus disease 2019 (COVID-19)."
      },
      {
        "text": "Notable examples include corticosteroids, interleukin 6 (IL-6), interleukin 1 (IL-1), Janus kinase (JAK), and tumor necrosis factor alpha (TNF-Î±) inhibitors."
      },
      {
        "text": "The aim of this narrative review is to analyze the mechanistic rationale and available evidence for these selected anti-rheumatic drugs for the treatment of COVID-19."
      },
      {
        "text": "Currently, only corticosteroids have consistently proven to be effective in decreasing mortality and are recommended in clinical guidelines for the treatment of severe and critical COVID-19."
      },
      {
        "text": "Multiple randomized controlled trials (RCTs) are ongoing to determine the role of other immunosuppressants."
      }
    ]
  },
  "33525632": {
    "title": "The SARS-Coronavirus Infection Cycle: A Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis.",
    "sentences": [
      {
        "text": "Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a novel epidemic strain of Betacoronavirus that is responsible for the current viral pandemic, coronavirus disease 2019 (COVID-19), a global health crisis."
      },
      {
        "text": "Other epidemic Betacoronaviruses include the 2003 SARS-CoV-1 and the 2009 Middle East Respiratory Syndrome Coronavirus (MERS-CoV), the genomes of which, particularly that of SARS-CoV-1, are similar to that of the 2019 SARS-CoV-2."
      },
      {
        "text": "In this extensive review, we document the most recent information on Coronavirus proteins, with emphasis on the membrane proteins in the Coronaviridae family."
      },
      {
        "text": "We include information on their structures, functions, and participation in pathogenesis."
      },
      {
        "text": "While the shared proteins among the different coronaviruses may vary in structure and function, they all seem to be multifunctional, a common theme interconnecting these viruses."
      },
      {
        "text": "Many transmembrane proteins encoded within the SARS-CoV-2 genome play important roles in the infection cycle while others have functions yet to be understood."
      },
      {
        "text": "We compare the various structural and nonstructural proteins within the Coronaviridae family to elucidate potential overlaps and parallels in function, focusing primarily on the transmembrane proteins and their influences on host membrane arrangements, secretory pathways, cellular growth inhibition, cell death and immune responses during the viral replication cycle."
      },
      {
        "text": "We also offer bioinformatic analyses of potential viroporin activities of the membrane proteins and their sequence similarities to the Envelope (E) protein."
      },
      {
        "text": "In the last major part of the review, we discuss complement, stimulation of inflammation, and immune evasion/suppression that leads to CoV-derived severe disease and mortality."
      },
      {
        "text": "The overall pathogenesis and disease progression of CoVs is put into perspective by indicating several stages in the resulting infection process in which both host and antiviral therapies could be targeted to block the viral cycle."
      },
      {
        "text": "Lastly, we discuss the development of adaptive immunity against various structural proteins, indicating specific vulnerable regions in the proteins."
      },
      {
        "text": "We discuss current CoV vaccine development approaches with purified proteins, attenuated viruses and DNA vaccines."
      }
    ]
  },
  "33525222": {
    "title": "A review of current knowledge on Pollution, Cigarette Smoking and COVID-19 diffusion and their relationship with inflammation.",
    "sentences": [
      {
        "text": "Coronavirus disease (COVID-19) is an infectious disease caused by the newly discovered coronavirus, Sars-Cov-2."
      },
      {
        "text": "This infection can cause mild to very severe respiratory and systemic illness mainly related with a cytokine storm."
      },
      {
        "text": "The epidemiology of COVID-19 is under continuous evolution, and studies are ongoing aiming at identifying the possible factors facilitating the diffusion of this infection."
      },
      {
        "text": "It is documented that air pollution and smoking are a leading cause of human morbidity and mortality globally, and can increase the risk of many diseases, including respiratory diseases."
      },
      {
        "text": "Overall, a linear relationship between exposure to atmospheric pollutants and diffusion of the Sars-Cov2 virus seems to exist."
      },
      {
        "text": "However, this correlation, cannot be regarded as a cause-effect relationship."
      },
      {
        "text": "The available data show that air pollution is responsible for inflammation and hyper-activation of innate immunity that are associated with the worst outcomes of covid-19 but do not allow to conclude that atmospheric particulate is responsible for increased contagion."
      },
      {
        "text": "As to smoking, nicotine activation of nicotinic receptors leads to enhanced protease activation, apoptosis and inflammatory signaling through the same pathways (Renin-angiotensin system (RAS) and angiotensin-converting enzyme 2 (ACE2)) used by the virus increasing the inflammatory/destructive action of the virus itself."
      },
      {
        "text": "The increase in non-communicable diseases and of chronic inflammatory diseases is in line with environmental pollution, related climate changes, and with an augmented susceptibility to infectious diseases with increased contagiousness and morbidity."
      },
      {
        "text": "Restrictive measures to limit environmental pollution are needed worldwide as this represents a threat for human health."
      }
    ]
  },
  "33524886": {
    "title": "Characterizing the immune responses of those who survived or succumbed to COVID-19: Can immunological signatures predict outcome?",
    "sentences": [
      {
        "text": "BACKGROUND Immunodeficiency has pivotal role in the pathogenesis of coronavirus disease 2019 (COVID-19)."
      },
      {
        "text": "Several studies have indicated defects in the immune system of COVID-19 patients at different disease stages."
      },
      {
        "text": "Therefore, this study investigated whether alters in immune responses of COVID-19 patients may be considered as predicting factors for disease outcome."
      },
      {
        "text": "METHODS The percentages of innate and adoptive immune cells in the recovered and dead patients with COVID-19, and healthy subjects were determined by flow cytometry."
      },
      {
        "text": "The levels of pro- and anti-inflammatory cytokines and other immune factors were also measured by enzyme-linked immunosorbent assay."
      },
      {
        "text": "RESULTS At the first day of hospitalization, the frequencies of CD56dim CD16+ NK cells and CD56bright CD16dim/- NK cells in patients who died during treatment were significantly increased compared to recovered and healthy individuals (PÂ <Â 0.0001)."
      },
      {
        "text": "The recovered and dead patients had a significant increase in monocyte number in comparison with healthy subjects (PÂ <Â 0.05)."
      },
      {
        "text": "No significant change was observed in Th1 cell numbers between the recovered and dead patients while Th2, Th17 cell, and Treg percentages in death cases were significantly lower than healthy control and those recovered, unlike exhausted CD4Â +Â and CD8Â +Â T cells and activated CD4Â +Â T cells (PÂ <Â 0.0001-0.05)."
      },
      {
        "text": "The activated CD8Â +Â T cell was significantly higher in the recovered patients than healthy individuals (PÂ <Â 0.0001-0.05)."
      },
      {
        "text": "IL-1Î±, IL-1Î², IL-6, and TNF-Î± levels in patients were significantly increased (PÂ <Â 0.0001-0.01)."
      },
      {
        "text": "However, there were no differences in TNF-Î± and IL-1Î² levels between dead and recovered patients."
      },
      {
        "text": "Unlike TGF-Î²1 level, IL-10 was significantly increased in recovered patients (PÂ <Â 0.05)."
      },
      {
        "text": "Lymphocyte numbers in recovered patients were significantly increased compared to dead patients, unlike ESR value (PÂ <Â 0.001-0.01)."
      },
      {
        "text": "CRP value in recovered patients significantly differed from dead patients (PÂ <Â 0.001)."
      },
      {
        "text": "CONCLUSION Changes in frequencies of some immune cells and levels of some immune factors may be considered as predictors of mortality in COVID-19 patients."
      }
    ]
  },
  "33521616": {
    "title": "Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab.",
    "sentences": [
      {
        "text": "Coronavirus disease 2019 (COVID-19) is associated with considerable morbidity and mortality."
      },
      {
        "text": "The number of confirmed cases of infection with SARS-CoV-2, the virus causing COVID-19 continues to escalate with over 70 million confirmed cases and over 1.6 million confirmed deaths."
      },
      {
        "text": "Severe-to-critical COVID-19 is associated with a dysregulated host immune response to the virus, which is thought to lead to pathogenic immune dysregulation and end-organ damage."
      },
      {
        "text": "Presently few effective treatment options are available to treat COVID-19."
      },
      {
        "text": "Leronlimab is a humanized IgG4, kappa monoclonal antibody that blocks C-C chemokine receptor type 5 (CCR5)."
      },
      {
        "text": "It has been shown that in patients with severe COVID-19 treatment with leronlimab reduces elevated plasma IL-6 and chemokine ligand 5 (CCL5), and normalized CD4/CD8 ratios."
      },
      {
        "text": "We administered leronlimab to 4 critically ill COVID-19 patients in intensive care."
      },
      {
        "text": "All 4 of these patients improved clinically as measured by vasopressor support, and discontinuation of hemodialysis and mechanical ventilation."
      },
      {
        "text": "Following administration of leronlimab there was a statistically significant decrease in IL-6 observed in patient A (p=0.034) from day 0-7 and patient D (p=0.027) from day 0-14."
      },
      {
        "text": "This corresponds to restoration of the immune function as measured by CD4+/CD8+ T cell ratio."
      },
      {
        "text": "Although two of the patients went on to survive the other two subsequently died of surgical complications after an initial recovery from SARS-CoV-2 infection."
      }
    ]
  },
  "33398242": {
    "title": "Potential therapeutic approaches of microRNAs for COVID-19: Challenges and opportunities.",
    "sentences": [
      {
        "text": "The coronavirus disease 2019 (COVID-19) emerges as current outbreak cause by Novel Severe Acute Respiratory Syndrome Corona Virus-2 (SARS-CoV-2)."
      },
      {
        "text": "This infection affects respiratory system and provides uncontrolled systemic inflammatory response as cytokine storm."
      },
      {
        "text": "The main concern about SARS-CoV-2 pandemic is high viral pathogenicity with no specific drugs."
      },
      {
        "text": "MicroRNAs (miRs) as small non-coding RNAs (21-25Â ânt) regulate gene expression."
      },
      {
        "text": "The SARS-CoV-2 encoded-miRs affect human genes that involved in transcription, translation, apoptosis, immune response and inflammation."
      },
      {
        "text": "Also, they alter self-gene regulation and hijacked host miRs that provide protective environment to maintain its latency."
      },
      {
        "text": "On the other hand, Host miRs play critical role in viral gene expression to restrict infection."
      },
      {
        "text": "Over expression/inhibition of miRs might result in cell cycle irregularity, impaired immune response or cancer."
      },
      {
        "text": "In this manner, exact role of each miR should be specified."
      },
      {
        "text": "Mimic encoded-miRs like antagomirs showed successful result in phases of clinical trial prevent from negative effects of viral encoded-miRs."
      },
      {
        "text": "Products of mimic miRs are inexpensive corresponds to synthesis of primer; they are short and nanoscale in size."
      },
      {
        "text": "Although SARS-CoV-2 genome is undergoing evaluation, detection of exact molecular pathogenesis open up opportunities to for vaccine development."
      },
      {
        "text": "Salivaomics can evaluate SARS-CoV-2 genome, transcriptome, proteome and biomarkers like miRs in oral related and cancer disease."
      },
      {
        "text": "In this review, we studied the challenge and opportunities of miRs in therapeutic approach for SARS-CoV-2 infection, then overviewed the role of miRs in saliva droplet during SARS-CoV-2 infection and related cancer."
      }
    ]
  },
  "33522942": {
    "title": "A false alarm of COVID-19 pneumonia in lung cancerÂ with anti-PD-1 related pneumonitis: a case report and review of the literature.",
    "sentences": [
      {
        "text": "BACKGROUND Pneumonitis belongs to the fatal toxicities of anti-PD-1/PD-L1 treatments."
      },
      {
        "text": "Its diagnosis is based on immunotherapeutic histories, clinical symptoms, and the computed tomography (CT) imaging."
      },
      {
        "text": "The radiological features were typically ground-glass opacities, similar to CT presentation of 2019 Novel Coronavirus (COVID-19) pneumonia."
      },
      {
        "text": "Thus, clinicians are cautious in differential diagnosis especially in COVID-19 epidemic areas."
      },
      {
        "text": "CASE PRESENTATION Herein, we report a 67-year-old Han Chinese male patient presenting with dyspnea and normal body temperature on the 15th day of close contact with his son, who returned from Wuhan."
      },
      {
        "text": "He was diagnosed as advanced non-small cell lung cancer and developed pneumonitis post Sintilimab injection during COIVD-19 pandemic period."
      },
      {
        "text": "The chest CT indicated peripherally subpleural lattice opacities at the inferior right lung lobe and bilateral thoracic effusion."
      },
      {
        "text": "The swab samples were taken twice within 72 hours and real-time reverse-transcription polymerase-chain-reaction (RT-PCR) results were COVID-19 negative."
      },
      {
        "text": "The patient was thereafter treated with prednisolone and antibiotics for over 2 weeks."
      },
      {
        "text": "The suspicious lesion has almost absorbed according to CT imaging, consistent with prominently falling CRP level."
      },
      {
        "text": "The anti-PD-1 related pneumonitis mixed with bacterial infection was clinically diagnosed based on the laboratory and radiological evidences and good response to the prednisolone and antibiotics."
      },
      {
        "text": "CONCLUSION The anti-PD-1 related pneumonitis and COVID-19 pneumonia possess similar clinical presentations and CT imaging features."
      },
      {
        "text": "Therefore, differential diagnosis depends on the epidemiological and immunotherapy histories, RT-PCR tests."
      },
      {
        "text": "The response to glucocorticoid is still controversial but helpful for the diagnosis."
      }
    ]
  },
  "33521759": {
    "title": "Predictive Model and Risk Factors for Case Fatality of COVID-19: A Cohort of 21,392 Cases in Hubei, China.",
    "sentences": [
      {
        "text": "An increasing number of patients are being killed by coronavirus disease 2019 (COVID-19), however, risk factors for the fatality of COVID-19 remain unclear."
      },
      {
        "text": "A total of 21,392 COVID-19 cases were recruited in the Hubei Province of China between December 2019 and February 2020, and followed up until March 18, 2020."
      },
      {
        "text": "We adopted Cox regression models to investigate the risk factors for case fatality and predicted the death probability under specific combinations of key predictors."
      },
      {
        "text": "Among the 21,392 patients, 1,020 (4.77%) died of COVID-19."
      },
      {
        "text": "Multivariable analyses showed that factors, including age (â¥60 versus <45 years, hazard ratio [HR]Â = 7.32; 95% confidence interval [CI], 5.42, 9.89), sex (male versus female, HRÂ = 1.31; 95% CI, 1.15, 1.50), severity of the disease (critical versus mild, HRÂ = 39.98; 95% CI, 29.52, 48.86), comorbidity (HRÂ = 1.40; 95% CI, 1.23, 1.60), highest body temperature (>39Â°C versus <39Â°C, HRÂ = 1.28; 95% CI, 1.09, 1.49), white blood cell counts (>10Â Ã 109/L versus (4-10) Ã 109/L, HRÂ = 1.69; 95% CI, 1.35, 2.13), and lymphocyte counts (<0.8Â Ã 109/L versus (0.8-4) Ã 109/L, HRÂ = 1.26; 95% CI, 1.06, 1.50) were significantly associated with case fatality of COVID-19 patients."
      },
      {
        "text": "Individuals of an older age, who were male, with comorbidities, and had a critical illness had the highest death probability, with 21%, 36%, 46%, and 54% within 1-4Â weeks after the symptom onset."
      },
      {
        "text": "Risk factors, including demographic characteristics, clinical symptoms, and laboratory factors were confirmed to be important determinants of fatality of COVID-19."
      },
      {
        "text": "Our predictive model can provide scientific evidence for a more rational, evidence-driven allocation of scarce medical resources to reduce the fatality of COVID-19."
      }
    ]
  },
  "33521322": {
    "title": "Statins in patients with COVID-19: a retrospective cohort study in Iranian COVID-19 patients.",
    "sentences": [
      {
        "text": "Background The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has profoundly affected the lives of millions of people."
      },
      {
        "text": "To date, there is no approved vaccine or specific drug to prevent or treat COVID-19, while the infection is globally spreading at an alarming rate."
      },
      {
        "text": "Because the development of effective vaccines or novel drugs could take several months (if not years), repurposing existing drugs is considered a more efficient strategy that could save lives now."
      },
      {
        "text": "Statins constitute a class of lipid-lowering drugs with proven safety profiles and various known beneficial pleiotropic effects."
      },
      {
        "text": "Our previous investigations showed that statins have antiviral effects and are involved in the process of wound healing in the lung."
      },
      {
        "text": "This triggered us to evaluate if statin use reduces mortality in COVID-19 patients."
      },
      {
        "text": "Results After initial recruitment of 459 patients with COVID-19 (Shiraz province, Iran) and careful consideration of the exclusion criteria, a total of 150 patients, of which 75 received statins, were included in our retrospective study."
      },
      {
        "text": "Cox proportional-hazards regression models were used to estimate the association between statin use and rate of death."
      },
      {
        "text": "After propensity score matching, we found that statin use appeared to be associated with a lower risk of morbidity [HRâ=â0.85, 95% CIâ=â(0.02, 3.93), Pâ=â0.762] and lower risk of death [(HRâ=â0.76; 95% CIâ=â(0.16, 3.72), Pâ=â0.735)]; however, these associations did not reach statistical significance."
      },
      {
        "text": "Furthermore, statin use reduced the chance of being subjected to mechanical ventilation [ORâ=â0.96, 95% CIâ=â(0.61-2.99), Pâ=â0.942] and patients on statins showed a more normal computed tomography (CT) scan result [ORâ=â0.41, 95% CIâ=â(0.07-2.33), Pâ=â0.312]."
      },
      {
        "text": "Conclusions Although we could not demonstrate a significant association between statin use and a reduction in mortality in patients with COVID19, we do feel that our results are promising and of clinical relevance and warrant the need for prospective randomized controlled trials and extensive retrospective studies to further evaluate and validate the potential beneficial effects of statin treatment on clinical symptoms and mortality rates associated with COVID-19."
      }
    ]
  },
  "33521069": {
    "title": "Gene Expression Profiling Reveals the Shared and Distinct Transcriptional Signatures in Human Lung Epithelial Cells Infected With SARS-CoV-2, MERS-CoV, or SARS-CoV: Potential Implications in Cardiovascular Complications of COVID-19.",
    "sentences": [
      {
        "text": "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative virus for the current global pandemic known as coronavirus disease 2019 (COVID-19)."
      },
      {
        "text": "SARS-CoV-2 belongs to the family of single-stranded RNA viruses known as coronaviruses, including the MERS-CoV and SARS-CoV that cause Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS), respectively."
      },
      {
        "text": "These coronaviruses are associated in the way that they cause mild to severe upper respiratory tract illness."
      },
      {
        "text": "This study has used an unbiased analysis of publicly available gene expression datasets from Gene Expression Omnibus to understand the shared and unique transcriptional signatures of human lung epithelial cells infected with SARS-CoV-2 relative to MERS-CoV or SARS-CoV."
      },
      {
        "text": "A major goal was to discover unique cellular responses to SARS-CoV-2 among these three coronaviruses."
      },
      {
        "text": "Analyzing differentially expressed genes (DEGs) shared by the three datasets led to a set of 17 genes, suggesting the lower expression of genes related to acute inflammatory response (TNF, IL32, IL1A, CXCL1, and CXCL3) in SARS-CoV-2."
      },
      {
        "text": "This subdued transcriptional response to SARS-CoV-2 may cause prolonged viral replication, leading to severe lung damage."
      },
      {
        "text": "Downstream analysis of unique DEGs of SARS-CoV-2 infection revealed changes in genes related to apoptosis (NRP1, FOXO1, TP53INP1, CSF2, and NLRP1), coagulation (F3, PROS1, ITGB3, and TFPI2), and vascular function (VAV3, TYMP, TCF4, and NR2F2), which may contribute to more systemic cardiovascular complications of COVID-19 than MERS and SARS."
      },
      {
        "text": "The study has uncovered a novel set of transcriptomic signatures unique to SARS-CoV-2 infection and shared by three coronaviruses, which may guide the initial efforts in the development of prognostic or therapeutic tools for COVID-19."
      }
    ]
  },
  "33519443": {
    "title": "COVID-19 Incidence in Patients With Immunomediated Inflammatory Diseases: Influence of Immunosuppressant Treatments.",
    "sentences": [
      {
        "text": "The effect of immunosuppressant treatments on the incidence of coronavirus disease (COVID-19) remains largely unknown."
      },
      {
        "text": "We studied the association between the pre-exposure to disease-modifying antirheumatic drugs (DMARDs) that decrease immunological responses and the incidence of COVID-19 to explore the possible effects of these treatments in early manifestations of the disease."
      },
      {
        "text": "For this purpose, we performed a cross-sectional study including 2,494 patients with immunomediated inflammatory diseases (IMIDs) recruited at the outpatient Rheumatology, Dermatology and Gastroenterology services of Hospital del Mar."
      },
      {
        "text": "The primary outcome was the clinical diagnosis of COVID-19 performed by a physician at the hospital or at the primary care center, from the March 1-29, 2020."
      },
      {
        "text": "Multivariable Poisson regression models were fitted to estimate COVID-19 relative risk (RR) adjusted by comorbidities."
      },
      {
        "text": "We revealed that biological (RR = 0.46, CI 95% = 0.31-0.67) and synthetic (RR = 0.62, CI 95% = 0.43-0.91) DMARDs used in IMIDs diminished the incidence of COVID-19."
      },
      {
        "text": "Striking sex differences were revealed with anti-TNFÎ± compounds (RR = 0.50, CI 95% = 0.33-0.75) with higher effects in women (RR = 0.33, CI 95% = 0.17-0.647)."
      },
      {
        "text": "Treatment with low glucocorticoid doses also revealed sex differences decreasing the incidence of COVID-19 predominantly in women (RR = 0.72, CI 95% = 0.42-1.22)."
      },
      {
        "text": "Our results report a decreased incidence of COVID-19 in patients receiving specific DMARDs with different immunodepressor mechanisms with striking sex differences."
      },
      {
        "text": "These results underline the interest of repurposing specific DMARDs for the possibility of minimizing the severity of disease progression in the early stages of COVID-19."
      }
    ]
  },
  "33517358": {
    "title": "Repurposing approved drugs for cancer therapy.",
    "sentences": [
      {
        "text": "BACKGROUND Many drugs approved for other indications can control the growth of tumor cells and limit adverse events (AE)."
      },
      {
        "text": "DATA SOURCES Literature searches with keywords 'repurposing and cancer' books, websites: https://clinicaltrials.gov/, for drug structures: https://pubchem."
      },
      {
        "text": "ncbi."
      },
      {
        "text": "nlm."
      },
      {
        "text": "nih.gov/."
      },
      {
        "text": "AREAS OF AGREEMENT Introducing approved drugs, such as those developed to treat diabetes (Metformin) or inflammation (Thalidomide), identified to have cytostatic activity, can enhance chemotherapy or even replace more cytotoxic drugs."
      },
      {
        "text": "Also, anti-inflammatory compounds, cytokines and inhibitors of proteolysis can be used to control the side effects of chemo- and immuno-therapies or as second-line treatments for tumors resistant to kinase inhibitors (KI)."
      },
      {
        "text": "Drugs specifically developed for cancer therapy, such as interferons (IFN), the tyrosine KI abivertinib TKI (tyrosine kinase inhibitor) and interleukin-6 (IL-6) receptor inhibitors, may help control symptoms of Covid-19."
      },
      {
        "text": "AREAS OF CONTROVERSY Better knowledge of mechanisms of drug activities is essential for repurposing."
      },
      {
        "text": "Chemotherapies induce ER stress and enhance mutation rates and chromosome alterations, leading to resistance that cannot always be related to mutations in the target gene."
      },
      {
        "text": "Metformin, thalidomide and cytokines (IFN, tumor necrosis factor (TNF), interleukin-2 (IL-2) and others) have pleiomorphic activities, some of which can enhance tumorigenesis."
      },
      {
        "text": "The small and fragile patient pools available for clinical trials can cloud the data on the usefulness of cotreatments."
      },
      {
        "text": "GROWING POINTS Better understanding of drug metabolism and mechanisms should aid in repurposing drugs for primary, adjuvant and adjunct treatments."
      },
      {
        "text": "AREAS TIMELY FOR DEVELOPING RESEARCH Optimizing drug combinations, reducing cytotoxicity of chemotherapeutics and controlling associated inflammation."
      }
    ]
  },
  "33516277": {
    "title": "Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients.",
    "sentences": [
      {
        "text": "Virus-specific humoral and cellular immunity act synergistically to protect the host from viral infection."
      },
      {
        "text": "We interrogate the dynamic changes of virological and immunological parameters in 12 patients with symptomatic acute SARS-CoV-2 infection from disease onset to convalescence or death."
      },
      {
        "text": "We quantify SARS-CoV-2 viral RNA in the respiratory tract in parallel with antibodies and circulating TÂ cells specific for various structural (nucleoprotein [NP], membrane [M], ORF3a, and spike) and non-structural (ORF7/8, NSP7, and NSP13) proteins."
      },
      {
        "text": "Although rapid induction and quantity of humoral responses associate with an increase in disease severity, early induction of interferon (IFN)-Î³-secreting SARS-CoV-2-specific TÂ cells is present in patients with mild disease and accelerated viral clearance."
      },
      {
        "text": "These findings provide support for the prognostic value of early functional SARS-CoV-2-specific TÂ cells with important implications in vaccine design and immune monitoring."
      }
    ]
  },
  "33515606": {
    "title": "Dual inhibition of SARS-CoV-2 and human rhinovirus with protease inhibitors in clinical development.",
    "sentences": [
      {
        "text": "The 3-chymotrypsin-like cysteine protease (3CLpro) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is considered a major target for the discovery of direct antiviral agents."
      },
      {
        "text": "We previously reported the evaluation of SARS-CoV-2 3CLpro inhibitors in a novel self-assembled monolayer desorption ionization mass spectrometry (SAMDI-MS) enzymatic assay (Gurard-Levin et al."
      },
      {
        "text": ", 2020)."
      },
      {
        "text": "The assay was further improved by adding the rhinovirus HRV3C protease to the same well as the SARS-CoV-2 3CLpro enzyme."
      },
      {
        "text": "High substrate specificity for each enzyme allowed the proteases to be combined in a single assay reaction without interfering with their individual activities."
      },
      {
        "text": "This novel duplex assay was used to profile a diverse set of reference protease inhibitors."
      },
      {
        "text": "The protease inhibitors were grouped into three categories based on their relative potency against 3CLpro and HRV3C including those that are: equipotent against 3CLpro and HRV3C (GC376 and calpain inhibitor II), selective for 3CLpro (PF-00835231, calpain inhibitor XII, boceprevir), and selective for HRV3C (rupintrivir)."
      },
      {
        "text": "Structural analysis showed that the combination of minimal interactions, conformational flexibility, and limited bulk allows GC376 and calpain inhibitor II to potently inhibit both enzymes."
      },
      {
        "text": "In contrast, bulkier compounds interacting more tightly with pockets P2, P3, and P4 due to optimization for a specific target display a more selective inhibition profile."
      },
      {
        "text": "Consistently, the most selective viral protease inhibitors were relatively weak inhibitors of human cathepsin L. Taken together, these results can guide the design of cysteine protease inhibitors that are either virus-specific or retain a broad antiviral spectrum against coronaviruses and rhinoviruses."
      }
    ]
  },
  "33514427": {
    "title": "Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series.",
    "sentences": [
      {
        "text": "BACKGROUND Acute respiratory distress syndrome (ARDS) is a fatal complication of coronavirus disease 2019 (COVID-19)."
      },
      {
        "text": "There are a few reports of allogeneic human mesenchymal stem cells (MSCs) as a potential treatment for ARDS."
      },
      {
        "text": "In this phase 1 clinical trial, we present the safety, feasibility, and tolerability of the multiple infusions of high dose MSCs, which originated from the placenta and umbilical cord, in critically ill COVID-19-induced ARDS patients."
      },
      {
        "text": "METHODS A total of 11 patients diagnosed with COVID-19-induced ARDS who were admitted to the intensive care units (ICUs) of two hospitals enrolled in this study."
      },
      {
        "text": "The patients were critically ill with severe hypoxemia and required mechanical ventilation."
      },
      {
        "text": "The patients received three intravenous infusions (200âÃâ106 cells) every other day for a total of 600âÃâ106 human umbilical cord MSCs (UC-MSCs; 6 cases) or placental MSCs (PL-MSCs; 5 cases)."
      },
      {
        "text": "FINDINGS There were eight men and three women who were 42 to 66âyears of age."
      },
      {
        "text": "Of these, six (55%) patients had comorbidities of diabetes, hypertension, chronic lymphocytic leukemia (CLL), and cardiomyopathy (CMP)."
      },
      {
        "text": "There were no serious adverse events reported 24-48âh after the cell infusions."
      },
      {
        "text": "We observed reduced dyspnea and increased SpO2 within 48-96âh after the first infusion in seven patients."
      },
      {
        "text": "Of these seven patients, five were discharged from the ICU within 2-7âdays (average: 4âdays), one patient who had signs of acute renal and hepatic failure was discharged from the ICU on day 18, and the last patient suddenly developed cardiac arrest on day 7 of the cell infusion."
      },
      {
        "text": "Significant reductions in serum levels of tumor necrosis factor-alpha (TNF-Î±; Pâ<â0.01), IL-8 (Pâ<â0.05), and C-reactive protein (CRP) (Pâ<â0.01) were seen in all six survivors."
      },
      {
        "text": "IL-6 levels decreased in five (Pâ=â0.06) patients and interferon gamma (IFN-Î³) levels decreased in four (Pâ=â0.14) patients."
      },
      {
        "text": "Four patients who had signs of multi-organ failure or sepsis died in 5-19âdays (average: 10âdays) after the first MSC infusion."
      },
      {
        "text": "A low percentage of lymphocytes (<â10%) and leukocytosis were associated with poor outcome (Pâ=â0.02)."
      },
      {
        "text": "All six survivors were well with no complaints of dyspnea on day 60 post-infusion."
      },
      {
        "text": "Radiological parameters of the lung computed tomography (CT) scans showed remarkable signs of recovery."
      },
      {
        "text": "INTERPRETATION We suggest that multiple infusions of high dose allogeneic prenatal MSCs are safe and can rapidly improve respiratory distress and reduce inflammatory biomarkers in some critically ill COVID-19-induced ARDS cases."
      },
      {
        "text": "Patients that develop sepsis or multi-organ failure may not be good candidates for stem cell therapy."
      },
      {
        "text": "Large randomized multicenter clinical trials are needed to discern the exact therapeutic potentials of MSC in COVID-19-induced ARDS."
      }
    ]
  },
  "33514373": {
    "title": "Tracking the time course of pathological patterns of lung injury in severe COVID-19.",
    "sentences": [
      {
        "text": "BACKGROUND Pulmonary involvement in COVID-19 is characterized pathologically by diffuse alveolar damage (DAD) and thrombosis, leading to the clinical picture of Acute Respiratory Distress Syndrome."
      },
      {
        "text": "The direct action of SARS-CoV-2 in lung cells and the dysregulated immuno-coagulative pathways activated in ARDS influence pulmonary involvement in severe COVID, that might be modulated by disease duration and individual factors."
      },
      {
        "text": "In this study we assessed the proportions of different lung pathology patterns in severe COVID-19 patients along the disease evolution and individual characteristics."
      },
      {
        "text": "METHODS We analysed lung tissue from 41 COVID-19 patients that died in the period March-June 2020 and were submitted to a minimally invasive autopsy."
      },
      {
        "text": "Eight pulmonary regions were sampled."
      },
      {
        "text": "Pulmonary pathologists analysed the H&E stained slides, performing semiquantitative scores on the following parameters: exudative, intermediate or advanced DAD, bronchopneumonia, alveolar haemorrhage, infarct (%), arteriolar (number) or capillary thrombosis (yes/no)."
      },
      {
        "text": "Histopathological data were correlated with demographic-clinical variables and periods of symptoms-hospital stay."
      },
      {
        "text": "RESULTS PatientÂ´s age varied from 22 to 88Â years (18f/23Â m), with hospital admission varying from 0 to 40Â days."
      },
      {
        "text": "All patients had different proportions of DAD in their biopsies."
      },
      {
        "text": "Ninety percent of the patients presented pulmonary microthrombosis."
      },
      {
        "text": "The proportion of exudative DAD was higher in the period 0-8Â days of hospital admission till death, whereas advanced DAD was higher after 17Â days of hospital admission."
      },
      {
        "text": "In the group of patients that died within eight days of hospital admission, elderly patients had less proportion of the exudative pattern and increased proportions of the intermediate patterns."
      },
      {
        "text": "Obese patients had lower proportion of advanced DAD pattern in their biopsies, and lower than patients with overweight."
      },
      {
        "text": "Clustering analysis showed that patterns of vascular lesions (microthrombosis, infarction) clustered together, but not the other patterns."
      },
      {
        "text": "The vascular pattern was not influenced by demographic or clinical parameters, including time of disease progression."
      },
      {
        "text": "CONCLUSION Patients with severe COVID-19 present different proportions of DAD patterns over time, with advanced DAD being more prevalent after 17Â days, which seems to be influenced by age and weight."
      },
      {
        "text": "Vascular involvement is present in a large proportion of patients, occurs early in disease progression, and does not change over time."
      }
    ]
  },
  "33513400": {
    "title": "Cardiovascular protective properties of oxytocin against COVID-19.",
    "sentences": [
      {
        "text": "SARS-CoV-2 infection or COVID-19 has become a worldwide pandemic; however, effective treatment for COVID-19 remains to be established."
      },
      {
        "text": "Along with acute respiratory distress syndrome (ARDS), new and old cardiovascular injuries are important causes of significant morbidity and mortality in COVID-19."
      },
      {
        "text": "Exploring new approaches managing cardiovascular complications is essential in controlling the disease progression and preventing long-term complications."
      },
      {
        "text": "Oxytocin (OXT), an immune-regulating neuropeptide, has recently emerged as a strong candidate for treatment and prevention of COVID-19 pandemic."
      },
      {
        "text": "OXT carries special functions in immunologic defense, homeostasis and surveillance."
      },
      {
        "text": "It suppresses neutrophil infiltration and inflammatory cytokine release, activates T-lymphocytes, and antagonizes negative effects of angiotensin II and other key pathological events of COVID-19."
      },
      {
        "text": "Additionally, OXT can promote Î³-interferon expression to inhibit cathepsin L and increases superoxide dismutase expression to reduce heparin and heparan sulphate fragmentation."
      },
      {
        "text": "Through these mechanisms, OXT can block viral invasion, suppress cytokine storm, reverse lymphocytopenia, and prevent progression to ARDS and multiple organ failures."
      },
      {
        "text": "Importantly, besides prevention of metabolic disorders associated with atherosclerosis and diabetes mellitus, OXT can protect the heart and vasculature through suppressing hypertension and brain-heart syndrome, and promoting regeneration of injured cardiomyocytes."
      },
      {
        "text": "Unlike other therapeutic agents, exogenous OXT can be used safely without the side-effects seen in remdesivir and corticosteroid."
      },
      {
        "text": "Importantly, OXT can be mobilized endogenously to prevent pathogenesis of COVID-19."
      },
      {
        "text": "This article summarizes our current understandings of cardiovascular pathogenesis caused by COVID-19, explores the protective potentials of OXT against COVID-19-associated cardiovascular diseases, and discusses challenges in applying OXT in treatment and prevention of COVID-19."
      },
      {
        "text": "CHEMICAL COMPOUNDS: Angiotensin-converting enzyme 2 (ACE2); atrial natriuretic peptide (ANP); cathepsin L; heparan sulphate proteoglycans (HSPGs); interferon; interleukin; oxytocin; superoxide dismutase; transmembrane serine protease isoform 2 (TMPRSS2)."
      }
    ]
  },
  "33511147": {
    "title": "Down-Regulation of Colonic ACE2 Expression in Patients With Inflammatory Bowel Disease Responding to Anti-TNF Therapy: Implications for COVID-19.",
    "sentences": [
      {
        "text": "Background and Aims: Angiotensin-converting enzyme II (ACE2) is the key molecule for understanding the pathophysiology of COVID-19."
      },
      {
        "text": "The risk of COVID-19 and impact of immunosuppressive treatment on disease course in patients with inflammatory bowel disease (IBD) remain controversial."
      },
      {
        "text": "We aimed to determine the change of intestinal ACE2 expression before and after biologics treatment including anti-tumor necrosis factor Î± (anti-TNFÎ±), anti-integrin, and anti-interleukin (IL)12/23 in IBD patients."
      },
      {
        "text": "Methods: We analyzed the ACE2 expression through the public database of paired intestinal biopsies from IBD patients before and after biologic therapy."
      },
      {
        "text": "Change of ACE2 RNA and protein expression were validated in two independent cohorts (Birmingham cohort and Guangzhou cohort)."
      },
      {
        "text": "The correlation between ACE2 expression and disease activity was also analyzed."
      },
      {
        "text": "Results: Mining information from the GEO database showed that compared with healthy control, intestinal ACE2 expression was downregulated in ileum of CD patients, while upregulated in colon of both CD and UC patients."
      },
      {
        "text": "Colonic ACE2 RNA expression was decreased significantly in patients responding to anti-TNFÎ± but not anti-integrin and anti-IL12/23, which was validated in the Birmingham cohort."
      },
      {
        "text": "Using the Guangzhou cohort including 53 patients matched by pre- and post-anti-TNFÎ± therapy, colonic ACE2 protein expression was significantly downregulated after anti-TNFÎ± treatment in responders (P < 0.001) rather than non-responders."
      },
      {
        "text": "Colonic ACE2 expression was significantly higher in patients with severe histologically active disease compared with those with moderate (P < 0.0001) and mild (P = 0.0002) histologically active disease."
      },
      {
        "text": "Conclusion: Intestinal inflammation influences the expression of intestinal ACE2 in IBD patients, with different alterations in the ileum and colon."
      },
      {
        "text": "Colonic ACE2 expression was downregulated after anti-TNFÎ± therapy in IBD patients responding to treatment."
      },
      {
        "text": "This might provide new clues regarding the risk of SARS-CoV-2 infection and the potential benefit of sustaining anti-TNFÎ± treatment in patients with IBD."
      }
    ]
  },
  "33510902": {
    "title": "Development of acute kidney injury with massive granular casts and microscopic hematuria in patients with COVID-19: two case presentations with literature review.",
    "sentences": [
      {
        "text": "Background Complications of acute kidney injury (AKI) are common in patients with coronavirus disease in 2019 (COVID-19)."
      },
      {
        "text": "However, clinical characteristics of COVID-19-associated AKI are poorly described."
      },
      {
        "text": "We present two cases of severe COVID-19 patients with AKI."
      },
      {
        "text": "Case presentation A 77-year-old woman was suspected of having vancomycin-associated AKI, and a 45-year-old man was suspected of having heme pigment-induced AKI caused by rhabdomyolysis."
      },
      {
        "text": "The granular cast, which is known to be a valuable diagnostic tool for confirming the diagnosis of acute tubular necrosis, was detected in both patients at the onset of AKI."
      },
      {
        "text": "Interestingly, both patients also developed microscopic hematuria at the occurrence of AKI, and one patient had elevated d-dimer and low platelet levels simultaneously."
      },
      {
        "text": "Conclusions Some reports suggested that COVID-19-associated microangiopathy contributed to the kidney damage."
      },
      {
        "text": "Therefore, it is possible that our patients might have accompanied renal microangiopathy, and that this pathological background may have caused exaggerated tubular damage by vancomycin or heme pigment."
      },
      {
        "text": "The etiology of AKI in patients with COVID-19 is multifactorial."
      },
      {
        "text": "Superimposition of nephrotoxin(s) and virus-associate intra-renal microangiopathy may be a crucial trigger of kidney injury leading to severe AKI in COVID-19 patients."
      },
      {
        "text": "Therefore, in COVID-19 patients, risk factors for AKI should be taken into consideration to prevent its progression into severe AKI."
      }
    ]
  },
  "33510633": {
    "title": "Impact of COVID-19 on Mitochondrial-Based Immunity in Aging and Age-Related Diseases.",
    "sentences": [
      {
        "text": "The coronavirus disease 2019 (COVID-19) has become a deadly pandemic with surging mortality rates and no cure."
      },
      {
        "text": "COVID-19 is caused by the severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) with a range of clinical symptoms, including cough, fever, chills, headache, shortness of breath, difficulty breathing, muscle pain, and a loss of smell or taste."
      },
      {
        "text": "Aged individuals with compromised immunity are highly susceptible to COVID-19 and the likelihood of mortality increases with age and the presence of comorbidities such as hypertension, diabetes mellitus, cardiovascular disease, or chronic obstructive pulmonary disease."
      },
      {
        "text": "Emerging evidence suggests that COVID-19 highjacks mitochondria of immune cells, replicates within mitochondrial structures, and impairs mitochondrial dynamics leading to cell death."
      },
      {
        "text": "Mitochondria are the powerhouses of the cell and are largely involved in maintaining cell immunity, homeostasis, and cell survival/death."
      },
      {
        "text": "Increasing evidence suggests that mitochondria from COVID-19 infected cells are highly vulnerable, and vulnerability increases with age."
      },
      {
        "text": "The purpose of our article is to summarize the role of various age-related comorbidities such as diabetes, obesity, and neurological diseases in increasing mortality rates amongst the elderly with COVID-19."
      },
      {
        "text": "Our article also highlights the interaction between coronavirus and mitochondrial dynamics in immune cells."
      },
      {
        "text": "We also highlight the current treatments, lifestyles, and safety measures that can help protect against COVID-19."
      },
      {
        "text": "Further research is urgently needed to understand the molecular mechanisms between the mitochondrial virus and disease progression in COVID-19 patients."
      }
    ]
  },
  "33513204": {
    "title": "The differential impact of pediatric COVID-19 between high-income countries and low- and middle-income countries: A systematic review of fatality and ICU admission in children worldwide.",
    "sentences": [
      {
        "text": "BACKGROUND The overall global impact of COVID-19 in children and regional variability in pediatric outcomes are presently unknown."
      },
      {
        "text": "METHODS To evaluate the magnitude of global COVID-19 death and intensive care unit (ICU) admission in children aged 0-19 years, a systematic review was conducted for articles and national reports as of December 7, 2020."
      },
      {
        "text": "This systematic review is registered with PROSPERO (registration number: CRD42020179696)."
      },
      {
        "text": "RESULTS We reviewed 16,027 articles as well as 225 national reports from 216 countries."
      },
      {
        "text": "Among the 3,788 global pediatric COVID-19 deaths, 3,394 (91.5%) deaths were reported from low- and middle-income countries (LMIC), while 83.5% of pediatric population from all included countries were from LMIC."
      },
      {
        "text": "The pediatric deaths/1,000,000 children and case fatality rate (CFR) were significantly higher in LMIC than in high-income countries (HIC) (2.77 in LMIC vs 1.32 in HIC; p < 0.001 and 0.24% in LMIC vs 0.01% in HIC; p < 0.001, respectively)."
      },
      {
        "text": "The ICU admission/1,000,000 children was 18.80 and 1.48 in HIC and LMIC, respectively (p < 0.001)."
      },
      {
        "text": "The highest deaths/1,000,000 children and CFR were in infants < 1 year old (10.03 and 0.58% in the world, 5.39 and 0.07% in HIC and 10.98 and 1.30% in LMIC, respectively)."
      },
      {
        "text": "CONCLUSIONS The study highlights that there may be a larger impact of pediatric COVID-19 fatality in LMICs compared to HICs."
      }
    ]
  },
  "33512610": {
    "title": "Apoptosis induced by SARS-CoV-2: can we target it?",
    "sentences": [
      {
        "text": "Some viruses are known to be associated with increased apoptosis."
      },
      {
        "text": "Apoptotic cell death triggered by these viruses has a complex role in host antiviral immunity, and might facilitate the viral clearance or act as a mechanism for virus-induced tissue injury and disease progression."
      },
      {
        "text": "The induction of apoptosis is a hallmark of SARS-CoV-2 infection."
      },
      {
        "text": "Accumulating evidence suggests that there is a direct relationship between apoptosis rate and COVID-19 pathogenicity/severity."
      },
      {
        "text": "Targeting virus-induced apoptosis could be a promising strategy in the treatment of SARS-CoV-2 virus infection."
      }
    ]
  },
  "33512415": {
    "title": "Antibody-induced procoagulant platelets in severe COVID-19 infection.",
    "sentences": [
      {
        "text": "The pathophysiology of COVID-19-associated thrombosis seems to be multifactorial."
      },
      {
        "text": "We hypothesized that COVID-19 is accompanied by procoagulant platelets with subsequent alteration of the coagulation system."
      },
      {
        "text": "We investigated depolarization of mitochondrial inner transmembrane potential (ÎÎ¨m), cytosolic calcium (Ca2+) concentration, and phosphatidylserine (PS) externalization."
      },
      {
        "text": "Platelets from COVID-19 patients in the intensive care unit (ICU; n = 21) showed higher ÎÎ¨m depolarization, cytosolic Ca2+, and PS externalization compared with healthy controls (n = 18) and non-ICU COVID-19 patients (n = 4)."
      },
      {
        "text": "Moreover, significant higher cytosolic Ca2+ and PS were observed compared with a septic ICU control group (ICU control; n = 5)."
      },
      {
        "text": "In the ICU control group, cytosolic Ca2+ and PS externalization were comparable with healthy controls, with an increase in ÎÎ¨m depolarization."
      },
      {
        "text": "Sera from COVID-19 patients in the ICU induced a significant increase in apoptosis markers (ÎÎ¨m depolarization, cytosolic Ca2+, and PS externalization) compared with healthy volunteers and septic ICU controls."
      },
      {
        "text": "Interestingly, immunoglobulin G fractions from COVID-19 patients induced an FcÎ³ receptor IIA-dependent platelet apoptosis (ÎÎ¨m depolarization, cytosolic Ca2+, and PS externalization)."
      },
      {
        "text": "Enhanced PS externalization in platelets from COVID-19 patients in the ICU was associated with increased sequential organ failure assessment score (r = 0.5635) and D-dimer (r = 0.4473)."
      },
      {
        "text": "Most importantly, patients with thrombosis had significantly higher PS externalization compared with those without."
      },
      {
        "text": "The strong correlations between markers for apoptosic and procoagulant platelets and D-dimer levels, as well as the incidence of thrombosis, may indicate that antibody-mediated procoagulant platelets potentially contributes to sustained increased thromboembolic risk in ICU COVID-19 patients."
      }
    ]
  },
  "33511519": {
    "title": "Mesenchymal Stem Cell-Derived Extracellular Vesicles Carrying miRNA as a Potential Multi Target Therapy to COVID-19: an In Silico Analysis.",
    "sentences": [
      {
        "text": "In the end of 2019 COVID-19 emerged as a new threat worldwide and this disease present impaired immune system, exacerbated production of inflammatory cytokines, and coagulation disturbs."
      },
      {
        "text": "Mesenchymal stem cell (MSC) derived extracellular vesicles (EVs) have emerged as a therapeutic option due to its intrinsic properties to alleviate inflammatory responses, capable to promote the restoring of injured tissue."
      },
      {
        "text": "EVs contain heterogeneous cargo, including active microRNAs, small noncoding sequences involved in post-transcriptional gene repression or degradation and can attach in multiple targets."
      },
      {
        "text": "This study investigated whether the MSC-EVs miRNA cargo has the capacity to modulate the exacerbated cytokines, cell death and coagulation disturbs present in severe COVID-19."
      },
      {
        "text": "Through bioinformatics analysis, four datasets of miRNA, using different stem cell tissue sources (bone marrow, umbilical cord and adipose tissue), and one dataset of mRNA (bone marrow) were analyzed."
      },
      {
        "text": "58 miRNAs overlap in the four miRNA datasets analyzed."
      },
      {
        "text": "Sequentially, those miRNAs present in at least two datasets, were analyzed using miRWalk for the 3'UTR binding target mRNA."
      },
      {
        "text": "The result predicted 258 miRNAs for exacerbated cytokines and chemokines, 266 miRNAs for cell death genes and 148 miRNAs for coagulation cascades."
      },
      {
        "text": "Some miRNAs may simultaneously attenuate inflammatory agents, inhibit cell death genes and key factors of coagulation cascade, consequently preventing tissue damage and coagulation disturbs."
      },
      {
        "text": "Therefore, the MSC-derived EVs due to their heterogeneous cargo are a potential multitarget approach able to improve the survival rates of severe COVID-19 patients."
      }
    ]
  },
  "33510041": {
    "title": "High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV Brasil registry.",
    "sentences": [
      {
        "text": "OBJECTIVES To evaluate risk factors associated with unfavourable outcomes: emergency care, hospitalisation, admission to intensive care unit (ICU), mechanical ventilation and death in patients with immune-mediated rheumatic disease (IMRD) and COVID-19."
      },
      {
        "text": "METHODS Analysis of the first 8âweeks of observational multicentre prospective cohort study (ReumaCoV Brasil register)."
      },
      {
        "text": "Patients with IMRD and COVID-19 according to the Ministry of Health criteria were classified as eligible for the study."
      },
      {
        "text": "RESULTS 334 participants were enrolled, a majority of them women, with a median age of 45 years; systemic lupus erythematosus (32.9%) was the most frequent IMRD."
      },
      {
        "text": "Emergency care was required in 160 patients, 33.0% were hospitalised, 15.0% were admitted to the ICU and 10.5% underwent mechanical ventilation; 28 patients (8.4%) died."
      },
      {
        "text": "In the multivariate adjustment model for emergency care, diabetes (prevalence ratio, PR 1.38; 95%âCI 1.11 to 1.73; p=0.004), kidney disease (PR 1.36; 95%âCI 1.05 to 1.77; p=0.020), oral glucocorticoids (GC) (PR 1.49; 95%âCI 1.21 to 1.85; p<0.001) and pulse therapy with methylprednisolone (PR 1.38; 95%âCI 1.14 to 1.67; p=0.001) remained significant; for hospitalisation, age >50 years (PR 1.89; 95%âCI 1.26 to 2.85; p=0.002), no use of tumour necrosis factor inhibitor (TNFi) (PR 2.51;95%âCI 1.16 to 5.45; p=0.004) and methylprednisolone pulse therapy (PR 2.50; 95%âCI 1.59 to 3.92; p<0.001); for ICU admission, oral GC (PR 2.24; 95%âCI 1.36 to 3.71; p<0.001) and pulse therapy with methylprednisolone (PR 1.65; 95%âCI 1.00 to 2.68; p<0.043); the two variables associated with death were pulse therapy with methylprednisolone or cyclophosphamide (PR 2.86; 95%âCI 1.59 to 5.14; p<0.018)."
      },
      {
        "text": "CONCLUSIONS Age >50 years and immunosuppression with GC and cyclophosphamide were associated with unfavourable outcomes of COVID-19."
      },
      {
        "text": "Treatment with TNFi may have been protective, perhaps leading to the COVID-19 inflammatory process."
      }
    ]
  },
  "33509253": {
    "title": "Analysis of chicken macrophage functions and gene expressions following infectious bronchitis virus M41 infection.",
    "sentences": [
      {
        "text": "Infectious bronchitis virus (IBV) is a pathogenic coronavirus with high morbidity and mortality in chicken breeding."
      },
      {
        "text": "Macrophages with normal biofunctions are essential for host immune responses."
      },
      {
        "text": "In this study, the HD11 chicken macrophage cell line and chicken peripheral blood mononuclear cell-derived macrophages (PBMCs-MÏ) were infected with IBV at multiplicity of infection (MOI) of 10."
      },
      {
        "text": "The dynamic changes of their biofunctions, including cell viability, pathogen elimination function, phagocytic ability, and gene expressions of related proteins/mediators in innate and acquired immunity, inflammation, autophagy and apoptosis were analyzed."
      },
      {
        "text": "Results showed that IBV infection decreased chicken macrophage viability and phagocytic ability, and increased pathogen elimination function."
      },
      {
        "text": "Moreover, IBV augmented the gene expressions of most related proteins in macrophages involved in multiple host bioprocesses, and the dynamic changes of gene expressions had a close relationship with virus replication."
      },
      {
        "text": "Among them, MHCII, Fc receptor, TLR3, IFN-Î±, CCL4, MIF, IL-1Î², IL-6, and iNOS showed significantly higher expressions in IBV-infected cells."
      },
      {
        "text": "However, TLR7, MyD88, MDA5, IFN-Î³, MHCII, Fc receptor, MARCO, CD36, MIF, XCL1, CXCL12, TNF-Î±, iNOS, and IL-10 showed early decreased expressions."
      },
      {
        "text": "Overall, chicken macrophages play an important role in host innate and acquired immune responses to resist IBV infection, despite early damage or suppression."
      },
      {
        "text": "Moreover, the IBV-induced autophagy and apoptosis might participate in the virus-host cell interaction which is attributed to the biological process."
      }
    ]
  },
  "33508291": {
    "title": "SARS-CoV-2 infection: The role of PD-1/PD-L1 and CTLA-4 axis.",
    "sentences": [
      {
        "text": "The outbreak of SARS-CoV-2 in Wuhan of China in December 2019 and its worldwide spread has turned into the COVID-19 pandemic."
      },
      {
        "text": "Respiratory disorders, lymphopenia, cytokine cascades, and the immune responses provoked by this virus play a major and fundamental role in the severity of the symptoms and the immunogenicity which it causes."
      },
      {
        "text": "Owing to the decrease in the inflammatory responses' regulation in the immune system and the sudden increase in the secretion of cytokines, it seems that an investigation of inhibitory immune checkpoints can influence theories regarding this disease's treatment methods."
      },
      {
        "text": "Acquired cell-mediated immune defense's T-cells have a key major contribution in clearing viral infections thus reducing the severity of COVID-19's symptoms."
      },
      {
        "text": "The most important diagnostic feature in individuals with COVID-19 is lymphocyte depletion, most importantly, T-cells."
      },
      {
        "text": "Due to the induction of interferon-Î³ (INF-Î³) production by neutrophils and monocytes, which are abundantly present in the peripheral blood of the individuals with COVID-19, the expression of inhibitory immune checkpoints including, PD-1 (programmed death), PD-L1 and CTLA4 on the T-cells' surface is enhanced."
      },
      {
        "text": "The purpose of this review is to discuss the functions of these checkpoints and their effects on the dysfunction and exhaustion of T-cells, making them almost ineffective in individuals with COVID-19, especially in the cases with extreme symptoms."
      }
    ]
  },
  "33506741": {
    "title": "Structural similarity-based prediction of host factors associated with SARS-CoV-2 infection and pathogenesis.",
    "sentences": [
      {
        "text": "The current pandemic resulted from SARS-CoV-2 still remains as the major public health concern globally."
      },
      {
        "text": "The precise mechanism of viral pathogenesis is not fully understood, which remains a major hurdle for medical intervention."
      },
      {
        "text": "Here we generated an interactome profile of protein-protein interactions based on host and viral protein structural similarities information."
      },
      {
        "text": "Further computational biological study combined with Gene enrichment analysis predicted key enriched pathways associated with viral pathogenesis."
      },
      {
        "text": "The results show that axon guidance, membrane trafficking, vesicle-mediated transport, apoptosis, clathrin-mediated endocytosis, Vpu mediated degradation of CD4 T cell, and interferon-gamma signaling are key events associated in SARS-CoV-2 life cycle."
      },
      {
        "text": "Further, degree centrality analysis reveals that IRF1/9/7, TP53, and CASP3, UBA52, and UBC are vital proteins for IFN-Î³-mediated signaling, apoptosis, and proteasomal degradation of CD4, respectively."
      },
      {
        "text": "We crafted chronological events of the virus life cycle."
      },
      {
        "text": "The SARS-CoV-2 enters through clathrin-mediated endocytosis, and the genome is trafficked to the early endosomes in a RAB5-dependent manner."
      },
      {
        "text": "It is predicted to replicate in a double-membrane vesicle (DMV) composed of the endoplasmic reticulum, autophagosome, and ERAD machinery."
      },
      {
        "text": "The SARS-CoV-2 down-regulates host translational machinery by interacting with protein kinase R, PKR-like endoplasmic reticulum kinase, and heme-regulated inhibitor and can phosphorylate eIF2a."
      },
      {
        "text": "The virion assembly occurs in the ER-Golgi intermediate compartment (ERGIC) organized by the spike and matrix protein."
      },
      {
        "text": "Collectively, we have established a spatial link between viral entry, RNA synthesis, assembly, pathogenesis, and their associated diverse host factors, those could pave the way for therapeutic intervention."
      }
    ]
  },
  "33505866": {
    "title": "Covid-19 and Confinement: Effect on Weight Load, Physical Activity and Eating Behavior of Higher Education Students in Southern Morocco.",
    "sentences": [
      {
        "text": "Background Pandemic confinement of COVID-19 may influence dietary behaviors and physical activity, and increases the risk of stress, especially among adolescents."
      },
      {
        "text": "This increases the subsequent risk of degenerative diseases such as obesity, diabetes, cardiovascular disease, etc."
      },
      {
        "text": ", which can lead to a higher risk of death."
      },
      {
        "text": "This study aims to evaluate the effect of confinement on the weight load, physical activity and dietary behavior of higher education students during the period of confinement."
      },
      {
        "text": "Methods Data was collected by an anonymous online questionnaire with 406 students."
      },
      {
        "text": "Physical activity was evaluated with the International Physical Activity Questionnaire."
      },
      {
        "text": "A reference score of the National Nutrition and Health Program (PNNS-GS) was used to determine the dietary habits."
      },
      {
        "text": "Stress appreciation was assessed by using a psychological instrument known as the \"Perceived Stress Scale\" provided by Mind Garden."
      },
      {
        "text": "Results More than a quarter of the students were overweight or obese."
      },
      {
        "text": "During the confinement of COVID-19, most of the students suffered from nutritional disorders, only one-third were moderately physically active, and the majority of students were at risk of stress."
      },
      {
        "text": "Multivariate analysis showed that the concept of threat of Stress increases the risk of weight gain at a risk level of 2.4 [95% CI 1.09-5.43], low physical activity increases the risk level to 1.9 [95% CI 1.18-3.04]."
      },
      {
        "text": "However, a balanced diet is protective against the occurrence of weight gain (ORa = 0.30, [95% CI 0.15-0.61])."
      },
      {
        "text": "Conclusion The study showed that confinement appeared to contribute to weight gain and those students were more sedentary than active with unhealthy eating behaviors."
      },
      {
        "text": "Understanding these behaviors during COVID-19 confinement will help public health authorities implement future policies on recommendations when new pandemics arrive and confinement policies are implemented."
      }
    ]
  },
  "33505145": {
    "title": "High prevalence of hepatic steatosis and vascular thrombosis in COVID-19: A systematic review and meta-analysis of autopsy data.",
    "sentences": [
      {
        "text": "BACKGROUND Coronavirus disease 2019 (COVID-19) disease can frequently affect the liver."
      },
      {
        "text": "Data on hepatic histopathological findings in COVID-19 is scarce."
      },
      {
        "text": "AIM To characterize hepatic pathological findings in patients with COVID-19."
      },
      {
        "text": "METHODS We conducted a systematic review with meta-analysis registered on PROSPERO (CRD42020192813), following PRISMA guidelines."
      },
      {
        "text": "Eligible trials were those including patients of any age and COVID-19 diagnosis based on a molecular test."
      },
      {
        "text": "Histopathological reports from deceased COVID-19 patients undergoing autopsy or liver biopsy were reviewed."
      },
      {
        "text": "Articles including less than ten patients were excluded."
      },
      {
        "text": "Proportions were pooled using random-effects models."
      },
      {
        "text": "Q statistic and I2 were used to assess heterogeneity and levels of evidence, respectively."
      },
      {
        "text": "RESULTS We identified 18 studies from 7 countries; all were case reports and case series from autopsies."
      },
      {
        "text": "All the patients were over 15 years old, and 67.2% were male."
      },
      {
        "text": "We performed a meta-analysis of 5 studies, including 116 patients."
      },
      {
        "text": "Pooled prevalence estimates of liver histopathological findings were hepatic steatosis 55.1% [95% confidence interval (CI): 46.2-63.8], congestion of hepatic sinuses 34.7% (95%CI: 7.9-68.4), vascular thrombosis 29.4% (95%CI: 0.4-87.2), fibrosis 20.5% (95%CI: 0.6-57.9), Kupffer cell hyperplasia 13.5% (95%CI: 0.6-54.3), portal inflammation 13.2% (95%CI: 0.1-48.8), and lobular inflammation 11.6% (95%CI: 0.3-35.7)."
      },
      {
        "text": "We also identified the presence of venous outflow obstruction, phlebosclerosis of the portal vein, herniated portal vein, periportal abnormal vessels, hemophagocytosis, and necrosis."
      },
      {
        "text": "CONCLUSION We found a high prevalence of hepatic steatosis and vascular thrombosis as major histological liver features."
      },
      {
        "text": "Other frequent findings included portal and lobular inflammation and Kupffer cell hyperplasia or proliferation."
      },
      {
        "text": "Further studies are needed to establish the mechanisms and implications of these findings."
      }
    ]
  },
  "33504824": {
    "title": "Altered high-density lipoprotein composition and functions during severe COVID-19.",
    "sentences": [
      {
        "text": "Coronavirus disease 2019 (COVID-19) pandemic is affecting millions of patients worldwide."
      },
      {
        "text": "The consequences of initial exposure to SARS-CoV-2 go beyond pulmonary damage, with a particular impact on lipid metabolism."
      },
      {
        "text": "Decreased levels in HDL-C were reported in COVID-19 patients."
      },
      {
        "text": "Since HDL particles display antioxidant, anti-inflammatory and potential anti-infectious properties, we aimed at characterizing HDL proteome and functionality during COVID-19 relative to healthy subjects."
      },
      {
        "text": "HDLs were isolated from plasma of 8 severe COVID-19 patients sampled at admission to intensive care unit (Day 1, D1) at D3 and D7, and from 16 sex- and age-matched healthy subjects."
      },
      {
        "text": "Proteomic analysis was performed by LC-MS/MS."
      },
      {
        "text": "The relative amounts of proteins identified in HDLs were compared between COVID-19 and controls."
      },
      {
        "text": "apolipoprotein A-I and paraoxonase 1 were confirmed by Western-blot analysis to be less abundant in COVID-19 versus controls, whereas serum amyloid A and alpha-1 antitrypsin were higher."
      },
      {
        "text": "HDLs from patients were less protective in endothelial cells stiumalted by TNFÎ± (permeability, VE-cadherin disorganization and apoptosis)."
      },
      {
        "text": "In these conditions, HDL inhibition of apoptosis was blunted in COVID-19 relative to controls."
      },
      {
        "text": "In conclusion, we show major changes in HDL proteome and decreased functionality in severe COVID-19 patients."
      }
    ]
  },
  "33504682": {
    "title": "Differential Signaling and Virus Production in Calu-3 Cells and Vero Cells upon SARS-CoV-2 Infection.",
    "sentences": [
      {
        "text": "Severe acute respiratory syndrome CoV-2 (SARS-CoV-2) is responsible for the current coronavirus disease 2019 (COVID-19) pandemic."
      },
      {
        "text": "Signaling pathways that are essential for virus production have potential as therapeutic targets against COVID-19."
      },
      {
        "text": "In this study, we investigated cellular responses in two cell lines, Vero and Calu-3, upon SARS-CoV-2 infection and evaluated the effects of pathway-specific inhibitors on virus production."
      },
      {
        "text": "SARS-CoV-2 infection induced dephosphorylation of STAT1 and STAT3, high virus production, and apoptosis in Vero cells."
      },
      {
        "text": "However, in Calu-3 cells, SARS-CoV-2 infection induced long-lasting phosphorylation of STAT1 and STAT3, low virus production, and no prominent apoptosis."
      },
      {
        "text": "Inhibitors that target STAT3 phosphorylation and dimerization reduced SARS-CoV-2 production in Calu-3 cells, but not in Vero cells."
      },
      {
        "text": "These results suggest a necessity to evaluate cellular consequences upon SARS-CoV-2 infection using various model cell lines to find out more appropriate cells recapitulating relevant responses to SARS-CoV-2 infection in vitro."
      }
    ]
  },
  "33503446": {
    "title": "Multi-organ proteomic landscape of COVID-19 autopsies.",
    "sentences": [
      {
        "text": "The molecular pathology of multi-organ injuries in COVID-19 patients remains unclear, preventing effective therapeutics development."
      },
      {
        "text": "Here, we report a proteomic analysis of 144 autopsy samples from seven organs in 19 COVID-19 patients."
      },
      {
        "text": "We quantified 11,394 proteins in these samples, in which 5,336 were perturbed in the COVID-19 patients compared to controls."
      },
      {
        "text": "Our data showed that cathepsin L1, rather than ACE2, was significantly upregulated in the lung from the COVID-19 patients."
      },
      {
        "text": "Systemic hyperinflammation and dysregulation of glucose and fatty acid metabolism were detected in multiple organs."
      },
      {
        "text": "We also observed dysregulation of keyÂ factors involved in hypoxia, angiogenesis, blood coagulation, and fibrosis in multiple organs from the COVID-19 patients."
      },
      {
        "text": "Evidence for testicular injuries includes reduced Leydig cells, suppressed cholesterol biosynthesis, and sperm mobility."
      },
      {
        "text": "In summary, this study depicts a multi-organ proteomic landscape of COVID-19 autopsies that furthers our understanding of the biological basis of COVID-19 pathology."
      }
    ]
  },
  "33502593": {
    "title": "Viral infections and their relationship to neurological disorders.",
    "sentences": [
      {
        "text": "The chronic dysfunction of neuronal cells, both central and peripheral, a characteristic of neurological disorders, may be caused by irreversible damage and cell death."
      },
      {
        "text": "In 2016, more than 276 million cases of neurological disorders were reported worldwide."
      },
      {
        "text": "Moreover, neurological disorders are the second leading cause of death."
      },
      {
        "text": "Generally, the etiology of neurological diseases is not fully understood."
      },
      {
        "text": "Recent studies have related the onset of neurological disorders to viral infections, which may cause neurological symptoms or lead to immune responses that trigger these pathological signs."
      },
      {
        "text": "Currently, this relationship is mostly based on epidemiological data on infections and seroprevalence of patients who present with neurological disorders."
      },
      {
        "text": "The number of studies aiming to elucidate the mechanism of action by which viral infections may directly or indirectly contribute to the development of neurological disorders has been increasing over the years but these studies are still scarce."
      },
      {
        "text": "Comprehending the pathogenesis of these diseases and exploring novel theories may favor the development of new strategies for diagnosis and therapy in the future."
      },
      {
        "text": "Therefore, the objective of the present study was to review the main pieces of evidence for the relationship between viral infection and neurological disorders such as Alzheimer's disease, Parkinson's disease, Guillain-BarrÃ© syndrome, multiple sclerosis, and epilepsy."
      },
      {
        "text": "Viruses belonging to the families Herpesviridae, Orthomyxoviridae, Flaviviridae, and Retroviridae have been reported to be involved in one or more of these conditions."
      },
      {
        "text": "Also, neurological symptoms and the future impact of infection with SARS-CoV-2, a member of the family Coronaviridae that is responsible for the COVID-19 pandemic that started in late 2019, are reported and discussed."
      }
    ]
  },
  "33501498": {
    "title": "Histopathologic Features of Chilblainlike Lesions Developing in the Setting of the Coronavirus Disease 2019 (COVID-19) Pandemic.",
    "sentences": [
      {
        "text": "CONTEXT."
      },
      {
        "text": "â During the coronavirus disease 2019 pandemic, several studies have described a distinctive cutaneous manifestation with a clinical picture resembling chilblains or chilblain lupus in young patients."
      },
      {
        "text": "OBJECTIVE."
      },
      {
        "text": "â To report the histopathologic description of a series of chilblainlike lesions appearing in the context of the severe acute respiratory syndrome coronavirus 2 epidemic."
      },
      {
        "text": "DESIGN."
      },
      {
        "text": "â The study included 13 patients with cutaneous acral lesions resembling chilblains occurring in the setting of suspected severe acute respiratory syndrome coronavirus 2 infection with available skin biopsy."
      },
      {
        "text": "RESULTS."
      },
      {
        "text": "â Two main histopathologic patterns were observed: a chilblainlike histopathologic pattern (10 of 13 cases; 77%) and a thrombotic vasculopathy pattern (3 of 13 cases; 23%)."
      },
      {
        "text": "The chilblainlike histopathologic pattern featured a superficial and deep perivascular infiltrate of lymphocytes of varying intensity."
      },
      {
        "text": "This infiltrate was sometimes peri-eccrine and alterations of eccrine glands were present in most cases."
      },
      {
        "text": "Vacuolar alteration of the basal layer of the epidermis was found in a majority of patients."
      },
      {
        "text": "Lichenoid interface dermatitis was rarely present."
      },
      {
        "text": "The thrombotic vasculopathy pattern featured an absent or mild inflammatory infiltrate, multiple intraluminal fibrin thrombi, and ischemic epidermal necrosis."
      },
      {
        "text": "In both patterns, no true vasculitis was observed."
      },
      {
        "text": "No patient tested positive for severe acute respiratory syndrome coronavirus 2 by polymerase chain reaction, possibly because these lesions may represent late cutaneous manifestations of the disease or are associated with an early effective immune response."
      },
      {
        "text": "CONCLUSIONS."
      },
      {
        "text": "â The relationship of chilblainlike lesions to severe acute respiratory syndrome coronavirus 2 requires further investigations."
      },
      {
        "text": "Histopathologic features mimic chilblains, chilblain lupus, and, less frequently, a thrombotic vasculopathy."
      },
      {
        "text": "Response to viral infection might trigger diverse mechanisms leading to the 2 histopathologic patterns described."
      }
    ]
  },
  "33501444": {
    "title": "An Autoantigen Atlas from Human Lung HFL1 Cells Offers Clues to Neurological and Diverse Autoimmune Manifestations of COVID-19.",
    "sentences": [
      {
        "text": "COVID-19 is accompanied by a myriad of both transient and long-lasting autoimmune responses."
      },
      {
        "text": "Dermatan sulfate (DS), a glycosaminoglycan crucial for wound healing, has unique affinity for autoantigens (autoAgs) from apoptotic cells."
      },
      {
        "text": "DS-autoAg complexes are capable of stimulating autoreactive B cells and autoantibody production."
      },
      {
        "text": "Using DS affinity, we identified an autoantigenome of 408 proteins from human fetal lung fibroblast HFL11 cells, at least 231 of which are known autoAgs."
      },
      {
        "text": "Comparing with available COVID data, 352 proteins of the autoantigenome have thus far been found to be altered at protein or RNA levels in SARS-Cov-2 infection, 210 of which are known autoAgs."
      },
      {
        "text": "The COVID-altered proteins are significantly associated with RNA metabolism, translation, vesicles and vesicle transport, cell death, supramolecular fibrils, cytoskeleton, extracellular matrix, and interleukin signaling."
      },
      {
        "text": "They offer clues to neurological problems, fibrosis, smooth muscle dysfunction, and thrombosis."
      },
      {
        "text": "In particular, 150 altered proteins are related to the nervous system, including axon, myelin sheath, neuron projection, neuronal cell body, and olfactory bulb."
      },
      {
        "text": "An association with the melanosome is also identified."
      },
      {
        "text": "The findings from our study illustrate a strong connection between viral infection and autoimmunity."
      },
      {
        "text": "The vast number of COVID-altered proteins with propensity to become autoAgs offers an explanation for the diverse autoimmune complications in COVID patients."
      },
      {
        "text": "The variety of autoAgs related to mRNA metabolism, translation, and vesicles raises concerns about potential adverse effects of mRNA vaccines."
      },
      {
        "text": "The COVID autoantigen atlas we are establishing provides a detailed molecular map for further investigation of autoimmune sequelae of the pandemic."
      }
    ]
  },
  "33500313": {
    "title": "Axillary artery thrombosis resulting in upper limb amputation as a COVID-19 sequela.",
    "sentences": [
      {
        "text": "Novel COVID-19 continues to intrigue medical professionals with its varied presentations."
      },
      {
        "text": "Though it affects the respiratory tract primarily, thrombogenesis has been the Achilles' heel."
      },
      {
        "text": "A 44-year-old man diagnosed with COVID-19 presented with upper limb pain at a local hospital and was found to have thrombosis of the right axillary artery."
      },
      {
        "text": "Despite a successful embolectomy at the local hospital, there was re-occlusion of the axillary artery and the limb became ischaemic."
      },
      {
        "text": "He was referred to our institution by which time the limb became gangrenous above the elbow and had to be amputated."
      },
      {
        "text": "Extensive sloughing of the nerves was also seen in the local area."
      },
      {
        "text": "Hypercoagulability presenting with various manifestations is common in COVID-19 and needs early anticoagulation."
      },
      {
        "text": "We present this asymptomatic patient who lost a limb to this COVID-19 sequelae."
      }
    ]
  },
  "33499580": {
    "title": "A systematic review of clinical and laboratory parameters of 3,000 COVID-19 cases.",
    "sentences": [
      {
        "text": "The coronavirus disease 2019 (COVID-19) has spread worldwide."
      },
      {
        "text": "It is still a pandemic and poses major health problem across the globe."
      },
      {
        "text": "In our review, clinical characteristics and laboratory parameters of COVID-19 patients were compiled systematically, with special reference to pregnant women in order to understand the disease course."
      },
      {
        "text": "An extensive literature search on various scientific databases for relevant manuscripts was conducted, which yielded 7 manuscripts for final analysis."
      },
      {
        "text": "The most common symptoms were fever (85%), cough (70.63%), chest tightness (37.36%), expectoration (33.27%), fatigue (32%), dyspnea (31.95%), and shortness of breath (31.19%), while hemoptysis (1.0%) was the least common."
      },
      {
        "text": "The associated comorbidities were hypertension (21.6%) and diabetes (10.0%)."
      },
      {
        "text": "In terms of hematological parameters, lower total leukocyte counts were observed in 65% of cases and biochemical parameters, patients demonstrated elevated levels of albumin (53.72%), lactate dehydrogenase (45.71%), and natriuretic peptide (34.84%); however, total bilirubin was elevated in only 8% of cases."
      },
      {
        "text": "In the acute inflammatory cytokine profile, C-reactive protein (59.0%), tumor necrosis factor (58.0%), erythrocyte sedimentation rate (57.0%), interleukin-2 (IL- 2, 54.0%), and IL-6 (52.0%) levels were increased, while prolactin levels (6.5%) were minimally elevated."
      },
      {
        "text": "The recovery rate was approximately 41%, and mortality was about 6.5%."
      },
      {
        "text": "The study also concluded that the clinical symptoms of COVID-19 were similar among pregnant and non-pregnant women."
      },
      {
        "text": "There was no evidence of vertical transmission of COVID-19 infection."
      },
      {
        "text": "This review critically analyzed COVID-19 as a public health hazard in order to help policy makers, health care givers, and primary physicians to promote early diagnosis and prevention."
      }
    ]
  },
  "33495896": {
    "title": "Acute necrotizing glomerulonephritis associated with COVID-19 infection: report of two pediatric cases.",
    "sentences": [
      {
        "text": "BACKGROUND Coronavirus disease 2019 (COVID-19) is thought to cause kidney injury via a variety of mechanisms."
      },
      {
        "text": "The most common reported kidney injury following COVID-19 infection is acute tubular injury (ATI); however, the procoagulant state induced by the virus may also damage the kidneys."
      },
      {
        "text": "CASE-DIAGNOSIS/TREATMENT Herein, we report two cases of acute necrotizing glomerulonephritis (GN) with fibrinoid necrosis in the context of COVID-19 infection."
      },
      {
        "text": "The one with more chronic features in the kidney biopsy progressed to permanent kidney failure but the second one had an excellent response to glucocorticoid pulse therapy with subsequent normal kidney function at 2-month follow-up."
      },
      {
        "text": "CONCLUSIONS Both reported cases had an acute presentation of kidney injury with positive nasopharyngeal PCR test for COVID-19."
      },
      {
        "text": "Based on the data review by the researchers, this is the first report of acute necrotizing GN associated with COVID-19 infection."
      }
    ]
  },
  "33495522": {
    "title": "A higher BMI is not associated with a different immune response and disease course in critically ill COVID-19 patients.",
    "sentences": [
      {
        "text": "BACKGROUND/OBJECTIVES Obesity appears to be an independent risk factor for ICU admission and a severe disease course in COVID-19 patients."
      },
      {
        "text": "An aberrant inflammatory response and impaired respiratory function have been suggested as underlying mechanisms."
      },
      {
        "text": "We investigated whether obesity is associated with differences in inflammatory, respiratory, and clinical outcome parameters in critically ill COVID-19 patients."
      },
      {
        "text": "SUBJECTS/METHODS Sixty-seven COVID-19 ICU patients were divided into obese (BMIââ¥â30âkg/m2, nâ=â18, 72% class I obesity, 28% class II obesity) and non-obese (BMIâ<â30âkg/m2, nâ=â49) groups."
      },
      {
        "text": "Concentrations of circulating interleukin (IL)-6, IL-8, IL-10, tumor necrosis factor alpha (TNF-Î±), interferon gamma (IFN-Î³), interferon gamma-induced protein (IP)-10, monocyte chemoattractant protein (MCP)-1, and IL-1 receptor antagonist (RA) were determined from ICU admission until 10 days afterward, and routine laboratory and clinical parameters were collected."
      },
      {
        "text": "RESULTS BMI was 32.6 [31.2-34.5] and 26.0 [24.4-27.7] kg/m2 in the obese and non-obese group, respectively."
      },
      {
        "text": "Apart from temperature, which was significantly lower in obese patients (38.1 [36.9-38.9] vs."
      },
      {
        "text": "38.7 [38.0 -39.5] Â°C, pâ=â0.02), there were no between-group differences on ICU admission."
      },
      {
        "text": "Plasma cytokine concentrations declined over time (pâ<â0.05 for all), but no differences between obese and non-obese patients were observed."
      },
      {
        "text": "Also, BMI did not correlate with the cytokine response (IL-6 râ=â0.09, pâ=â0.61, TNF-Î± râ=â0.03, pâ=â0.99, IP-10 râ=â0.28, pâ=â0.11)."
      },
      {
        "text": "The kinetics of clinical inflammatory parameters and respiratory mechanics were also similar in both groups."
      },
      {
        "text": "Finally, no differences in time on ventilator, ICU length of stay or 40-day mortality between obese and non-obese patients were apparent."
      },
      {
        "text": "CONCLUSIONS In COVID-19 patients requiring mechanical ventilation in the ICU, a higher BMI is not related to a different immunological response, unfavorable respiratory mechanics, or impaired outcome."
      }
    ]
  },
  "33495187": {
    "title": "Streptokinase in a COVID-19-positive patient with STEMI in a PPCI centre: a local experience.",
    "sentences": [
      {
        "text": "Primary percutaneous coronary intervention is the recommended modality of treatment for acute ST-elevation myocardial infarction (STEMI)."
      },
      {
        "text": "However, different countries now have different consensus about treatment of patients with STEMI during the COVID-19 pandemic."
      },
      {
        "text": "In this report, we describe a case of SARS-CoV-2-positive patient admitted with pneumonia."
      },
      {
        "text": "During hospital stay in COVID-19 designated special care, the patient developed inferoposterior wall myocardial infarction (MI) without haemodynamic instability and was treated successfully with thrombolytics (streptokinase) without any severe complications."
      },
      {
        "text": "To decrease the risk of in-hospital exposure to COVID-19 infection among the staff, in circumstances where there is no negative-pressure catheterisation laboratory and there is shortage in medical staff, thrombolytics can be used as a modality of treatment in low-risk, haemodynamically stable MI during this pandemic, as recommended by different cardiac societies."
      },
      {
        "text": "However, this needs further studies in order to reach local and international consensus."
      }
    ]
  },
  "33493861": {
    "title": "Interleukin 6, soluble interleukin 2 receptor alpha (CD25), monocyte colony-stimulating factor, and hepatocyte growth factor linked with systemic hyperinflammation, innate immunity hyperactivation, and organ damage in COVID-19 pneumonia.",
    "sentences": [
      {
        "text": "BACKGROUND Patients infected by SARS-CoV-2 can develop interstitial pneumonia, requiring hospitalisation or mechanical ventilation."
      },
      {
        "text": "Increased levels of inflammatory biomarkers are associated with development of acute respiratory distress syndrome (ARDS)."
      },
      {
        "text": "The aim of the present study was to determine which cytokines are associated with respiratory insufficiency in patients hospitalised for COVID-19."
      },
      {
        "text": "PATIENTS AND METHODS Data on 67 consecutive patients were collected between March 8 and March 30, 2020."
      },
      {
        "text": "PaO2/FiO2 ratio (P/F) was calculated at hospital admission."
      },
      {
        "text": "The following cytokines were analysed: interleukin (IL)-6, IL-1Î±, IL-18, tumour necrosis factor (TNF)-Î², macrophage colony-stimulating factor (M-CSF), macrophage migration inhibitory factor (MIF), soluble IL-2 receptor alpha (sIL-2RÎ±; CD25), IL-12Î², IL-3, interferon (IFN) Î±2a, monokine induced by gamma interferon (MIG), monocyte-chemotactic protein 3 (MCP3) and hepatocyte growth factor (HGF)."
      },
      {
        "text": "RESULTS P/F lower than 300 was recorded in 22 out of 67 patients (32.8%)."
      },
      {
        "text": "P/F strongly correlated with IL-6 (rÂ =Â -0.62, PÂ <Â 0.0001), M-CSF (rÂ =Â -0.63, PÂ <Â 0.0001), sIL-2RÎ± (rÂ =Â -0.54, PÂ <Â 0.0001), and HGF (rÂ =Â -0.53, PÂ <Â 0.0001)."
      },
      {
        "text": "ROC curve analyses for IL-6 (AUC 0.83, 95% CI 0.73-0.93, PÂ <Â 0.0001), M-CSF (AUC 0.87, 95% CI 0.79-0.96, PÂ <Â 0.0001), HGF (AUC 0.81, 95% CI 0.70-0.93, PÂ <Â 0.0001), and sIL-2RÎ± (AUC 0.80, 95% CI, 0.69-0.90, PÂ <Â 0.0001) showed that these four soluble factors were highly significant."
      },
      {
        "text": "All four soluble factors correlated with LDH, white blood cell count, neutrophil count, lymphocyte count, and CRP."
      },
      {
        "text": "CONCLUSION IL-6, M-CSF, sIL-2RÎ±, and HGF are possibly involved in the main biological processes of severe COVID-19, mirroring the level of systemic hyperinflammatory state, the level of lung inflammation, and the severity of organ damage."
      }
    ]
  },
  "33493677": {
    "title": "SARS-CoV-2 Mediated Hyperferritinemia and Cardiac Arrest: Preliminary Insights.",
    "sentences": []
  },
  "33493637": {
    "title": "Immunotoxic role of organophosphates: An unseen risk escalating SARS-CoV-2 pathogenicity.",
    "sentences": [
      {
        "text": "Consistent gathering of immunotoxic substances on earth is a serious global issue affecting people under pathogenic stress."
      },
      {
        "text": "Organophosphates are among such hazardous compounds that are ubiquitous in nature."
      },
      {
        "text": "They fuel oxidative stress to impair antiviral immune response in living entities."
      },
      {
        "text": "Aside, organophosphates promote cytokine burst and pyroptosis in broncho-alveolar chambers leading to severe respiratory ailments."
      },
      {
        "text": "At present, we witness COVID-19 outbreak caused by SARS-CoV-2."
      },
      {
        "text": "Infection triggers cytokine storm coupled with inflammatory manifestations and pulmonary disorders in patients."
      },
      {
        "text": "Since organophosphate-exposure promotes necroinflammation and respiratory troubles hence during current pandemic situation, additional exposure to such chemicals can exacerbate inflammatory outcome and pulmonary maladies in patients, or pre-exposure to organophosphates might turn-out to be a risk factor for compromised immunity."
      },
      {
        "text": "Fortunately, antioxidants alleviate organophosphate-induced immunosuppression and hence under co-exposure circumstances, dietary intake of antioxidants would be beneficial to boost immunity against SARS-CoV-2 infection."
      }
    ]
  },
  "33424043": {
    "title": "Restoring Good Health in Elderly with Diverse Gut Microbiome and Food Intake Restriction to Combat COVID-19.",
    "sentences": [
      {
        "text": "COVID-19 continues to be an ongoing global threat."
      },
      {
        "text": "The elderly with underlying health conditions like cardiovascular and lung diseases, diabetes, obesity, are the most vulnerable to this disease."
      },
      {
        "text": "Curing the pre-existing health conditions will greatly increase a person's resilience to COVID-19 and lower the death rate of the old people."
      },
      {
        "text": "Digestion and immunity form an integrated nutrition acquisition process, especially in obtaining essential amino acids and essential fatty acids from living microbial cells."
      },
      {
        "text": "A mature strong immunity coupled with gut dysbiosis in adults is the main cause of nutritional disorders like morbid obesity, diabetes mellitus, cardiovascular and pulmonary diseases."
      },
      {
        "text": "Nutrition disorders in return worsen dysbiosis."
      },
      {
        "text": "Human microbiome has an intrinsic duality."
      },
      {
        "text": "While a diverse microbiome provides a full spectrum of essential nutrients to our body, nutrition disorders fuel overgrowth of microbiota (dysbiosis) at many sites on or inside our body, and are the main causes of chronic inflammation at these sites."
      },
      {
        "text": "In the case of COVID-19, nutritional disorder impairs the immunity, causes hyperinflammation, and leads to the protracted overload of cytokines by the immune system, i.e., the cytokine storm."
      },
      {
        "text": "Autophagy induced by restrictive eating is an ideal inhibitor of microbiota overgrowth, as autophagy deprives microbiota of excessive nutrition for replication."
      },
      {
        "text": "Autophagy also attenuates inflammation."
      },
      {
        "text": "Therefore, as a precaution, the author suggests restoring good health in the elderly with the support from a diverse gut microbiome and daily regular food intake restriction, so as to lower the risk of developing into severe case even if they are infected by COVID-19."
      }
    ]
  },
  "33391385": {
    "title": "Necrotizing Skin Findings in Coronavirus Disease 2019: A Case Report.",
    "sentences": [
      {
        "text": "Coronavirus is a single-stranded RNA virus that causes acute respiratory syndrome and various skin lesions."
      },
      {
        "text": "In addition, ischemic acral lesions have been reported in patients with severe coronavirus disease 2019 (COVID-19) due to coagulation disorders."
      },
      {
        "text": "We here present a case with ischemic acral lesions caused by COVID-19."
      },
      {
        "text": "The patient was 51-year old male who was hospitalized with COVID-19 pneumonia."
      },
      {
        "text": "After 28 days in the Intensive Care Unit, patient developed acroischemic lesions in the fingers and toes."
      },
      {
        "text": "In the histopathologic examination, vasculitis was observed as the infiltration of mixed-type inflammatory cells in the mid-sized muscular arteries wall."
      },
      {
        "text": "Moreover, microthrombosis was detected in small capillaries."
      },
      {
        "text": "It is clear that thrombotic lesions have occurred as a result of COVID-19 or administered treatment."
      },
      {
        "text": "Further studies are required to confirm and better characterize the skin reactions in COVID-19."
      }
    ]
  },
  "33362782": {
    "title": "NF-ÎºB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients.",
    "sentences": [
      {
        "text": "Patients infected with SARS-CoV-2 show a wide spectrum of clinical manifestations ranging from mild febrile illness and cough up to acute respiratory distress syndrome, multiple organ failure, and death."
      },
      {
        "text": "Data from patients with severe clinical manifestations compared to patients with mild symptoms indicate that highly dysregulated exuberant inflammatory responses correlate with severity of disease and lethality."
      },
      {
        "text": "Epithelial-immune cell interactions and elevated cytokine and chemokine levels, i.e. cytokine storm, seem to play a central role in severity and lethality in COVID-19."
      },
      {
        "text": "The present perspective places a central cellular pro-inflammatory signal pathway, NF-ÎºB, in the context of recently published data for COVID-19 and provides a hypothesis for a therapeutic approach aiming at the simultaneous inhibition of whole cascades of pro-inflammatory cytokines and chemokines."
      },
      {
        "text": "The simultaneous inhibition of multiple cytokines/chemokines is expected to have much higher therapeutic potential as compared to single target approaches to prevent cascade (i.e. redundant, triggering, amplifying, and synergistic) effects of multiple induced cytokines and chemokines in critical stage COVID-19 patients."
      }
    ]
  },
  "33339541": {
    "title": "Impact of COVID-19 pandemic and diabetes on mechanical reperfusion in patients with STEMI: insights from the ISACS STEMI COVID 19 Registry.",
    "sentences": [
      {
        "text": "BACKGROUND It has been suggested the COVID pandemic may have indirectly affected the treatment and outcome of STEMI patients, by avoidance or significant delays in contacting the emergency system."
      },
      {
        "text": "No data have been reported on the impact of diabetes on treatment and outcome of STEMI patients, that was therefore the aim of the current subanalysis conducted in patients included in the International Study on Acute Coronary Syndromes-ST Elevation Myocardial Infarction (ISACS-STEMI) COVID-19."
      },
      {
        "text": "METHODS The ISACS-STEMI COVID-19 is a retrospective registry performed in European centers with an annual volume ofâ>â120 primary percutaneous coronary intervention (PCI) and assessed STEMI patients, treated with primary PCI during the same periods of the years 2019 versus 2020 (March and April)."
      },
      {
        "text": "Main outcomes are the incidences of primary PCI, delayed treatment, and in-hospital mortality."
      },
      {
        "text": "RESULTS A total of 6609 patients underwent primary PCI in 77 centers, located in 18 countries."
      },
      {
        "text": "Diabetes was observed in a total of 1356 patients (20.5%), with similar proportion between 2019 and 2020."
      },
      {
        "text": "During the pandemic, there was a significant reduction in primary PCI as compared to 2019, similar in both patients with (Incidence rate ratio (IRR) 0.79 (95% CI: 0.73-0.85, pâ<â0.0001) and without diabetes (IRR 0.81 (95% CI: 0.78-0.85, pâ<â0.0001) (p intâ=â0.40)."
      },
      {
        "text": "We observed a significant heterogeneity among centers in the population with and without diabetes (pâ<â0.001, respectively)."
      },
      {
        "text": "The heterogeneity among centers was not related to the incidence of death due to COVID-19 in both groups of patients."
      },
      {
        "text": "Interaction was observed for Hypertension (pâ=â0.024) only in absence of diabetes."
      },
      {
        "text": "Furthermore, the pandemic was independently associated with a significant increase in door-to-balloon and total ischemia times only among patients without diabetes, which may have contributed to the higher mortality, during the pandemic, observed in this group of patients."
      },
      {
        "text": "CONCLUSIONS The COVID-19 pandemic had aÂ significant impact on the treatment of patients with STEMI, with a similar reduction in primary PCI procedures in both patients with and without diabetes."
      },
      {
        "text": "Hypertension had a significant impact on PCI reduction only among patients without diabetes."
      },
      {
        "text": "We observed a significant increase in ischemia time and door-to-balloon time mainly in absence of diabetes, that contributed to explain the increased mortality observed in this group of patients during the pandemic."
      },
      {
        "text": "TRIAL REGISTRATION NUMBER NCT04412655."
      }
    ]
  },
  "33492919": {
    "title": "Transforaminal Epidural Steroid Injections: A Systematic Review and Meta-Analysis of Efficacy and Safety.",
    "sentences": [
      {
        "text": "BACKGROUND Transforaminal epidural injections have been used since the late 1990s to treat lumbar radicular pain."
      },
      {
        "text": "They have been the subject of considerable attention, with varying conclusions from systematic reviews as to their efficacy."
      },
      {
        "text": "Transforaminal injections have been associated with rare but major complications."
      },
      {
        "text": "Further, the use of transforaminal injections has increased since the passage of the Affordable Care Act."
      },
      {
        "text": "Finally, with the SARS-CoV-2 pandemic, there has been heightened concern regarding the risk associated with steroid injections."
      },
      {
        "text": "OBJECTIVES To evaluate and update the effectiveness of transforaminal injections for 4 indications: radicular pain; from spinal stenosis; from failed back surgery syndrome; and for axial low back pain; and to evaluate the safety of the procedure."
      },
      {
        "text": "STUDY DESIGN A systematic review and meta-analysis of the efficacy of transforaminal injections."
      },
      {
        "text": "METHODS The available literature on transforaminal injections was reviewed and the quality assessed."
      },
      {
        "text": "The level of evidence was classified on a 5-point scale based on the quality of evidence developed by the US Preventive Services Task Force (USPSTF) and modified by the American Society of Interventional Pain Physicians (ASIPP)."
      },
      {
        "text": "Data sources included relevant literature from 1966 to April 2020, and manual searches of the bibliographies of known primary and review articles."
      },
      {
        "text": "Pain relief and functional improvement were the primary outcome measures."
      },
      {
        "text": "A minimum of 6 months pain relief follow-up was required."
      },
      {
        "text": "RESULTS For this systematic review, 66 studies were identified."
      },
      {
        "text": "Eighteen randomized controlled trials met the inclusion criteria."
      },
      {
        "text": "No observational studies were included."
      },
      {
        "text": "Eleven randomized controlled trials dealt with various aspects of transforaminal injections for radicular pain owing to disc herniation."
      },
      {
        "text": "Based on these studies, there is Level 1 evidence supporting the use of transforaminal injections for radicular pain owing to disc herniation."
      },
      {
        "text": "A meta-analysis showed that at both 3 and 6 months, there was highly statistically significant improvement in both pain and function with both particulate and nonparticulate steroids."
      },
      {
        "text": "For radicular pain from central stenosis there is one moderate quality study, with Level IV evidence."
      },
      {
        "text": "For radicular pain caused by failed back surgery syndrome there is one moderate quality study, with Level IV evidence."
      },
      {
        "text": "For radicular pain from foraminal stenosis and for axial pain there is Level V evidence, opinion-based/consensus, supporting the use of transforaminal injections."
      },
      {
        "text": "Transforaminal injections are generally safe."
      },
      {
        "text": "However, they have been associated with major neurologic complications related to cord infarct."
      },
      {
        "text": "Causes other than intraluminal injection of particulates appear to be at play."
      },
      {
        "text": "The use of an infraneural approach and of blunt needles appear to offer the greatest patient safety."
      },
      {
        "text": "Because of concern over the role of particulate steroids, multiple other injectates have been evaluated, including nonparticulate steroids, tumor necrosis factor alpha (TNF-a) inhibitors, and local anesthetics without steroids."
      },
      {
        "text": "No injectate has been proven superior."
      },
      {
        "text": "If there is concern about immunosuppression because of risk of COVID-19 infection, either the lowest possible dose of steroid or no steroid should be used."
      },
      {
        "text": "LIMITATIONS The study was limited by the paucity of literature for some indications."
      },
      {
        "text": "CONCLUSIONS There is Level I evidence for the use of transforaminal injections for radicular pain from disc herniations."
      }
    ]
  },
  "33491759": {
    "title": "Immune-checkpoint inhibitors from cancer to COVIDâ19: A promising avenue for the treatment of patients with COVIDâ19 (Review).",
    "sentences": [
      {
        "text": "The severe acute respiratory syndrome associated coronavirusâ2 (SARSâCoVâ2) poses a threat to human life worldwide."
      },
      {
        "text": "Since early March,Â 2020, coronavirus diseaseÂ 2019Â (COVIDâ19), characterized by an acute and often severe form of pneumonia, has been declared a pandemic."
      },
      {
        "text": "This has led to a boom in biomedical research studies at all stages of the pipeline, from the inÂ vitro to the clinical phase."
      },
      {
        "text": "In line with this global effort, known drugs, currently used for the treatment of other pathologies, including antivirals, immunomodulating compounds and antibodies, are currently used offâlabel for the treatment of COVIDâ19, in association with the supportive standard care."
      },
      {
        "text": "Yet, no effective treatments have been identified."
      },
      {
        "text": "A new hope stems from medical oncology and relies on the use of immuneâcheckpoint inhibitorsÂ (ICIs)."
      },
      {
        "text": "In particular, amongst the ICIs, antibodies able to block the programmed deathâ1Â (PDâ1)/PD ligand-1Â (PDâL1) pathway have revealed a hidden potential."
      },
      {
        "text": "In fact, patients with severe and critical COVIDâ19, even prior to the appearance of acute respiratory distress syndrome, exhibit lymphocytopenia and suffer from Tâcell exhaustion, which may lead to viral sepsis and an increased mortality rate."
      },
      {
        "text": "It has been observed that cancer patients, who usually are immunocompromised, may restore their antiâtumoral immune response when treated with ICIs."
      },
      {
        "text": "Moreover, viral-infected mice and humans, exhibit a Tâcell exhaustion, which is also observed following SARSâCoVâ2 infection."
      },
      {
        "text": "Importantly, when treated with antiâPDâ1 and antiâPDâL1 antibodies, they restore their Tâcell competence and efficiently counteract the viral infection."
      },
      {
        "text": "Based on these observations, four clinical trials are currently open, to examine the efficacy of antiâPDâ1 antibody administration to both cancer and nonâcancer individuals affected by COVIDâ19."
      },
      {
        "text": "The results may prove the hypothesis that restoring exhausted Tâcells may be a winning strategy to beat SARSâCoVâ2 infection."
      }
    ]
  },
  "33489841": {
    "title": "Endocrine Involvement in COVID-19: Mechanisms, Clinical Features, and Implications for Care.",
    "sentences": [
      {
        "text": "Coronavirus 2019 (COVID -19) has rapidly emerged as a global pandemic with multi-system involvement."
      },
      {
        "text": "Involvement of the endocrine system is expected in COVID-19 as the interplay between severe acute respiratory syndrome corona virus-2 (SARS CoV-2) and the endocrine system occurs at multiple levels."
      },
      {
        "text": "The widespread presence of ACE-2 receptors on various tissues suggests scope for direct viral infection."
      },
      {
        "text": "The interactions via the activation of inflammatory mediators and indirect immune-mediated damage are also postulated."
      },
      {
        "text": "Evidence so far suggests that COVID-19 can cause functional hypopituitarism by direct and indirect effects on the hypothalamo-pituitary axis resulting in inappropriate adrenal response to stress."
      },
      {
        "text": "Several reports highlight possible immune-mediated damage to thyroid glands resulting in subacute thyroiditis."
      },
      {
        "text": "COVID-19 is implicated in precipitating hyperglycemia in known diabetics and uncovering insulin resistance in those previously undiagnosed."
      },
      {
        "text": "COVID-19 has also been shown to trigger Type 1 Diabetes with ketosis."
      },
      {
        "text": "Various mechanisms including direct virus-induced beta cell apoptosis and immune-mediated beta-cell damage have been demonstrated."
      },
      {
        "text": "The presence of virus in semen has unclear clinical significance at present."
      },
      {
        "text": "In this mini-review summarize the endocrine manifestations reported so far in COVID-19 disease and explore mechanisms to decipher how SARS CoV-2 may affect various endocrine organs."
      }
    ]
  },
  "33489409": {
    "title": "A Rare Presentation of Renal Papillary Necrosis in a COVID-19-Positive Patient.",
    "sentences": [
      {
        "text": "In this case report we describe an unusual presentation of severe acute papillary necrosis in a COVID-19-positive patient."
      },
      {
        "text": "An emergency flexible ureteroscopy greatly helped in the establishment of the diagnosis."
      },
      {
        "text": "In the international literature, there is a paucity of intraoperative endoscopic images representing severe renal papillary necrosis."
      },
      {
        "text": "We present a case of severe acute renal papillary necrosis in a 49-year-old south-Asian, COVID-19-positive male patient who needed emergency urological intervention for macroscopic hematuria and urinary retention due to clot formation in the urinary bladder."
      },
      {
        "text": "The patient underwent emergency cystoscopy, clot evacuation, and by rigid and flexible ureteroscopy."
      },
      {
        "text": "The diagnosis was only confirmed in the postoperative period, retrospectively."
      },
      {
        "text": "Finally, the patient fully recovered due to the multidisciplinary management."
      },
      {
        "text": "Diagnosis of rare clinical entities can be sometimes challenging in the everyday routine practice."
      },
      {
        "text": "Having atypical clinical course, the surgeon should be prepared and sometimes must take responsible decisions promptly, even if needed intraoperatively, to manage unexpected findings in order to get the right diagnosis without compromising the patient's safety."
      }
    ]
  },
  "33488306": {
    "title": "The Long Haul of COVID-19 Recovery: Immune Rejuvenation versus Immune Support.",
    "sentences": [
      {
        "text": "With the COVID-19 pandemic still affecting communities all over the world and \"Long Haul\" chronic health issues emerging, it is time for us to look back at past multi-symptom health conditions that required a different approach to their treatment, beyond just managing symptoms."
      },
      {
        "text": "It is important for us to consider how to apply what we have learned about immune rejuvenation and its impact on conditions associated with chronic immune dysfunction."
      },
      {
        "text": "We know more than we ever have before about how to reduce chronic inflammation at its source through the support of selective immune cell autophagy/mitophagy and improved immune cell mitochondrial activity, followed by remodeling of the immune epigenome, and-ultimately-a reset of immune function."
      }
    ]
  },
  "33486202": {
    "title": "Human endeavor for anti-SARS-CoV-2 pharmacotherapy: A major strategy to fight the pandemic.",
    "sentences": [
      {
        "text": "The global spread of COVID-19 constitutes the most dangerous pandemic to emerge during the last one hundred years."
      },
      {
        "text": "About seventy-nine million infections and more than 1.7 million death have been reported to date, along with destruction of the global economy."
      },
      {
        "text": "With the uncertainty evolved by alarming level of genome mutations, coupled with likelihood of generating only a short lived immune response by the vaccine injections, the identification of antiviral drugs for direct therapy is the need of the hour."
      },
      {
        "text": "Strategies to inhibit virus infection and replication focus on targets such as the spike protein and non-structural proteins including the highly conserved RNA-dependent-RNA-polymerase, nucleotidyl-transferases, main protease and papain-like proteases."
      },
      {
        "text": "There is also an indirect option to target the host cell recognition systems such as angiotensin-converting enzyme 2 (ACE2), transmembrane protease, serine 2, host cell expressed CD147, and the host furin."
      },
      {
        "text": "A drug search strategy consensus in tandem with analysis of currently available information is extremely important for the rapid identification of anti-viral."
      },
      {
        "text": "An unprecedented display of cooperation among the scientific community regarding SARS-CoV-2 research has resulted in the accumulation of an enormous amount of literature that requires curation."
      },
      {
        "text": "Drug repurposing and drug combinations have drawn tremendous attention for rapid therapeutic application, while high throughput screening and virtual searches support de novo drug identification."
      },
      {
        "text": "Here, we examine how certain approved drugs targeting different viruses can play a role in combating this new virus and analyze how they demonstrate efficacy under clinical assessment."
      },
      {
        "text": "Suggestions on repurposing and de novo strategies are proposed to facilitate the fight against the COVID-19 pandemic."
      }
    ]
  },
  "33486200": {
    "title": "The race to treat COVID-19: Potential therapeutic agents for the prevention and treatment of SARS-CoV-2.",
    "sentences": [
      {
        "text": "The unforeseen emergence of coronavirus disease 2019 (COVID-19), a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at the Wuhan province of China in December 2019, subsequently its abrupt spread across the world has severely affected human life."
      },
      {
        "text": "In a short span of time, COVID-19 has sacked more than one million human lives and marked as a severe global pandemic, which is drastically accountable for the adverse effect directly to the human society, particularly the health care system and the economy."
      },
      {
        "text": "The unavailability of approved and effective drugs or vaccines against COVID-19 further created conditions more adverse and terrifying."
      },
      {
        "text": "To win the war against this pandemic within time there is a desperate need for the most adequate therapeutic treatment, which can be achieved by the collaborative research work among scientists worldwide."
      },
      {
        "text": "In continuation of our efforts to support the scientific community, a review has been presented which discusses the structure and the activity of numerous molecules exhibiting promising SARS-CoV-2 and other CoVs inhibition activities."
      },
      {
        "text": "Furthermore, this review offers an overview of the structure, a plausible mechanism of action of SARS-CoV-2, and crucial structural features substantial to inhibit the primary virus-based and host-based targets involved in SARS-CoV-2 treatment."
      },
      {
        "text": "We anticipate optimistically that this perspective will provide the reader and researcher's better understanding regarding COVID-19 and pave the path in the direction of COVID-19 drug discovery and development paradigm."
      }
    ]
  },
  "33485182": {
    "title": "The effects of novel coronavirus (SARS-CoV-2) infection on cardiovascular diseases and cardiopulmonary injuries.",
    "sentences": [
      {
        "text": "COVID-19 caused by a novel coronavirus named SARS-CoV-2, can elites severe acute respiratory syndrome, severe lung injury, cardiac injury, and even death and became a worldwide pandemic."
      },
      {
        "text": "SARS-CoV-2 infection may result in cardiac injury via several mechanisms, including the expression of angiotensin-converting enzyme 2 (ACE2) receptor and leading to a cytokine storm, can elicit an exaggerated host immune response."
      },
      {
        "text": "This response contributes to multi-organ dysfunction."
      },
      {
        "text": "As an emerging infectious disease, there are limited data on the effects of this infection on patients with underlying cardiovascular comorbidities."
      },
      {
        "text": "In this review, we summarize the early-stage clinical experiences with COVID-19, with particular focus on patients with cardiovascular diseases and cardiopulmonary injuries, and explores potential available evidence regarding the association between COVID-19, and cardiovascular complications."
      }
    ]
  },
  "33482337": {
    "title": "Interleukin 1Î±: a comprehensive review on the role of IL-1Î± in the pathogenesis and treatment of autoimmune and inflammatory diseases.",
    "sentences": [
      {
        "text": "The interleukin (IL)-1 family member IL-1Î± is a ubiquitous and pivotal pro-inflammatory cytokine."
      },
      {
        "text": "The IL-1Î± precursor is constitutively present in nearly all cell types in health, but is released upon necrotic cell death as a bioactive mediator."
      },
      {
        "text": "IL-1Î± is also expressed by infiltrating myeloid cells within injured tissues."
      },
      {
        "text": "The cytokine binds the IL-1 receptor 1 (IL-1R1), as does IL-1Î², and induces the same pro-inflammatory effects."
      },
      {
        "text": "Being a bioactive precursor released upon tissue damage and necrotic cell death, IL-1Î± is central to the pathogenesis of numerous conditions characterized by organ or tissue inflammation."
      },
      {
        "text": "These include conditions affecting the lung and respiratory tract, dermatoses and inflammatory skin disorders, systemic sclerosis, myocarditis, pericarditis, myocardial infarction, coronary artery disease, inflammatory thrombosis, as well as complex multifactorial conditions such as COVID-19, vasculitis and Kawasaki disease, Behcet's syndrome, Sjogren Syndrome, and cancer."
      },
      {
        "text": "This review illustrates the clinical relevance of IL-1Î± to the pathogenesis of inflammatory diseases, as well as the rationale for the targeted inhibition of this cytokine for treatment of these conditions."
      },
      {
        "text": "Three biologics are available to reduce the activities of IL-1Î±; the monoclonal antibody bermekimab, the IL-1 soluble receptor rilonacept, and the IL-1 receptor antagonist anakinra."
      },
      {
        "text": "These advances in mechanistic understanding and therapeutic management make it incumbent on physicians to be aware of IL-1Î± and of the opportunity for therapeutic inhibition of this cytokine in a broad spectrum of diseases."
      }
    ]
  },
  "33481202": {
    "title": "Clinical Characteristics of Patients with Severe and Critical COVID-19 in Wuhan: A Single-Center, Retrospective Study.",
    "sentences": [
      {
        "text": "INTRODUCTION This retrospective, single-center study was performed to systemically describe the characteristics and outcomes of patients with severe and critical coronavirus disease 2019 (COVID-19) in Wuhan, analyze the risk factors, and propose suggestions for clinical diagnosis and treatment to guide the subsequent clinical practice."
      },
      {
        "text": "METHODS A total of 753 consecutive patients with COVID-19 admitted to the West Campus of Wuhan Union Hospital from JanuaryÂ 22, 2020 to MayÂ 7, 2020 were enrolled in this study."
      },
      {
        "text": "Demographic, clinical, laboratory, and outcome data were extracted from the electronic medical records of Wuhan Union Hospital and were exhaustively analyzed using R (version 3.6."
      },
      {
        "text": "1)."
      },
      {
        "text": "RESULTS A total of 493 severe and 228 critical cases out of 753 COVID-19 cases were considered in this study."
      },
      {
        "text": "Among the critical cases, the death rate was 79.4%, and age was a risk factor for death."
      },
      {
        "text": "Compared to the severe disease group, the critical disease group had higher white blood cell (WBC) and neutrophil counts and a decreased lymphocyte count at admission."
      },
      {
        "text": "Compared to early death cases (death within 1Â week after admission), a more prolonged course of the disease was associated with a higher risk of hypoproteinemia, liver injury, thrombocytopenia, anemia, disseminated intravascular coagulation (DIC), coagulation disorders, acute kidney injury (AKI), and infection."
      },
      {
        "text": "Higher creatine kinase (CK) and lactate dehydrogenase (LDH) levels were related to early death events, but univariate and multivariate analyses confirmed only LDH as an independent predictor of early death."
      },
      {
        "text": "Notably, anticoagulation therapy was associated with an improved prognosis of critical cases in this cohort."
      },
      {
        "text": "CONCLUSION Our results showed large differences between patients with severe and critical COVID-19."
      },
      {
        "text": "During the course of COVID-19 in the critical disease group, the incidence of hypoproteinemia, anemia, thrombocytopenia, and coagulation disorders increased significantly, which highlighted the importance of medical care in the first week after admission."
      },
      {
        "text": "LDH could act as an independent predictor of early death in critical cases, and anticoagulation therapy was correlated with an improved prognosis of patients with critical COVID-19."
      }
    ]
  },
  "33480671": {
    "title": "Design of SARS-CoV-2 hFc-Conjugated Receptor-Binding Domain mRNA Vaccine Delivered via Lipid Nanoparticles.",
    "sentences": [
      {
        "text": "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been identified as the causal agent of COVID-19 and stands at the center of the current global human pandemic, with death toll exceeding one million."
      },
      {
        "text": "The urgent need for a vaccine has led to the development of various immunization approaches."
      },
      {
        "text": "mRNA vaccines represent a cell-free, simple, and rapid platform for immunization, and therefore have been employed in recent studies toward the development of a SARS-CoV-2 vaccine."
      },
      {
        "text": "Herein, we present the design of an mRNA vaccine, based on lipid nanoparticles (LNPs)-encapsulated SARS-CoV-2 human Fc-conjugated receptor-binding domain (RBD-hFc)."
      },
      {
        "text": "Several ionizable lipids have been evaluated in vivo in a luciferase (luc) mRNA reporter assay, and two leading LNPs formulations have been chosen for the subsequent RBD-hFc mRNA vaccine strategy."
      },
      {
        "text": "Intramuscular administration of LNP RBD-hFc mRNA elicited robust humoral response, a high level of neutralizing antibodies and a Th1-biased cellular response in BALB/c mice."
      },
      {
        "text": "The data in the current study demonstrate the potential of these lipids as promising candidates for LNP-based mRNA vaccines in general and for a COVID19 vaccine in particular."
      }
    ]
  },
  "33479399": {
    "title": "COVID-19 vaccines: where we stand and challenges ahead.",
    "sentences": [
      {
        "text": "In the eleven months elapsed since the identification of the SARS-CoV-2 virus and its genome, an exceptional effort by the scientific community has led to the development of over 300 vaccine projects."
      },
      {
        "text": "Over 40 are now undergoing clinical evaluation, ten of these are in Phase III clinical trials, three of them have ended Phase III with positive results."
      },
      {
        "text": "A few of these new vaccines are being approved for emergency use."
      },
      {
        "text": "Existing data suggest that new vaccine candidates may be instrumental in protecting individuals and reducing the spread of pandemic."
      },
      {
        "text": "The conceptual and technological platforms exploited are diverse, and it is likely that different vaccines will show to be better suited to distinct groups of the human population."
      },
      {
        "text": "Moreover, it remains to be elucidated whether and to what extent the capacity of vaccines under evaluation and of unrelated vaccines such as BCG can increase immunological fitness by training innate immunity to SARS-CoV-2 and pathogen-agnostic protection."
      },
      {
        "text": "Due to the short development time and the novelty of the technologies adopted, these vaccines will be deployed with several unresolved issues that only the passage of time will permit to clarify."
      },
      {
        "text": "Technical problems connected with the production of billions of doses and ethical ones connected with the availably of these vaccines also in the poorest countries, are imminent challenges facing us."
      },
      {
        "text": "It is our tenet that in the long run more than one vaccine will be needed to ensure equitable global access, protection of diverse subjects and immunity against viral variants."
      }
    ]
  },
  "33477869": {
    "title": "Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice.",
    "sentences": [
      {
        "text": "Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection can cause neurological disease in humans, but little is known about the pathogenesis of SARS-CoV-2 infection in the central nervous system (CNS)."
      },
      {
        "text": "Herein, using K18-hACE2 mice, we demonstrate that SARS-CoV-2 neuroinvasion and encephalitis is associated with mortality in these mice."
      },
      {
        "text": "Intranasal infection of K18-hACE2 mice with 105 plaque-forming units of SARS-CoV-2 resulted in 100% mortality by day 6 after infection."
      },
      {
        "text": "The highest virus titers in the lungs were observed on day 3 and declined on days 5 and 6 after infection."
      },
      {
        "text": "By contrast, very high levels of infectious virus were uniformly detected in the brains of all the animals on days 5 and 6."
      },
      {
        "text": "Onset of severe disease in infected mice correlated with peak viral levels in the brain."
      },
      {
        "text": "SARS-CoV-2-infected mice exhibited encephalitis hallmarks characterized by production of cytokines and chemokines, leukocyte infiltration, hemorrhage and neuronal cell death."
      },
      {
        "text": "SARS-CoV-2 was also found to productively infect cells within the nasal turbinate, eye and olfactory bulb, suggesting SARS-CoV-2 entry into the brain by this route after intranasal infection."
      },
      {
        "text": "Our data indicate that direct infection of CNS cells together with the induced inflammatory response in the brain resulted in the severe disease observed in SARS-CoV-2-infected K18-hACE2 mice."
      }
    ]
  },
  "33476696": {
    "title": "Cholesterol 25-hydroxylase suppresses porcine deltacoronavirus infection by inhibiting viral entry.",
    "sentences": [
      {
        "text": "Cholesterol 25-hydroxylase (CH25 H) is a key enzyme regulating cholesterol metabolism and also acts as a broad antiviral host restriction factor."
      },
      {
        "text": "Porcine deltacoronavirus (PDCoV) is an emerging swine enteropathogenic coronavirus that can cause vomiting, diarrhea, dehydration and even death in newborn piglets."
      },
      {
        "text": "In this study, we found that PDCoV infection significantly upregulated the expression of CH25H in IPI-FX cells, a cell line of porcine ileum epithelium."
      },
      {
        "text": "Overexpression of CH25H inhibited PDCoV replication, whereas CH25H silencing using RNA interference promoted PDCoV infection."
      },
      {
        "text": "Treatment with 25-hydroxycholesterol (25HC), the catalysate of cholesterol via CH25H, inhibited PDCoV proliferation by impairing viral invasion of IPI-FX cells."
      },
      {
        "text": "Furthermore, a mutant CH25H (CH25H-M) lacking hydroxylase activity also inhibited PDCoV infection to a lesser extent."
      },
      {
        "text": "Taken together, our data suggest that CH25H acts as a host restriction factor to inhibit the proliferation of PDCoV but this inhibitory effect is not completely dependent on its enzymatic activity."
      }
    ]
  },
  "33476632": {
    "title": "Protective effect of Rosuvastatin on Azithromycin induced cardiotoxicity in a rat model.",
    "sentences": [
      {
        "text": "AIMS Azithromycin is widely used broad spectrum antibiotic recently used in treatment protocol of COVID-19 for its antiviral and immunomodulatory effects combined with Hydroxychloroquine or alone."
      },
      {
        "text": "Rat models showed that Azithromycin produces oxidative stress, inflammation, and apoptosis of myocardial tissue."
      },
      {
        "text": "Rosuvastatin, a synthetic statin, can attenuate myocardial ischemia with antioxidant and antiapoptotic effects."
      },
      {
        "text": "This study aims to evaluate the probable protective effect of Rosuvastatin against Azithromycin induced cardiotoxicity."
      },
      {
        "text": "MAIN METHOD Twenty adult male albino rats were divided randomly into four groups, five rats each control, Azithromycin, Rosuvastatin, and Azithromycin +Rosuvastatin groups."
      },
      {
        "text": "Azithromycin 30Â mg/kg/day and Rosuvastatin 2Â mg/kg/day were administrated for two weeks by an intragastric tube."
      },
      {
        "text": "Twenty-four hours after the last dose, rats were anesthetized and the following measures were carried out; Electrocardiogram, Blood samples for Biochemical analysis of lactate dehydrogenase (LDH), and creatine phosphokinase (CPK)."
      },
      {
        "text": "The animals sacrificed, hearts excised, apical part processed for H&E, immunohistochemical staining, and examined by light microscope."
      },
      {
        "text": "The remaining parts of the heart were collected for assessment of Malondialdehyde (MDA) and Reduced Glutathione (GSH)."
      },
      {
        "text": "KEY FINDINGS The results revealed that Rosuvastatin significantly ameliorates ECG changes, biochemical, and Oxidative stress markers alterations of Azithromycin."
      },
      {
        "text": "Histological evaluation from Azithromycin group showed marked areas of degeneration, myofibers disorganization, inflammatory infiltrate, and hemorrhage."
      },
      {
        "text": "Immunohistochemical evaluation showed significant increase in both Caspase 3 and Tumor necrosis factor (TNF) immune stain."
      },
      {
        "text": "Rosuvastatin treated group showed restoration of the cardiac muscle fibers in H&E and Immunohistochemical results."
      },
      {
        "text": "SIGNIFICANCE We concluded that Rosuvastatin significantly ameliorates the toxic changes of Azithromycin on the heart."
      }
    ]
  },
  "33472985": {
    "title": "Interplay of Antibody and Cytokine Production Reveals CXCL13 as a Potential Novel Biomarker of Lethal SARS-CoV-2 Infection.",
    "sentences": [
      {
        "text": "The SARS-CoV-2 pandemic is impacting the global population."
      },
      {
        "text": "This study was designed to assess the interplay of antibodies with the cytokine response in SARS-CoV-2 patients."
      },
      {
        "text": "We demonstrate that significant levels of anti-SARS-CoV-2 antibody to receptor binding domain (RBD), nucleocapsid, and spike S1 subunit of SARS-CoV-2 develop over the first 10 to 20âdays of infection."
      },
      {
        "text": "The majority of patients produced antibodies against all three antigens (219/255 SARS-CoV-2+ patient specimens, 86%), suggesting a broad response to viral proteins."
      },
      {
        "text": "Antibody levels to SARS-CoV-2 antigens were different based on patient mortality, sex, blood type, and age."
      },
      {
        "text": "Analyses of these findings may help explain variation in immunity between these populations."
      },
      {
        "text": "To better understand the systemic immune response, we analyzed the levels of 20 cytokines by SARS-CoV-2 patients throughout infection."
      },
      {
        "text": "Cytokine analysis of SARS-CoV-2+ patients exhibited increases in proinflammatory markers (interleukin 6 [IL-6], IL-8, IL-18, and gamma interferon [IFN-Î³]) and chemotactic markers (IP-10 and eotaxin) relative to healthy individuals."
      },
      {
        "text": "Patients who succumbed to infection produced decreased IL-2, IL-4, IL-12, RANTES, tumor necrosis factor alpha (TNF-Î±), GRO-Î±, and MIP-1Î± relative to patients who survived infection."
      },
      {
        "text": "We also observed that the chemokine CXCL13 was particularly elevated in patients who succumbed to infection."
      },
      {
        "text": "CXCL13 is involved in B cell activation, germinal center development, and antibody maturation, and we observed that CXCL13 levels in blood trended with anti-SARS-CoV-2 antibody levels."
      },
      {
        "text": "Furthermore, patients who succumbed to infection produced high CXCL13 and had a higher ratio of nucleocapsid to RBD antibodies."
      },
      {
        "text": "This study provides insights into SARS-CoV-2 immunity implicating the magnitude and specificity of response in relation to patient outcomes."
      },
      {
        "text": "IMPORTANCE The SARS-CoV-2 pandemic is continuing to impact the global population, and knowledge of the immune response to COVID-19 is still developing."
      },
      {
        "text": "This study assesses the interplay of different parts of the immune system during COVID-19 disease."
      },
      {
        "text": "We demonstrate that COVID-19 patients produce antibodies to three proteins of the COVID-19 virus (SARS-CoV-2) and identify many other immunological proteins that are involved during infection."
      },
      {
        "text": "The data suggest that one of these proteins (CXCL13) may be a novel biomarker for severe COVID-19 that can be readily measured in blood."
      },
      {
        "text": "This information combined with our broad-scale analysis of immune activity during COVID-19 provides new information on the immunological response throughout the course of disease and identifies a novel potential marker for assessing disease severity."
      }
    ]
  },
  "33472631": {
    "title": "Evaluation and improvement of the National Early Warning Score (NEWS2) for COVID-19: a multi-hospital study.",
    "sentences": [
      {
        "text": "BACKGROUND The National Early Warning Score (NEWS2) is currently recommended in the UK for the risk stratification of COVID-19 patients, but little is known about its ability to detect severe cases."
      },
      {
        "text": "We aimed to evaluate NEWS2 for the prediction of severe COVID-19 outcome and identify and validate a set of blood and physiological parameters routinely collected at hospital admission to improve upon the use of NEWS2 alone for medium-term risk stratification."
      },
      {
        "text": "METHODS Training cohorts comprised 1276 patients admitted to King's College Hospital National Health Service (NHS) Foundation Trust with COVID-19 disease from 1 March to 30 April 2020."
      },
      {
        "text": "External validation cohorts included 6237 patients from five UK NHS Trusts (Guy's and St Thomas' Hospitals, University Hospitals Southampton, University Hospitals Bristol and Weston NHS Foundation Trust, University College London Hospitals, University Hospitals Birmingham), one hospital in Norway (Oslo University Hospital), and two hospitals in Wuhan, China (Wuhan Sixth Hospital and Taikang Tongji Hospital)."
      },
      {
        "text": "The outcome was severe COVID-19 disease (transfer to intensive care unit (ICU) or death) at 14âdays after hospital admission."
      },
      {
        "text": "Age, physiological measures, blood biomarkers, sex, ethnicity, and comorbidities (hypertension, diabetes, cardiovascular, respiratory and kidney diseases) measured at hospital admission were considered in the models."
      },
      {
        "text": "RESULTS A baseline model of 'NEWS2 + age' had poor-to-moderate discrimination for severe COVID-19 infection at 14âdays (area under receiver operating characteristic curve (AUC) in training cohortâ=â0.700, 95% confidence interval (CI) 0.680, 0.722; Brier scoreâ=â0.192, 95% CI 0.186, 0.197)."
      },
      {
        "text": "A supplemented model adding eight routinely collected blood and physiological parameters (supplemental oxygen flow rate, urea, age, oxygen saturation, C-reactive protein, estimated glomerular filtration rate, neutrophil count, neutrophil/lymphocyte ratio) improved discrimination (AUCâ=â0.735; 95% CI 0.715, 0.757), and these improvements were replicated across seven UK and non-UK sites."
      },
      {
        "text": "However, there was evidence of miscalibration with the model tending to underestimate risks in most sites."
      },
      {
        "text": "CONCLUSIONS NEWS2 score had poor-to-moderate discrimination for medium-term COVID-19 outcome which raises questions about its use as a screening tool at hospital admission."
      },
      {
        "text": "Risk stratification was improved by including readily available blood and physiological parameters measured at hospital admission, but there was evidence of miscalibration in external sites."
      },
      {
        "text": "This highlights the need for a better understanding of the use of early warning scores for COVID."
      }
    ]
  },
  "33472576": {
    "title": "Anatomical and Pathological Observation and Analysis of SARS and COVID-19: Microthrombosis Is the Main Cause of Death.",
    "sentences": [
      {
        "text": "The spread of the coronavirus (SARS-CoV-2, COVID-19 for short) has caused a large number of deaths around the world."
      },
      {
        "text": "We summarized the data reported in the past few months and emphasized that the main causes of death of COVID-19 patients are DAD (Diffuse Alveolar Damage) and DIC (Disseminated intravascular coagulation)."
      },
      {
        "text": "Microthrombosis is a prominent clinical feature of COVID-19, and 91.3% of dead patients had microthrombosis."
      },
      {
        "text": "Endothelial damage caused by SARS-CoV-2 cell invasion and subsequent host response disorders involving inflammation and coagulation pathways play a key role in the progression of severe COVID-19."
      },
      {
        "text": "Microvascular thrombosis may lead to microcirculation disorders and multiple organ failure lead to death."
      },
      {
        "text": "The characteristic pathological changes of DAD include alveolar epithelial and vascular endothelial injury, increased alveolar membrane permeability, large numbers of neutrophil infiltration, alveolar hyaline membrane formation, and hypoxemia and respiratory distress as the main clinical manifestations."
      },
      {
        "text": "DAD leads to ARDS in COVID-19 patients."
      },
      {
        "text": "DIC is a syndrome characterized by the activation of systemic intravascular coagulation, which leads to extensive fibrin deposition in the blood."
      },
      {
        "text": "Its occurrence and development begin with the expression of tissue factor and interact with physiological anticoagulation pathways."
      },
      {
        "text": "The down-regulation of fibrin and the impaired fibrinolysis together lead to extensive fibrin deposition."
      },
      {
        "text": "DIC is described as a decrease in the number of platelets and an increase in fibrin degradation products, such as D-dimer and low fibrinogen."
      },
      {
        "text": "The formation of microthrombus leads to the disturbance of microcirculation, which in turn leads to the death of the patient."
      },
      {
        "text": "However, the best prevention and treatment of COVID-19 microthrombosis is still uncertain."
      },
      {
        "text": "This review discusses the latest findings of basic and clinical research on COVID-19-related microthrombosis, and then we proposed the theory of microcirculation perfusion bundle therapy to explore effective methods for preventing and treating COVID-19-related microthrombosis."
      },
      {
        "text": "Further research is urgently needed to clarify how SARS-CoV-2 infection causes thrombotic complications, and how it affects the course and severity of the disease."
      },
      {
        "text": "To cultivate a more comprehensive understanding of the underlying mechanism of this disease."
      },
      {
        "text": "Raise awareness of the importance of preventing and treating microthrombosis in patients with COVID-19."
      }
    ]
  },
  "33469569": {
    "title": "Synthetic Siglec-9 Agonists Inhibit Neutrophil Activation Associated with COVID-19.",
    "sentences": [
      {
        "text": "Severe cases of coronavirus disease 2019 (COVID-19), caused by infection with SARS-Cov-2, are characterized by a hyperinflammatory immune response that leads to numerous complications."
      },
      {
        "text": "Production of proinflammatory neutrophil extracellular traps (NETs) has been suggested to be a key factor in inducing a hyperinflammatory signaling cascade, allegedly causing both pulmonary tissue damage and peripheral inflammation."
      },
      {
        "text": "Accordingly, therapeutic blockage of neutrophil activation and NETosis, the cell death pathway accompanying NET formation, could limit respiratory damage and death from severe COVID-19."
      },
      {
        "text": "Here, we demonstrate that synthetic glycopolymers that activate the neutrophil checkpoint receptor Siglec-9 suppress NETosis induced by agonists of viral toll-like receptors (TLRs) and plasma from patients with severe COVID-19."
      },
      {
        "text": "Thus, Siglec-9 agonism is a promising therapeutic strategy to curb neutrophilic hyperinflammation in COVID-19."
      },
      {
        "text": "<br>."
      }
    ]
  },
  "33469056": {
    "title": "Clinical and laboratory features of hypercoagulability in COVID-19 and other respiratory viral infections amongst predominantly younger adults with few comorbidities.",
    "sentences": [
      {
        "text": "COVID-19 caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and other respiratory viral (non-CoV-2-RV) infections are associated with thrombotic complications."
      },
      {
        "text": "The differences in prothrombotic potential between SARS-CoV-2 and non-CoV-2-RV have not been well characterised."
      },
      {
        "text": "We compared the thrombotic rates between these two groups of patients directly and further delved into their coagulation profiles."
      },
      {
        "text": "In this single-center, retrospective cohort study, all consecutive COVID-19 and non-CoV-2-RV patients admitted between January 15th and April 10th 2020 were included."
      },
      {
        "text": "Coagulation parameters studied were prothrombin time and activated partial thromboplastin time and its associated clot waveform analysis (CWA) parameter, min1, min2 and max2."
      },
      {
        "text": "In the COVID-19 (nâ=â181) group there were two (1.0 event/1000-hospital-days) myocardial infarction events while one (1.8 event/1000-hospital-day) was reported in the non-CoV-2-RV (nâ=â165) group."
      },
      {
        "text": "These events occurred in patients who were severely ill."
      },
      {
        "text": "There were no venous thrombotic events."
      },
      {
        "text": "Coagulation parameters did not differ throughout the course of mild COVID-19."
      },
      {
        "text": "However, CWA parameters were significantly higher in severe COVID-19 compared with mild disease, suggesting hypercoagulability (min1: 6.48%/s vs 5.05%/s, Pâ<â0.001; min2: 0.92%/s2 vs 0.74%/s2, Pâ=â0.033)."
      },
      {
        "text": "In conclusion, the thrombotic rates were low and did not differ between COVID-19 and non-CoV-2-RV patients."
      },
      {
        "text": "The hypercoagulability in COVID-19 is a highly dynamic process with the highest risk occurring when patients were most severely ill."
      },
      {
        "text": "Such changes in haemostasis could be detected by CWA."
      },
      {
        "text": "In our population, a more individualized thromboprophylaxis approach, considering clinical and laboratory factors, is preferred over universal pharmacological thromboprophylaxis for all hospitalized COVID-19 patients and such personalized approach warrants further research."
      }
    ]
  },
  "33467585": {
    "title": "The Prognostic Value of Eosinophil Recovery in COVID-19: A Multicentre, Retrospective Cohort Study on Patients Hospitalised in Spanish Hospitals.",
    "sentences": [
      {
        "text": "OBJECTIVES A decrease in blood cell counts, especially lymphocytes and eosinophils, has been described in patients with serious Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), but there is no knowledge of their potential role of the recovery in these patients' prognosis."
      },
      {
        "text": "This article aims to analyse the effect of blood cell depletion and blood cell recovery on mortality due to COVID-19."
      },
      {
        "text": "DESIGN This work was a retrospective, multicentre cohort study of 9644 hospitalised patients with confirmed COVID-19 from the Spanish Society of Internal Medicine's SEMI-COVID-19 Registry."
      },
      {
        "text": "SETTING This study examined patients hospitalised in 147 hospitals throughout Spain."
      },
      {
        "text": "PARTICIPANTS This work analysed 9644 patients (57.12% male) out of a cohort of 12,826 patients â¥18 years of age hospitalised with COVID-19 in Spain included in the SEMI-COVID-19 Registry as of 29 May 2020."
      },
      {
        "text": "MAIN OUTCOME MEASURES The main outcome measure of this work is the effect of blood cell depletion and blood cell recovery on mortality due to COVID-19."
      },
      {
        "text": "Univariate analysis was performed to determine possible predictors of death, and then multivariate analysis was carried out to control for potential confounders."
      },
      {
        "text": "RESULTS An increase in the eosinophil count on the seventh day of hospitalisation was associated with a better prognosis, including lower mortality rates (5.2% vs."
      },
      {
        "text": "22.6% in non-recoverers, OR 0.234; 95% CI, 0.154 to 0.354) and lower complication rates, especially regarding the development of acute respiratory distress syndrome (8% vs."
      },
      {
        "text": "20.1%, p = 0.000) and ICU admission (5.4% vs."
      },
      {
        "text": "10.8%, p = 0.000)."
      },
      {
        "text": "Lymphocyte recovery was found to have no effect on prognosis."
      },
      {
        "text": "Treatment with inhaled or systemic glucocorticoids was not found to be a confounding factor."
      },
      {
        "text": "CONCLUSION Eosinophil recovery in patients with COVID-19 who required hospitalisation had an independent prognostic value for all-cause mortality and a milder course."
      }
    ]
  },
  "33466585": {
    "title": "Severe COVID-19 Lung Infection in Older People and Periodontitis.",
    "sentences": [
      {
        "text": "Periodontal bacteria dissemination into the lower respiratory tract may create favorable conditions for severe COVID-19 lung infection."
      },
      {
        "text": "Once lung tissues are colonized, cells that survive persistent bacterial infection can undergo permanent damage and accelerated cellular senescence."
      },
      {
        "text": "Consequently, several morphological and functional features of senescent lung cells facilitate SARS-CoV-2 replication."
      },
      {
        "text": "The higher risk for severe SARS-CoV-2 infection, the virus that causes COVID-19, and death in older patients has generated the question whether basic aging mechanisms could be implicated in such susceptibility."
      },
      {
        "text": "Mounting evidence indicates that cellular senescence, a manifestation of aging at the cellular level, contributes to the development of age-related lung pathologies and facilitates respiratory infections."
      },
      {
        "text": "Apparently, a relationship between life-threatening COVID-19 lung infection and pre-existing periodontal disease seems improbable."
      },
      {
        "text": "However, periodontal pathogens can be inoculated during endotracheal intubation and/or aspirated into the lower respiratory tract."
      },
      {
        "text": "This review focuses on how the dissemination of periodontal bacteria into the lungs could aggravate age-related senescent cell accumulation and facilitate more efficient SARS-CoV-2 cell attachment and replication."
      },
      {
        "text": "We also consider how periodontal bacteria-induced premature senescence could influence the course of COVID-19 lung infection."
      },
      {
        "text": "Finally, we highlight the role of saliva as a reservoir for both pathogenic bacteria and SARS-CoV-2."
      },
      {
        "text": "Therefore, the identification of active severe periodontitis can be an opportune and valid clinical parameter for risk stratification of old patients with COVID-19."
      }
    ]
  },
  "33466289": {
    "title": "SARS-CoV-2 Infection and Oral Health: Therapeutic Opportunities and Challenges.",
    "sentences": [
      {
        "text": "The novel corona virus, Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), and the disease it causes, COVID-19 (Coronavirus Disease-2019) have had multi-faceted effects on a number of lives on a global scale both directly and indirectly."
      },
      {
        "text": "A growing body of evidence suggest that COVID-19 patients experience several oral health problems such as dry mouth, mucosal blistering, mouth rash, lip necrosis, and loss of taste and smell."
      },
      {
        "text": "Periodontal disease (PD), a severe inflammatory gum disease, may worsen the symptoms associated with COVID-19."
      },
      {
        "text": "Routine dental and periodontal treatment may help decrease the symptoms of COVID-19."
      },
      {
        "text": "PD is more prevalent among patients experiencing metabolic diseases such as obesity, diabetes mellitus and cardiovascular risk."
      },
      {
        "text": "Studies have shown that these patients are highly susceptible for SARS-CoV-2 infection."
      },
      {
        "text": "Pro-inflammatory cytokines and oxidative stress known to contribute to the development of PD and other metabolic diseases are highly elevated among COVID-19 patients."
      },
      {
        "text": "Periodontal health may help to determine the severity of COVID-19 infection."
      },
      {
        "text": "Accumulating evidence shows that African-Americans (AAs) and vulnerable populations are disproportionately susceptible to PD, metabolic diseases and COVID-19 compared to other ethnicities in the United States."
      },
      {
        "text": "Dentistry and dental healthcare professionals are particularly susceptible to this virus due to the transferability via the oral cavity and the use of aerosol creating instruments that are ubiquitous in this field."
      },
      {
        "text": "In this review, we attempt to provide a comprehensive and updated source of information about SARS-CoV-2/COVID-19 and the various effects it has had on the dental profession and patients visits to dental clinics."
      },
      {
        "text": "Finally, this review is a valuable resource for the management of oral hygiene and reduction of the severity of infection."
      }
    ]
  },
  "33465165": {
    "title": "Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2.",
    "sentences": [
      {
        "text": "Hydroxychloroquine, used to treat malaria and some autoimmune disorders, potently inhibits viral infection of SARS coronavirus (SARS-CoV-1) and SARS-CoV-2 in cell-culture studies."
      },
      {
        "text": "However, human clinical trials of hydroxychloroquine failed to establish its usefulness as treatment for COVID-19."
      },
      {
        "text": "This compound is known to interfere with endosomal acidification necessary to the proteolytic activity of cathepsins."
      },
      {
        "text": "Following receptor binding and endocytosis, cathepsin L can cleave the SARS-CoV-1 and SARS-CoV-2 spike (S) proteins, thereby activating membrane fusion for cell entry."
      },
      {
        "text": "The plasma membrane-associated protease TMPRSS2 can similarly cleave these S proteins and activate viral entry at the cell surface."
      },
      {
        "text": "Here we show that the SARS-CoV-2 entry process is more dependent than that of SARS-CoV-1 on TMPRSS2 expression."
      },
      {
        "text": "This difference can be reversed when the furin-cleavage site of the SARS-CoV-2 S protein is ablated or when it is introduced into the SARS-CoV-1 S protein."
      },
      {
        "text": "We also show that hydroxychloroquine efficiently blocks viral entry mediated by cathepsin L, but not by TMPRSS2, and that a combination of hydroxychloroquine and a clinically-tested TMPRSS2 inhibitor prevents SARS-CoV-2 infection more potently than either drug alone."
      },
      {
        "text": "These studies identify functional differences between SARS-CoV-1 and -2 entry processes, and provide a mechanistic explanation for the limited in vivo utility of hydroxychloroquine as a treatment for COVID-19."
      }
    ]
  },
  "33465050": {
    "title": "Fighting the storm: could novel anti-TNFÎ± and anti-IL-6 C. sativa cultivars tame cytokine storm in COVID-19?",
    "sentences": [
      {
        "text": "The main aspects of severe COVID-19 disease pathogenesis include hyper-induction of proinflammatory cytokines, also known as 'cytokine storm', that precedes acute respiratory distress syndrome (ARDS) and often leads to death."
      },
      {
        "text": "COVID-19 patients often suffer from lung fibrosis, a serious and untreatable condition."
      },
      {
        "text": "There remains no effective treatment for these complications."
      },
      {
        "text": "Out of all cytokines, TNFÎ± and IL-6 play crucial roles in cytokine storm pathogenesis and are likely responsible for the escalation in disease severity."
      },
      {
        "text": "These cytokines also partake in the molecular pathogenesis of fibrosis."
      },
      {
        "text": "Therefore, new approaches are urgently needed, that can efficiently and swiftly downregulate TNFÎ±, IL-6, and the inflammatory cytokine cascade, in order to curb inflammation and prevent fibrosis, and lead to disease remission."
      },
      {
        "text": "Cannabis sativa has been proposed to modulate gene expression and inflammation and is under investigation for several potential therapeutic applications against autoinflammatory diseases and cancer."
      },
      {
        "text": "Here, we hypothesized that the extracts of novel C. sativa cultivars may be used to downregulate the expression of pro-inflammatory cytokines and pathways involved in inflammation and fibrosis."
      },
      {
        "text": "Initially, to analyze the anti-inflammatory effects of novel C. sativa cultivars, we used a well-established full thickness human 3D skin artificial EpiDermFTTM tissue model, whereby tissues were exposed to UV to induce inflammation and then treated with extracts of seven new cannabis cultivars."
      },
      {
        "text": "We noted that out of seven studied extracts of novel C. sativa cultivars, three (#4, #8 and #14) were the most effective, causing profound and concerted down-regulation of COX2, TNFÎ±, IL-6, CCL2, and other cytokines and pathways related to inflammation and fibrosis."
      },
      {
        "text": "These data were further confirmed in the WI-38 lung fibroblast cell line model."
      },
      {
        "text": "Most importantly, one of the tested extracts had no effect at all, and one exerted effect that may be deleterious, signifying that careful cannabis cultivar selection must be based on thorough pre-clinical studies."
      },
      {
        "text": "The observed pronounced inhibition of TNFÎ± and IL-6 is the most important finding, because these molecules are currently considered to be the main targets in COVID-19 cytokine storm and ARDS pathogenesis."
      },
      {
        "text": "Novel anti-TNFÎ± and anti-IL-6 cannabis extracts can be useful additions to the current anti-inflammatory regimens to treat COVID-19, as well as various rheumatological diseases and conditions, and 'inflammaging' - the inflammatory underpinning of aging and frailty."
      }
    ]
  },
  "33465045": {
    "title": "The Use of Topical Oxygen Therapy to Treat a Calciphylaxis Wound During a Global Pandemic: A Case Report.",
    "sentences": [
      {
        "text": "INTRODUCTION Calciphylaxis is a rare, highly morbid pathological syndrome of vascular calcification and tissue necrosis."
      },
      {
        "text": "It is predominantly seen in patients with end-stage renal disease (ESRD) on chronic dialysis."
      },
      {
        "text": "There is no definitive standard of care for calciphylaxis, and the overall prognosis for patients, particularly those with ulcerated lesions, is bleak."
      },
      {
        "text": "One important role of wound care clinicians during the COVID-19 pandemic is to ensure that the continuity of care of an at-risk population is maintained while limiting the patient's potential exposure to the virus."
      },
      {
        "text": "Innovative therapies paired with alternative treatment sites of service are one such method."
      },
      {
        "text": "CASE REPORT A 56-year-old female with ESRD on at-home peritoneal dialysis (PD) presented to the outpatient wound clinic with a punch biopsy-proven calciphylaxis lesion."
      },
      {
        "text": "Within days, state-wide \"shelter-at-home\" orders due to the COVID-19 pandemic went into effect."
      },
      {
        "text": "To prevent disruption in care and to minimize risk to the patient, the lesion was treated with bi-weekly self-application of a continuous topical oxygen therapy (cTOT) device paired with weekly telemedicine visits."
      },
      {
        "text": "The wound completely resolved after 9 weeks of topical oxygen therapy with no complications or device malfunctions."
      },
      {
        "text": "CONCLUSIONS This case, to the authors' knowledge, is the first to document healing in a calciphylaxis wound with the use of cTOT."
      },
      {
        "text": "Topical oxygen therapy may be a beneficial adjunctive therapy in the treatment of wounds caused by calciphylaxis."
      },
      {
        "text": "Finding creative ways to navigate this current health care crisis is essential to help mitigate risk for vulnerable patients with advanced comorbidities."
      }
    ]
  },
  "33464168": {
    "title": "Androgens, the kidney, and COVID-19: an opportunity for translational research.",
    "sentences": [
      {
        "text": "Coronavirus disease 2019 (COVID-19) has reached pandemic proportions, affecting millions of people worldwide."
      },
      {
        "text": "Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the causative agent of COVID-19."
      },
      {
        "text": "Epidemiological reports have shown that the severity of SARS-CoV-2 infection is associated with preexisting comorbidities such as hypertension, diabetes mellitus, cardiovascular diseases, and chronic kidney diseases, all of which are also risk factors for acute kidney injury (AKI)."
      },
      {
        "text": "The kidney has emerged as a key organ affected by SARS-CoV-2."
      },
      {
        "text": "AKI is associated with increased morbidity and mortality in patients with COVID-19."
      },
      {
        "text": "Male sex is an independent predictor for AKI, and an increased death rate has been reported in male patients with COVID-19 worldwide."
      },
      {
        "text": "The mechanism(s) that mediate the sex discrepancy in mortality due to COVID-19 remain(s) unknown."
      },
      {
        "text": "Angiotensin-converting enzyme (ACE)2 is the receptor for SARS-CoV-2."
      },
      {
        "text": "Alterations in the ACE-to-ACE2 ratio have been implicated in renal diseases."
      },
      {
        "text": "This perspective aims to discuss data that suggest that androgens, via alterations in the intrarenal renin-angiotensin system, impair renal hemodynamics, predisposing patients to AKI during COVID-19 infection, which could explain the higher mortality observed in men with COVID-19."
      },
      {
        "text": "Clinicians should ensure early and effective cardiometabolic control for all patients to ameliorate the compensatory elevation of ACE2 and alterations in the ACE-to-ACE2 ratio."
      },
      {
        "text": "A better understanding of the role of androgens in SARS-CoV-2-associated AKI and mortality is imperative."
      },
      {
        "text": "The kidney could constitute a key organ that may explain the sex disparities of the higher mortality and worst outcomes associated with COVID-19 in men."
      }
    ]
  },
  "33462671": {
    "title": "The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV.",
    "sentences": [
      {
        "text": "The number of descriptions of emerging viruses has grown at an unprecedented rate since the beginning of the 21st century."
      },
      {
        "text": "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), is the third highly pathogenic coronavirus that has introduced itself into the human population in the current era, after SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV)."
      },
      {
        "text": "Molecular and cellular studies of the pathogenesis of this novel coronavirus are still in the early stages of research; however, based on similarities of SARS-CoV-2 to other coronaviruses, it can be hypothesized that the NF-ÎºB, cytokine regulation, ERK, and TNF-Î± signaling pathways are the likely causes of inflammation at the onset of COVID-19."
      },
      {
        "text": "Several drugs have been prescribed and used to alleviate the adverse effects of these inflammatory cellular signaling pathways, and these might be beneficial for developing novel therapeutic modalities against COVID-19."
      },
      {
        "text": "In this review, we briefly summarize alterations of cellular signaling pathways that are associated with coronavirus infection, particularly SARS-CoV and MERS-CoV, and tabulate the therapeutic agents that are currently approved for treating other human diseases."
      }
    ]
  },
  "33462369": {
    "title": "Effects of social distancing on the spreading of COVID-19 inferred from mobile phone data.",
    "sentences": [
      {
        "text": "A better understanding of how the COVID-19 pandemic responds to social distancing efforts is required for the control of future outbreaks and to calibrate partial lock-downs."
      },
      {
        "text": "We present quantitative relationships between key parameters characterizing the COVID-19 epidemiology and social distancing efforts of nine selected European countries."
      },
      {
        "text": "Epidemiological parameters were extracted from the number of daily deaths data, while mitigation efforts are estimated from mobile phone tracking data."
      },
      {
        "text": "The decrease of the basic reproductive number ([Formula: see text]) as well as the duration of the initial exponential expansion phase of the epidemic strongly correlates with the magnitude of mobility reduction."
      },
      {
        "text": "Utilizing these relationships we decipher the relative impact of the timing and the extent of social distancing on the total death burden of the pandemic."
      }
    ]
  },
  "33462059": {
    "title": "Severe acute mitral valve regurgitation in a COVID-19-infected patient.",
    "sentences": [
      {
        "text": "The ongoing SARS-CoV-2 (COVID-19) pandemic has presented many difficult and unique challenges to the medical community."
      },
      {
        "text": "We describe a case of a middle-aged COVID-19-positive man who presented with pulmonary oedema and acute respiratory failure."
      },
      {
        "text": "He was initially diagnosed with acute respiratory distress syndrome."
      },
      {
        "text": "Later in the hospital course, his pulmonary oedema and respiratory failure worsened as result of severe acute mitral valve regurgitation secondary to direct valvular damage from COVID-19 infection."
      },
      {
        "text": "The patient underwent emergent surgical mitral valve replacement."
      },
      {
        "text": "Pathological evaluation of the damaged valve was confirmed to be secondary to COVID-19 infection."
      },
      {
        "text": "The histopathological findings were consistent with prior cardiopulmonary autopsy sections of patients with COVID-19 described in the literature as well as proposed theories regarding ACE2 receptor activity."
      },
      {
        "text": "This case highlights the potential of SARS-CoV-2 causing direct mitral valve damage resulting in severe mitral valve insufficiency with subsequent pulmonary oedema and respiratory failure."
      }
    ]
  },
  "33461499": {
    "title": "Higher comorbidities and early death in hospitalized African-American patients with Covid-19.",
    "sentences": [
      {
        "text": "BACKGROUND African-Americans/Blacks have suffered higher morbidity and mortality from COVID-19 than all other racial groups."
      },
      {
        "text": "This study aims to identify the causes of this health disparity, determine prognostic indicators, and assess efficacy of treatment interventions."
      },
      {
        "text": "METHODS We performed a retrospective cohort study of clinical features and laboratory data of COVID-19 patients admitted over a 52-day period at the height of the pandemic in the United States."
      },
      {
        "text": "This study was performed at an urban academic medical center in New York City, declared a COVID-only facility, serving a majority Black population."
      },
      {
        "text": "RESULTS Of the 1103 consecutive patients who tested positive for COVID-19, 529 required hospitalization and were included in the study."
      },
      {
        "text": "88% of patients were Black; and a majority (52%) were 61-80âyears old with a mean body mass index in the \"obese\" range."
      },
      {
        "text": "98% had one or more comorbidities."
      },
      {
        "text": "Hypertension was the most common (79%) pre-existing condition followed by diabetes mellitus (56%) and chronic kidney disease (17%)."
      },
      {
        "text": "Patients with chronic kidney disease who received hemodialysis were found to have lower mortality, than those who did not receive it, suggesting benefit from hemodialysis Ageâ>â60âyears and coronary artery disease were independent predictors of mortality in multivariate analysis."
      },
      {
        "text": "Cox proportional hazards modeling for time to death demonstrated a significantly high ratio for COPD/Asthma, and favorable effects on outcomes for pre-admission ACE inhibitors and ARBs."
      },
      {
        "text": "CRP (180, 283âmg/L), LDH (551, 638âU/L), glucose (182, 163âmg/dL), procalcitonin (1.03, 1.68âng/mL), and neutrophil:lymphocyte ratio (8.3:10.0) were predictive of mortality on admission and at 48-96 h. Of the 529 inpatients 48% died, and one third of them died within the first 3 days of admission."
      },
      {
        "text": "159/529patients received invasive mechanical ventilation, of which 86% died and of the remaining 370 patients, 30% died."
      },
      {
        "text": "CONCLUSIONS COVID-19 patients in our predominantly Black neighborhood had higher in-hospital mortality, likely due to higher prevalence of comorbidities."
      },
      {
        "text": "Early dialysis and pre-admission intake of ACE inhibitors/ARBs improved patient outcomes."
      },
      {
        "text": "Early escalation of care based on comorbidities and key laboratory indicators is critical for improving outcomes in African-American patients."
      }
    ]
  },
  "33459559": {
    "title": "The histo-blood group antigens of the host cell may determine the binding of different viruses such as SARS-CoV-2.",
    "sentences": [
      {
        "text": "Viruses have caused the death of millions of people worldwide."
      },
      {
        "text": "Specifically, human viruses are grouped into 21 families, including the family of coronaviruses (CoVs)."
      },
      {
        "text": "In December 2019, in Wuhan, China, a new human CoV was identified, SARS-CoV-2."
      },
      {
        "text": "The first step of the infection mechanism of the SARS-CoV-2 in the human host is adhesion, which occurs through the S glycoprotein that is found in diverse human organs."
      },
      {
        "text": "Another way through which SARS-CoV-2 could possibly attach to the host's cells is by means of the histo-blood group antigens."
      },
      {
        "text": "In this work, we have reviewed the mechanisms by which some viruses bind to the histo-blood group antigens, which could be related to the susceptibility of the individual and are dependent on the histo-blood group."
      }
    ]
  },
  "33457304": {
    "title": "Epidemiological and clinical characteristics analysis of 11 children with 2019 novel coronavirus infection in Chongqing: a single-center retrospective study.",
    "sentences": [
      {
        "text": "Background The global epidemic of the 2019 novel coronavirus (2019-nCoV) is still going on."
      },
      {
        "text": "This article shares information about the infected children from a treatment center in Chongqing, China."
      },
      {
        "text": "Methods A retrospective analysis of the epidemiology, clinical symptoms, signs, laboratory examinations, chest computed tomography results, treatment effect of 11 children infected by 2019-nCoV was performed."
      },
      {
        "text": "Children were diagnosed from January 25 to February 29, 2020 in Chongqing University Three Gorges Hospital."
      },
      {
        "text": "Results The mean age of the 11 children with 2019-nCoV infection was 11 years and 5 months."
      },
      {
        "text": "Two cases (18%) were imported cases from Wuhan."
      },
      {
        "text": "The 9 cases (82%) were family cluster cases."
      },
      {
        "text": "There were 5 asymptomatic type cases (45%), 2 mild cases (18%), and 4 common type cases (37%)."
      },
      {
        "text": "The most common symptom was fever (5 cases), cough (3 cases), sore throat (1 case) and diarrhea (1 case)."
      },
      {
        "text": "There were abnormal chest CT changes in 6 cases, including 4 cases with patchy ground-glass opacities and 2 cases with thickened lung texture."
      },
      {
        "text": "Laboratory tests showed that procalcitonin increased in 4 cases (36%), and C-reactive protein (CRP) increased in 1 case (9%)."
      },
      {
        "text": "In lymphocyte subgroup examination, lymphocyte count increased in 2 cases (18%) and decreased in 1 case (9%); T%, cluster of differentiation 8 (CD8)+ T%, and natural killer (NK) cell% were normal in 11 cases; CD4+ T% was increased in 2 cases (18%), and CD4+ T%/CD8+ T% was decreased in 1 case (9%); B% was increased in 1 case (9%)."
      },
      {
        "text": "The interleukin 4 (IL-4), IL-10, and IL-17 in 11 cases were normal; IL-6 was increased in 7 cases (64%); tumor necrosis factor-alpha (TNF-Î±) was increased in 1 case (9%); and interferon gamma (IFN-Î³) was increased in 6 cases (55%)."
      },
      {
        "text": "All patients had been discharged from the hospital."
      },
      {
        "text": "Conclusions Children are generally susceptible to 2019-nCoV, and the main way of infection is close contact with an infected person in the family."
      },
      {
        "text": "Clinical symptoms are mild."
      },
      {
        "text": "Laboratory and chest CT examinations are not as typical as those of adults."
      },
      {
        "text": "The prognosis is generally good."
      },
      {
        "text": "The unique immune function of children may help fight the new coronavirus."
      }
    ]
  },
  "33454595": {
    "title": "The role of iron in the pathogenesis of COVID-19 and possible treatment with lactoferrin and other iron chelators.",
    "sentences": [
      {
        "text": "Iron overload is increasingly implicated as a contributor to the pathogenesis of COVID-19."
      },
      {
        "text": "Indeed, several of the manifestations of COVID-19, such as inflammation, hypercoagulation, hyperferritinemia, and immune dysfunction are also reminiscent of iron overload."
      },
      {
        "text": "Although iron is essential for all living cells, free unbound iron, resulting from iron dysregulation and overload, is very reactive and potentially toxic due to its role in the generation of reactive oxygen species (ROS)."
      },
      {
        "text": "ROS react with and damage cellular lipids, nucleic acids, and proteins, with consequent activation of either acute or chronic inflammatory processes implicated in multiple clinical conditions."
      },
      {
        "text": "Moreover, iron-catalyzed lipid damage exerts a direct causative effect on the newly discovered nonapoptotic cell death known as ferroptosis."
      },
      {
        "text": "Unlike apoptosis, ferroptosis is immunogenic and not only leads to amplified cell death but also promotes a series of reactions associated with inflammation."
      },
      {
        "text": "Iron chelators are generally safe and are proven to protect patients in clinical conditions characterized by iron overload."
      },
      {
        "text": "There is also an abundance of evidence that iron chelators possess antiviral activities."
      },
      {
        "text": "Furthermore, the naturally occurring iron chelator lactoferrin (Lf) exerts immunomodulatory as well as anti-inflammatory effects and can bind to several receptors used by coronaviruses thereby blocking their entry into host cells."
      },
      {
        "text": "Iron chelators may consequently be of high therapeutic value during the present COVID-19 pandemic."
      }
    ]
  },
  "33451910": {
    "title": "COVID-19 in IBD: The experience of a single tertiary IBD center.",
    "sentences": [
      {
        "text": "BACKGROUND Italy has been one of the most affected countries in the world by COVID-19."
      },
      {
        "text": "There has been increasing concern regarding the impact of COVID-19 on patients with inflammatory bowel disease (IBD), particularly in patients treated with immunosuppressants or biologics."
      },
      {
        "text": "The aim of our study is to understand the incidence of COVID-19 in a large cohort of patients with IBD."
      },
      {
        "text": "Furthermore, we analyzed possible risk factors for infection and severity of COVID-19."
      },
      {
        "text": "METHODS This was an observational study evaluating the impact of COVID-19 on IBD patients in a single tertiary center."
      },
      {
        "text": "A 23 multiple-choice-question anonymous survey was administered to 1200 patients with IBD between March 10th and June 10th 2020."
      },
      {
        "text": "RESULTS 1158 questionnaires were analyzed."
      },
      {
        "text": "The majority of patients had Crohn's disease (CD) (60%) and most of them were in clinical remission."
      },
      {
        "text": "Among the 26 patients (2.2%) who tested positive for COVID-19, only 5 (3CD) were on biological treatment and none required hospitalization."
      },
      {
        "text": "Two patients died and were on treatment with mesalazine only."
      },
      {
        "text": "Of the 1158 patients, 521 were on biological therapy, which was discontinued in 85 (16.3%) and delayed in 195 patients (37.4%)."
      },
      {
        "text": "A worsening of IBD symptoms was observed in 200 patients on biological therapy (38.4%)."
      },
      {
        "text": "Most of these patients, 189 (94.5%), had stopped or delayed biological treatment, while 11 (5.5%) had continued their therapy regularly (p<0.001)."
      },
      {
        "text": "CONCLUSIONS Our data are in line with the current literature and confirm a higher incidence compared to the general population."
      },
      {
        "text": "Biological therapy for IBD seems to not be a risk factor for infection and should not be discontinued in order to avoid IBD relapse."
      }
    ]
  },
  "33451000": {
    "title": "Cutaneous Manifestations in COVID-19: Report on 31 Cases from Five Countries.",
    "sentences": [
      {
        "text": "The increasingly frequent cutaneous manifestations of coronavirus disease (COVID-19) remain to pose a problem to clinicians."
      },
      {
        "text": "Herein, we aimed to describe the clinical and pathological findings of skin lesions in patients with COVID-19."
      },
      {
        "text": "The case series, which was based on the International Dermatological Registry circulated to dermatologists worldwide, was conducted across organizations and societies belonging to five different countries."
      },
      {
        "text": "We documented 31 patients with dermatologic manifestations associated with COVID-19, including maculopapular rashes (16.10%), urticarial lesions (26.80%), pseudochilblains (22.60%), petechiae/purpura (6.50%), distal ischaemia and necrosis (6.50%), livedo racemosa (12.90%), and others (9.70%)."
      },
      {
        "text": "Twenty-six cases (83.90%) were qRT-PCR-confirmed COVID-19 cases, two (6.50%) were serologically confirmed, while two others (9.7%) were suspected cases owing to previous contact with COVID-19-positive patients."
      },
      {
        "text": "Therefore, our findings indicate that a febrile rash or even a rash in an afebrile state in the early stages of the disease may be the only clinical manifestation of COVID-19."
      },
      {
        "text": "In the future, we recommend close monitoring of all patients with skin lesions not attributable to other causal factors; in the diagnostic perspective, clinicians should aim to confirm if the skin lesions are associated with COVID-19."
      }
    ]
  },
  "33450483": {
    "title": "The papain-like protease of coronaviruses cleaves ULK1 to disrupt host autophagy.",
    "sentences": [
      {
        "text": "The ongoing pandemic of COVID-19 alongside the outbreaks of SARS in 2003 and MERS in 2012 underscore the significance to understand betacoronaviruses as a global health challenge."
      },
      {
        "text": "SARS-CoV-2, the etiological agent for COVID-19, has infected over 50 million individuals' worldwide with more than â¼1 million fatalities."
      },
      {
        "text": "Autophagy modulators have emerged as potential therapeutic candidates against SARS-CoV-2 but recent clinical setbacks urge for better understanding of viral subversion of autophagy."
      },
      {
        "text": "Using MHV-A59 as a model betacoronavirus, time-course infections revealed significant loss in the protein level of ULK1, a canonical autophagy-regulating kinase, and the concomitant appearance of a possible cleavage fragment."
      },
      {
        "text": "To investigate whether virus-encoded proteases target ULK1, we conducted in-vitro and cellular cleavage assays and identified ULK1 as a novel bona fide substrate of SARS-CoV-2 papain-like protease (PLpro)."
      },
      {
        "text": "Mutagenesis studies discovered that ULK1 is cleaved at a conserved PLpro recognition sequence (LGGG) after G499, separating its N-terminal kinase domain from a C-terminal substrate recognition region."
      },
      {
        "text": "Over-expression of SARS-CoV-2 PLpro is sufficient to impair starvation-induced autophagy and disrupt formation of ULK1-ATG13 complex."
      },
      {
        "text": "Finally, we demonstrated a dual role for ULK1 in MHV-A59 replication, serving a pro-viral functions during early replication that is inactivated at late stages of infection."
      },
      {
        "text": "In conclusion, our study identified a new mechanism by which PLpro of betacoronaviruses induces viral pathogenesis by targeting cellular autophagy."
      }
    ]
  },
  "33449998": {
    "title": "A Postmortem Portrait of the Coronavirus Disease 2019 (COVID-19) Pandemic: A Large Multiinstitutional Autopsy Survey Study.",
    "sentences": [
      {
        "text": "CONTEXT This study represents the largest compilation to date of clinical and postmortem data from decedents with coronavirus disease 2019 (COVID-19)."
      },
      {
        "text": "It will augment previously published small series of autopsy case reports, refine clinicopathologic considerations, and improve the accuracy of future vital statistical reporting."
      },
      {
        "text": "OBJECTIVE To accurately reflect the pre-existing diseases and pathologic conditions of decedents with Sars-CoV-2 infection through autopsy."
      },
      {
        "text": "DESIGN Comprehensive data from 135 autopsy evaluations of COVID-19-positive decedents is presented, including histologic assessment."
      },
      {
        "text": "Postmortem examinations were performed by 36 pathologists at 19 medical centers or forensic institutions in the United States and Brazil."
      },
      {
        "text": "Data from each autopsy were collected through the online submission of multiple choice and openended survey responses."
      },
      {
        "text": "RESULTS Patients dying of or with COVID-19 had an average of 8.89 pathologic conditions documented at autopsy, spanning a combination of prior chronic disease and acute conditions acquired during hospitalization."
      },
      {
        "text": "Virtually all decedents were cited as having more than one preexisting condition, encompassing an average of 2.88 such diseases each."
      },
      {
        "text": "Clinical conditions during terminal hospitalization were cited 395 times for the 135 autopsied decedents and predominantly encompassed acute failure of multiple organ systems and/or impaired coagulation."
      },
      {
        "text": "Myocarditis was rarely cited."
      },
      {
        "text": "CONCLUSIONS Cause-of-death statements in both autopsy reports and death certificates may not encompass the severity or spectrum of co-morbid conditions in those dying of or with COVID-19."
      },
      {
        "text": "If supported by additional research, this finding may have implications for public health decisions and reporting moving forward through the pandemic."
      }
    ]
  },
  "33446625": {
    "title": "The Role of Anticoagulation in Post-COVID-19 Concomitant Stroke, Myocardial Infarction, and Left Ventricular Thrombus: A Case Report.",
    "sentences": [
      {
        "text": "BACKGROUND Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) primarily affects the lungs but can involve any organ."
      },
      {
        "text": "The medical community is struggling to cope with the critical illness associated with the disease."
      },
      {
        "text": "On top of that, patients who have recovered from COVID-19 have presented with complications such as thrombotic episodes in various organs both during and after being infected with SARS-CoV-2."
      },
      {
        "text": "A COVID-19-associated prothrombotic state has been mentioned in multiple recent research articles."
      },
      {
        "text": "The role of anticoagulants is debatable, because even after receiving them prophylactically, many patients have experienced thrombotic episodes."
      },
      {
        "text": "The situation, therefore, represents a challenge to the medical community."
      },
      {
        "text": "CASE REPORT We report on a COVID-19-associated prothrombotic state in a 65-year-old man with no history of comorbid illness."
      },
      {
        "text": "Initially, he presented with right-sided weakness and was found to have had an acute ischemic stroke."
      },
      {
        "text": "Urgent imaging after the stroke revealed changes on electrocardiography that were remarkable for left bundle branch block."
      },
      {
        "text": "The patient's elevated cardiac enzyme levels correlated with a silent acute myocardial infarction (MI)."
      },
      {
        "text": "His echocardiogram revealed a left ventricular (LV) thrombus."
      },
      {
        "text": "He was managed with a multidisciplinary approach involving Neurology, Cardiology, and Medicine."
      },
      {
        "text": "CONCLUSIONS COVID-19-associated prothrombotic episodes involving arterial and venous systems have been reported in the literature."
      },
      {
        "text": "But concomitant stroke, acute MI, and LV thrombus rarely have been documented."
      },
      {
        "text": "The role of prophylactic or therapeutic anticoagulation is still unclear because even when patients are on these drugs, they continue to develop thrombotic episodes."
      },
      {
        "text": "Indeed, further studies are required to develop a standard management plan for what can be a fatal situation."
      }
    ]
  },
  "33446606": {
    "title": "Collapse induration of alveoli is an ultrastructural finding in a COVID-19 patient.",
    "sentences": []
  },
  "33446428": {
    "title": "Anxiety level and clinical course of patients with sickle cell disease during the COVID-19 outbreak.",
    "sentences": [
      {
        "text": "OBJECTIVES Besides infectious pneumonia and death risks, the COVID-19 pandemic has prompted negative psychological impacts on communities, especially on people with chronic diseases."
      },
      {
        "text": "We aimed to evaluate COVID-19 and sickle cell disease (SCD)-related experiences, and the clinical course during the outbreak, to measure anxiety levels of adolescent and young adult patients with homozygous SCD, to analyze the correlations between their COVID-19 experiences and anxiety levels and painful episodes."
      },
      {
        "text": "METHODS In this cross-sectional study, 47 patients aged between 14Â andÂ 24Â years responded to a descriptive instrument and the State-Trait Anxiety Inventory."
      },
      {
        "text": "Clinical features requiring hospitalization for the same period (between MarchÂ 10Â andÂ MayÂ 10) of two sequential years were compared."
      },
      {
        "text": "RESULTS Sixty-six percent of the patients had at least one negative COVID-19 experience of dizziness, sleep disturbance, tonic immobility, appetite loss or nausea/abdominal distress."
      },
      {
        "text": "The number of negative COVID-19 experiences was correlated with the state anxiety score, the trait anxiety score, and the number of painful episodes (Ï=0.552, P<0.001; Ï=0.529, P<0.001; Ï=0.448, P=0.002, respectively)."
      },
      {
        "text": "Both median state anxiety and trait anxiety scores were below the cut-off scores indicating significant clinical symptoms."
      },
      {
        "text": "The number of hospitalizations requiring vaso-occlusive crisis management and blood/exchange transfusion were similar for the same period of two sequential years, 2019Â andÂ 2020."
      },
      {
        "text": "CONCLUSION These descriptive and correlation findings are the first reported on COVID-19-related anxiety in SCD patients."
      },
      {
        "text": "To develop screening and support strategies for mental health needs in pandemic times, further SCD studies should be conducted."
      }
    ]
  },
  "33445833": {
    "title": "Clinical features, diagnosis, and outcomes of multisystem inflammatory syndrome in children associated with coronavirus disease 2019.",
    "sentences": [
      {
        "text": "The novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been spreading worldwide since December 2019."
      },
      {
        "text": "Hundreds of cases of children and adolescents with Kawasaki disease (KD)-like hyperinflammatory illness have been reported in Europe and the United States during the peak of the COVID-19 pandemic with or without shock and cardiac dysfunction."
      },
      {
        "text": "These patients tested positive for the polymerase chain reaction or antibody test for SARS-CoV-2 or had a history of recent exposure to COVID-19."
      },
      {
        "text": "Clinicians managing such patients coined new terms for this new illness, such as COVID-19-associated hyperinflammatory response syndrome, pediatric inflammatory multisystem syndrome temporally associated with COVID-19, or COVID-19-associated multisystem inflammatory syndrome in children (MIS-C)."
      },
      {
        "text": "The pathogenesis of MIS-C is unclear; however, it appears similar to that of cytokine storm syndrome."
      },
      {
        "text": "MIS-C shows clinical features similar to KD, but differences between them exist with respect to age, sex, and racial distributions and proportions of patients with shock or cardiac dysfunction."
      },
      {
        "text": "Recommended treatments for MIS-C include intravenous immunoglobulin, corticosteroids, and inotropic or vasopressor support."
      },
      {
        "text": "For refractory patients, monoclonal antibody to interleukin-6 receptor (tocilizumab), interleukin-1 receptor antagonist (anakinra), or monoclonal antibody to tumor necrosis factor (infliximab) may be recommended."
      },
      {
        "text": "Patients with coronary aneurysms require aspirin or anticoagulant therapy."
      },
      {
        "text": "The prognosis of MIS-C seemed favorable without sequelae in most patients despite a reported mortality rate of approximately 1.5%."
      }
    ]
  },
  "33444702": {
    "title": "Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system.",
    "sentences": [
      {
        "text": "The newly emerged severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) coronavirus initiated a pneumonia outbreak (COVID-19) that rapidly spread worldwide and quickly became a public health emergency of international concern; However to date, except Remdesivir, there are no clinically approved specific or effective medicines to prevent or treat COVID-19."
      },
      {
        "text": "Therefore, the development of novel treatments against coronavirus infections caused by the current SARS-CoV-2 virus, as well as other highly pathogenic human coronaviruses, represents an urgent unmet need."
      },
      {
        "text": "Stimulator of interferon genes (STING) plays a central role in host defense mechanisms against microbial infections."
      },
      {
        "text": "STING activation leads to the induction of both type I interferon and autophagy responses, which elicit strong inhibitory effect against the infections caused by a broad range of microbial pathogens."
      },
      {
        "text": "However, whether STING activation can impact infections from SARS-CoV-2 or other coronaviruses remains largely unknown."
      },
      {
        "text": "In this study, we investigated the anti-coronavirus activity triggered by STING activation."
      },
      {
        "text": "We discovered that dimeric amidobenzimidazole (diABZI), a synthetic small molecule STING receptor agonist, showed potent anti-coronavirus activity against both the common cold human coronavirus 229E (HCoV-229E) and SARS-CoV-2 in cell culture systems."
      },
      {
        "text": "In addition, we demonstrated that the antiviral activity of diABZI was dependent on the interferon pathway in HCoV-229E infected normal human fibroblast lung cells (MRC-5) and reconstituted primary human airway air-liquid interface (ALI) cultures."
      },
      {
        "text": "Furthermore, low-dose of diABZI treatment at 0.1Â Î¼M effectively reduced the SARS-CoV-2 viral load at the epithelial apical surface and prevented epithelial damage in the reconstituted primary human bronchial airway epithelial ALI system."
      },
      {
        "text": "Our findings have thus revealed the therapeutic potential of STING agonists, such as diABZI, as treatments for SARS-CoV-2 and other human coronavirus infections."
      }
    ]
  },
  "33299552": {
    "title": "A proposed molecular mechanism for pathogenesis of severe RNA-viral pulmonary infections.",
    "sentences": [
      {
        "text": "Background: Certain riboviruses can cause severe pulmonary complications leading to death in some infected patients."
      },
      {
        "text": "We propose that DNA damage induced-apoptosis accelerates viral release, triggered by depletion of host RNA binding proteins (RBPs) from nuclear RNA bound to replicating viral sequences."
      },
      {
        "text": "Methods: Information theory-based analysis of interactions between RBPs and individual sequences in the Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2), Influenza A (H3N2), HIV-1, and Dengue genomes identifies strong RBP binding sites in these viral genomes."
      },
      {
        "text": "Replication and expression of viral sequences is expected to increasingly sequester RBPs - SRSF1 and RNPS1."
      },
      {
        "text": "Ordinarily, RBPs bound to nascent host transcripts prevents their annealing to complementary DNA."
      },
      {
        "text": "Their depletion induces destabilizing R-loops."
      },
      {
        "text": "Chromosomal breakage occurs when an excess of unresolved R-loops collide with incoming replication forks, overwhelming the DNA repair machinery."
      },
      {
        "text": "We estimated stoichiometry of inhibition of RBPs in host nuclear RNA by counting competing binding sites in replicating viral genomes and host RNA."
      },
      {
        "text": "Results: Host RBP binding sites are frequent and conserved among different strains of RNA viral genomes."
      },
      {
        "text": "Similar binding motifs of SRSF1 and RNPS1 explain why DNA damage resulting from SRSF1 depletion is complemented by expression of RNPS1."
      },
      {
        "text": "Clustering of strong RBP binding sites coincides with the distribution of RNA-DNA hybridization sites across the genome."
      },
      {
        "text": "SARS-CoV-2 replication is estimated to require 32.5-41.8 hours to effectively compete for binding of an equal proportion of SRSF1 binding sites in host encoded nuclear RNAs."
      },
      {
        "text": "Significant changes in expression of transcripts encoding DNA repair and apoptotic proteins were found in an analysis of influenza A and Dengue-infected cells in some individuals."
      },
      {
        "text": "Conclusions: R-loop-induced apoptosis indirectly resulting from viral replication could release significant quantities of membrane-associated virions into neighboring alveoli."
      },
      {
        "text": "These could infect adjacent pneumocytes and other tissues, rapidly compromising lung function, causing multiorgan system failure and other described symptoms."
      }
    ]
  },
  "33444408": {
    "title": "Quercetin as a potential treatment for COVID-19-induced acute kidney injury: Based on network pharmacology and molecular docking study.",
    "sentences": [
      {
        "text": "Kidneys are one of the targets for SARS-CoV-2, it is reported that up to 36% of patients with SARS-CoV-2 infection would develop into acute kidney injury (AKI)."
      },
      {
        "text": "AKI is associated with high mortality in the clinical setting and contributes to the transition of AKI to chronic kidney disease (CKD)."
      },
      {
        "text": "Up to date, the underlying mechanisms are obscure and there is no effective and specific treatment for COVID-19-induced AKI."
      },
      {
        "text": "In the present study, we investigated the mechanisms and interactions between Quercetin and SARS-CoV-2 targets proteins by using network pharmacology and molecular docking."
      },
      {
        "text": "The renal protective effects of Quercetin on COVID-19-induced AKI may be associated with the blockade of the activation of inflammatory, cell apoptosis-related signaling pathways."
      },
      {
        "text": "Quercetin may also serve as SARS-CoV-2 inhibitor by binding with the active sites of SARS-CoV-2 main protease 3CL and ACE2, therefore suppressing the functions of the proteins to cut the viral life cycle."
      },
      {
        "text": "In conclusion, Quercetin may be a novel therapeutic agent for COVID-19-induced AKI."
      },
      {
        "text": "Inhibition of inflammatory, cell apoptosis-related signaling pathways may be the critical mechanisms by which Quercetin protects kidney from SARS-CoV-2 injury."
      }
    ]
  },
  "33443816": {
    "title": "The role of SARS-CoV-2 target ACE2 in cardiovascular diseases.",
    "sentences": [
      {
        "text": "SARS-CoV-2, the virus responsible for the global coronavirus disease (COVID-19) pandemic, attacks multiple organs of the human body by binding to angiotensin-converting enzyme 2 (ACE2) to enter cells."
      },
      {
        "text": "More than 20 million people have already been infected by the virus."
      },
      {
        "text": "ACE2 is not only a functional receptor of COVID-19 but also an important endogenous antagonist of the renin-angiotensin system (RAS)."
      },
      {
        "text": "A large number of studies have shown that ACE2 can reverse myocardial injury in various cardiovascular diseases (CVDs) as well as is exert anti-inflammatory, antioxidant, anti-apoptotic and anticardiomyocyte fibrosis effects by regulating transforming growth factor beta, mitogen-activated protein kinases, calcium ions in cells and other major pathways."
      },
      {
        "text": "The ACE2/angiotensin-(1-7)/Mas receptor axis plays a decisive role in the cardiovascular system to combat the negative effects of the ACE/angiotensin II/angiotensin II type 1 receptor axis."
      },
      {
        "text": "However, the underlying mechanism of ACE2 in cardiac protection remains unclear."
      },
      {
        "text": "Some approaches for enhancing ACE2 expression in CVDs have been suggested, which may provide targets for the development of novel clinical therapies."
      },
      {
        "text": "In this review, we aimed to identify and summarize the role of ACE2 in CVDs."
      }
    ]
  },
  "33442386": {
    "title": "Repurposing of Biologic and Targeted Synthetic Anti-Rheumatic Drugs in COVID-19 and Hyper-Inflammation: A Comprehensive Review of Available and Emerging Evidence at the Peak of the Pandemic.",
    "sentences": [
      {
        "text": "Coronavirus disease 2019 (COVID-19) is a condition caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)."
      },
      {
        "text": "Severe cases of COVID-19 result in acute respiratory distress syndrome and death."
      },
      {
        "text": "A detrimental, hyper-inflammatory immune response with excess release of cytokines is the main driver of disease development and of tissue damage in these patients."
      },
      {
        "text": "Thus, repurposing of biologic agents and other pharmacological inhibitors of cytokines used for the treatment of various inflammatory conditions emerged as a logical therapeutic strategy to quench inflammation and improve the clinical outcome of COVID-19 patients."
      },
      {
        "text": "Evaluated agents include the interleukin one receptor blocker anakinra, monoclonal antibodies inhibiting IL-6 tocilizumab and sarilumab, monoclonal antibodies inhibiting granulocyte-monocyte colony stimulating factor and tumor necrosis factor, and Janus kinase inhibitors."
      },
      {
        "text": "In this review, we discuss the efficacy and safety of these therapeutic options based on direct personal experience and on published evidence from observational studies and randomized clinical trials."
      }
    ]
  },
  "33442367": {
    "title": "A Rare Case of Hairy Cell Leukemia with Unusual Loss of CD123 Associated with COVID-19 at the Time of Presentation.",
    "sentences": [
      {
        "text": "Coronavirus disease 2019 (COVID-19) pandemic has been a serious threat and has been reported with different presentations and complications."
      },
      {
        "text": "Older age, along with comorbidities such as diabetes, hypertension, or cardiac disease, increases the risk factors for COVID-19 severity and death [N Engl J Med."
      },
      {
        "text": "2020;382(18):1708-20 and Lancet Respir Med."
      },
      {
        "text": "2020 05;8(5):475-81]."
      },
      {
        "text": "It is proposed that cancer patients have a significantly higher incidence of severe incidents including admission to the intensive care unit, the necessity for assisted ventilation, and even death after catching the virus compared with non-cancer patients [Lancet Oncol."
      },
      {
        "text": "2020;21(3):335-7]."
      },
      {
        "text": "It is also described that cancer patients appear to be twice as likely to contract infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) [JAMA Oncol."
      },
      {
        "text": "2020;6(7):1108-10]."
      },
      {
        "text": "Hairy cell leukemia (HCL) is a rare B-cell lymphoproliferative disorder, with patients typically presenting with cytopenias, marked splenomegaly in 80-90% of patients, circulating leukemia cells, bone marrow infiltration and the presence of BRAF V600E somatic mutation [Indian J Hematol Blood Transfus."
      },
      {
        "text": "2014;30(Suppl 1):413-7]."
      },
      {
        "text": "Leukemic cells classically have central nuclei and abundant cytoplasm with hairy-like projections and express CD11c, CD25, CD103, and CD123 [Indian J Hematol Blood Transfus."
      },
      {
        "text": "2014;30(Suppl 1):413-7]."
      },
      {
        "text": "Loss of CD123 in HCL has been rarely reported in the literature [Am J Hematol."
      },
      {
        "text": "2019;94(12):1413-22]."
      },
      {
        "text": "We describe a unique case of a COVID-19-positive male who presented with severe respiratory symptoms, deteriorated quickly, and was intubated."
      },
      {
        "text": "Workup of severe progressive pancytopenia and bone marrow examination revealed HCL without splenomegaly and with atypical unusual loss of CD123."
      },
      {
        "text": "To our knowledge, this is the first case of CD123-negative HCL without splenomegaly associated with COVID-19 infection as the initial presentation."
      }
    ]
  }
}